data_2lfl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lfl _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.545 0.764 0 CA-C-O 121.015 0.436 . . . . 0.0 112.028 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.4 p -115.89 135.38 54.05 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.625 1.57 . . . . 0.0 111.587 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.7 m -139.97 159.04 43.09 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.53 1.932 . . . . 0.0 109.844 -174.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 p -51.58 118.53 11.46 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 124.857 1.263 . . . . 0.0 112.322 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -78.09 175.37 11.23 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.509 2.806 . . . . 0.0 112.228 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.3 mm -58.13 133.93 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.725 1.21 . . . . 0.0 111.39 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.19 -60.79 0.66 Allowed Glycine 0 CA--C 1.531 1.037 0 C-N-CA 126.322 1.915 . . . . 0.0 111.522 -177.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -85.23 175.72 8.77 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.826 1.25 . . . . 0.0 113.24 175.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.9 m -143.19 122.64 13.14 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.874 2.07 . . . . 0.0 110.218 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.5 152.87 96.2 Favored Pre-proline 0 CA--C 1.554 1.105 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 175.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.77 121.95 8.63 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 124.389 3.393 . . . . 0.0 111.653 176.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.5 p -70.14 -27.06 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.107 0.963 . . . . 0.0 112.572 175.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -70.87 168.65 16.39 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.707 2.003 . . . . 0.0 113.328 175.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.85 148.77 16.58 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.313 1.435 . . . . 0.0 111.919 170.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 29.5 tp -150.93 79.59 1.32 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.632 1.173 . . . . 0.0 111.463 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 85.1 m -68.67 -3.94 13.85 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -68.8 -21.08 64.35 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.91 2.084 . . . . 0.0 114.289 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.7 158.3 30.5 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.712 0.768 . . . . 0.0 112.859 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -92.95 6.64 47.13 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.075 1.75 . . . . 0.0 113.175 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -144.13 167.18 23.01 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 129.488 3.115 . . . . 0.0 108.277 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.6 m -142.15 152.8 43.54 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.551 1.94 . . . . 0.0 109.635 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.9 tpp85 -127.98 146.1 50.76 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.77 1.228 . . . . 0.0 111.758 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -138.26 125.73 21.96 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.032 1.333 . . . . 0.0 110.301 -170.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -131.86 128.63 39.04 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.342 1.057 . . . . 0.0 111.564 -172.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.3 t -70.8 123.6 22.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.326 0.65 . . . . 0.0 111.681 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.1 mmt -84.97 -90.68 0.09 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.842 0.857 . . . . 0.0 110.268 170.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -94.27 -55.21 1.49 Allowed Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.74 1.162 . . . . 0.0 112.821 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -131.43 -49.2 0.99 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.518 1.527 . . . . 0.0 112.919 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 89.0 m -93.5 167.83 11.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.191 1.397 . . . . 0.0 112.353 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.6 p -121.66 103.01 8.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.102 1.361 . . . . 0.0 112.982 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -70.44 167.31 18.55 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.923 1.289 . . . . 0.0 112.73 171.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.1 p -89.73 126.36 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.592 1.557 . . . . 0.0 112.264 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -133.41 160.99 35.76 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.822 1.649 . . . . 0.0 111.052 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -127.82 80.99 1.99 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.556 1.142 . . . . 0.0 111.266 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.06 167.16 30.98 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.295 1.902 . . . . 0.0 112.776 175.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 92.6 m -85.12 72.03 10.83 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.815 1.246 . . . . 0.0 111.138 176.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -74.12 79.39 1.75 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.348 1.859 . . . . 0.0 111.104 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.6 m 55.02 31.33 15.9 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 125.726 1.61 . . . . 0.0 113.368 -177.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.13 -63.35 3.89 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 126.081 1.8 . . . . 0.0 114.154 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 51.81 -118.29 6.99 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 126.968 2.223 . . . . 0.0 114.628 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -125.89 153.21 44.52 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.296 1.438 . . . . 0.0 112.08 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.3 m -118.15 5.75 11.99 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.119 1.368 . . . . 0.0 114.054 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.2 mmt85 -134.03 140.83 46.94 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.881 2.072 . . . . 0.0 110.218 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 51.3 ttm -63.34 -30.98 72.02 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 122.929 0.492 . . . . 0.0 112.084 173.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.38 -43.3 98.51 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 121.483 -0.761 . . . . 0.0 113.086 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -65.64 -48.0 73.65 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.074 0.95 . . . . 0.0 112.537 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.1 p -67.58 -21.54 65.42 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.44 -61.91 1.85 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.326 1.45 . . . . 0.0 111.455 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -61.53 -27.88 68.93 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -172.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 -81.64 -2.76 51.44 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.563 1.145 . . . . 0.0 113.577 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -126.81 167.38 17.66 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 126.336 1.854 . . . . 0.0 112.999 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.4 -8.74 15.04 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.2 2.6 . . . . 0.0 114.693 -176.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.325 0 C-N-CA 125.968 1.747 . . . . 0.0 113.147 178.611 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 N--CA 1.474 0.729 0 CA-C-O 120.868 0.366 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.7 m -96.7 58.41 1.67 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.674 1.189 . . . . 0.0 112.185 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.4 p -67.66 160.04 28.76 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.034 1.334 . . . . 0.0 111.907 167.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.6 m -81.35 157.6 70.25 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 124.592 1.157 . . . . 0.0 112.243 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.45 177.76 8.39 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.056 2.504 . . . . 0.0 111.945 166.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.476 HD12 ' H ' ' A' ' 28' ' ' ILE . 4.1 mp -54.21 132.39 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.901 1.68 . . . . 0.0 112.066 -176.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.74 -48.5 0.94 Allowed Glycine 0 CA--C 1.533 1.164 0 C-N-CA 126.569 2.033 . . . . 0.0 113.536 175.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -89.25 -174.64 4.49 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.345 1.458 . . . . 0.0 113.496 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.5 t -135.31 -79.24 0.43 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.122 1.369 . . . . 0.0 111.929 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -153.78 162.43 26.74 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.86 1.264 . . . . 0.0 112.884 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -71.12 83.98 0.91 Allowed 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.58 2.853 . . . . 0.0 111.559 167.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.5 t -68.32 -43.99 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.412 1.085 . . . . 0.0 110.744 173.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -82.61 173.24 12.12 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.762 2.025 . . . . 0.0 111.816 175.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.43 64.99 0.97 Allowed Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.041 1.305 . . . . 0.0 112.654 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.0 mp -128.94 19.93 5.97 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.741 2.016 . . . . 0.0 111.744 175.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 80.3 m -63.4 168.63 4.34 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.339 1.856 . . . . 0.0 113.322 -174.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.417 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -110.09 14.51 22.91 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.19 1.796 . . . . 0.0 113.087 -179.338 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.64 171.97 2.37 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.626 1.57 . . . . 0.0 113.478 175.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -98.54 1.0 46.12 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.028 1.731 . . . . 0.0 114.271 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -130.04 98.98 4.92 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.245 1.818 . . . . 0.0 112.303 -169.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.9 m -72.95 100.81 3.04 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.122 1.369 . . . . 0.0 110.822 176.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -87.39 142.02 28.19 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.764 0.826 . . . . 0.0 111.941 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -126.11 150.71 48.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.88 1.672 . . . . 0.0 111.974 -176.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -147.94 148.02 30.33 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.012 1.325 . . . . 0.0 112.984 173.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 41.5 t -88.26 113.44 23.87 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.075 1.35 . . . . 0.0 111.884 173.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.0 mmt -72.63 -42.86 63.98 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 173.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.54 -84.33 0.05 OUTLIER Glycine 0 N--CA 1.471 1.008 0 C-N-CA 123.732 0.682 . . . . 0.0 113.164 -175.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -86.76 -40.08 15.34 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 176.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -130.81 169.38 15.8 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.031 2.132 . . . . 0.0 111.671 -173.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 22.7 p -117.51 155.15 30.24 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -132.39 173.9 10.81 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.85 2.46 . . . . 0.0 111.95 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.12 137.68 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 127.008 2.123 . . . . 0.0 112.358 174.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -138.12 -21.51 1.07 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.719 1.608 . . . . 0.0 114.441 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 60.7 16.37 6.61 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 171.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -149.46 173.42 29.28 Favored Glycine 0 N--CA 1.474 1.197 0 O-C-N 120.606 -1.309 . . . . 0.0 114.2 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 71.8 m -78.33 65.18 3.6 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.711 1.204 . . . . 0.0 111.644 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -55.08 -43.1 73.62 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.465 1.506 . . . . 0.0 112.74 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.8 t -142.71 -19.17 0.67 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.357 1.463 . . . . 0.0 113.744 173.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -176.68 -85.05 0.06 OUTLIER Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.595 1.093 . . . . 0.0 111.311 175.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.43 108.26 0.63 Allowed Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.005 0.812 . . . . 0.0 114.383 170.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -60.67 154.46 21.36 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.38 0.672 . . . . 0.0 111.85 165.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.5 t -80.39 -40.35 26.67 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.14 1.376 . . . . 0.0 112.456 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -143.55 157.93 44.05 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 127.016 2.126 . . . . 0.0 111.266 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 5.0 ttt -64.83 -23.63 67.29 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.216 1.007 . . . . 0.0 113.136 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.26 -21.97 64.77 Favored Glycine 0 CA--C 1.535 1.331 0 O-C-N 120.786 -1.196 . . . . 0.0 114.289 171.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -78.93 -44.66 22.14 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.892 1.346 . . . . 0.0 111.925 173.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.0 p -66.53 -22.2 66.17 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 175.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.19 -62.35 1.46 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.208 1.403 . . . . 0.0 111.769 167.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -61.0 -27.98 68.7 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 -172.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -77.69 -6.2 53.1 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.354 1.061 . . . . 0.0 113.757 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m -123.2 164.93 24.72 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 126.208 1.803 . . . . 0.0 113.313 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -79.9 -10.31 14.13 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.17 2.58 . . . . 0.0 114.314 -173.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.381 0 C-N-CA 125.966 1.746 . . . . 0.0 113.797 -178.99 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 61.6 m -120.81 -78.77 0.6 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.238 1.815 . . . . 0.0 110.853 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 70.5 m -156.17 151.58 26.83 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 127.988 2.515 . . . . 0.0 108.547 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.8 m -129.94 156.78 78.53 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 125.221 1.408 . . . . 0.0 112.042 170.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -64.34 152.1 82.79 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.24 2.627 . . . . 0.0 112.244 172.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.2 pt -66.46 149.99 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.606 0.762 . . . . 0.0 112.014 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.03 -2.76 12.06 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 125.077 1.322 . . . . 0.0 116.169 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.27 172.97 11.5 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.218 1.509 . . . . 0.0 112.755 178.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 56.5 m -133.33 92.68 3.04 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.255 1.422 . . . . 0.0 111.149 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -63.51 148.46 93.8 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 124.176 0.991 . . . . 0.0 113.496 -178.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -78.3 75.05 5.08 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.163 3.242 . . . . 0.0 111.592 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 p -59.83 -23.9 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.869 1.668 . . . . 0.0 113.432 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -109.98 7.38 23.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.876 2.471 . . . . 0.0 114.128 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.81 49.81 2.87 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.945 1.736 . . . . 0.0 115.88 -172.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.0 mp -76.26 47.49 0.46 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 126.936 2.095 . . . . 0.0 113.092 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 59.7 m -69.43 154.38 42.1 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.526 -1.358 . . . . 0.0 112.195 169.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.23 16.54 1.52 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -177.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -120.73 167.05 12.89 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.355 1.462 . . . . 0.0 113.17 -177.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -18.43 63.51 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -70.88 -29.25 65.28 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.141 1.376 . . . . 0.0 113.83 -169.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.2 m -76.95 162.93 27.18 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.509 1.524 . . . . 0.0 111.769 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.89 168.31 11.61 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.616 1.566 . . . . 0.0 113.051 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -135.53 140.23 44.58 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.157 1.383 . . . . 0.0 110.482 -171.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -142.01 134.6 28.25 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.826 0.85 . . . . 0.0 112.695 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 31.5 t -75.02 119.16 18.82 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.312 0.645 . . . . 0.0 111.88 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.2 mmt -94.87 -2.86 49.89 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.57 -54.24 0.15 Allowed Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.373 0.987 . . . . 0.0 112.81 175.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -133.78 -19.89 2.03 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 175.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -136.67 167.59 21.13 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.358 1.463 . . . . 0.0 111.325 177.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 11.1 p -121.5 109.41 14.79 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -176.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -76.64 175.18 9.56 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.321 1.048 . . . . 0.0 112.047 167.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.7 p -85.88 137.79 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 126.855 2.062 . . . . 0.0 112.336 171.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -140.23 142.3 35.83 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.268 1.427 . . . . 0.0 111.434 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -93.83 -4.78 49.52 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -165.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -135.41 172.31 22.21 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 126.231 1.872 . . . . 0.0 112.396 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 22.5 t -66.57 145.2 55.88 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 122.052 -0.676 . . . . 0.0 112.607 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.05 82.66 2.06 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.241 1.816 . . . . 0.0 109.235 171.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.4 m 55.08 27.35 9.3 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.8 1.64 . . . . 0.0 113.822 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.58 13.98 74.77 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.358 1.456 . . . . 0.0 116.175 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -43.67 -82.84 0.02 OUTLIER Glycine 0 CA--C 1.539 1.593 0 C-N-CA 127.094 2.283 . . . . 0.0 116.991 -172.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -139.84 166.57 24.27 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.215 1.406 . . . . 0.0 112.435 -170.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.3 m -134.23 -18.45 2.01 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.193 1.397 . . . . 0.0 114.215 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -115.97 153.71 31.13 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.803 1.641 . . . . 0.0 111.544 175.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.0 tpp -65.04 -39.33 93.17 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.772 0.829 . . . . 0.0 111.359 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.77 -30.05 75.83 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.372 -0.682 . . . . 0.0 114.115 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -69.92 -57.79 4.62 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 118.577 1.189 . . . . 0.0 111.369 175.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.6 p -65.89 -26.04 67.44 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.91 -61.01 1.95 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.141 1.377 . . . . 0.0 111.81 168.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -61.98 -29.61 70.37 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -172.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -75.37 -13.59 60.42 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -113.55 166.22 11.73 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 126.413 1.885 . . . . 0.0 112.613 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.38 -17.95 23.54 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.888 2.392 . . . . 0.0 113.837 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.383 0 CA-C-O 117.061 -1.966 . . . . 0.0 115.046 -178.83 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 CA--C 1.543 0.699 0 N-CA-C 111.431 0.16 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.3 t -124.5 78.31 1.66 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.201 1.001 . . . . 0.0 111.077 173.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.3 t -70.14 161.04 30.96 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.358 1.063 . . . . 0.0 111.607 170.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.3 t -81.47 134.27 51.62 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 124.414 1.086 . . . . 0.0 110.184 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -74.62 173.85 13.64 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.194 3.262 . . . . 0.0 112.933 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.9 mt -60.14 137.5 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.327 1.451 . . . . 0.0 110.903 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.67 -55.63 0.67 Allowed Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.329 1.919 . . . . 0.0 112.342 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -78.32 178.96 7.25 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.73 1.212 . . . . 0.0 113.281 174.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.2 p -138.37 92.57 2.65 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.618 1.967 . . . . 0.0 110.982 -175.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -66.12 154.9 88.87 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 124.098 0.959 . . . . 0.0 113.569 -177.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.84 151.59 51.34 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.935 2.424 . . . . 0.0 112.36 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.2 t -102.26 -20.62 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 125.136 1.374 . . . . 0.0 112.01 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.89 172.9 6.71 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 127.054 2.142 . . . . 0.0 111.657 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.87 85.77 0.07 OUTLIER Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.622 1.106 . . . . 0.0 112.616 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 tt -133.14 72.37 1.49 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.028 1.331 . . . . 0.0 111.107 -175.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 78.2 m -78.12 97.39 5.43 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.435 1.494 . . . . 0.0 111.346 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -61.55 -60.74 3.23 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.85 1.26 . . . . 0.0 112.751 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.5 167.78 21.04 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.784 0.834 . . . . 0.0 112.274 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -75.32 2.62 10.75 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.975 1.71 . . . . 0.0 114.446 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -93.29 90.05 6.64 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.355 1.862 . . . . 0.0 111.003 -173.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 m -123.14 157.02 33.86 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.506 1.522 . . . . 0.0 111.106 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.9 ttm105 -134.93 155.3 50.95 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.7 1.2 . . . . 0.0 111.79 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -135.55 134.03 39.0 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.578 1.151 . . . . 0.0 110.441 -165.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -136.46 133.59 36.75 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.969 0.908 . . . . 0.0 112.312 -171.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.8 t -72.96 132.1 43.02 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 122.161 -0.337 . . . . 0.0 111.59 174.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.1 mmt -93.47 -91.0 0.19 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.85 0.86 . . . . 0.0 109.831 167.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -97.61 -40.73 3.56 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.509 1.052 . . . . 0.0 114.636 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -146.02 -58.43 0.31 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.493 1.517 . . . . 0.0 110.966 -173.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.7 p -83.27 168.81 16.35 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.672 1.189 . . . . 0.0 112.117 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.0 p -121.11 105.99 11.13 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.495 1.118 . . . . 0.0 112.844 169.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -73.88 177.27 5.68 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.567 1.147 . . . . 0.0 112.14 173.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.2 p -88.9 134.17 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.271 1.828 . . . . 0.0 111.842 173.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -137.22 172.19 13.37 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.323 1.449 . . . . 0.0 111.107 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -127.12 108.01 10.53 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.784 1.234 . . . . 0.0 111.629 -174.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.82 168.21 36.51 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.2 1.381 . . . . 0.0 113.717 -176.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 7.9 p -58.92 129.69 43.36 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -138.18 -40.63 0.53 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.33 1.452 . . . . 0.0 113.208 -174.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.3 t -144.89 -22.4 0.5 Allowed 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -168.0 -161.73 18.38 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.867 1.699 . . . . 0.0 112.122 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -153.48 58.59 0.41 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.328 0.966 . . . . 0.0 113.876 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -70.77 -32.37 69.47 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -174.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.6 p 55.53 -3.4 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 128.868 2.867 . . . . 0.0 117.522 -171.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -131.14 135.11 47.17 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.374 1.87 . . . . 0.0 112.217 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 40.2 ttm -63.62 -33.0 74.64 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.516 1.126 . . . . 0.0 112.862 175.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.42 -22.89 77.8 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 121.456 -0.777 . . . . 0.0 113.799 174.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -83.87 -40.77 18.21 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.529 1.165 . . . . 0.0 112.33 175.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.6 p -65.14 -23.76 67.22 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.487 1.039 . . . . 0.0 113.06 173.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.52 -60.48 2.26 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.88 1.672 . . . . 0.0 111.89 170.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -61.34 -28.38 69.18 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -172.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -73.9 -8.09 54.75 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.322 1.049 . . . . 0.0 113.557 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.91 167.48 19.37 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 125.688 1.595 . . . . 0.0 114.213 -174.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.99 -9.61 16.73 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 123.172 2.581 . . . . 0.0 114.595 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.236 0 C-N-CA 125.864 1.697 . . . . 0.0 113.459 179.259 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 CA--C 1.548 0.891 0 CA-C-O 120.549 0.214 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 47.2 t -133.29 123.79 26.12 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.26 1.424 . . . . 0.0 110.654 172.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.1 m -63.31 122.26 15.76 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.52 1.528 . . . . 0.0 112.245 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.3 t -78.01 134.12 64.4 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.837 1.255 . . . . 0.0 110.716 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.54 164.81 30.0 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.196 3.264 . . . . 0.0 113.442 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.9 mm -60.3 145.24 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.844 1.257 . . . . 0.0 111.21 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.08 25.62 57.23 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.074 0.845 . . . . 0.0 114.2 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -63.54 178.21 0.6 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.701 2.001 . . . . 0.0 115.271 -178.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.0 t -139.67 48.96 1.81 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.373 1.869 . . . . 0.0 110.905 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.55 151.81 68.85 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.424 1.489 . . . . 0.0 112.968 175.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -74.79 158.25 43.12 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.231 2.62 . . . . 0.0 113.54 -170.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.77 -29.97 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.836 0.854 . . . . 0.0 112.55 177.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.41 177.51 7.09 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.415 1.486 . . . . 0.0 112.571 175.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.59 -107.29 0.29 Allowed Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.522 1.058 . . . . 0.0 112.416 172.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.1 tp -154.17 115.54 4.12 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.672 1.589 . . . . 0.0 109.751 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.5 t -68.73 173.14 5.46 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.82 1.648 . . . . 0.0 112.337 174.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.39 5.94 21.88 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.324 1.85 . . . . 0.0 114.71 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.25 156.47 12.4 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.664 1.185 . . . . 0.0 113.298 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -81.27 4.38 20.68 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.883 1.673 . . . . 0.0 115.051 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -140.55 117.65 11.22 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.944 2.097 . . . . 0.0 110.521 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.9 m -142.45 154.56 44.66 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.332 1.453 . . . . 0.0 110.777 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -100.95 151.73 21.41 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.49 1.116 . . . . 0.0 111.316 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -125.06 138.81 54.19 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.578 1.151 . . . . 0.0 111.185 -174.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -132.36 135.76 46.37 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.076 1.351 . . . . 0.0 111.051 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 38.5 t -80.19 104.7 10.93 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.901 0.48 . . . . 0.0 111.004 169.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 87.5 mmm -76.04 -18.74 59.11 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.29 -78.29 0.05 OUTLIER Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.554 1.073 . . . . 0.0 112.861 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -109.26 -3.83 16.92 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.059 1.344 . . . . 0.0 114.058 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 25.1 p -149.13 157.99 43.82 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.946 2.099 . . . . 0.0 109.895 -176.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.4 p -111.17 147.81 34.12 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 168.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.0 mtpp -140.72 167.33 22.42 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.542 1.937 . . . . 0.0 111.844 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.78 125.76 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.915 1.286 . . . . 0.0 111.884 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -146.21 166.3 26.63 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.51 1.524 . . . . 0.0 110.72 177.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -142.68 103.05 4.16 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.353 1.061 . . . . 0.0 112.104 -172.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.7 -175.94 45.32 Favored Glycine 0 CA--C 1.532 1.132 0 O-C-N 121.455 -0.778 . . . . 0.0 113.742 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 63.1 m -68.01 14.41 0.06 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 127.207 2.203 . . . . 0.0 115.163 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -60.48 99.97 0.09 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 128.133 2.573 . . . . 0.0 110.797 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 21.7 m -53.69 -61.61 2.19 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.476 1.911 . . . . 0.0 113.003 -175.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.1 93.21 1.29 Allowed Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.444 1.497 . . . . 0.0 113.47 -174.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -147.65 175.05 27.19 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.158 1.361 . . . . 0.0 113.273 175.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -121.23 -17.71 7.61 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.521 1.675 . . . . 0.0 115.521 -165.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 58.63 4.48 0.37 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.572 1.949 . . . . 0.0 116.136 -176.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -138.13 142.89 40.14 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.93 2.092 . . . . 0.0 111.266 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.6 tpp -71.62 -32.19 67.71 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.323 1.049 . . . . 0.0 112.741 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.09 -48.12 67.69 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 121.598 -0.689 . . . . 0.0 111.402 175.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -64.86 -37.31 87.22 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.466 1.506 . . . . 0.0 113.409 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.5 p -71.57 -27.34 63.08 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.925 1.239 . . . . 0.0 113.39 171.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.16 -43.27 21.89 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.821 1.249 . . . . 0.0 112.992 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -63.52 -26.62 68.79 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 120.723 1.601 . . . . 0.0 113.482 -177.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -78.89 -9.26 59.43 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.641 1.577 . . . . 0.0 113.698 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 m -131.71 167.12 23.51 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 125.015 1.326 . . . . 0.0 113.97 -173.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.39 -11.66 15.81 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.968 2.445 . . . . 0.0 114.19 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.22 0 C-N-CA 126.919 2.2 . . . . 0.0 112.552 179.431 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 . . . . . 0 N--CA 1.476 0.831 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.6 p -75.48 156.45 35.2 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.727 0.811 . . . . 0.0 112.304 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.3 m -144.89 143.42 30.58 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.917 1.287 . . . . 0.0 110.73 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.0 t -68.74 133.95 90.38 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 124.112 0.965 . . . . 0.0 110.655 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.59 -175.36 2.41 Favored 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 124.401 3.401 . . . . 0.0 112.232 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.1 pt -59.51 166.06 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.987 1.315 . . . . 0.0 113.501 175.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.36 -59.38 4.11 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.666 1.603 . . . . 0.0 112.378 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -73.35 -178.37 2.95 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.866 1.266 . . . . 0.0 112.925 170.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.4 p -126.83 133.29 50.79 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.873 1.669 . . . . 0.0 111.063 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -74.97 152.46 86.59 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 123.869 0.868 . . . . 0.0 112.659 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.44 169.44 22.41 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.713 2.942 . . . . 0.0 111.906 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.9 t -131.35 -19.84 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.732 1.213 . . . . 0.0 112.05 -171.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt 55.27 2.75 0.06 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 128.326 2.65 . . . . 0.0 116.271 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -108.25 -7.89 29.93 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.756 1.646 . . . . 0.0 115.492 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.1 mp -74.95 -66.44 0.75 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.011 1.406 . . . . 0.0 110.855 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.4 t -139.0 153.12 48.11 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.273 1.429 . . . . 0.0 112.199 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.0 mtpt -135.72 83.99 2.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.618 2.367 . . . . 0.0 109.872 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.67 174.12 10.86 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.431 1.493 . . . . 0.0 112.514 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.02 -5.62 54.4 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.63 1.572 . . . . 0.0 114.697 -174.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -85.28 -15.61 42.86 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.094 1.357 . . . . 0.0 114.348 -170.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.5 m -68.79 158.82 33.57 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.836 1.254 . . . . 0.0 111.959 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -133.22 165.3 25.11 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.487 1.515 . . . . 0.0 111.82 -176.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -114.24 133.25 55.76 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.072 1.349 . . . . 0.0 111.466 -169.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -134.96 162.42 32.48 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.86 1.264 . . . . 0.0 111.805 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.7 t -101.68 108.69 20.3 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.563 1.145 . . . . 0.0 110.856 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 16.7 mmt -73.4 -60.27 2.32 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.101 0.56 . . . . 0.0 112.264 174.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -169.59 97.44 0.12 Allowed Glycine 0 N--CA 1.469 0.894 0 C-N-CA 124.149 0.881 . . . . 0.0 112.244 -170.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 58.92 11.43 1.91 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.88 2.072 . . . . 0.0 114.994 -175.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 6.4 t -151.49 147.74 27.2 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.053 2.141 . . . . 0.0 109.078 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 13.6 p -125.19 143.67 50.83 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 170.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.4 mtpp -149.57 170.94 17.48 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.253 1.421 . . . . 0.0 112.348 -172.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.3 p -75.01 128.52 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.509 1.524 . . . . 0.0 111.008 169.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -136.5 108.48 7.15 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.528 1.131 . . . . 0.0 111.439 -175.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -64.22 147.45 52.34 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.731 1.213 . . . . 0.0 112.149 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.98 177.62 21.54 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 125.771 1.653 . . . . 0.0 113.902 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 64.7 m -73.42 146.5 45.01 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 122.004 -0.703 . . . . 0.0 111.667 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -154.69 119.88 5.0 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.321 1.449 . . . . 0.0 108.742 170.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.2 m -57.56 -49.19 77.18 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.051 0.94 . . . . 0.0 112.632 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.44 172.61 45.1 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.811 1.196 . . . . 0.0 113.536 172.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 170.56 170.12 34.46 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.473 1.035 . . . . 0.0 114.933 176.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -111.68 -22.51 11.15 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.6 p 55.38 -4.28 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 128.85 2.86 . . . . 0.0 117.714 -172.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -133.29 137.7 46.12 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.472 1.909 . . . . 0.0 111.756 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.1 tpp -64.15 -33.12 75.06 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.603 1.161 . . . . 0.0 112.072 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.21 -38.17 82.12 Favored Glycine 0 CA--C 1.531 1.086 0 O-C-N 121.582 -0.699 . . . . 0.0 112.852 176.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -68.62 -47.55 66.37 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.011 0.924 . . . . 0.0 112.52 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.3 p -62.37 -25.9 68.17 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.392 0.996 . . . . 0.0 112.773 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.72 -64.46 1.07 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.52 1.528 . . . . 0.0 111.404 171.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -63.68 -27.47 69.24 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -171.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -78.93 -2.04 38.08 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.953 0.901 . . . . 0.0 113.251 174.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.67 170.55 7.85 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 127.023 2.129 . . . . 0.0 112.347 176.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -82.54 -8.07 11.54 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.071 2.514 . . . . 0.0 114.092 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.277 0 C-N-CA 126.548 2.023 . . . . 0.0 114.265 -178.764 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 CA--C 1.545 0.777 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.4 t -140.19 153.48 46.62 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.166 1.787 . . . . 0.0 110.161 176.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.6 t -69.33 165.27 21.05 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.852 0.861 . . . . 0.0 112.168 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.3 t -145.07 133.56 10.85 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 125.619 1.568 . . . . 0.0 110.002 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.8 163.88 32.82 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.362 3.375 . . . . 0.0 113.376 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.426 HD11 ' H ' ' A' ' 28' ' ' ILE . 4.5 mp -58.93 138.43 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.161 1.384 . . . . 0.0 110.755 177.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.39 28.03 41.5 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.142 0.877 . . . . 0.0 114.472 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -63.88 176.22 0.99 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.295 1.838 . . . . 0.0 115.886 -176.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 72.5 m -131.87 63.07 1.62 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.223 2.209 . . . . 0.0 110.65 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -63.25 156.59 68.35 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 125.123 1.369 . . . . 0.0 112.841 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.26 172.47 13.99 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.2 2.6 . . . . 0.0 113.815 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 p -119.45 20.86 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 126.957 2.103 . . . . 0.0 112.178 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -57.67 164.37 2.09 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.151 2.18 . . . . 0.0 115.195 -174.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 144.94 -29.52 1.83 Allowed Glycine 0 CA--C 1.536 1.397 0 C-N-CA 126.051 1.786 . . . . 0.0 114.321 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.24 1.95 6.4 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.698 1.599 . . . . 0.0 113.956 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.6 t -62.59 138.68 58.54 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.359 1.064 . . . . 0.0 112.317 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -113.55 -7.68 13.37 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.767 1.627 . . . . 0.0 114.598 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.19 170.58 12.69 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.875 0.87 . . . . 0.0 112.401 172.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -124.1 9.92 8.72 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.986 1.714 . . . . 0.0 114.472 -175.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -88.83 74.35 8.29 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.155 1.382 . . . . 0.0 112.03 -170.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.16 133.91 55.86 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.736 0.815 . . . . 0.0 111.404 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -137.28 154.86 50.02 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.424 1.09 . . . . 0.0 111.846 -172.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -132.87 129.18 38.08 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.856 1.263 . . . . 0.0 110.454 -169.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -139.55 129.42 24.82 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.24 1.016 . . . . 0.0 111.597 -171.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 40.6 t -71.83 129.87 39.67 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.753 -0.592 . . . . 0.0 112.587 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 43.7 mtm -132.79 -80.37 0.49 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.687 1.195 . . . . 0.0 112.042 167.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -86.35 60.56 4.54 Favored Glycine 0 N--CA 1.474 1.177 0 O-C-N 121.201 -0.937 . . . . 0.0 114.353 -170.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.4 m120 59.68 14.04 3.8 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.448 1.899 . . . . 0.0 113.901 -172.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 28.2 p -144.89 160.62 41.01 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.711 2.804 . . . . 0.0 109.322 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 18.5 p -115.15 87.39 2.65 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.765 0.826 . . . . 0.0 111.879 170.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -67.24 164.32 18.53 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 122.12 0.962 . . . . 0.0 111.85 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.2 p -82.49 128.5 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.929 1.292 . . . . 0.0 111.587 174.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -131.39 154.37 48.7 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.509 1.524 . . . . 0.0 110.829 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -132.0 89.52 2.69 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.135 1.374 . . . . 0.0 110.366 -174.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.61 175.71 42.37 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.902 1.239 . . . . 0.0 112.889 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 29.5 m -66.71 141.89 57.6 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.472 0.709 . . . . 0.0 111.765 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.63 121.93 5.67 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.887 1.275 . . . . 0.0 109.097 173.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.0 m -59.18 -37.13 76.65 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.472 1.109 . . . . 0.0 113.343 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -100.1 -161.98 28.55 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 126.405 1.955 . . . . 0.0 113.623 176.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 123.74 172.01 13.65 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.988 1.756 . . . . 0.0 114.541 174.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -107.1 -18.21 13.96 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -173.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.4 t 60.47 -14.07 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 127.728 2.411 . . . . 0.0 116.496 -174.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 42.2 mmt180 -125.24 136.52 53.62 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.519 1.927 . . . . 0.0 112.094 -177.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 62.2 tpp -59.8 -38.27 81.47 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.191 1.396 . . . . 0.0 112.129 175.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.33 -29.69 65.89 Favored Glycine 0 CA--C 1.533 1.194 0 O-C-N 121.716 -0.615 . . . . 0.0 113.769 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -82.25 -41.29 20.41 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.15 0.975 . . . . 0.0 112.403 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.0 p -64.89 -23.41 67.22 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.07 0.85 . . . . 0.0 112.895 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.27 -64.03 1.11 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.481 1.512 . . . . 0.0 111.589 169.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -61.41 -28.1 69.02 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -171.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -78.46 -6.27 54.86 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.11 0.964 . . . . 0.0 113.565 174.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -122.35 170.85 7.19 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 126.625 1.97 . . . . 0.0 112.437 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.11 -7.16 17.11 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.229 2.62 . . . . 0.0 114.724 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.286 0 C-N-CA 126.747 2.117 . . . . 0.0 114.742 -178.735 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 CA--C 1.547 0.847 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.2 p -127.47 170.46 12.54 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.901 1.68 . . . . 0.0 112.542 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.7 p -90.31 161.69 15.52 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.756 1.223 . . . . 0.0 111.925 173.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.8 m -66.06 155.54 86.93 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 123.524 0.729 . . . . 0.0 112.257 176.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -64.17 156.24 60.46 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.493 2.795 . . . . 0.0 112.47 172.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 40.5 pt -61.69 143.78 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.783 0.833 . . . . 0.0 112.083 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.86 -6.73 11.41 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.116 1.341 . . . . 0.0 116.188 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -76.71 172.32 13.26 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.42 1.61 . . . . 0.0 112.243 176.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.5 t -128.97 92.98 3.49 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.856 1.262 . . . . 0.0 111.827 -174.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -61.75 152.62 75.0 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 125.158 1.383 . . . . 0.0 113.864 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.36 86.95 1.4 Allowed 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.867 3.045 . . . . 0.0 112.243 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.6 p -68.19 -29.64 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.639 1.176 . . . . 0.0 113.161 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -78.71 -68.13 0.68 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.884 1.674 . . . . 0.0 112.593 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.67 43.79 91.41 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.138 1.351 . . . . 0.0 114.498 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.0 tp -113.11 92.85 4.15 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.971 1.708 . . . . 0.0 111.174 -169.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 31.3 p -120.41 178.21 4.75 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.588 1.955 . . . . 0.0 113.502 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -127.84 -60.0 1.17 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.396 1.878 . . . . 0.0 112.099 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.05 173.23 6.76 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.636 1.174 . . . . 0.0 113.259 176.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -110.1 47.66 0.94 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.63 1.972 . . . . 0.0 113.297 -173.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -122.25 95.53 4.68 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.894 1.678 . . . . 0.0 110.788 -176.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.6 m -132.35 154.63 49.57 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.111 1.364 . . . . 0.0 110.876 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -138.78 124.21 19.38 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.808 1.243 . . . . 0.0 111.485 -174.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -76.98 140.03 40.28 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.649 1.18 . . . . 0.0 111.483 -177.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -131.36 127.42 37.56 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.87 1.268 . . . . 0.0 111.141 -176.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.7 t -65.98 122.86 18.33 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.809 0.338 . . . . 0.0 110.846 171.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 37.6 mtp -137.5 111.96 8.66 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.159 1.384 . . . . 0.0 110.327 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.05 -68.48 2.84 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.6 1.095 . . . . 0.0 112.39 -174.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -145.94 -52.22 0.25 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 8.4 p -83.82 172.62 11.99 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.295 0.952 . . . . 0.0 112.437 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.4 p -121.2 90.69 3.37 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.311 1.044 . . . . 0.0 112.75 172.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -74.12 173.59 9.88 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.358 1.063 . . . . 0.0 112.218 172.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.02 130.11 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.48 1.512 . . . . 0.0 111.26 168.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -142.99 163.63 32.27 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.161 1.784 . . . . 0.0 110.61 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -130.76 -1.36 4.24 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.39 170.55 54.88 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.416 1.007 . . . . 0.0 114.079 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 56.6 m -67.74 105.08 1.81 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.653 1.181 . . . . 0.0 111.358 177.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.44 98.88 4.07 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.574 1.15 . . . . 0.0 109.985 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.0 m -53.64 -47.36 70.4 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.676 1.59 . . . . 0.0 113.373 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.06 60.78 4.65 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.499 1.523 . . . . 0.0 114.29 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.97 164.01 35.14 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.613 1.101 . . . . 0.0 114.324 176.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -120.35 -26.72 5.36 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 59.95 5.5 0.76 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.653 1.981 . . . . 0.0 115.735 -175.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -136.63 129.75 31.21 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.647 1.979 . . . . 0.0 111.428 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 31.5 ttm -61.58 -31.23 71.27 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.732 1.213 . . . . 0.0 113.043 175.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.45 -37.02 48.02 Favored Glycine 0 CA--C 1.528 0.903 0 O-C-N 121.889 -0.507 . . . . 0.0 113.268 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -76.05 -44.49 38.89 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.731 0.812 . . . . 0.0 112.132 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.4 p -64.93 -21.75 66.88 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.58 -63.14 1.48 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.495 1.518 . . . . 0.0 111.466 170.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -61.68 -28.44 69.4 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -76.56 -5.0 45.81 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 174.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -126.07 167.15 17.77 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 125.865 1.666 . . . . 0.0 113.656 -175.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.21 -8.11 14.05 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.277 2.652 . . . . 0.0 114.531 -174.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.375 0 C-N-CA 126.106 1.812 . . . . 0.0 114.357 179.383 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 N--CA 1.472 0.667 0 CA-C-O 121.089 0.471 . . . . 0.0 112.263 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 61.3 m -71.16 154.04 42.02 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.462 0.705 . . . . 0.0 111.558 173.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.6 t -70.14 -175.73 1.02 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.267 1.027 . . . . 0.0 112.529 170.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.4 t -135.09 134.23 21.44 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 126.354 1.862 . . . . 0.0 110.03 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.36 162.8 37.66 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.074 3.183 . . . . 0.0 113.171 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.411 HD12 ' H ' ' A' ' 28' ' ' ILE . 4.2 mp -60.67 141.02 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.883 1.273 . . . . 0.0 110.593 176.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.35 26.12 40.98 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.099 0.857 . . . . 0.0 114.336 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -63.69 177.86 0.67 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.432 2.293 . . . . 0.0 116.016 -176.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.0 p -134.93 65.73 1.55 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 127.398 2.279 . . . . 0.0 111.122 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.45 154.68 53.11 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 124.983 1.313 . . . . 0.0 113.84 178.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -72.61 169.27 22.28 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.555 2.836 . . . . 0.0 112.738 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.0 t -132.48 56.06 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.518 1.527 . . . . 0.0 109.277 -177.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.4 mtmm -59.82 131.49 51.05 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.637 1.175 . . . . 0.0 110.88 172.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.08 79.98 0.12 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.905 1.24 . . . . 0.0 111.9 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.2 mt 55.18 32.97 19.53 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.11 1.764 . . . . 0.0 113.565 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 67.0 m -58.54 153.15 16.72 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.914 1.685 . . . . 0.0 113.464 -174.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.0 mmpt? -123.85 73.57 1.22 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.168 1.787 . . . . 0.0 111.015 -174.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -137.32 163.03 31.98 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.568 1.547 . . . . 0.0 111.781 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.1 mtp85 -129.68 12.37 5.82 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.109 1.764 . . . . 0.0 113.8 -175.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -132.52 109.46 9.8 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.528 1.931 . . . . 0.0 110.899 -175.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.6 156.82 38.33 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.231 1.012 . . . . 0.0 111.547 174.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -142.5 166.47 24.59 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.136 1.375 . . . . 0.0 111.681 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -131.08 144.6 51.55 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.344 1.058 . . . . 0.0 111.424 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -141.34 132.3 26.08 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.838 1.255 . . . . 0.0 111.005 -171.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 36.1 t -82.42 109.73 16.92 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.631 1.172 . . . . 0.0 111.766 173.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 6.9 mmt -72.33 -9.8 58.96 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 173.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.09 -37.15 0.46 Allowed Glycine 0 N--CA 1.474 1.211 0 C-N-CA 124.257 0.932 . . . . 0.0 114.76 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -141.82 -53.98 0.44 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.669 1.588 . . . . 0.0 111.248 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 36.8 t -107.7 110.3 22.11 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.462 1.505 . . . . 0.0 110.215 -175.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 21.4 p -74.97 146.95 41.26 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -128.58 171.86 11.73 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.524 1.93 . . . . 0.0 111.097 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 p -75.22 131.95 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.69 1.196 . . . . 0.0 111.019 172.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -145.11 163.47 34.21 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.575 1.15 . . . . 0.0 111.195 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -154.47 149.54 26.87 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.278 1.431 . . . . 0.0 110.229 174.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 135.16 -172.86 21.9 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.925 1.25 . . . . 0.0 113.359 -172.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 63.6 m -72.8 6.73 2.35 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 -172.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -68.36 97.46 0.75 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.472 1.909 . . . . 0.0 111.789 -177.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.8 m -55.16 -41.57 71.99 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 126.319 1.848 . . . . 0.0 114.206 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.49 58.44 4.99 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.16 1.362 . . . . 0.0 115.029 -171.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -100.83 173.7 24.84 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 125.118 1.342 . . . . 0.0 114.591 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -107.38 159.07 16.67 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.133 1.773 . . . . 0.0 111.186 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.3 p -79.59 -40.4 29.45 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 120.855 -1.153 . . . . 0.0 113.256 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.8 mmp_? -139.39 161.82 36.53 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.93 2.092 . . . . 0.0 111.627 -177.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 49.1 ttm -67.43 -29.19 68.61 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.398 0.679 . . . . 0.0 112.382 -177.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.53 -28.71 70.1 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.445 -0.642 . . . . 0.0 113.855 171.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -74.65 -50.85 16.16 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.796 1.298 . . . . 0.0 111.901 172.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.7 p -66.33 -19.76 65.9 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.73 -66.48 0.74 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.465 1.506 . . . . 0.0 111.887 164.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -60.48 -28.65 68.51 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -169.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -81.05 -7.0 59.47 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.335 1.054 . . . . 0.0 113.78 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -119.72 164.98 19.01 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 125.956 1.702 . . . . 0.0 112.723 -177.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -75.94 -6.38 17.35 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.527 2.818 . . . . 0.0 115.089 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.237 0 C-N-CA 126.075 1.798 . . . . 0.0 113.429 177.47 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 120.74 0.305 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.9 m -71.0 135.15 47.68 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.394 0.677 . . . . 0.0 111.516 178.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.1 t -74.06 167.21 21.99 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.452 0.701 . . . . 0.0 111.842 169.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.1 t -84.63 132.86 45.36 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 124.698 1.199 . . . . 0.0 109.789 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.85 179.98 5.74 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 124.525 3.484 . . . . 0.0 112.67 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.9 mm -56.49 147.95 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 126.038 1.735 . . . . 0.0 112.414 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.48 -60.02 1.07 Allowed Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.919 1.723 . . . . 0.0 111.918 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -81.77 -178.71 7.09 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.047 1.339 . . . . 0.0 112.654 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.0 t -147.41 174.88 11.27 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.082 1.753 . . . . 0.0 110.627 172.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -83.64 111.29 30.9 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 125.275 1.43 . . . . 0.0 113.266 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -74.93 158.56 42.4 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.978 2.452 . . . . 0.0 111.559 168.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.1 t -107.11 -35.12 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.835 1.254 . . . . 0.0 111.543 173.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -63.07 152.52 36.84 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.597 1.159 . . . . 0.0 112.4 175.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.29 -6.88 62.29 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.039 1.304 . . . . 0.0 116.21 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.8 mp -78.96 32.55 0.21 Allowed 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 119.308 1.554 . . . . 0.0 112.566 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 57.0 m -66.17 12.83 0.06 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 128.85 2.86 . . . . 0.0 115.428 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 61.03 9.07 2.17 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 129.164 2.986 . . . . 0.0 115.607 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.6 169.66 13.83 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.778 1.631 . . . . 0.0 113.324 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.1 mtm180 -116.75 -8.68 11.37 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -173.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -77.99 -25.83 48.26 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.3 m -62.52 147.2 49.67 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.885 1.274 . . . . 0.0 111.635 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -87.86 159.03 18.56 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.338 1.055 . . . . 0.0 111.322 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -119.66 123.86 44.88 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.258 1.023 . . . . 0.0 110.879 -172.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -119.42 130.17 55.15 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.246 1.018 . . . . 0.0 111.129 -171.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 41.8 t -73.42 97.08 2.47 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.679 0.792 . . . . 0.0 111.653 176.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 15.4 mmt -72.52 80.6 1.07 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.692 1.597 . . . . 0.0 110.668 169.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.43 -63.22 3.37 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.497 1.522 . . . . 0.0 114.456 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -123.63 -53.81 1.77 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.336 1.454 . . . . 0.0 112.408 -173.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 9.6 m -101.98 171.64 7.39 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.316 1.446 . . . . 0.0 111.018 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 11.0 p -120.6 158.82 26.55 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.027 0.931 . . . . 0.0 113.372 172.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -150.07 172.99 14.38 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 126.126 1.77 . . . . 0.0 111.239 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.3 p -76.96 125.62 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.506 1.523 . . . . 0.0 111.974 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -145.09 111.62 5.74 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.544 1.138 . . . . 0.0 111.206 -178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -75.88 98.39 4.19 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.254 -0.904 . . . . 0.0 110.901 169.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.69 167.95 38.1 Favored Glycine 0 CA--C 1.533 1.186 0 O-C-N 121.107 -0.996 . . . . 0.0 114.36 174.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.4 m -72.69 101.6 3.11 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.023 1.329 . . . . 0.0 111.335 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -133.42 97.41 3.95 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.75 1.22 . . . . 0.0 109.716 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.7 m -49.47 -49.31 46.03 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.111 1.764 . . . . 0.0 113.618 -175.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.48 77.4 0.95 Allowed Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.317 1.437 . . . . 0.0 112.784 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -131.13 175.63 19.43 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.431 1.491 . . . . 0.0 114.491 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -130.39 134.67 47.31 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.841 1.256 . . . . 0.0 112.014 -173.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 65.4 p -79.56 -8.47 59.19 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -129.12 138.42 51.8 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.574 1.549 . . . . 0.0 112.282 -176.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 61.4 tpp -65.45 -33.5 76.09 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.574 1.15 . . . . 0.0 112.056 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.45 -37.02 85.18 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 121.71 -0.619 . . . . 0.0 112.922 175.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 82.0 mm-40 -72.01 -46.37 57.43 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.294 1.037 . . . . 0.0 112.22 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.8 p -63.54 -24.21 67.71 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.07 0.85 . . . . 0.0 113.046 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.62 -64.13 1.25 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.481 1.513 . . . . 0.0 112.045 170.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -62.69 -28.18 69.76 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -169.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -81.43 -6.35 58.85 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.4 164.14 17.22 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 126.198 1.799 . . . . 0.0 112.786 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.56 -17.18 16.44 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.66 2.24 . . . . 0.0 113.854 -173.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.381 0 C-N-CA 126.587 2.042 . . . . 0.0 115.074 -179.705 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 120.9 0.381 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.0 t -69.75 128.21 35.61 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.467 0.707 . . . . 0.0 111.287 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 50.6 p -136.38 169.38 17.76 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.501 1.521 . . . . 0.0 112.281 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.6 t -69.24 133.93 89.37 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.96 0.904 . . . . 0.0 110.169 177.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.8 158.65 56.99 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.128 3.219 . . . . 0.0 112.516 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.7 mt -63.63 136.07 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.936 0.895 . . . . 0.0 109.817 177.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.42 -10.56 63.74 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.523 1.535 . . . . 0.0 115.456 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.27 172.22 11.57 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.535 1.667 . . . . 0.0 112.853 172.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.0 t -107.65 91.55 3.7 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.093 1.357 . . . . 0.0 110.437 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -56.73 115.36 10.0 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 125.071 1.349 . . . . 0.0 113.32 -176.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.86 94.57 1.07 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.481 2.788 . . . . 0.0 111.739 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 p -70.83 -24.42 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 124.337 1.055 . . . . 0.0 113.0 175.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -62.76 154.02 30.96 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.69 1.596 . . . . 0.0 111.78 173.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.62 31.87 62.36 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 123.726 0.679 . . . . 0.0 114.538 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.8 tp -74.05 59.97 0.75 Allowed 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.947 1.699 . . . . 0.0 112.583 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 31.8 p -149.7 173.74 13.36 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.457 1.903 . . . . 0.0 112.555 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.25 78.31 1.78 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.55 1.94 . . . . 0.0 110.984 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.74 178.55 4.11 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.787 0.804 . . . . 0.0 112.29 168.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -12.31 59.87 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.814 1.646 . . . . 0.0 113.429 171.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -126.63 105.03 8.42 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.708 2.803 . . . . 0.0 108.896 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.4 m -128.77 158.63 38.12 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.501 1.92 . . . . 0.0 110.313 -175.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -114.07 162.08 16.92 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.476 1.111 . . . . 0.0 112.834 170.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -146.98 127.83 14.41 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.999 1.32 . . . . 0.0 110.051 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -132.4 137.88 47.49 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.757 1.223 . . . . 0.0 111.701 -174.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 35.4 t -79.68 115.89 19.54 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.164 0.986 . . . . 0.0 111.792 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 96.3 mmm -90.25 -10.95 42.38 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.846 1.258 . . . . 0.0 114.22 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.54 -87.94 0.08 OUTLIER Glycine 0 N--CA 1.469 0.869 0 C-N-CA 124.536 1.065 . . . . 0.0 111.807 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -86.54 -31.6 21.17 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 171.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.5 p -125.98 166.33 17.13 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.732 2.013 . . . . 0.0 111.74 -170.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.5 p -113.87 153.3 29.43 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 167.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.7 ttpt -124.39 165.72 17.24 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.549 1.94 . . . . 0.0 110.513 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.2 p -69.98 135.72 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.273 1.029 . . . . 0.0 111.609 171.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -144.15 177.37 8.63 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.167 1.787 . . . . 0.0 110.515 174.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -136.38 156.79 48.13 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.982 0.913 . . . . 0.0 112.353 175.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.45 175.93 10.71 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.665 1.126 . . . . 0.0 113.969 -170.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 76.9 m -91.96 85.32 5.52 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.557 1.143 . . . . 0.0 110.375 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -70.08 84.82 0.53 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.01 1.324 . . . . 0.0 111.268 -178.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 m 61.7 7.07 1.77 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 126.612 1.965 . . . . 0.0 114.018 -174.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.78 149.44 9.47 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 127.212 2.339 . . . . 0.0 113.295 -174.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.12 -91.36 0.08 OUTLIER Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.491 1.044 . . . . 0.0 112.513 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -135.31 157.41 46.97 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.346 1.058 . . . . 0.0 113.162 -174.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.9 m -123.29 5.53 9.11 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.153 1.781 . . . . 0.0 113.092 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 -138.47 139.38 38.8 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.968 2.107 . . . . 0.0 111.0 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 30.0 tpp -59.35 -35.47 73.94 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.788 1.235 . . . . 0.0 112.14 172.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.09 -24.85 73.36 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 121.196 -0.94 . . . . 0.0 114.383 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -80.32 -46.28 16.4 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.641 1.221 . . . . 0.0 111.952 175.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.6 p -64.17 -25.03 67.9 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.28 -61.62 1.76 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.59 1.556 . . . . 0.0 111.855 171.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -61.56 -27.37 68.58 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -173.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -79.68 -4.82 53.48 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.442 1.097 . . . . 0.0 113.702 174.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m -125.61 166.43 21.09 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 126.431 1.892 . . . . 0.0 113.077 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.29 -13.76 16.76 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.772 2.314 . . . . 0.0 114.05 -176.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.214 0 C-N-CA 126.507 2.003 . . . . 0.0 112.95 179.611 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 CA--C 1.546 0.808 0 CA-C-O 120.788 0.328 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.2 m -68.28 75.77 0.25 Allowed 'General case' 0 CA--C 1.549 0.915 0 O-C-N 120.647 -1.283 . . . . 0.0 112.223 174.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.4 m -125.15 139.39 53.8 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.384 2.274 . . . . 0.0 109.624 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.8 t -72.89 136.25 80.09 Favored Pre-proline 0 N--CA 1.477 0.876 0 O-C-N 121.694 -0.629 . . . . 0.0 110.376 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.6 150.34 88.37 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.658 2.905 . . . . 0.0 112.22 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.4 mp -61.66 133.43 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.357 1.063 . . . . 0.0 110.181 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.58 -12.87 63.92 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.712 1.625 . . . . 0.0 115.415 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -73.51 159.87 32.53 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.76 1.78 . . . . 0.0 112.529 174.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.4 m -82.79 76.05 9.66 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.301 1.04 . . . . 0.0 111.749 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -54.21 111.87 3.3 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 125.586 1.554 . . . . 0.0 113.457 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.18 113.09 3.34 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.241 2.627 . . . . 0.0 111.954 -176.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.7 p -76.4 -25.1 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.002 0.921 . . . . 0.0 113.171 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 pmtp? -66.74 168.16 10.02 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.101 1.36 . . . . 0.0 113.798 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.71 166.56 39.44 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.6 1.572 . . . . 0.0 112.566 174.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.0 tp -146.75 74.04 1.34 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.744 1.217 . . . . 0.0 110.987 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 76.2 m -63.68 165.56 8.13 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.474 1.11 . . . . 0.0 112.375 176.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm 60.13 -0.91 0.21 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.177 2.591 . . . . 0.0 116.505 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.18 160.4 26.96 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.023 1.329 . . . . 0.0 113.121 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.9 ptt85 -80.95 -0.74 40.71 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.276 1.43 . . . . 0.0 114.81 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -137.33 137.24 38.73 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.073 2.149 . . . . 0.0 109.781 -176.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.5 m -141.65 144.53 34.19 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.664 1.985 . . . . 0.0 110.098 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -123.66 157.02 34.77 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.504 1.521 . . . . 0.0 110.547 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -143.95 137.89 28.1 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.895 0.878 . . . . 0.0 111.217 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -141.0 131.33 25.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.467 1.107 . . . . 0.0 111.541 -177.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 15.2 t -77.47 126.32 30.72 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.018 0.927 . . . . 0.0 111.911 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 96.6 mmm -108.7 0.3 20.48 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.191 1.397 . . . . 0.0 113.828 -174.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.39 -78.37 0.14 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 125.33 1.443 . . . . 0.0 111.79 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -115.11 -1.04 13.12 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.017 1.327 . . . . 0.0 113.567 177.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 38.7 t -149.07 156.4 42.17 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.252 1.821 . . . . 0.0 110.038 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.2 p -119.87 103.93 9.76 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.34 1.056 . . . . 0.0 113.005 176.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -70.52 165.97 21.55 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.245 1.018 . . . . 0.0 111.408 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -77.37 139.04 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.756 1.222 . . . . 0.0 111.647 168.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -138.74 172.17 13.26 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.722 2.009 . . . . 0.0 110.335 173.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.6 mp0 -134.44 123.66 24.38 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.906 1.282 . . . . 0.0 110.665 -173.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.06 173.26 49.67 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.627 1.108 . . . . 0.0 113.322 -170.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 75.9 m -82.91 85.72 7.08 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.466 1.106 . . . . 0.0 111.527 -177.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -73.95 93.91 2.27 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.116 0.966 . . . . 0.0 110.508 174.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 59.6 p 54.29 -0.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 128.972 2.909 . . . . 0.0 117.972 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.64 153.67 30.32 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 127.247 2.356 . . . . 0.0 113.359 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.61 -86.76 0.1 OUTLIER Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.333 0.968 . . . . 0.0 113.376 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -132.65 162.76 30.52 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.319 1.448 . . . . 0.0 112.371 -175.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 74.0 m -126.59 -3.88 6.61 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -137.98 147.83 44.61 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.262 1.825 . . . . 0.0 110.306 172.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 32.7 ttm -62.52 -32.29 73.2 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 122.62 0.368 . . . . 0.0 111.934 177.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -58.72 -33.75 74.11 Favored Glycine 0 CA--C 1.533 1.163 0 O-C-N 121.446 -0.783 . . . . 0.0 114.126 175.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -72.41 -50.34 27.09 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.434 1.117 . . . . 0.0 111.799 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.3 p -65.5 -30.07 70.8 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.37 -58.63 3.34 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.706 1.202 . . . . 0.0 112.192 173.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -60.68 -30.05 69.69 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -171.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 -82.27 -22.57 35.69 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.194 0.998 . . . . 0.0 113.57 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m -97.03 168.66 9.9 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 125.717 1.607 . . . . 0.0 112.208 176.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.71 -7.44 15.65 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.017 2.478 . . . . 0.0 114.617 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.29 0 C-N-CA 126.264 1.888 . . . . 0.0 113.862 -178.401 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.1 m -61.81 128.42 36.13 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.751 1.22 . . . . 0.0 111.953 170.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.6 t -145.66 164.92 30.25 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.161 1.384 . . . . 0.0 111.243 171.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.4 m -71.72 154.9 92.83 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 125.46 1.504 . . . . 0.0 112.546 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -69.94 155.64 64.85 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.906 2.404 . . . . 0.0 110.662 174.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.9 mt -61.28 134.98 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.86 0.864 . . . . 0.0 110.634 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.04 51.17 47.2 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.032 1.301 . . . . 0.0 114.006 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 37.7 p90 -76.65 -177.76 4.41 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.808 1.643 . . . . 0.0 112.528 177.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.9 m -133.54 93.09 3.08 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.473 1.909 . . . . 0.0 110.142 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -57.32 115.78 11.73 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 124.536 1.134 . . . . 0.0 113.629 -173.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.6 105.81 2.13 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.649 2.899 . . . . 0.0 111.651 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.6 t -130.64 75.76 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.126 1.37 . . . . 0.0 109.622 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -149.82 176.11 11.02 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.825 2.05 . . . . 0.0 111.656 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.15 65.67 3.23 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.58 1.086 . . . . 0.0 114.146 172.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.26 -3.76 1.48 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -177.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 67.1 m -61.17 164.26 5.42 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.952 1.701 . . . . 0.0 113.526 177.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -127.55 74.98 1.56 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.79 1.636 . . . . 0.0 111.638 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.94 165.9 16.8 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.87 0.868 . . . . 0.0 112.378 172.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -77.83 1.47 20.22 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.623 1.569 . . . . 0.0 114.12 176.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -143.2 164.67 29.55 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.746 2.818 . . . . 0.0 108.398 175.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.1 m -132.98 151.91 52.01 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.281 1.832 . . . . 0.0 110.479 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -85.24 150.69 24.62 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.752 1.221 . . . . 0.0 112.151 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -132.95 129.28 38.06 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.527 1.131 . . . . 0.0 110.935 -177.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -125.87 130.62 51.71 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.259 1.024 . . . . 0.0 111.707 -172.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.7 t -70.15 119.16 13.93 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.99 0.516 . . . . 0.0 111.116 171.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 81.8 mmm -118.05 94.37 4.48 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.293 1.837 . . . . 0.0 109.086 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.74 -65.07 4.19 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.728 1.156 . . . . 0.0 113.678 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -133.97 -59.76 0.83 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.376 1.47 . . . . 0.0 112.043 -172.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 p -96.91 168.17 10.64 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.198 1.799 . . . . 0.0 111.458 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 14.3 p -109.49 150.25 28.4 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 172.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -133.34 162.6 31.39 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.973 1.709 . . . . 0.0 112.684 -175.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 p -78.86 126.29 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 125.884 1.673 . . . . 0.0 111.724 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -145.98 103.4 3.74 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.191 0.996 . . . . 0.0 111.308 -178.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -62.88 111.69 2.25 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.044 1.338 . . . . 0.0 110.826 172.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.47 -156.88 26.94 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.096 0.855 . . . . 0.0 113.863 -175.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 78.0 m -134.31 114.65 13.21 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.048 2.139 . . . . 0.0 109.959 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -124.94 92.14 3.58 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.661 1.985 . . . . 0.0 109.329 -178.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 m 50.07 35.94 11.01 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.589 1.955 . . . . 0.0 114.19 174.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.08 23.0 78.53 Favored Glycine 0 CA--C 1.539 1.567 0 O-C-N 120.865 -1.147 . . . . 0.0 115.678 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.99 174.26 5.74 Favored Glycine 0 CA--C 1.542 1.757 0 C-N-CA 125.232 1.396 . . . . 0.0 116.184 -176.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -62.87 139.32 58.72 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 -159.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.5 m -74.64 -19.04 60.45 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.904 1.681 . . . . 0.0 114.828 176.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -137.96 154.66 49.36 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.247 1.819 . . . . 0.0 112.061 -176.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 49.3 ttm -75.48 -29.79 59.69 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.15 -29.54 75.59 Favored Glycine 0 CA--C 1.533 1.184 0 O-C-N 121.385 -0.822 . . . . 0.0 113.047 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -74.52 -48.33 27.68 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.874 1.67 . . . . 0.0 111.838 173.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.9 p -66.27 -25.98 67.13 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.284 0.947 . . . . 0.0 113.426 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.09 -59.16 2.85 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.377 1.471 . . . . 0.0 111.791 173.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -61.92 -28.3 69.43 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 -172.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -78.57 -6.7 56.26 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.461 1.104 . . . . 0.0 113.765 175.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -129.16 168.69 15.24 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 125.845 1.658 . . . . 0.0 113.346 -175.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -74.52 -19.25 19.29 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.756 2.304 . . . . 0.0 113.555 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.657 1.599 . . . . 0.0 114.287 -179.391 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.7 t -73.82 94.87 2.33 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.113 0.965 . . . . 0.0 110.452 167.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.5 p -80.99 175.18 10.91 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.259 1.424 . . . . 0.0 111.843 170.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.9 t -118.66 134.62 23.51 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 125.357 1.463 . . . . 0.0 109.866 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -78.05 -170.37 0.95 Allowed 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 124.685 3.59 . . . . 0.0 112.614 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.1 pt -55.24 165.39 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 126.341 1.856 . . . . 0.0 114.021 175.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.06 -61.23 4.76 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.803 1.668 . . . . 0.0 111.936 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -78.45 -179.45 6.35 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.057 1.343 . . . . 0.0 112.85 170.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.7 t -145.45 177.06 9.13 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.211 1.804 . . . . 0.0 110.201 164.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -84.87 112.31 41.97 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 125.062 1.345 . . . . 0.0 112.15 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.05 122.6 8.57 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.61 2.873 . . . . 0.0 112.542 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -78.89 -25.33 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.405 1.082 . . . . 0.0 113.414 174.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -66.9 154.99 39.63 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.458 1.503 . . . . 0.0 112.663 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.6 50.96 0.04 OUTLIER Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.933 1.254 . . . . 0.0 114.445 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.87 60.71 2.35 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.245 1.418 . . . . 0.0 111.991 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 83.3 m -117.44 155.57 29.45 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.224 1.81 . . . . 0.0 111.661 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.43 24.9 1.9 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.752 1.621 . . . . 0.0 113.944 -171.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.51 168.71 13.26 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.852 1.661 . . . . 0.0 112.279 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -73.38 0.99 10.58 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.526 1.93 . . . . 0.0 115.787 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -84.72 83.23 8.1 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.6 1.56 . . . . 0.0 111.987 -173.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.51 156.98 44.76 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.584 1.554 . . . . 0.0 111.317 -173.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 24.3 ttp180 -145.54 162.64 36.95 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.742 1.217 . . . . 0.0 111.77 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -123.28 111.58 16.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.284 1.034 . . . . 0.0 111.377 -167.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -108.8 122.73 47.79 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.763 0.825 . . . . 0.0 111.729 -171.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.4 t -69.77 111.72 5.72 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.939 1.296 . . . . 0.0 111.4 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 57.7 mtp -138.26 84.35 2.03 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.943 2.097 . . . . 0.0 110.394 -175.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.4 64.01 1.41 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.245 0.926 . . . . 0.0 114.111 175.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 56.74 22.93 7.37 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 126.331 1.853 . . . . 0.0 114.485 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 9.8 t -149.48 153.0 36.57 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 128.479 2.711 . . . . 0.0 108.102 172.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 7.1 p -114.51 121.55 43.84 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.026 0.931 . . . . 0.0 111.497 165.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -100.44 160.92 13.96 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.582 1.553 . . . . 0.0 111.039 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.7 p -74.76 129.05 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.629 0.772 . . . . 0.0 110.834 166.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -134.94 149.33 50.22 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.693 0.797 . . . . 0.0 111.597 171.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -88.47 154.7 20.15 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.685 1.194 . . . . 0.0 110.928 173.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.26 -176.84 33.64 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-O 122.21 0.894 . . . . 0.0 114.81 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 65.3 m -94.82 23.09 5.74 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.335 1.454 . . . . 0.0 114.504 -171.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -40.18 -44.37 1.83 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 127.019 2.128 . . . . 0.0 115.419 -170.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 98.0 m -155.28 82.65 1.06 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.857 1.663 . . . . 0.0 109.224 174.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -51.72 101.99 0.07 OUTLIER Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.526 1.536 . . . . 0.0 114.862 -176.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -126.74 -90.31 0.74 Allowed Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.764 1.65 . . . . 0.0 114.008 -175.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -121.77 116.69 24.95 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.641 1.177 . . . . 0.0 113.234 -164.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.7 m -84.71 -2.34 57.44 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -127.96 139.14 52.75 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.584 1.554 . . . . 0.0 111.378 174.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 38.9 ttm -69.45 -26.41 64.58 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.61 -33.69 72.1 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 121.798 -0.564 . . . . 0.0 112.96 172.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -74.19 -48.0 31.9 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.068 0.947 . . . . 0.0 111.835 173.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.6 p -63.79 -24.24 67.68 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.36 -65.38 0.93 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.661 1.584 . . . . 0.0 112.226 168.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -61.46 -28.7 69.47 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -168.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -84.11 -5.99 59.33 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.142 0.977 . . . . 0.0 113.474 177.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.45 169.84 6.35 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 126.373 1.869 . . . . 0.0 112.257 177.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -77.59 -8.81 17.2 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.056 2.504 . . . . 0.0 113.765 -178.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.311 0 C-N-CA 127.57 2.51 . . . . 0.0 112.615 177.424 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 71.8 m -65.03 134.58 54.17 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.712 0.805 . . . . 0.0 111.473 173.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.7 p -129.46 173.43 10.57 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.934 1.694 . . . . 0.0 111.287 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.6 t -58.18 134.74 84.49 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 124.39 1.076 . . . . 0.0 110.863 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -65.92 155.94 66.86 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 124.488 3.459 . . . . 0.0 112.658 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.1 pt -57.37 135.42 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.738 0.815 . . . . 0.0 112.368 -178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.47 -13.45 22.12 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.451 1.5 . . . . 0.0 116.075 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -75.55 146.06 40.77 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 119.833 1.816 . . . . 0.0 112.252 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.0 t -90.93 96.12 10.47 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.445 1.098 . . . . 0.0 111.717 -175.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -57.72 142.99 77.26 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 124.611 1.164 . . . . 0.0 113.791 -176.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.47 81.0 2.9 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.913 3.075 . . . . 0.0 112.677 -171.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 p -61.07 -28.4 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 125.169 1.388 . . . . 0.0 113.114 -178.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -83.08 -4.91 58.85 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.083 2.153 . . . . 0.0 114.576 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.3 -139.35 6.58 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.365 1.459 . . . . 0.0 112.789 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.5 mt 65.22 11.21 7.05 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 127.051 2.14 . . . . 0.0 115.419 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 16.7 t -73.45 150.73 41.44 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.04 1.336 . . . . 0.0 112.777 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.6 37.87 0.36 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.958 2.503 . . . . 0.0 113.593 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.16 159.7 25.71 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.107 -0.996 . . . . 0.0 113.088 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -86.03 0.38 53.52 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.703 1.601 . . . . 0.0 114.88 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -144.26 122.24 12.07 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.183 2.193 . . . . 0.0 109.705 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.9 m -148.31 167.57 24.83 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.969 1.308 . . . . 0.0 111.445 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.0 ttm180 -129.61 159.95 34.79 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.707 1.603 . . . . 0.0 111.513 -176.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -126.63 103.74 7.73 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.942 0.897 . . . . 0.0 111.953 -166.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -103.76 122.54 45.29 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.89 0.876 . . . . 0.0 112.346 -169.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.8 t -71.18 103.93 2.93 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.371 1.068 . . . . 0.0 110.794 171.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -136.07 111.21 8.96 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.499 1.92 . . . . 0.0 110.944 -177.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.46 53.78 5.37 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 123.945 0.783 . . . . 0.0 112.8 -170.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 63.24 -11.0 0.1 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 129.328 3.051 . . . . 0.0 116.896 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 48.4 t -126.9 158.24 37.28 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.884 2.074 . . . . 0.0 110.213 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.9 p -108.2 150.76 26.83 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 174.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -141.35 169.47 17.54 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.017 1.327 . . . . 0.0 111.798 172.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.26 126.16 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.006 1.322 . . . . 0.0 111.406 171.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -144.2 165.08 28.84 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.232 1.413 . . . . 0.0 111.217 174.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -126.49 104.79 8.33 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.037 1.335 . . . . 0.0 110.603 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.94 -178.31 36.96 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.466 1.508 . . . . 0.0 111.932 -176.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 77.8 m -99.36 103.35 15.15 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.625 1.17 . . . . 0.0 111.167 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -121.7 86.9 2.66 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.969 1.308 . . . . 0.0 110.402 -178.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.264 1.3 t 49.43 14.67 0.11 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 129.012 2.925 . . . . 0.0 117.182 174.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.88 33.72 45.17 Favored Glycine 0 CA--C 1.537 1.426 0 O-C-N 120.302 -1.499 . . . . 0.0 114.241 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.37 176.24 6.58 Favored Glycine 0 CA--C 1.543 1.812 0 C-N-CA 124.923 1.249 . . . . 0.0 115.564 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -70.07 147.59 49.84 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -162.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -89.38 -30.04 18.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.656 1.182 . . . . 0.0 113.158 174.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -91.17 135.51 33.73 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.84 1.256 . . . . 0.0 111.651 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 38.1 ttm -69.09 -25.32 64.37 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.432 0.693 . . . . 0.0 112.551 176.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.35 -46.86 75.23 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.585 0.612 . . . . 0.0 111.967 171.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.25 -47.05 86.07 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.149 0.98 . . . . 0.0 112.553 176.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.2 p -65.32 -23.48 67.02 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.67 -67.47 0.76 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.0 1.32 . . . . 0.0 111.643 168.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.08 -26.3 68.2 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -168.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -86.05 -4.86 59.26 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.024 0.93 . . . . 0.0 113.381 175.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.37 166.5 10.85 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 126.174 1.79 . . . . 0.0 112.077 176.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.86 -8.76 16.87 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.217 2.612 . . . . 0.0 114.426 -175.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.231 0 C-N-CA 126.493 1.997 . . . . 0.0 114.714 179.459 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 CA--C 1.546 0.792 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.9 t -69.39 149.94 47.83 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 119.175 0.898 . . . . 0.0 112.842 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.9 p -131.52 166.6 21.01 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.316 1.846 . . . . 0.0 112.15 -177.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.6 m -69.82 155.08 94.1 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.345 1.058 . . . . 0.0 112.341 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.7 156.14 67.22 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.934 2.423 . . . . 0.0 111.777 173.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 74.4 mt -66.92 136.15 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.034 0.934 . . . . 0.0 110.049 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.26 -0.84 83.17 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.216 1.388 . . . . 0.0 115.746 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.91 174.99 7.0 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.135 1.467 . . . . 0.0 112.693 175.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.9 t -128.31 92.23 3.4 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.926 1.29 . . . . 0.0 111.033 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.59 148.48 90.73 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 124.85 1.26 . . . . 0.0 113.798 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -70.98 169.33 20.73 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.762 2.975 . . . . 0.0 113.336 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.8 t -108.57 94.96 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.075 1.75 . . . . 0.0 109.366 -172.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.19 172.27 7.01 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.111 2.164 . . . . 0.0 112.831 -175.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.1 -18.85 0.73 Allowed Glycine 0 CA--C 1.536 1.364 0 N-CA-C 115.916 1.126 . . . . 0.0 115.916 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.8 mp -80.83 61.78 4.6 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 119.171 1.486 . . . . 0.0 110.941 178.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.7 t -71.19 3.22 3.73 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 126.564 1.946 . . . . 0.0 114.189 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -65.42 -21.88 66.71 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.318 1.847 . . . . 0.0 113.884 177.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.24 168.81 11.59 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.491 1.117 . . . . 0.0 112.772 171.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -115.03 17.11 16.98 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.214 1.805 . . . . 0.0 113.732 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -138.26 123.38 19.16 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.543 2.337 . . . . 0.0 109.679 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -137.27 164.23 29.05 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.526 1.931 . . . . 0.0 110.149 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -133.5 171.7 13.73 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.675 1.19 . . . . 0.0 112.835 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -136.72 110.36 8.05 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.938 1.295 . . . . 0.0 110.394 -163.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -99.02 134.62 41.59 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.184 0.994 . . . . 0.0 111.219 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.9 t -69.14 128.44 36.66 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.924 -0.485 . . . . 0.0 110.947 171.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 98.7 mmm -114.68 81.55 1.58 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.581 1.952 . . . . 0.0 109.78 176.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.43 -62.42 4.08 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.304 1.43 . . . . 0.0 114.087 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -133.32 -53.83 0.9 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.296 1.439 . . . . 0.0 112.647 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 14.6 p -76.02 176.3 8.07 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.535 1.134 . . . . 0.0 111.335 171.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.23 163.27 16.23 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.261 -0.899 . . . . 0.0 111.617 161.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -134.22 154.81 51.04 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.441 1.496 . . . . 0.0 112.042 175.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 p -82.26 130.17 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.54 1.136 . . . . 0.0 112.52 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -145.06 170.34 16.37 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.349 1.46 . . . . 0.0 111.579 173.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -124.57 161.03 27.05 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.102 1.361 . . . . 0.0 112.082 -169.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.74 177.64 24.39 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.843 1.211 . . . . 0.0 114.324 -177.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.3 t -81.83 80.81 8.04 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.521 -0.988 . . . . 0.0 111.184 175.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -84.01 76.46 10.05 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 122.167 0.984 . . . . 0.0 110.511 171.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.6 m 60.82 32.07 20.09 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.926 1.29 . . . . 0.0 112.861 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.47 -85.34 0.84 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.799 1.666 . . . . 0.0 113.319 178.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 59.24 -131.63 51.73 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.811 1.672 . . . . 0.0 113.744 -176.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -100.52 163.92 12.14 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.775 1.23 . . . . 0.0 112.133 -176.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.0 m -129.12 -0.7 5.19 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.771 1.228 . . . . 0.0 114.112 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -143.4 162.16 36.5 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.697 1.599 . . . . 0.0 112.833 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -42.5 95.26 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.205 1.802 . . . . 0.0 111.286 177.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.14 -25.67 75.25 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 121.493 -0.755 . . . . 0.0 114.155 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -74.26 -46.71 39.68 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.006 1.403 . . . . 0.0 112.037 175.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.7 p -61.14 -31.45 71.16 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.69 -0.631 . . . . 0.0 112.339 176.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.07 -53.47 6.38 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.999 1.72 . . . . 0.0 113.05 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -58.77 -28.17 65.67 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 120.203 1.365 . . . . 0.0 114.385 -174.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -84.08 -6.28 59.38 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.086 1.354 . . . . 0.0 113.858 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.0 m -129.85 162.97 50.31 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 125.197 1.399 . . . . 0.0 114.311 -172.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.98 -9.82 14.14 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.468 2.779 . . . . 0.0 114.943 -175.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.41 0 C-N-CA 125.816 1.674 . . . . 0.0 114.593 -177.685 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 120.495 0.188 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 75.3 m -80.69 170.55 16.17 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.754 0.821 . . . . 0.0 112.174 170.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.9 p -135.36 159.6 41.06 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.462 1.505 . . . . 0.0 111.541 168.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.0 p -79.9 130.67 66.09 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 124.701 1.2 . . . . 0.0 110.997 176.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.46 141.43 42.37 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.457 2.105 . . . . 0.0 110.993 171.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.1 pt -56.68 134.67 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.551 0.74 . . . . 0.0 112.336 -178.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.7 -8.01 57.95 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.388 1.47 . . . . 0.0 115.53 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 24.6 t-105 -77.75 152.85 33.4 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 119.728 1.764 . . . . 0.0 110.12 168.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.5 t -78.24 72.58 4.78 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 122.564 1.173 . . . . 0.0 112.178 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -66.79 154.52 91.69 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 125.67 1.588 . . . . 0.0 114.022 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -76.26 150.8 33.33 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.09 2.527 . . . . 0.0 111.627 175.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.5 t -136.84 76.86 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.099 1.36 . . . . 0.0 109.813 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.71 -28.57 0.43 Allowed 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 116.143 1.905 . . . . 0.0 116.143 -177.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.3 -169.61 24.99 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.16 0.886 . . . . 0.0 113.169 -165.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 98.0 mt -134.75 113.46 11.67 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.311 2.244 . . . . 0.0 108.404 177.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 63.1 m 61.4 29.3 18.43 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.437 1.895 . . . . 0.0 114.628 177.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -53.49 -53.57 49.56 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 126.123 1.769 . . . . 0.0 112.57 175.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.26 169.31 10.48 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.091 1.356 . . . . 0.0 112.19 174.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -108.49 5.07 24.87 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.348 1.859 . . . . 0.0 114.592 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -143.48 102.81 4.01 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.751 2.02 . . . . 0.0 110.85 -176.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.3 m -150.36 155.38 39.51 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 120.806 -1.184 . . . . 0.0 111.51 -177.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -77.71 160.99 28.08 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.771 1.228 . . . . 0.0 112.673 173.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -131.58 107.67 9.01 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.911 1.285 . . . . 0.0 110.759 -174.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -114.6 122.26 45.96 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.959 1.304 . . . . 0.0 112.462 -168.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 35.3 t -67.64 122.7 18.62 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.279 1.032 . . . . 0.0 112.008 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.34 -10.6 1.24 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -171.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 169.23 70.97 0.03 OUTLIER Glycine 0 N--CA 1.47 0.921 0 O-C-N 121.498 -0.751 . . . . 0.0 111.84 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.7 m120 60.83 1.86 0.48 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 127.953 2.501 . . . . 0.0 116.253 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 79.8 m -132.14 160.44 36.03 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.121 1.768 . . . . 0.0 110.158 163.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.7 p -101.26 91.22 4.41 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.93 1.292 . . . . 0.0 111.13 167.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -67.64 154.25 41.89 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.727 1.611 . . . . 0.0 112.319 -176.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 p -66.64 121.49 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.425 1.49 . . . . 0.0 112.351 172.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -140.05 122.48 16.09 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.451 1.5 . . . . 0.0 111.796 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -74.33 150.68 40.02 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.491 0.716 . . . . 0.0 112.02 171.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.8 174.65 13.41 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.138 1.352 . . . . 0.0 115.417 176.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 17.6 p -80.33 39.08 0.44 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.513 1.925 . . . . 0.0 114.14 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -51.51 -34.91 38.11 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.196 1.398 . . . . 0.0 113.522 178.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.1 t -144.05 -23.86 0.56 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 169.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.63 15.0 81.54 Favored Glycine 0 CA--C 1.539 1.537 0 O-C-N 120.908 -1.12 . . . . 0.0 115.675 171.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -54.26 -68.63 1.56 Allowed Glycine 0 CA--C 1.535 1.33 0 C-N-CA 126.054 1.787 . . . . 0.0 115.073 -174.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -140.31 151.14 44.82 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.889 1.276 . . . . 0.0 112.525 -172.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.8 m -117.89 0.84 12.01 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.341 1.456 . . . . 0.0 114.499 -177.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -135.96 144.77 45.59 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.193 1.797 . . . . 0.0 110.771 174.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -62.91 -35.58 80.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.873 0.869 . . . . 0.0 111.755 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.75 -11.34 77.72 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.356 0.979 . . . . 0.0 114.925 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -96.16 -37.7 10.46 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.986 1.393 . . . . 0.0 112.099 176.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.7 p -70.79 -45.91 63.82 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.194 -0.941 . . . . 0.0 112.005 171.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.21 -12.48 61.19 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -177.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -85.33 -25.53 27.09 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 119.821 1.192 . . . . 0.0 113.626 168.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -91.47 -29.0 17.26 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.844 1.258 . . . . 0.0 112.995 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.3 m -106.53 165.41 13.0 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 126.009 1.724 . . . . 0.0 112.68 175.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -79.12 -4.92 14.18 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.049 2.5 . . . . 0.0 114.775 -171.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.333 0 C-N-CA 126.823 2.154 . . . . 0.0 115.236 -178.737 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 CA--C 1.541 0.611 0 CA-C-O 121.079 0.466 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 35.8 t -140.27 143.45 35.93 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.936 1.294 . . . . 0.0 111.149 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.4 m -132.79 146.03 51.49 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.445 1.498 . . . . 0.0 110.937 -168.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.1 m -100.49 155.94 35.79 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 125.037 1.335 . . . . 0.0 112.822 -173.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.3 157.06 62.68 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.436 2.757 . . . . 0.0 112.435 172.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.4 mp -66.06 137.22 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.832 1.253 . . . . 0.0 110.385 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.31 -4.56 67.04 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.549 1.547 . . . . 0.0 115.781 176.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.03 172.66 11.26 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 118.826 1.313 . . . . 0.0 113.048 177.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -115.77 80.75 1.49 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.127 1.371 . . . . 0.0 111.53 -175.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -67.96 155.04 92.74 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 125.275 1.43 . . . . 0.0 114.176 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.24 168.27 25.02 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 124.025 3.15 . . . . 0.0 112.594 174.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.3 t -130.54 10.85 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 125.216 1.406 . . . . 0.0 112.706 -174.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -131.12 170.16 14.91 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.575 1.95 . . . . 0.0 112.252 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.69 31.55 0.22 Allowed Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.988 1.28 . . . . 0.0 115.053 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.6 mp -90.14 85.18 6.21 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.442 1.497 . . . . 0.0 110.735 -175.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.0 m -68.3 77.39 0.26 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.711 1.604 . . . . 0.0 112.9 176.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? -129.86 73.26 1.52 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.571 2.348 . . . . 0.0 110.88 -176.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 46.33 42.47 10.48 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.407 1.883 . . . . 0.0 114.659 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -74.05 -30.31 62.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.146 1.378 . . . . 0.0 113.088 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 50.81 26.57 2.65 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.897 2.079 . . . . 0.0 114.589 -175.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.1 m -60.03 152.67 23.38 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.749 2.42 . . . . 0.0 113.026 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.6 152.21 45.68 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.378 1.471 . . . . 0.0 112.028 176.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -129.6 144.89 51.48 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.84 1.256 . . . . 0.0 111.366 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -143.78 139.91 29.63 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.304 1.442 . . . . 0.0 110.722 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 38.0 t -89.95 123.18 33.65 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.878 0.871 . . . . 0.0 111.981 173.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 29.5 mtt -79.25 -12.84 59.96 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 175.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 154.46 -39.72 0.65 Allowed Glycine 0 N--CA 1.475 1.288 0 CA-C-N 119.293 0.951 . . . . 0.0 114.974 171.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -126.61 -12.06 6.11 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 174.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 25.8 p -151.91 163.43 39.26 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.878 2.071 . . . . 0.0 110.284 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 2.4 p -119.57 151.34 38.8 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.37 1.068 . . . . 0.0 112.68 176.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -122.53 178.89 4.79 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.795 1.638 . . . . 0.0 111.668 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.1 p -115.09 122.56 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.636 1.974 . . . . 0.0 110.806 -174.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -129.33 116.69 19.46 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.133 1.373 . . . . 0.0 111.068 -169.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -57.62 117.97 4.75 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.34 1.456 . . . . 0.0 112.972 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.42 173.52 49.86 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 125.387 1.47 . . . . 0.0 114.478 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 76.4 m -78.38 84.4 4.55 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.443 -1.033 . . . . 0.0 111.159 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -50.25 -50.66 49.37 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.453 1.501 . . . . 0.0 112.703 -178.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 90.6 m -136.89 -44.68 0.58 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.08 1.752 . . . . 0.0 111.723 169.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.5 56.82 0.08 OUTLIER Glycine 0 CA--C 1.536 1.367 0 C-N-CA 126.409 1.957 . . . . 0.0 112.636 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.09 -92.62 0.5 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.826 1.203 . . . . 0.0 113.745 -173.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -110.93 158.18 19.05 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.578 1.151 . . . . 0.0 112.6 -174.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.8 t -102.7 -30.29 10.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.594 1.958 . . . . 0.0 111.87 174.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -132.3 151.09 52.0 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.319 1.848 . . . . 0.0 111.589 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 48.8 ttm -66.93 -19.01 65.65 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.54 0.736 . . . . 0.0 112.926 177.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.61 -16.35 55.38 Favored Glycine 0 CA--C 1.539 1.548 0 O-C-N 121.149 -0.969 . . . . 0.0 114.561 168.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -87.78 -25.5 23.35 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 118.894 1.347 . . . . 0.0 112.761 173.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -61.05 -59.3 5.57 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.392 -0.817 . . . . 0.0 109.752 165.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.84 -12.45 59.17 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -170.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -92.37 -25.19 18.63 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 170.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -90.79 -13.7 33.38 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.946 1.298 . . . . 0.0 113.186 175.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.5 m -129.63 159.17 70.94 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.852 1.661 . . . . 0.0 113.187 -175.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -76.59 -10.39 18.68 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 123.85 3.033 . . . . 0.0 114.63 -176.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 C-N-CA 127.017 2.246 . . . . 0.0 112.276 176.922 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 CA--C 1.55 0.946 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.6 p -110.47 16.22 21.69 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.952 1.701 . . . . 0.0 114.49 -171.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -16.2 -72.93 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 130.085 3.354 . . . . 0.0 116.378 -163.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 m -143.28 151.29 54.64 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 127.195 2.198 . . . . 0.0 111.399 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.9 -27.3 7.18 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.575 2.85 . . . . 0.0 113.621 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.2 pt -136.06 -177.62 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.466 2.306 . . . . 0.0 111.014 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.39 41.64 0.3 Allowed Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.691 1.615 . . . . 0.0 114.248 172.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -59.31 143.52 49.13 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.931 2.092 . . . . 0.0 111.211 175.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.5 t -76.41 85.3 3.16 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.475 1.11 . . . . 0.0 112.116 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -63.98 155.74 76.82 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 125.155 1.382 . . . . 0.0 113.236 175.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.05 138.75 31.54 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.173 2.582 . . . . 0.0 111.076 174.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.6 t -73.39 -40.11 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.733 0.813 . . . . 0.0 111.141 175.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -69.52 161.32 29.77 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.137 1.375 . . . . 0.0 112.124 174.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.0 -126.12 1.34 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.41 1.481 . . . . 0.0 111.274 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 60.9 mt 49.27 45.48 23.43 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.771 1.628 . . . . 0.0 112.479 -177.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 65.9 m -63.22 149.66 44.94 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.964 1.706 . . . . 0.0 112.364 -177.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.97 -5.15 3.12 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.502 1.521 . . . . 0.0 114.804 -177.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.17 168.89 16.26 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.063 0.945 . . . . 0.0 112.144 169.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -105.62 5.64 31.41 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.563 1.945 . . . . 0.0 113.939 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -147.3 116.28 6.86 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.119 2.167 . . . . 0.0 110.335 -176.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.0 m -142.16 159.16 42.77 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.994 1.317 . . . . 0.0 110.775 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -76.92 147.06 37.19 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.538 1.135 . . . . 0.0 111.319 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -132.94 120.55 21.59 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.122 0.969 . . . . 0.0 111.908 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -113.63 122.88 48.54 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.709 1.204 . . . . 0.0 111.567 -175.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.7 t -70.95 115.9 10.62 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.937 0.895 . . . . 0.0 110.852 171.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.4 mmt -82.23 -16.79 48.34 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 165.99 -45.21 0.27 Allowed Glycine 0 N--CA 1.468 0.792 0 C-N-CA 124.675 1.131 . . . . 0.0 113.22 -173.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -136.55 -62.68 0.65 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.292 1.837 . . . . 0.0 110.471 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -81.13 168.43 18.59 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.3 1.04 . . . . 0.0 111.198 173.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 p -121.88 143.89 49.17 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.182 0.993 . . . . 0.0 112.993 170.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -110.48 148.88 31.19 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.778 1.631 . . . . 0.0 111.578 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 p -69.44 127.51 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 126.465 1.906 . . . . 0.0 112.254 169.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -136.02 129.86 32.66 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.085 1.354 . . . . 0.0 111.013 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.85 100.55 0.57 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.999 1.32 . . . . 0.0 112.114 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.73 179.63 50.21 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.076 1.322 . . . . 0.0 114.937 176.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 79.4 m -75.19 75.69 2.33 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.044 1.338 . . . . 0.0 112.002 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -50.18 -49.78 51.35 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.02 1.728 . . . . 0.0 113.116 177.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.4 t -146.93 1.27 0.76 Allowed 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 174.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 111.04 33.54 2.35 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.773 1.178 . . . . 0.0 115.704 173.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.32 -173.67 42.35 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.776 1.655 . . . . 0.0 114.469 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -64.81 148.66 50.84 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.858 1.263 . . . . 0.0 114.108 -173.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.1 t -100.79 -5.43 26.32 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.617 1.567 . . . . 0.0 113.549 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 89.2 mmt-85 -134.84 139.54 45.14 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.314 1.446 . . . . 0.0 111.351 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 47.4 ttm -69.15 -26.32 64.81 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -58.88 -42.81 96.86 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 121.946 -0.471 . . . . 0.0 112.589 169.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -70.06 -45.84 66.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.794 0.838 . . . . 0.0 112.968 177.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 12.9 p -66.68 -20.41 65.97 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.584 1.084 . . . . 0.0 113.355 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.14 -66.19 0.91 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.58 1.552 . . . . 0.0 111.919 168.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -60.22 -27.75 67.45 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 115.356 1.614 . . . . 0.0 115.356 -168.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -85.48 -3.16 58.77 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.576 1.15 . . . . 0.0 113.253 176.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -122.14 166.29 17.57 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 126.858 2.063 . . . . 0.0 112.671 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.71 -8.11 13.48 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.253 2.636 . . . . 0.0 114.838 -176.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.429 0 C-N-CA 125.88 1.705 . . . . 0.0 114.298 -179.53 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 . . . . . 0 CA--C 1.544 0.726 0 CA-C-O 122.265 1.031 . . . . 0.0 113.48 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.8 t -62.91 120.02 10.53 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.267 1.427 . . . . 0.0 112.697 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.9 m -68.39 154.44 41.8 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.548 1.539 . . . . 0.0 111.4 174.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.7 t -111.05 135.78 20.85 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 125.594 1.557 . . . . 0.0 110.803 -173.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.62 165.69 26.67 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.685 3.59 . . . . 0.0 113.546 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 63.2 mt -58.96 140.33 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.199 1.399 . . . . 0.0 110.629 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.85 25.05 47.13 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.143 0.878 . . . . 0.0 114.622 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -63.02 175.26 0.91 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.293 1.837 . . . . 0.0 115.505 -178.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.7 m -139.74 65.99 1.41 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 127.374 2.269 . . . . 0.0 110.45 178.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.8 155.61 69.9 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 124.583 1.153 . . . . 0.0 113.564 177.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.78 96.97 1.02 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.724 2.949 . . . . 0.0 113.253 -174.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.5 t -59.97 -43.87 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.316 1.046 . . . . 0.0 111.274 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -76.43 3.66 10.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.288 1.835 . . . . 0.0 114.927 173.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.76 -11.44 30.03 Favored Glycine 0 CA--C 1.541 1.698 0 C-N-CA 124.534 1.064 . . . . 0.0 115.531 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.43 -27.31 67.72 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.525 1.53 . . . . 0.0 113.228 167.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 9.2 t -76.81 165.54 24.57 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.341 1.456 . . . . 0.0 112.077 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -118.05 70.87 0.81 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.228 1.811 . . . . 0.0 110.805 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.36 158.71 19.79 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.428 1.091 . . . . 0.0 112.846 176.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -95.26 9.35 40.11 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.09 1.756 . . . . 0.0 114.577 -177.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -136.17 118.21 15.37 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.467 2.307 . . . . 0.0 110.057 -175.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.64 139.66 47.48 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.467 -0.771 . . . . 0.0 110.41 169.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.37 154.24 44.47 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.694 1.197 . . . . 0.0 112.201 -177.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -140.35 130.8 25.36 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.829 1.252 . . . . 0.0 111.069 -164.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -141.12 126.39 18.56 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.323 1.049 . . . . 0.0 111.956 -168.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 18.1 t -75.39 120.1 20.39 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.514 0.597 . . . . 0.0 112.303 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 37.5 mtm -135.73 87.11 2.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.353 1.461 . . . . 0.0 110.528 171.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.0 68.05 1.26 Allowed Glycine 0 N--CA 1.47 0.945 0 C-N-CA 124.777 1.18 . . . . 0.0 113.479 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 66.31 -2.67 0.95 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 127.759 2.424 . . . . 0.0 115.682 175.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.7 p -137.23 151.07 48.31 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.807 2.043 . . . . 0.0 110.4 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.5 p -118.88 93.94 4.27 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.848 0.859 . . . . 0.0 112.72 173.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -67.72 167.02 14.06 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.642 1.177 . . . . 0.0 112.784 170.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.21 129.0 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.736 1.614 . . . . 0.0 111.69 175.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -135.17 113.9 11.82 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.091 1.757 . . . . 0.0 110.426 -174.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -71.58 169.23 15.95 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.096 0.959 . . . . 0.0 112.667 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.42 167.39 42.6 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.064 1.316 . . . . 0.0 113.557 -176.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 8.8 t -83.47 71.74 10.29 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.489 -1.006 . . . . 0.0 112.157 -177.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -81.94 83.05 7.35 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.251 -0.906 . . . . 0.0 110.711 169.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.0 m -48.7 -35.08 13.19 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.434 1.494 . . . . 0.0 114.828 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.34 73.11 2.64 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.319 1.438 . . . . 0.0 114.948 -171.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.85 -115.8 0.5 Allowed Glycine 0 CA--C 1.53 1.0 0 CA-C-N 118.079 0.94 . . . . 0.0 114.257 171.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -129.8 175.61 8.7 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.156 1.382 . . . . 0.0 112.432 -170.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 80.8 p -123.82 -2.94 8.23 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.219 1.407 . . . . 0.0 114.76 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -140.06 144.95 37.12 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.21 1.804 . . . . 0.0 111.97 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 38.6 tpp -60.67 -31.12 70.37 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.657 1.183 . . . . 0.0 112.202 173.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.94 -14.34 70.5 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.568 1.08 . . . . 0.0 115.296 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -89.97 -43.73 10.36 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.051 1.425 . . . . 0.0 111.823 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 18.1 p -67.62 -23.03 65.32 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.42 -61.99 1.57 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.128 1.371 . . . . 0.0 111.845 170.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -62.29 -26.97 68.71 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -174.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -77.18 -6.61 53.64 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.1 m -123.43 164.91 25.32 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 126.347 1.859 . . . . 0.0 112.607 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -76.44 -17.59 16.37 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.009 2.473 . . . . 0.0 113.934 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.256 0 C-N-CA 126.081 1.801 . . . . 0.0 114.503 -177.593 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.474 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -67.28 134.46 51.64 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.245 1.018 . . . . 0.0 111.875 176.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -114.06 -6.75 13.1 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -176.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -72.05 157.97 36.82 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.05 0.94 . . . . 0.0 112.259 174.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.31 178.4 8.12 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.065 1.746 . . . . 0.0 112.028 173.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.4 p -115.89 135.38 54.05 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.625 1.57 . . . . 0.0 111.587 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.7 m -139.97 159.04 43.09 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.53 1.932 . . . . 0.0 109.844 -174.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 p -51.58 118.53 11.46 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 124.857 1.263 . . . . 0.0 112.322 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -78.09 175.37 11.23 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.509 2.806 . . . . 0.0 112.228 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.3 mm -58.13 133.93 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.725 1.21 . . . . 0.0 111.39 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.19 -60.79 0.66 Allowed Glycine 0 CA--C 1.531 1.037 0 C-N-CA 126.322 1.915 . . . . 0.0 111.522 -177.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -85.23 175.72 8.77 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.826 1.25 . . . . 0.0 113.24 175.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.9 m -143.19 122.64 13.14 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.874 2.07 . . . . 0.0 110.218 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.5 152.87 96.2 Favored Pre-proline 0 CA--C 1.554 1.105 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 175.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.77 121.95 8.63 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 124.389 3.393 . . . . 0.0 111.653 176.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.5 p -70.14 -27.06 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.107 0.963 . . . . 0.0 112.572 175.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -70.87 168.65 16.39 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.707 2.003 . . . . 0.0 113.328 175.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.85 148.77 16.58 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.313 1.435 . . . . 0.0 111.919 170.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 29.5 tp -150.93 79.59 1.32 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.632 1.173 . . . . 0.0 111.463 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 85.1 m -68.67 -3.94 13.85 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -68.8 -21.08 64.35 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.91 2.084 . . . . 0.0 114.289 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.7 158.3 30.5 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.712 0.768 . . . . 0.0 112.859 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -92.95 6.64 47.13 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.075 1.75 . . . . 0.0 113.175 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -144.13 167.18 23.01 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 129.488 3.115 . . . . 0.0 108.277 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.6 m -142.15 152.8 43.54 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.551 1.94 . . . . 0.0 109.635 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.9 tpp85 -127.98 146.1 50.76 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.77 1.228 . . . . 0.0 111.758 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -138.26 125.73 21.96 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.032 1.333 . . . . 0.0 110.301 -170.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -131.86 128.63 39.04 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.342 1.057 . . . . 0.0 111.564 -172.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.3 t -70.8 123.6 22.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.326 0.65 . . . . 0.0 111.681 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.1 mmt -84.97 -90.68 0.09 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.842 0.857 . . . . 0.0 110.268 170.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -94.27 -55.21 1.49 Allowed Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.74 1.162 . . . . 0.0 112.821 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -131.43 -49.2 0.99 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.518 1.527 . . . . 0.0 112.919 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 89.0 m -93.5 167.83 11.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.191 1.397 . . . . 0.0 112.353 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.6 p -121.66 103.01 8.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.102 1.361 . . . . 0.0 112.982 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -70.44 167.31 18.55 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.923 1.289 . . . . 0.0 112.73 171.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.1 p -89.73 126.36 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.592 1.557 . . . . 0.0 112.264 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -133.41 160.99 35.76 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.822 1.649 . . . . 0.0 111.052 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -127.82 80.99 1.99 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.556 1.142 . . . . 0.0 111.266 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.06 167.16 30.98 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.295 1.902 . . . . 0.0 112.776 175.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 92.6 m -85.12 72.03 10.83 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.815 1.246 . . . . 0.0 111.138 176.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -74.12 79.39 1.75 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.348 1.859 . . . . 0.0 111.104 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.6 m 55.02 31.33 15.9 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 125.726 1.61 . . . . 0.0 113.368 -177.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.13 -63.35 3.89 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 126.081 1.8 . . . . 0.0 114.154 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 51.81 -118.29 6.99 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 126.968 2.223 . . . . 0.0 114.628 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -125.89 153.21 44.52 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.296 1.438 . . . . 0.0 112.08 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.3 m -118.15 5.75 11.99 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.119 1.368 . . . . 0.0 114.054 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.2 mmt85 -134.03 140.83 46.94 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.881 2.072 . . . . 0.0 110.218 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 51.3 ttm -63.34 -30.98 72.02 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 122.929 0.492 . . . . 0.0 112.084 173.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.38 -43.3 98.51 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 121.483 -0.761 . . . . 0.0 113.086 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -65.64 -48.0 73.65 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.074 0.95 . . . . 0.0 112.537 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.1 p -67.58 -21.54 65.42 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.44 -61.91 1.85 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.326 1.45 . . . . 0.0 111.455 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -61.53 -27.88 68.93 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -172.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 -81.64 -2.76 51.44 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.563 1.145 . . . . 0.0 113.577 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -126.81 167.38 17.66 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 126.336 1.854 . . . . 0.0 112.999 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.4 -8.74 15.04 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.2 2.6 . . . . 0.0 114.693 -176.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.325 0 C-N-CA 125.968 1.747 . . . . 0.0 113.147 178.611 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.53 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -72.27 167.19 20.92 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.996 0.918 . . . . 0.0 112.19 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -82.65 -33.18 27.88 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.459 1.504 . . . . 0.0 111.939 171.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -77.68 174.8 10.55 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.095 1.358 . . . . 0.0 112.945 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -119.23 155.01 32.49 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.802 1.641 . . . . 0.0 111.33 173.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.7 m -96.7 58.41 1.67 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.674 1.189 . . . . 0.0 112.185 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.4 p -67.66 160.04 28.76 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.034 1.334 . . . . 0.0 111.907 167.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.6 m -81.35 157.6 70.25 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 124.592 1.157 . . . . 0.0 112.243 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.45 177.76 8.39 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.056 2.504 . . . . 0.0 111.945 166.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.476 HD12 ' H ' ' A' ' 28' ' ' ILE . 4.1 mp -54.21 132.39 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.901 1.68 . . . . 0.0 112.066 -176.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.74 -48.5 0.94 Allowed Glycine 0 CA--C 1.533 1.164 0 C-N-CA 126.569 2.033 . . . . 0.0 113.536 175.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -89.25 -174.64 4.49 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.345 1.458 . . . . 0.0 113.496 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.5 t -135.31 -79.24 0.43 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.122 1.369 . . . . 0.0 111.929 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -153.78 162.43 26.74 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.86 1.264 . . . . 0.0 112.884 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -71.12 83.98 0.91 Allowed 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.58 2.853 . . . . 0.0 111.559 167.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.5 t -68.32 -43.99 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.412 1.085 . . . . 0.0 110.744 173.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -82.61 173.24 12.12 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.762 2.025 . . . . 0.0 111.816 175.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.43 64.99 0.97 Allowed Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.041 1.305 . . . . 0.0 112.654 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.0 mp -128.94 19.93 5.97 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.741 2.016 . . . . 0.0 111.744 175.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 80.3 m -63.4 168.63 4.34 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.339 1.856 . . . . 0.0 113.322 -174.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.417 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -110.09 14.51 22.91 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.19 1.796 . . . . 0.0 113.087 -179.338 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.64 171.97 2.37 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.626 1.57 . . . . 0.0 113.478 175.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -98.54 1.0 46.12 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.028 1.731 . . . . 0.0 114.271 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -130.04 98.98 4.92 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.245 1.818 . . . . 0.0 112.303 -169.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.9 m -72.95 100.81 3.04 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.122 1.369 . . . . 0.0 110.822 176.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -87.39 142.02 28.19 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.764 0.826 . . . . 0.0 111.941 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -126.11 150.71 48.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.88 1.672 . . . . 0.0 111.974 -176.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -147.94 148.02 30.33 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.012 1.325 . . . . 0.0 112.984 173.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 41.5 t -88.26 113.44 23.87 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.075 1.35 . . . . 0.0 111.884 173.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.0 mmt -72.63 -42.86 63.98 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 173.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.54 -84.33 0.05 OUTLIER Glycine 0 N--CA 1.471 1.008 0 C-N-CA 123.732 0.682 . . . . 0.0 113.164 -175.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -86.76 -40.08 15.34 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 176.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -130.81 169.38 15.8 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.031 2.132 . . . . 0.0 111.671 -173.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 22.7 p -117.51 155.15 30.24 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -132.39 173.9 10.81 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.85 2.46 . . . . 0.0 111.95 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.12 137.68 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 127.008 2.123 . . . . 0.0 112.358 174.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -138.12 -21.51 1.07 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.719 1.608 . . . . 0.0 114.441 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 60.7 16.37 6.61 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 171.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -149.46 173.42 29.28 Favored Glycine 0 N--CA 1.474 1.197 0 O-C-N 120.606 -1.309 . . . . 0.0 114.2 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 71.8 m -78.33 65.18 3.6 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.711 1.204 . . . . 0.0 111.644 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -55.08 -43.1 73.62 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.465 1.506 . . . . 0.0 112.74 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.8 t -142.71 -19.17 0.67 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.357 1.463 . . . . 0.0 113.744 173.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -176.68 -85.05 0.06 OUTLIER Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.595 1.093 . . . . 0.0 111.311 175.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.43 108.26 0.63 Allowed Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.005 0.812 . . . . 0.0 114.383 170.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -60.67 154.46 21.36 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.38 0.672 . . . . 0.0 111.85 165.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.5 t -80.39 -40.35 26.67 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.14 1.376 . . . . 0.0 112.456 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -143.55 157.93 44.05 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 127.016 2.126 . . . . 0.0 111.266 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 5.0 ttt -64.83 -23.63 67.29 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.216 1.007 . . . . 0.0 113.136 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.26 -21.97 64.77 Favored Glycine 0 CA--C 1.535 1.331 0 O-C-N 120.786 -1.196 . . . . 0.0 114.289 171.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -78.93 -44.66 22.14 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.892 1.346 . . . . 0.0 111.925 173.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.0 p -66.53 -22.2 66.17 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 175.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.19 -62.35 1.46 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.208 1.403 . . . . 0.0 111.769 167.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -61.0 -27.98 68.7 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 -172.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -77.69 -6.2 53.1 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.354 1.061 . . . . 0.0 113.757 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m -123.2 164.93 24.72 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 126.208 1.803 . . . . 0.0 113.313 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -79.9 -10.31 14.13 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.17 2.58 . . . . 0.0 114.314 -173.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.381 0 C-N-CA 125.966 1.746 . . . . 0.0 113.797 -178.99 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -80.13 84.65 5.8 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.055 1.342 . . . . 0.0 113.64 -172.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -61.57 177.69 0.38 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.199 1.399 . . . . 0.0 111.815 163.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -56.94 147.04 24.85 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 120.838 -1.164 . . . . 0.0 112.621 170.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -112.95 -28.28 7.77 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 61.6 m -120.81 -78.77 0.6 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.238 1.815 . . . . 0.0 110.853 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 70.5 m -156.17 151.58 26.83 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 127.988 2.515 . . . . 0.0 108.547 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.8 m -129.94 156.78 78.53 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 125.221 1.408 . . . . 0.0 112.042 170.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -64.34 152.1 82.79 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.24 2.627 . . . . 0.0 112.244 172.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.2 pt -66.46 149.99 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.606 0.762 . . . . 0.0 112.014 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.03 -2.76 12.06 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 125.077 1.322 . . . . 0.0 116.169 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.27 172.97 11.5 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.218 1.509 . . . . 0.0 112.755 178.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 56.5 m -133.33 92.68 3.04 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.255 1.422 . . . . 0.0 111.149 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -63.51 148.46 93.8 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 124.176 0.991 . . . . 0.0 113.496 -178.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -78.3 75.05 5.08 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.163 3.242 . . . . 0.0 111.592 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 p -59.83 -23.9 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.869 1.668 . . . . 0.0 113.432 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -109.98 7.38 23.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.876 2.471 . . . . 0.0 114.128 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.81 49.81 2.87 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.945 1.736 . . . . 0.0 115.88 -172.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.0 mp -76.26 47.49 0.46 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 126.936 2.095 . . . . 0.0 113.092 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 59.7 m -69.43 154.38 42.1 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.526 -1.358 . . . . 0.0 112.195 169.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.23 16.54 1.52 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -177.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -120.73 167.05 12.89 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.355 1.462 . . . . 0.0 113.17 -177.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -18.43 63.51 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -70.88 -29.25 65.28 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.141 1.376 . . . . 0.0 113.83 -169.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.2 m -76.95 162.93 27.18 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.509 1.524 . . . . 0.0 111.769 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.89 168.31 11.61 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.616 1.566 . . . . 0.0 113.051 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -135.53 140.23 44.58 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.157 1.383 . . . . 0.0 110.482 -171.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -142.01 134.6 28.25 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.826 0.85 . . . . 0.0 112.695 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 31.5 t -75.02 119.16 18.82 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.312 0.645 . . . . 0.0 111.88 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.2 mmt -94.87 -2.86 49.89 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.57 -54.24 0.15 Allowed Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.373 0.987 . . . . 0.0 112.81 175.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -133.78 -19.89 2.03 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 175.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -136.67 167.59 21.13 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.358 1.463 . . . . 0.0 111.325 177.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 11.1 p -121.5 109.41 14.79 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -176.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -76.64 175.18 9.56 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.321 1.048 . . . . 0.0 112.047 167.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.7 p -85.88 137.79 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 126.855 2.062 . . . . 0.0 112.336 171.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -140.23 142.3 35.83 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.268 1.427 . . . . 0.0 111.434 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -93.83 -4.78 49.52 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -165.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -135.41 172.31 22.21 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 126.231 1.872 . . . . 0.0 112.396 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 22.5 t -66.57 145.2 55.88 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 122.052 -0.676 . . . . 0.0 112.607 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.05 82.66 2.06 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.241 1.816 . . . . 0.0 109.235 171.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.4 m 55.08 27.35 9.3 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.8 1.64 . . . . 0.0 113.822 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.58 13.98 74.77 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.358 1.456 . . . . 0.0 116.175 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -43.67 -82.84 0.02 OUTLIER Glycine 0 CA--C 1.539 1.593 0 C-N-CA 127.094 2.283 . . . . 0.0 116.991 -172.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -139.84 166.57 24.27 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.215 1.406 . . . . 0.0 112.435 -170.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.3 m -134.23 -18.45 2.01 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.193 1.397 . . . . 0.0 114.215 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -115.97 153.71 31.13 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.803 1.641 . . . . 0.0 111.544 175.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.0 tpp -65.04 -39.33 93.17 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.772 0.829 . . . . 0.0 111.359 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.77 -30.05 75.83 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.372 -0.682 . . . . 0.0 114.115 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -69.92 -57.79 4.62 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 118.577 1.189 . . . . 0.0 111.369 175.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.6 p -65.89 -26.04 67.44 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.91 -61.01 1.95 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.141 1.377 . . . . 0.0 111.81 168.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -61.98 -29.61 70.37 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -172.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -75.37 -13.59 60.42 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -113.55 166.22 11.73 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 126.413 1.885 . . . . 0.0 112.613 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.38 -17.95 23.54 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.888 2.392 . . . . 0.0 113.837 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.383 0 CA-C-O 117.061 -1.966 . . . . 0.0 115.046 -178.83 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.527 0 N-CA-C 111.801 -0.52 . . . . 0.0 111.801 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -126.69 161.59 27.77 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.707 1.603 . . . . 0.0 111.976 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -118.04 123.01 44.61 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.177 1.791 . . . . 0.0 111.382 -173.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -71.55 -23.34 61.74 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.02 0.928 . . . . 0.0 113.287 177.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -150.68 169.47 21.53 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.7 2.0 . . . . 0.0 111.431 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.3 t -124.5 78.31 1.66 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.201 1.001 . . . . 0.0 111.077 173.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.3 t -70.14 161.04 30.96 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.358 1.063 . . . . 0.0 111.607 170.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.3 t -81.47 134.27 51.62 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 124.414 1.086 . . . . 0.0 110.184 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -74.62 173.85 13.64 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.194 3.262 . . . . 0.0 112.933 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.9 mt -60.14 137.5 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.327 1.451 . . . . 0.0 110.903 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.67 -55.63 0.67 Allowed Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.329 1.919 . . . . 0.0 112.342 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -78.32 178.96 7.25 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.73 1.212 . . . . 0.0 113.281 174.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.2 p -138.37 92.57 2.65 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.618 1.967 . . . . 0.0 110.982 -175.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -66.12 154.9 88.87 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 124.098 0.959 . . . . 0.0 113.569 -177.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.84 151.59 51.34 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.935 2.424 . . . . 0.0 112.36 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.2 t -102.26 -20.62 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 125.136 1.374 . . . . 0.0 112.01 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.89 172.9 6.71 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 127.054 2.142 . . . . 0.0 111.657 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.87 85.77 0.07 OUTLIER Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.622 1.106 . . . . 0.0 112.616 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 tt -133.14 72.37 1.49 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.028 1.331 . . . . 0.0 111.107 -175.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 78.2 m -78.12 97.39 5.43 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.435 1.494 . . . . 0.0 111.346 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -61.55 -60.74 3.23 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.85 1.26 . . . . 0.0 112.751 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.5 167.78 21.04 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.784 0.834 . . . . 0.0 112.274 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -75.32 2.62 10.75 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.975 1.71 . . . . 0.0 114.446 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -93.29 90.05 6.64 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.355 1.862 . . . . 0.0 111.003 -173.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 m -123.14 157.02 33.86 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.506 1.522 . . . . 0.0 111.106 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.9 ttm105 -134.93 155.3 50.95 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.7 1.2 . . . . 0.0 111.79 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -135.55 134.03 39.0 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.578 1.151 . . . . 0.0 110.441 -165.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -136.46 133.59 36.75 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.969 0.908 . . . . 0.0 112.312 -171.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.8 t -72.96 132.1 43.02 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 122.161 -0.337 . . . . 0.0 111.59 174.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.1 mmt -93.47 -91.0 0.19 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.85 0.86 . . . . 0.0 109.831 167.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -97.61 -40.73 3.56 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.509 1.052 . . . . 0.0 114.636 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -146.02 -58.43 0.31 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.493 1.517 . . . . 0.0 110.966 -173.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.7 p -83.27 168.81 16.35 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.672 1.189 . . . . 0.0 112.117 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.0 p -121.11 105.99 11.13 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.495 1.118 . . . . 0.0 112.844 169.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -73.88 177.27 5.68 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.567 1.147 . . . . 0.0 112.14 173.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.2 p -88.9 134.17 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.271 1.828 . . . . 0.0 111.842 173.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -137.22 172.19 13.37 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.323 1.449 . . . . 0.0 111.107 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -127.12 108.01 10.53 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.784 1.234 . . . . 0.0 111.629 -174.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.82 168.21 36.51 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.2 1.381 . . . . 0.0 113.717 -176.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 7.9 p -58.92 129.69 43.36 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -138.18 -40.63 0.53 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.33 1.452 . . . . 0.0 113.208 -174.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.3 t -144.89 -22.4 0.5 Allowed 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -168.0 -161.73 18.38 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.867 1.699 . . . . 0.0 112.122 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -153.48 58.59 0.41 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.328 0.966 . . . . 0.0 113.876 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -70.77 -32.37 69.47 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -174.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.6 p 55.53 -3.4 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 128.868 2.867 . . . . 0.0 117.522 -171.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -131.14 135.11 47.17 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.374 1.87 . . . . 0.0 112.217 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 40.2 ttm -63.62 -33.0 74.64 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.516 1.126 . . . . 0.0 112.862 175.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.42 -22.89 77.8 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 121.456 -0.777 . . . . 0.0 113.799 174.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -83.87 -40.77 18.21 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.529 1.165 . . . . 0.0 112.33 175.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.6 p -65.14 -23.76 67.22 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.487 1.039 . . . . 0.0 113.06 173.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.52 -60.48 2.26 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.88 1.672 . . . . 0.0 111.89 170.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -61.34 -28.38 69.18 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -172.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -73.9 -8.09 54.75 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.322 1.049 . . . . 0.0 113.557 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.91 167.48 19.37 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 125.688 1.595 . . . . 0.0 114.213 -174.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.99 -9.61 16.73 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 123.172 2.581 . . . . 0.0 114.595 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.236 0 C-N-CA 125.864 1.697 . . . . 0.0 113.459 179.259 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.51 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -127.58 80.87 1.98 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.605 1.162 . . . . 0.0 111.216 -157.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -78.38 80.85 4.76 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.138 1.375 . . . . 0.0 111.079 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -61.99 -38.23 87.8 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.183 0.993 . . . . 0.0 112.361 175.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -156.06 -178.79 7.57 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.982 2.113 . . . . 0.0 111.395 173.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 47.2 t -133.29 123.79 26.12 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.26 1.424 . . . . 0.0 110.654 172.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.1 m -63.31 122.26 15.76 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.52 1.528 . . . . 0.0 112.245 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.3 t -78.01 134.12 64.4 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.837 1.255 . . . . 0.0 110.716 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.54 164.81 30.0 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.196 3.264 . . . . 0.0 113.442 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.9 mm -60.3 145.24 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.844 1.257 . . . . 0.0 111.21 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.08 25.62 57.23 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.074 0.845 . . . . 0.0 114.2 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -63.54 178.21 0.6 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.701 2.001 . . . . 0.0 115.271 -178.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.0 t -139.67 48.96 1.81 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.373 1.869 . . . . 0.0 110.905 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.55 151.81 68.85 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.424 1.489 . . . . 0.0 112.968 175.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -74.79 158.25 43.12 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.231 2.62 . . . . 0.0 113.54 -170.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.77 -29.97 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.836 0.854 . . . . 0.0 112.55 177.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.41 177.51 7.09 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.415 1.486 . . . . 0.0 112.571 175.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.59 -107.29 0.29 Allowed Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.522 1.058 . . . . 0.0 112.416 172.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.1 tp -154.17 115.54 4.12 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.672 1.589 . . . . 0.0 109.751 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.5 t -68.73 173.14 5.46 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.82 1.648 . . . . 0.0 112.337 174.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.39 5.94 21.88 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.324 1.85 . . . . 0.0 114.71 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.25 156.47 12.4 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.664 1.185 . . . . 0.0 113.298 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -81.27 4.38 20.68 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.883 1.673 . . . . 0.0 115.051 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -140.55 117.65 11.22 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.944 2.097 . . . . 0.0 110.521 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.9 m -142.45 154.56 44.66 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.332 1.453 . . . . 0.0 110.777 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -100.95 151.73 21.41 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.49 1.116 . . . . 0.0 111.316 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -125.06 138.81 54.19 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.578 1.151 . . . . 0.0 111.185 -174.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -132.36 135.76 46.37 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.076 1.351 . . . . 0.0 111.051 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 38.5 t -80.19 104.7 10.93 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.901 0.48 . . . . 0.0 111.004 169.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 87.5 mmm -76.04 -18.74 59.11 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.29 -78.29 0.05 OUTLIER Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.554 1.073 . . . . 0.0 112.861 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -109.26 -3.83 16.92 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.059 1.344 . . . . 0.0 114.058 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 25.1 p -149.13 157.99 43.82 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.946 2.099 . . . . 0.0 109.895 -176.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.4 p -111.17 147.81 34.12 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 168.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.0 mtpp -140.72 167.33 22.42 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.542 1.937 . . . . 0.0 111.844 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.78 125.76 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.915 1.286 . . . . 0.0 111.884 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -146.21 166.3 26.63 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.51 1.524 . . . . 0.0 110.72 177.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -142.68 103.05 4.16 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.353 1.061 . . . . 0.0 112.104 -172.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.7 -175.94 45.32 Favored Glycine 0 CA--C 1.532 1.132 0 O-C-N 121.455 -0.778 . . . . 0.0 113.742 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 63.1 m -68.01 14.41 0.06 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 127.207 2.203 . . . . 0.0 115.163 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -60.48 99.97 0.09 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 128.133 2.573 . . . . 0.0 110.797 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 21.7 m -53.69 -61.61 2.19 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.476 1.911 . . . . 0.0 113.003 -175.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.1 93.21 1.29 Allowed Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.444 1.497 . . . . 0.0 113.47 -174.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -147.65 175.05 27.19 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.158 1.361 . . . . 0.0 113.273 175.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -121.23 -17.71 7.61 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.521 1.675 . . . . 0.0 115.521 -165.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 58.63 4.48 0.37 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.572 1.949 . . . . 0.0 116.136 -176.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -138.13 142.89 40.14 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.93 2.092 . . . . 0.0 111.266 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.6 tpp -71.62 -32.19 67.71 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.323 1.049 . . . . 0.0 112.741 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.09 -48.12 67.69 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 121.598 -0.689 . . . . 0.0 111.402 175.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -64.86 -37.31 87.22 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.466 1.506 . . . . 0.0 113.409 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.5 p -71.57 -27.34 63.08 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.925 1.239 . . . . 0.0 113.39 171.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.16 -43.27 21.89 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.821 1.249 . . . . 0.0 112.992 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -63.52 -26.62 68.79 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 120.723 1.601 . . . . 0.0 113.482 -177.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -78.89 -9.26 59.43 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.641 1.577 . . . . 0.0 113.698 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 m -131.71 167.12 23.51 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 125.015 1.326 . . . . 0.0 113.97 -173.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.39 -11.66 15.81 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.968 2.445 . . . . 0.0 114.19 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.22 0 C-N-CA 126.919 2.2 . . . . 0.0 112.552 179.431 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.641 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -65.87 -21.51 66.46 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -171.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -67.85 -19.04 65.0 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -176.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -114.76 116.23 28.31 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.996 1.319 . . . . 0.0 111.312 172.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -78.02 -16.87 57.73 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.6 p -75.48 156.45 35.2 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.727 0.811 . . . . 0.0 112.304 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.3 m -144.89 143.42 30.58 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.917 1.287 . . . . 0.0 110.73 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.0 t -68.74 133.95 90.38 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 124.112 0.965 . . . . 0.0 110.655 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.59 -175.36 2.41 Favored 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 124.401 3.401 . . . . 0.0 112.232 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.1 pt -59.51 166.06 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.987 1.315 . . . . 0.0 113.501 175.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.36 -59.38 4.11 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.666 1.603 . . . . 0.0 112.378 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -73.35 -178.37 2.95 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.866 1.266 . . . . 0.0 112.925 170.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.4 p -126.83 133.29 50.79 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.873 1.669 . . . . 0.0 111.063 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -74.97 152.46 86.59 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 123.869 0.868 . . . . 0.0 112.659 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.44 169.44 22.41 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.713 2.942 . . . . 0.0 111.906 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.9 t -131.35 -19.84 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.732 1.213 . . . . 0.0 112.05 -171.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt 55.27 2.75 0.06 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 128.326 2.65 . . . . 0.0 116.271 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -108.25 -7.89 29.93 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.756 1.646 . . . . 0.0 115.492 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.1 mp -74.95 -66.44 0.75 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.011 1.406 . . . . 0.0 110.855 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.4 t -139.0 153.12 48.11 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.273 1.429 . . . . 0.0 112.199 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.0 mtpt -135.72 83.99 2.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.618 2.367 . . . . 0.0 109.872 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.67 174.12 10.86 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.431 1.493 . . . . 0.0 112.514 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.02 -5.62 54.4 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.63 1.572 . . . . 0.0 114.697 -174.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -85.28 -15.61 42.86 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.094 1.357 . . . . 0.0 114.348 -170.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.5 m -68.79 158.82 33.57 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.836 1.254 . . . . 0.0 111.959 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -133.22 165.3 25.11 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.487 1.515 . . . . 0.0 111.82 -176.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -114.24 133.25 55.76 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.072 1.349 . . . . 0.0 111.466 -169.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -134.96 162.42 32.48 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.86 1.264 . . . . 0.0 111.805 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.7 t -101.68 108.69 20.3 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.563 1.145 . . . . 0.0 110.856 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 16.7 mmt -73.4 -60.27 2.32 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.101 0.56 . . . . 0.0 112.264 174.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -169.59 97.44 0.12 Allowed Glycine 0 N--CA 1.469 0.894 0 C-N-CA 124.149 0.881 . . . . 0.0 112.244 -170.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 58.92 11.43 1.91 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.88 2.072 . . . . 0.0 114.994 -175.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 6.4 t -151.49 147.74 27.2 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.053 2.141 . . . . 0.0 109.078 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 13.6 p -125.19 143.67 50.83 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 170.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.4 mtpp -149.57 170.94 17.48 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.253 1.421 . . . . 0.0 112.348 -172.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.3 p -75.01 128.52 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.509 1.524 . . . . 0.0 111.008 169.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -136.5 108.48 7.15 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.528 1.131 . . . . 0.0 111.439 -175.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -64.22 147.45 52.34 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.731 1.213 . . . . 0.0 112.149 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.98 177.62 21.54 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 125.771 1.653 . . . . 0.0 113.902 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 64.7 m -73.42 146.5 45.01 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 122.004 -0.703 . . . . 0.0 111.667 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -154.69 119.88 5.0 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.321 1.449 . . . . 0.0 108.742 170.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.2 m -57.56 -49.19 77.18 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.051 0.94 . . . . 0.0 112.632 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.44 172.61 45.1 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.811 1.196 . . . . 0.0 113.536 172.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 170.56 170.12 34.46 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.473 1.035 . . . . 0.0 114.933 176.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -111.68 -22.51 11.15 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.6 p 55.38 -4.28 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 128.85 2.86 . . . . 0.0 117.714 -172.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -133.29 137.7 46.12 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.472 1.909 . . . . 0.0 111.756 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.1 tpp -64.15 -33.12 75.06 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.603 1.161 . . . . 0.0 112.072 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.21 -38.17 82.12 Favored Glycine 0 CA--C 1.531 1.086 0 O-C-N 121.582 -0.699 . . . . 0.0 112.852 176.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -68.62 -47.55 66.37 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.011 0.924 . . . . 0.0 112.52 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.3 p -62.37 -25.9 68.17 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.392 0.996 . . . . 0.0 112.773 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.72 -64.46 1.07 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.52 1.528 . . . . 0.0 111.404 171.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -63.68 -27.47 69.24 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -171.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -78.93 -2.04 38.08 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.953 0.901 . . . . 0.0 113.251 174.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.67 170.55 7.85 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 127.023 2.129 . . . . 0.0 112.347 176.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -82.54 -8.07 11.54 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.071 2.514 . . . . 0.0 114.092 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.277 0 C-N-CA 126.548 2.023 . . . . 0.0 114.265 -178.764 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.575 0 N-CA-C 112.207 -0.357 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -70.79 168.94 15.64 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.489 1.515 . . . . 0.0 113.612 175.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -129.48 109.19 10.85 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.432 1.893 . . . . 0.0 109.884 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -64.58 155.91 31.61 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.929 0.892 . . . . 0.0 112.567 178.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -146.92 177.25 9.28 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.149 1.38 . . . . 0.0 112.803 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.4 t -140.19 153.48 46.62 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.166 1.787 . . . . 0.0 110.161 176.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.6 t -69.33 165.27 21.05 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.852 0.861 . . . . 0.0 112.168 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.3 t -145.07 133.56 10.85 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 125.619 1.568 . . . . 0.0 110.002 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.8 163.88 32.82 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.362 3.375 . . . . 0.0 113.376 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.426 HD11 ' H ' ' A' ' 28' ' ' ILE . 4.5 mp -58.93 138.43 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.161 1.384 . . . . 0.0 110.755 177.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.39 28.03 41.5 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.142 0.877 . . . . 0.0 114.472 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -63.88 176.22 0.99 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.295 1.838 . . . . 0.0 115.886 -176.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 72.5 m -131.87 63.07 1.62 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.223 2.209 . . . . 0.0 110.65 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -63.25 156.59 68.35 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 125.123 1.369 . . . . 0.0 112.841 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.26 172.47 13.99 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.2 2.6 . . . . 0.0 113.815 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 p -119.45 20.86 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 126.957 2.103 . . . . 0.0 112.178 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -57.67 164.37 2.09 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.151 2.18 . . . . 0.0 115.195 -174.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 144.94 -29.52 1.83 Allowed Glycine 0 CA--C 1.536 1.397 0 C-N-CA 126.051 1.786 . . . . 0.0 114.321 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.24 1.95 6.4 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.698 1.599 . . . . 0.0 113.956 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.6 t -62.59 138.68 58.54 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.359 1.064 . . . . 0.0 112.317 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -113.55 -7.68 13.37 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.767 1.627 . . . . 0.0 114.598 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.19 170.58 12.69 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.875 0.87 . . . . 0.0 112.401 172.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -124.1 9.92 8.72 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.986 1.714 . . . . 0.0 114.472 -175.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -88.83 74.35 8.29 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.155 1.382 . . . . 0.0 112.03 -170.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.16 133.91 55.86 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.736 0.815 . . . . 0.0 111.404 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -137.28 154.86 50.02 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.424 1.09 . . . . 0.0 111.846 -172.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -132.87 129.18 38.08 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.856 1.263 . . . . 0.0 110.454 -169.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -139.55 129.42 24.82 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.24 1.016 . . . . 0.0 111.597 -171.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 40.6 t -71.83 129.87 39.67 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.753 -0.592 . . . . 0.0 112.587 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 43.7 mtm -132.79 -80.37 0.49 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.687 1.195 . . . . 0.0 112.042 167.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -86.35 60.56 4.54 Favored Glycine 0 N--CA 1.474 1.177 0 O-C-N 121.201 -0.937 . . . . 0.0 114.353 -170.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.4 m120 59.68 14.04 3.8 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.448 1.899 . . . . 0.0 113.901 -172.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 28.2 p -144.89 160.62 41.01 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.711 2.804 . . . . 0.0 109.322 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 18.5 p -115.15 87.39 2.65 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.765 0.826 . . . . 0.0 111.879 170.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -67.24 164.32 18.53 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 122.12 0.962 . . . . 0.0 111.85 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.2 p -82.49 128.5 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.929 1.292 . . . . 0.0 111.587 174.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -131.39 154.37 48.7 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.509 1.524 . . . . 0.0 110.829 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -132.0 89.52 2.69 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.135 1.374 . . . . 0.0 110.366 -174.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.61 175.71 42.37 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.902 1.239 . . . . 0.0 112.889 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 29.5 m -66.71 141.89 57.6 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.472 0.709 . . . . 0.0 111.765 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.63 121.93 5.67 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.887 1.275 . . . . 0.0 109.097 173.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.0 m -59.18 -37.13 76.65 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.472 1.109 . . . . 0.0 113.343 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -100.1 -161.98 28.55 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 126.405 1.955 . . . . 0.0 113.623 176.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 123.74 172.01 13.65 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.988 1.756 . . . . 0.0 114.541 174.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -107.1 -18.21 13.96 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -173.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.4 t 60.47 -14.07 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 127.728 2.411 . . . . 0.0 116.496 -174.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 42.2 mmt180 -125.24 136.52 53.62 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.519 1.927 . . . . 0.0 112.094 -177.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 62.2 tpp -59.8 -38.27 81.47 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.191 1.396 . . . . 0.0 112.129 175.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.33 -29.69 65.89 Favored Glycine 0 CA--C 1.533 1.194 0 O-C-N 121.716 -0.615 . . . . 0.0 113.769 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -82.25 -41.29 20.41 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.15 0.975 . . . . 0.0 112.403 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.0 p -64.89 -23.41 67.22 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.07 0.85 . . . . 0.0 112.895 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.27 -64.03 1.11 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.481 1.512 . . . . 0.0 111.589 169.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -61.41 -28.1 69.02 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -171.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -78.46 -6.27 54.86 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.11 0.964 . . . . 0.0 113.565 174.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -122.35 170.85 7.19 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 126.625 1.97 . . . . 0.0 112.437 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.11 -7.16 17.11 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.229 2.62 . . . . 0.0 114.724 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.286 0 C-N-CA 126.747 2.117 . . . . 0.0 114.742 -178.735 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.642 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -68.9 -23.43 64.19 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -169.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -125.18 23.22 7.72 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 126.37 1.868 . . . . 0.0 113.112 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -58.82 120.42 8.97 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.507 1.923 . . . . 0.0 112.636 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -146.18 172.51 13.33 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.816 1.646 . . . . 0.0 112.145 172.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.2 p -127.47 170.46 12.54 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.901 1.68 . . . . 0.0 112.542 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.7 p -90.31 161.69 15.52 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.756 1.223 . . . . 0.0 111.925 173.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.8 m -66.06 155.54 86.93 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 123.524 0.729 . . . . 0.0 112.257 176.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -64.17 156.24 60.46 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.493 2.795 . . . . 0.0 112.47 172.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 40.5 pt -61.69 143.78 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.783 0.833 . . . . 0.0 112.083 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.86 -6.73 11.41 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.116 1.341 . . . . 0.0 116.188 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -76.71 172.32 13.26 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.42 1.61 . . . . 0.0 112.243 176.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.5 t -128.97 92.98 3.49 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.856 1.262 . . . . 0.0 111.827 -174.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -61.75 152.62 75.0 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 125.158 1.383 . . . . 0.0 113.864 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.36 86.95 1.4 Allowed 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.867 3.045 . . . . 0.0 112.243 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.6 p -68.19 -29.64 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.639 1.176 . . . . 0.0 113.161 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -78.71 -68.13 0.68 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.884 1.674 . . . . 0.0 112.593 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.67 43.79 91.41 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.138 1.351 . . . . 0.0 114.498 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.0 tp -113.11 92.85 4.15 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.971 1.708 . . . . 0.0 111.174 -169.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 31.3 p -120.41 178.21 4.75 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.588 1.955 . . . . 0.0 113.502 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -127.84 -60.0 1.17 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.396 1.878 . . . . 0.0 112.099 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.05 173.23 6.76 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.636 1.174 . . . . 0.0 113.259 176.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -110.1 47.66 0.94 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.63 1.972 . . . . 0.0 113.297 -173.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -122.25 95.53 4.68 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.894 1.678 . . . . 0.0 110.788 -176.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.6 m -132.35 154.63 49.57 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.111 1.364 . . . . 0.0 110.876 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -138.78 124.21 19.38 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.808 1.243 . . . . 0.0 111.485 -174.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -76.98 140.03 40.28 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.649 1.18 . . . . 0.0 111.483 -177.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -131.36 127.42 37.56 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.87 1.268 . . . . 0.0 111.141 -176.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.7 t -65.98 122.86 18.33 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.809 0.338 . . . . 0.0 110.846 171.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 37.6 mtp -137.5 111.96 8.66 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.159 1.384 . . . . 0.0 110.327 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.05 -68.48 2.84 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.6 1.095 . . . . 0.0 112.39 -174.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -145.94 -52.22 0.25 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 8.4 p -83.82 172.62 11.99 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.295 0.952 . . . . 0.0 112.437 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.4 p -121.2 90.69 3.37 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.311 1.044 . . . . 0.0 112.75 172.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -74.12 173.59 9.88 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.358 1.063 . . . . 0.0 112.218 172.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.02 130.11 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.48 1.512 . . . . 0.0 111.26 168.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -142.99 163.63 32.27 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.161 1.784 . . . . 0.0 110.61 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -130.76 -1.36 4.24 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.39 170.55 54.88 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.416 1.007 . . . . 0.0 114.079 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 56.6 m -67.74 105.08 1.81 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.653 1.181 . . . . 0.0 111.358 177.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.44 98.88 4.07 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.574 1.15 . . . . 0.0 109.985 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.0 m -53.64 -47.36 70.4 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.676 1.59 . . . . 0.0 113.373 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.06 60.78 4.65 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.499 1.523 . . . . 0.0 114.29 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.97 164.01 35.14 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.613 1.101 . . . . 0.0 114.324 176.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -120.35 -26.72 5.36 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 59.95 5.5 0.76 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.653 1.981 . . . . 0.0 115.735 -175.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -136.63 129.75 31.21 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.647 1.979 . . . . 0.0 111.428 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 31.5 ttm -61.58 -31.23 71.27 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.732 1.213 . . . . 0.0 113.043 175.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.45 -37.02 48.02 Favored Glycine 0 CA--C 1.528 0.903 0 O-C-N 121.889 -0.507 . . . . 0.0 113.268 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -76.05 -44.49 38.89 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.731 0.812 . . . . 0.0 112.132 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.4 p -64.93 -21.75 66.88 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.58 -63.14 1.48 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.495 1.518 . . . . 0.0 111.466 170.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -61.68 -28.44 69.4 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -76.56 -5.0 45.81 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 174.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -126.07 167.15 17.77 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 125.865 1.666 . . . . 0.0 113.656 -175.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.21 -8.11 14.05 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.277 2.652 . . . . 0.0 114.531 -174.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.375 0 C-N-CA 126.106 1.812 . . . . 0.0 114.357 179.383 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.496 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -82.0 -19.64 40.08 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -174.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -85.0 165.13 17.82 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.292 1.437 . . . . 0.0 112.292 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -76.05 74.29 2.92 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.497 1.519 . . . . 0.0 111.749 176.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -141.65 157.09 45.51 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.621 1.568 . . . . 0.0 112.263 175.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 61.3 m -71.16 154.04 42.02 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.462 0.705 . . . . 0.0 111.558 173.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.6 t -70.14 -175.73 1.02 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.267 1.027 . . . . 0.0 112.529 170.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.4 t -135.09 134.23 21.44 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 126.354 1.862 . . . . 0.0 110.03 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.36 162.8 37.66 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.074 3.183 . . . . 0.0 113.171 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.411 HD12 ' H ' ' A' ' 28' ' ' ILE . 4.2 mp -60.67 141.02 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.883 1.273 . . . . 0.0 110.593 176.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.35 26.12 40.98 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.099 0.857 . . . . 0.0 114.336 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -63.69 177.86 0.67 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.432 2.293 . . . . 0.0 116.016 -176.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.0 p -134.93 65.73 1.55 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 127.398 2.279 . . . . 0.0 111.122 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.45 154.68 53.11 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 124.983 1.313 . . . . 0.0 113.84 178.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -72.61 169.27 22.28 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.555 2.836 . . . . 0.0 112.738 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.0 t -132.48 56.06 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.518 1.527 . . . . 0.0 109.277 -177.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.4 mtmm -59.82 131.49 51.05 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.637 1.175 . . . . 0.0 110.88 172.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.08 79.98 0.12 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.905 1.24 . . . . 0.0 111.9 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.2 mt 55.18 32.97 19.53 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.11 1.764 . . . . 0.0 113.565 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 67.0 m -58.54 153.15 16.72 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.914 1.685 . . . . 0.0 113.464 -174.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.0 mmpt? -123.85 73.57 1.22 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.168 1.787 . . . . 0.0 111.015 -174.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -137.32 163.03 31.98 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.568 1.547 . . . . 0.0 111.781 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.1 mtp85 -129.68 12.37 5.82 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.109 1.764 . . . . 0.0 113.8 -175.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -132.52 109.46 9.8 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.528 1.931 . . . . 0.0 110.899 -175.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.6 156.82 38.33 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.231 1.012 . . . . 0.0 111.547 174.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -142.5 166.47 24.59 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.136 1.375 . . . . 0.0 111.681 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -131.08 144.6 51.55 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.344 1.058 . . . . 0.0 111.424 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -141.34 132.3 26.08 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.838 1.255 . . . . 0.0 111.005 -171.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 36.1 t -82.42 109.73 16.92 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.631 1.172 . . . . 0.0 111.766 173.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 6.9 mmt -72.33 -9.8 58.96 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 173.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.09 -37.15 0.46 Allowed Glycine 0 N--CA 1.474 1.211 0 C-N-CA 124.257 0.932 . . . . 0.0 114.76 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -141.82 -53.98 0.44 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.669 1.588 . . . . 0.0 111.248 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 36.8 t -107.7 110.3 22.11 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.462 1.505 . . . . 0.0 110.215 -175.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 21.4 p -74.97 146.95 41.26 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -128.58 171.86 11.73 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.524 1.93 . . . . 0.0 111.097 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 p -75.22 131.95 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.69 1.196 . . . . 0.0 111.019 172.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -145.11 163.47 34.21 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.575 1.15 . . . . 0.0 111.195 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -154.47 149.54 26.87 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.278 1.431 . . . . 0.0 110.229 174.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 135.16 -172.86 21.9 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.925 1.25 . . . . 0.0 113.359 -172.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 63.6 m -72.8 6.73 2.35 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 -172.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -68.36 97.46 0.75 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.472 1.909 . . . . 0.0 111.789 -177.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.8 m -55.16 -41.57 71.99 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 126.319 1.848 . . . . 0.0 114.206 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.49 58.44 4.99 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.16 1.362 . . . . 0.0 115.029 -171.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -100.83 173.7 24.84 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 125.118 1.342 . . . . 0.0 114.591 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -107.38 159.07 16.67 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.133 1.773 . . . . 0.0 111.186 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.3 p -79.59 -40.4 29.45 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 120.855 -1.153 . . . . 0.0 113.256 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.8 mmp_? -139.39 161.82 36.53 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.93 2.092 . . . . 0.0 111.627 -177.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 49.1 ttm -67.43 -29.19 68.61 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.398 0.679 . . . . 0.0 112.382 -177.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.53 -28.71 70.1 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.445 -0.642 . . . . 0.0 113.855 171.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -74.65 -50.85 16.16 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.796 1.298 . . . . 0.0 111.901 172.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.7 p -66.33 -19.76 65.9 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.73 -66.48 0.74 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.465 1.506 . . . . 0.0 111.887 164.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -60.48 -28.65 68.51 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -169.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -81.05 -7.0 59.47 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.335 1.054 . . . . 0.0 113.78 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -119.72 164.98 19.01 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 125.956 1.702 . . . . 0.0 112.723 -177.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -75.94 -6.38 17.35 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.527 2.818 . . . . 0.0 115.089 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.237 0 C-N-CA 126.075 1.798 . . . . 0.0 113.429 177.47 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.575 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -136.2 96.82 3.46 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.112 1.365 . . . . 0.0 110.656 -167.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -66.72 -37.14 84.09 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.809 1.243 . . . . 0.0 113.341 -176.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -111.28 173.53 6.3 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.286 1.834 . . . . 0.0 111.771 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -129.15 148.34 51.09 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.468 1.507 . . . . 0.0 111.15 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.9 m -71.0 135.15 47.68 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.394 0.677 . . . . 0.0 111.516 178.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.1 t -74.06 167.21 21.99 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.452 0.701 . . . . 0.0 111.842 169.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.1 t -84.63 132.86 45.36 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 124.698 1.199 . . . . 0.0 109.789 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.85 179.98 5.74 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 124.525 3.484 . . . . 0.0 112.67 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.9 mm -56.49 147.95 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 126.038 1.735 . . . . 0.0 112.414 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.48 -60.02 1.07 Allowed Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.919 1.723 . . . . 0.0 111.918 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -81.77 -178.71 7.09 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.047 1.339 . . . . 0.0 112.654 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.0 t -147.41 174.88 11.27 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.082 1.753 . . . . 0.0 110.627 172.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -83.64 111.29 30.9 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 125.275 1.43 . . . . 0.0 113.266 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -74.93 158.56 42.4 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.978 2.452 . . . . 0.0 111.559 168.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.1 t -107.11 -35.12 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.835 1.254 . . . . 0.0 111.543 173.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -63.07 152.52 36.84 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.597 1.159 . . . . 0.0 112.4 175.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.29 -6.88 62.29 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.039 1.304 . . . . 0.0 116.21 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.8 mp -78.96 32.55 0.21 Allowed 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 119.308 1.554 . . . . 0.0 112.566 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 57.0 m -66.17 12.83 0.06 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 128.85 2.86 . . . . 0.0 115.428 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 61.03 9.07 2.17 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 129.164 2.986 . . . . 0.0 115.607 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.6 169.66 13.83 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.778 1.631 . . . . 0.0 113.324 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.1 mtm180 -116.75 -8.68 11.37 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -173.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -77.99 -25.83 48.26 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.3 m -62.52 147.2 49.67 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.885 1.274 . . . . 0.0 111.635 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -87.86 159.03 18.56 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.338 1.055 . . . . 0.0 111.322 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -119.66 123.86 44.88 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.258 1.023 . . . . 0.0 110.879 -172.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -119.42 130.17 55.15 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.246 1.018 . . . . 0.0 111.129 -171.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 41.8 t -73.42 97.08 2.47 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.679 0.792 . . . . 0.0 111.653 176.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 15.4 mmt -72.52 80.6 1.07 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.692 1.597 . . . . 0.0 110.668 169.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.43 -63.22 3.37 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.497 1.522 . . . . 0.0 114.456 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -123.63 -53.81 1.77 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.336 1.454 . . . . 0.0 112.408 -173.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 9.6 m -101.98 171.64 7.39 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.316 1.446 . . . . 0.0 111.018 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 11.0 p -120.6 158.82 26.55 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.027 0.931 . . . . 0.0 113.372 172.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -150.07 172.99 14.38 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 126.126 1.77 . . . . 0.0 111.239 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.3 p -76.96 125.62 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.506 1.523 . . . . 0.0 111.974 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -145.09 111.62 5.74 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.544 1.138 . . . . 0.0 111.206 -178.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -75.88 98.39 4.19 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.254 -0.904 . . . . 0.0 110.901 169.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.69 167.95 38.1 Favored Glycine 0 CA--C 1.533 1.186 0 O-C-N 121.107 -0.996 . . . . 0.0 114.36 174.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.4 m -72.69 101.6 3.11 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.023 1.329 . . . . 0.0 111.335 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -133.42 97.41 3.95 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.75 1.22 . . . . 0.0 109.716 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.7 m -49.47 -49.31 46.03 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.111 1.764 . . . . 0.0 113.618 -175.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.48 77.4 0.95 Allowed Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.317 1.437 . . . . 0.0 112.784 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -131.13 175.63 19.43 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.431 1.491 . . . . 0.0 114.491 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -130.39 134.67 47.31 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.841 1.256 . . . . 0.0 112.014 -173.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 65.4 p -79.56 -8.47 59.19 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -129.12 138.42 51.8 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.574 1.549 . . . . 0.0 112.282 -176.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 61.4 tpp -65.45 -33.5 76.09 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.574 1.15 . . . . 0.0 112.056 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.45 -37.02 85.18 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 121.71 -0.619 . . . . 0.0 112.922 175.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 82.0 mm-40 -72.01 -46.37 57.43 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.294 1.037 . . . . 0.0 112.22 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.8 p -63.54 -24.21 67.71 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.07 0.85 . . . . 0.0 113.046 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.62 -64.13 1.25 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.481 1.513 . . . . 0.0 112.045 170.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -62.69 -28.18 69.76 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -169.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -81.43 -6.35 58.85 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.4 164.14 17.22 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 126.198 1.799 . . . . 0.0 112.786 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.56 -17.18 16.44 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.66 2.24 . . . . 0.0 113.854 -173.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.381 0 C-N-CA 126.587 2.042 . . . . 0.0 115.074 -179.705 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.556 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -98.55 9.48 43.13 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.054 1.742 . . . . 0.0 114.972 -170.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -58.14 161.41 4.18 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.855 1.662 . . . . 0.0 112.782 175.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -64.57 149.79 48.12 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.841 0.856 . . . . 0.0 111.892 172.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -138.57 168.26 20.16 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.974 1.71 . . . . 0.0 111.414 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.0 t -69.75 128.21 35.61 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.467 0.707 . . . . 0.0 111.287 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 50.6 p -136.38 169.38 17.76 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.501 1.521 . . . . 0.0 112.281 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.6 t -69.24 133.93 89.37 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.96 0.904 . . . . 0.0 110.169 177.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.8 158.65 56.99 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.128 3.219 . . . . 0.0 112.516 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.7 mt -63.63 136.07 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.936 0.895 . . . . 0.0 109.817 177.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.42 -10.56 63.74 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.523 1.535 . . . . 0.0 115.456 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.27 172.22 11.57 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.535 1.667 . . . . 0.0 112.853 172.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.0 t -107.65 91.55 3.7 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.093 1.357 . . . . 0.0 110.437 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -56.73 115.36 10.0 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 125.071 1.349 . . . . 0.0 113.32 -176.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.86 94.57 1.07 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.481 2.788 . . . . 0.0 111.739 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 p -70.83 -24.42 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 124.337 1.055 . . . . 0.0 113.0 175.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -62.76 154.02 30.96 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.69 1.596 . . . . 0.0 111.78 173.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.62 31.87 62.36 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 123.726 0.679 . . . . 0.0 114.538 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.8 tp -74.05 59.97 0.75 Allowed 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.947 1.699 . . . . 0.0 112.583 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 31.8 p -149.7 173.74 13.36 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.457 1.903 . . . . 0.0 112.555 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.25 78.31 1.78 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.55 1.94 . . . . 0.0 110.984 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.74 178.55 4.11 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.787 0.804 . . . . 0.0 112.29 168.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -12.31 59.87 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.814 1.646 . . . . 0.0 113.429 171.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -126.63 105.03 8.42 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.708 2.803 . . . . 0.0 108.896 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.4 m -128.77 158.63 38.12 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.501 1.92 . . . . 0.0 110.313 -175.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -114.07 162.08 16.92 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.476 1.111 . . . . 0.0 112.834 170.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -146.98 127.83 14.41 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.999 1.32 . . . . 0.0 110.051 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -132.4 137.88 47.49 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.757 1.223 . . . . 0.0 111.701 -174.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 35.4 t -79.68 115.89 19.54 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.164 0.986 . . . . 0.0 111.792 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 96.3 mmm -90.25 -10.95 42.38 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.846 1.258 . . . . 0.0 114.22 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.54 -87.94 0.08 OUTLIER Glycine 0 N--CA 1.469 0.869 0 C-N-CA 124.536 1.065 . . . . 0.0 111.807 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -86.54 -31.6 21.17 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 171.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.5 p -125.98 166.33 17.13 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.732 2.013 . . . . 0.0 111.74 -170.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.5 p -113.87 153.3 29.43 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 167.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.7 ttpt -124.39 165.72 17.24 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.549 1.94 . . . . 0.0 110.513 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.2 p -69.98 135.72 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.273 1.029 . . . . 0.0 111.609 171.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -144.15 177.37 8.63 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.167 1.787 . . . . 0.0 110.515 174.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -136.38 156.79 48.13 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.982 0.913 . . . . 0.0 112.353 175.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.45 175.93 10.71 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.665 1.126 . . . . 0.0 113.969 -170.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 76.9 m -91.96 85.32 5.52 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.557 1.143 . . . . 0.0 110.375 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -70.08 84.82 0.53 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.01 1.324 . . . . 0.0 111.268 -178.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 m 61.7 7.07 1.77 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 126.612 1.965 . . . . 0.0 114.018 -174.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.78 149.44 9.47 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 127.212 2.339 . . . . 0.0 113.295 -174.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.12 -91.36 0.08 OUTLIER Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.491 1.044 . . . . 0.0 112.513 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -135.31 157.41 46.97 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.346 1.058 . . . . 0.0 113.162 -174.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.9 m -123.29 5.53 9.11 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.153 1.781 . . . . 0.0 113.092 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 -138.47 139.38 38.8 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.968 2.107 . . . . 0.0 111.0 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 30.0 tpp -59.35 -35.47 73.94 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.788 1.235 . . . . 0.0 112.14 172.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.09 -24.85 73.36 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 121.196 -0.94 . . . . 0.0 114.383 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -80.32 -46.28 16.4 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.641 1.221 . . . . 0.0 111.952 175.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.6 p -64.17 -25.03 67.9 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.28 -61.62 1.76 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.59 1.556 . . . . 0.0 111.855 171.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -61.56 -27.37 68.58 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -173.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -79.68 -4.82 53.48 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.442 1.097 . . . . 0.0 113.702 174.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m -125.61 166.43 21.09 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 126.431 1.892 . . . . 0.0 113.077 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.29 -13.76 16.76 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.772 2.314 . . . . 0.0 114.05 -176.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.214 0 C-N-CA 126.507 2.003 . . . . 0.0 112.95 179.611 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.521 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -132.22 80.01 1.89 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.526 1.13 . . . . 0.0 110.928 -165.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.65 18.03 2.62 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 127.109 2.164 . . . . 0.0 114.885 -175.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -65.82 145.39 56.02 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.297 1.439 . . . . 0.0 111.403 172.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -134.58 -162.57 1.27 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.132 1.773 . . . . 0.0 110.724 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.2 m -68.28 75.77 0.25 Allowed 'General case' 0 CA--C 1.549 0.915 0 O-C-N 120.647 -1.283 . . . . 0.0 112.223 174.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.4 m -125.15 139.39 53.8 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.384 2.274 . . . . 0.0 109.624 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.8 t -72.89 136.25 80.09 Favored Pre-proline 0 N--CA 1.477 0.876 0 O-C-N 121.694 -0.629 . . . . 0.0 110.376 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.6 150.34 88.37 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.658 2.905 . . . . 0.0 112.22 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.4 mp -61.66 133.43 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.357 1.063 . . . . 0.0 110.181 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.58 -12.87 63.92 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.712 1.625 . . . . 0.0 115.415 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -73.51 159.87 32.53 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.76 1.78 . . . . 0.0 112.529 174.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.4 m -82.79 76.05 9.66 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.301 1.04 . . . . 0.0 111.749 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -54.21 111.87 3.3 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 125.586 1.554 . . . . 0.0 113.457 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.18 113.09 3.34 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.241 2.627 . . . . 0.0 111.954 -176.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.7 p -76.4 -25.1 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.002 0.921 . . . . 0.0 113.171 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 pmtp? -66.74 168.16 10.02 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.101 1.36 . . . . 0.0 113.798 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.71 166.56 39.44 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.6 1.572 . . . . 0.0 112.566 174.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.0 tp -146.75 74.04 1.34 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.744 1.217 . . . . 0.0 110.987 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 76.2 m -63.68 165.56 8.13 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.474 1.11 . . . . 0.0 112.375 176.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm 60.13 -0.91 0.21 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.177 2.591 . . . . 0.0 116.505 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.18 160.4 26.96 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.023 1.329 . . . . 0.0 113.121 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.9 ptt85 -80.95 -0.74 40.71 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.276 1.43 . . . . 0.0 114.81 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -137.33 137.24 38.73 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.073 2.149 . . . . 0.0 109.781 -176.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.5 m -141.65 144.53 34.19 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.664 1.985 . . . . 0.0 110.098 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -123.66 157.02 34.77 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.504 1.521 . . . . 0.0 110.547 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -143.95 137.89 28.1 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.895 0.878 . . . . 0.0 111.217 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -141.0 131.33 25.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.467 1.107 . . . . 0.0 111.541 -177.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 15.2 t -77.47 126.32 30.72 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.018 0.927 . . . . 0.0 111.911 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 96.6 mmm -108.7 0.3 20.48 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.191 1.397 . . . . 0.0 113.828 -174.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.39 -78.37 0.14 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 125.33 1.443 . . . . 0.0 111.79 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -115.11 -1.04 13.12 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.017 1.327 . . . . 0.0 113.567 177.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 38.7 t -149.07 156.4 42.17 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.252 1.821 . . . . 0.0 110.038 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.2 p -119.87 103.93 9.76 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.34 1.056 . . . . 0.0 113.005 176.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -70.52 165.97 21.55 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.245 1.018 . . . . 0.0 111.408 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -77.37 139.04 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.756 1.222 . . . . 0.0 111.647 168.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -138.74 172.17 13.26 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.722 2.009 . . . . 0.0 110.335 173.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.6 mp0 -134.44 123.66 24.38 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.906 1.282 . . . . 0.0 110.665 -173.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.06 173.26 49.67 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.627 1.108 . . . . 0.0 113.322 -170.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 75.9 m -82.91 85.72 7.08 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.466 1.106 . . . . 0.0 111.527 -177.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -73.95 93.91 2.27 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.116 0.966 . . . . 0.0 110.508 174.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 59.6 p 54.29 -0.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 128.972 2.909 . . . . 0.0 117.972 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.64 153.67 30.32 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 127.247 2.356 . . . . 0.0 113.359 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.61 -86.76 0.1 OUTLIER Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.333 0.968 . . . . 0.0 113.376 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -132.65 162.76 30.52 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.319 1.448 . . . . 0.0 112.371 -175.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 74.0 m -126.59 -3.88 6.61 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -137.98 147.83 44.61 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.262 1.825 . . . . 0.0 110.306 172.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 32.7 ttm -62.52 -32.29 73.2 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 122.62 0.368 . . . . 0.0 111.934 177.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -58.72 -33.75 74.11 Favored Glycine 0 CA--C 1.533 1.163 0 O-C-N 121.446 -0.783 . . . . 0.0 114.126 175.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -72.41 -50.34 27.09 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.434 1.117 . . . . 0.0 111.799 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.3 p -65.5 -30.07 70.8 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.37 -58.63 3.34 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.706 1.202 . . . . 0.0 112.192 173.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -60.68 -30.05 69.69 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -171.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 -82.27 -22.57 35.69 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.194 0.998 . . . . 0.0 113.57 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m -97.03 168.66 9.9 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 125.717 1.607 . . . . 0.0 112.208 176.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.71 -7.44 15.65 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.017 2.478 . . . . 0.0 114.617 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.29 0 C-N-CA 126.264 1.888 . . . . 0.0 113.862 -178.401 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.429 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -151.48 165.36 34.42 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.066 1.746 . . . . 0.0 111.783 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -84.57 102.62 13.02 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.066 1.346 . . . . 0.0 111.413 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.1 -5.16 38.01 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.498 1.519 . . . . 0.0 114.178 178.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -134.22 163.64 29.16 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.346 1.858 . . . . 0.0 112.987 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.1 m -61.81 128.42 36.13 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.751 1.22 . . . . 0.0 111.953 170.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.6 t -145.66 164.92 30.25 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.161 1.384 . . . . 0.0 111.243 171.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.4 m -71.72 154.9 92.83 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 125.46 1.504 . . . . 0.0 112.546 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -69.94 155.64 64.85 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.906 2.404 . . . . 0.0 110.662 174.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.9 mt -61.28 134.98 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.86 0.864 . . . . 0.0 110.634 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.04 51.17 47.2 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.032 1.301 . . . . 0.0 114.006 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 37.7 p90 -76.65 -177.76 4.41 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.808 1.643 . . . . 0.0 112.528 177.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.9 m -133.54 93.09 3.08 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.473 1.909 . . . . 0.0 110.142 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -57.32 115.78 11.73 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 124.536 1.134 . . . . 0.0 113.629 -173.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.6 105.81 2.13 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.649 2.899 . . . . 0.0 111.651 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.6 t -130.64 75.76 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.126 1.37 . . . . 0.0 109.622 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -149.82 176.11 11.02 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.825 2.05 . . . . 0.0 111.656 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.15 65.67 3.23 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.58 1.086 . . . . 0.0 114.146 172.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.26 -3.76 1.48 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -177.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 67.1 m -61.17 164.26 5.42 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.952 1.701 . . . . 0.0 113.526 177.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -127.55 74.98 1.56 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.79 1.636 . . . . 0.0 111.638 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.94 165.9 16.8 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.87 0.868 . . . . 0.0 112.378 172.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -77.83 1.47 20.22 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.623 1.569 . . . . 0.0 114.12 176.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -143.2 164.67 29.55 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.746 2.818 . . . . 0.0 108.398 175.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.1 m -132.98 151.91 52.01 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.281 1.832 . . . . 0.0 110.479 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -85.24 150.69 24.62 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.752 1.221 . . . . 0.0 112.151 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -132.95 129.28 38.06 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.527 1.131 . . . . 0.0 110.935 -177.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -125.87 130.62 51.71 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.259 1.024 . . . . 0.0 111.707 -172.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.7 t -70.15 119.16 13.93 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.99 0.516 . . . . 0.0 111.116 171.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 81.8 mmm -118.05 94.37 4.48 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.293 1.837 . . . . 0.0 109.086 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.74 -65.07 4.19 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.728 1.156 . . . . 0.0 113.678 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -133.97 -59.76 0.83 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.376 1.47 . . . . 0.0 112.043 -172.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 p -96.91 168.17 10.64 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.198 1.799 . . . . 0.0 111.458 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 14.3 p -109.49 150.25 28.4 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 172.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -133.34 162.6 31.39 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.973 1.709 . . . . 0.0 112.684 -175.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 p -78.86 126.29 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 125.884 1.673 . . . . 0.0 111.724 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -145.98 103.4 3.74 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.191 0.996 . . . . 0.0 111.308 -178.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -62.88 111.69 2.25 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.044 1.338 . . . . 0.0 110.826 172.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.47 -156.88 26.94 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.096 0.855 . . . . 0.0 113.863 -175.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 78.0 m -134.31 114.65 13.21 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.048 2.139 . . . . 0.0 109.959 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -124.94 92.14 3.58 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.661 1.985 . . . . 0.0 109.329 -178.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 m 50.07 35.94 11.01 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.589 1.955 . . . . 0.0 114.19 174.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.08 23.0 78.53 Favored Glycine 0 CA--C 1.539 1.567 0 O-C-N 120.865 -1.147 . . . . 0.0 115.678 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.99 174.26 5.74 Favored Glycine 0 CA--C 1.542 1.757 0 C-N-CA 125.232 1.396 . . . . 0.0 116.184 -176.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -62.87 139.32 58.72 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 -159.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.5 m -74.64 -19.04 60.45 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.904 1.681 . . . . 0.0 114.828 176.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -137.96 154.66 49.36 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.247 1.819 . . . . 0.0 112.061 -176.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 49.3 ttm -75.48 -29.79 59.69 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.15 -29.54 75.59 Favored Glycine 0 CA--C 1.533 1.184 0 O-C-N 121.385 -0.822 . . . . 0.0 113.047 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -74.52 -48.33 27.68 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.874 1.67 . . . . 0.0 111.838 173.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.9 p -66.27 -25.98 67.13 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.284 0.947 . . . . 0.0 113.426 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.09 -59.16 2.85 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.377 1.471 . . . . 0.0 111.791 173.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -61.92 -28.3 69.43 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 -172.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -78.57 -6.7 56.26 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.461 1.104 . . . . 0.0 113.765 175.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -129.16 168.69 15.24 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 125.845 1.658 . . . . 0.0 113.346 -175.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -74.52 -19.25 19.29 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.756 2.304 . . . . 0.0 113.555 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.657 1.599 . . . . 0.0 114.287 -179.391 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.548 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -73.48 157.66 36.39 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.318 1.047 . . . . 0.0 112.522 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -127.42 145.44 50.82 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.165 1.786 . . . . 0.0 111.669 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -91.62 87.81 6.49 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.07 1.348 . . . . 0.0 110.977 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -106.8 -44.61 4.4 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.372 1.069 . . . . 0.0 112.908 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.7 t -73.82 94.87 2.33 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.113 0.965 . . . . 0.0 110.452 167.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.5 p -80.99 175.18 10.91 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.259 1.424 . . . . 0.0 111.843 170.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.9 t -118.66 134.62 23.51 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 125.357 1.463 . . . . 0.0 109.866 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -78.05 -170.37 0.95 Allowed 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 124.685 3.59 . . . . 0.0 112.614 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.1 pt -55.24 165.39 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 126.341 1.856 . . . . 0.0 114.021 175.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.06 -61.23 4.76 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.803 1.668 . . . . 0.0 111.936 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -78.45 -179.45 6.35 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.057 1.343 . . . . 0.0 112.85 170.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.7 t -145.45 177.06 9.13 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.211 1.804 . . . . 0.0 110.201 164.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -84.87 112.31 41.97 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 125.062 1.345 . . . . 0.0 112.15 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.05 122.6 8.57 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.61 2.873 . . . . 0.0 112.542 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -78.89 -25.33 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.405 1.082 . . . . 0.0 113.414 174.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -66.9 154.99 39.63 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.458 1.503 . . . . 0.0 112.663 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.6 50.96 0.04 OUTLIER Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.933 1.254 . . . . 0.0 114.445 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.87 60.71 2.35 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.245 1.418 . . . . 0.0 111.991 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 83.3 m -117.44 155.57 29.45 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.224 1.81 . . . . 0.0 111.661 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.43 24.9 1.9 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.752 1.621 . . . . 0.0 113.944 -171.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.51 168.71 13.26 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.852 1.661 . . . . 0.0 112.279 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -73.38 0.99 10.58 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.526 1.93 . . . . 0.0 115.787 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -84.72 83.23 8.1 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.6 1.56 . . . . 0.0 111.987 -173.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.51 156.98 44.76 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.584 1.554 . . . . 0.0 111.317 -173.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 24.3 ttp180 -145.54 162.64 36.95 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.742 1.217 . . . . 0.0 111.77 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -123.28 111.58 16.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.284 1.034 . . . . 0.0 111.377 -167.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -108.8 122.73 47.79 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.763 0.825 . . . . 0.0 111.729 -171.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.4 t -69.77 111.72 5.72 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.939 1.296 . . . . 0.0 111.4 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 57.7 mtp -138.26 84.35 2.03 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.943 2.097 . . . . 0.0 110.394 -175.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.4 64.01 1.41 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.245 0.926 . . . . 0.0 114.111 175.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 56.74 22.93 7.37 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 126.331 1.853 . . . . 0.0 114.485 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 9.8 t -149.48 153.0 36.57 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 128.479 2.711 . . . . 0.0 108.102 172.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 7.1 p -114.51 121.55 43.84 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.026 0.931 . . . . 0.0 111.497 165.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -100.44 160.92 13.96 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.582 1.553 . . . . 0.0 111.039 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.7 p -74.76 129.05 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.629 0.772 . . . . 0.0 110.834 166.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -134.94 149.33 50.22 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.693 0.797 . . . . 0.0 111.597 171.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -88.47 154.7 20.15 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.685 1.194 . . . . 0.0 110.928 173.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.26 -176.84 33.64 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-O 122.21 0.894 . . . . 0.0 114.81 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 65.3 m -94.82 23.09 5.74 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.335 1.454 . . . . 0.0 114.504 -171.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -40.18 -44.37 1.83 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 127.019 2.128 . . . . 0.0 115.419 -170.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 98.0 m -155.28 82.65 1.06 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.857 1.663 . . . . 0.0 109.224 174.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -51.72 101.99 0.07 OUTLIER Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.526 1.536 . . . . 0.0 114.862 -176.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -126.74 -90.31 0.74 Allowed Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.764 1.65 . . . . 0.0 114.008 -175.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -121.77 116.69 24.95 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.641 1.177 . . . . 0.0 113.234 -164.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.7 m -84.71 -2.34 57.44 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -127.96 139.14 52.75 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.584 1.554 . . . . 0.0 111.378 174.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 38.9 ttm -69.45 -26.41 64.58 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.61 -33.69 72.1 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 121.798 -0.564 . . . . 0.0 112.96 172.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -74.19 -48.0 31.9 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.068 0.947 . . . . 0.0 111.835 173.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.6 p -63.79 -24.24 67.68 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.36 -65.38 0.93 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.661 1.584 . . . . 0.0 112.226 168.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -61.46 -28.7 69.47 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -168.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -84.11 -5.99 59.33 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.142 0.977 . . . . 0.0 113.474 177.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.45 169.84 6.35 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 126.373 1.869 . . . . 0.0 112.257 177.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -77.59 -8.81 17.2 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.056 2.504 . . . . 0.0 113.765 -178.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.311 0 C-N-CA 127.57 2.51 . . . . 0.0 112.615 177.424 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.523 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -82.61 104.36 12.82 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.776 1.23 . . . . 0.0 112.522 -175.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -65.03 -30.87 71.88 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.015 1.326 . . . . 0.0 113.919 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -82.52 113.82 20.51 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.599 1.56 . . . . 0.0 110.778 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -142.05 166.98 23.22 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.731 1.213 . . . . 0.0 112.894 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 71.8 m -65.03 134.58 54.17 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.712 0.805 . . . . 0.0 111.473 173.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.7 p -129.46 173.43 10.57 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.934 1.694 . . . . 0.0 111.287 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.6 t -58.18 134.74 84.49 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 124.39 1.076 . . . . 0.0 110.863 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -65.92 155.94 66.86 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 124.488 3.459 . . . . 0.0 112.658 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.1 pt -57.37 135.42 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.738 0.815 . . . . 0.0 112.368 -178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.47 -13.45 22.12 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.451 1.5 . . . . 0.0 116.075 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -75.55 146.06 40.77 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 119.833 1.816 . . . . 0.0 112.252 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.0 t -90.93 96.12 10.47 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.445 1.098 . . . . 0.0 111.717 -175.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -57.72 142.99 77.26 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 124.611 1.164 . . . . 0.0 113.791 -176.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.47 81.0 2.9 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.913 3.075 . . . . 0.0 112.677 -171.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 p -61.07 -28.4 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 125.169 1.388 . . . . 0.0 113.114 -178.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -83.08 -4.91 58.85 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.083 2.153 . . . . 0.0 114.576 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.3 -139.35 6.58 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.365 1.459 . . . . 0.0 112.789 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.5 mt 65.22 11.21 7.05 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 127.051 2.14 . . . . 0.0 115.419 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 16.7 t -73.45 150.73 41.44 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.04 1.336 . . . . 0.0 112.777 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.6 37.87 0.36 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.958 2.503 . . . . 0.0 113.593 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.16 159.7 25.71 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.107 -0.996 . . . . 0.0 113.088 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -86.03 0.38 53.52 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.703 1.601 . . . . 0.0 114.88 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -144.26 122.24 12.07 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.183 2.193 . . . . 0.0 109.705 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.9 m -148.31 167.57 24.83 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.969 1.308 . . . . 0.0 111.445 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.0 ttm180 -129.61 159.95 34.79 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.707 1.603 . . . . 0.0 111.513 -176.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -126.63 103.74 7.73 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.942 0.897 . . . . 0.0 111.953 -166.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -103.76 122.54 45.29 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.89 0.876 . . . . 0.0 112.346 -169.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.8 t -71.18 103.93 2.93 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.371 1.068 . . . . 0.0 110.794 171.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -136.07 111.21 8.96 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.499 1.92 . . . . 0.0 110.944 -177.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.46 53.78 5.37 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 123.945 0.783 . . . . 0.0 112.8 -170.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 63.24 -11.0 0.1 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 129.328 3.051 . . . . 0.0 116.896 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 48.4 t -126.9 158.24 37.28 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.884 2.074 . . . . 0.0 110.213 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.9 p -108.2 150.76 26.83 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 174.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -141.35 169.47 17.54 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.017 1.327 . . . . 0.0 111.798 172.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.26 126.16 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.006 1.322 . . . . 0.0 111.406 171.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -144.2 165.08 28.84 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.232 1.413 . . . . 0.0 111.217 174.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -126.49 104.79 8.33 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.037 1.335 . . . . 0.0 110.603 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.94 -178.31 36.96 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.466 1.508 . . . . 0.0 111.932 -176.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 77.8 m -99.36 103.35 15.15 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.625 1.17 . . . . 0.0 111.167 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -121.7 86.9 2.66 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.969 1.308 . . . . 0.0 110.402 -178.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.264 1.3 t 49.43 14.67 0.11 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 129.012 2.925 . . . . 0.0 117.182 174.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.88 33.72 45.17 Favored Glycine 0 CA--C 1.537 1.426 0 O-C-N 120.302 -1.499 . . . . 0.0 114.241 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.37 176.24 6.58 Favored Glycine 0 CA--C 1.543 1.812 0 C-N-CA 124.923 1.249 . . . . 0.0 115.564 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -70.07 147.59 49.84 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -162.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -89.38 -30.04 18.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.656 1.182 . . . . 0.0 113.158 174.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -91.17 135.51 33.73 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.84 1.256 . . . . 0.0 111.651 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 38.1 ttm -69.09 -25.32 64.37 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.432 0.693 . . . . 0.0 112.551 176.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.35 -46.86 75.23 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.585 0.612 . . . . 0.0 111.967 171.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.25 -47.05 86.07 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.149 0.98 . . . . 0.0 112.553 176.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.2 p -65.32 -23.48 67.02 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.67 -67.47 0.76 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.0 1.32 . . . . 0.0 111.643 168.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.08 -26.3 68.2 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -168.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -86.05 -4.86 59.26 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.024 0.93 . . . . 0.0 113.381 175.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.37 166.5 10.85 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 126.174 1.79 . . . . 0.0 112.077 176.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.86 -8.76 16.87 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.217 2.612 . . . . 0.0 114.426 -175.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.231 0 C-N-CA 126.493 1.997 . . . . 0.0 114.714 179.459 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.476 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -149.33 153.45 37.48 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.417 1.487 . . . . 0.0 110.843 173.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.1 tptm 49.3 29.78 2.87 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.914 2.086 . . . . 0.0 114.218 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -66.28 108.84 2.45 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.674 1.99 . . . . 0.0 113.081 -173.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -80.94 -17.24 51.16 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.9 t -69.39 149.94 47.83 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 119.175 0.898 . . . . 0.0 112.842 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.9 p -131.52 166.6 21.01 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.316 1.846 . . . . 0.0 112.15 -177.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.6 m -69.82 155.08 94.1 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.345 1.058 . . . . 0.0 112.341 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.7 156.14 67.22 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.934 2.423 . . . . 0.0 111.777 173.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 74.4 mt -66.92 136.15 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.034 0.934 . . . . 0.0 110.049 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.26 -0.84 83.17 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.216 1.388 . . . . 0.0 115.746 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.91 174.99 7.0 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.135 1.467 . . . . 0.0 112.693 175.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.9 t -128.31 92.23 3.4 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.926 1.29 . . . . 0.0 111.033 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.59 148.48 90.73 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 124.85 1.26 . . . . 0.0 113.798 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -70.98 169.33 20.73 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.762 2.975 . . . . 0.0 113.336 -178.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.8 t -108.57 94.96 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.075 1.75 . . . . 0.0 109.366 -172.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.19 172.27 7.01 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.111 2.164 . . . . 0.0 112.831 -175.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.1 -18.85 0.73 Allowed Glycine 0 CA--C 1.536 1.364 0 N-CA-C 115.916 1.126 . . . . 0.0 115.916 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.8 mp -80.83 61.78 4.6 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 119.171 1.486 . . . . 0.0 110.941 178.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.7 t -71.19 3.22 3.73 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 126.564 1.946 . . . . 0.0 114.189 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -65.42 -21.88 66.71 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.318 1.847 . . . . 0.0 113.884 177.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.24 168.81 11.59 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.491 1.117 . . . . 0.0 112.772 171.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -115.03 17.11 16.98 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.214 1.805 . . . . 0.0 113.732 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -138.26 123.38 19.16 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.543 2.337 . . . . 0.0 109.679 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -137.27 164.23 29.05 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.526 1.931 . . . . 0.0 110.149 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -133.5 171.7 13.73 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.675 1.19 . . . . 0.0 112.835 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -136.72 110.36 8.05 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.938 1.295 . . . . 0.0 110.394 -163.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -99.02 134.62 41.59 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.184 0.994 . . . . 0.0 111.219 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.9 t -69.14 128.44 36.66 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.924 -0.485 . . . . 0.0 110.947 171.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 98.7 mmm -114.68 81.55 1.58 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.581 1.952 . . . . 0.0 109.78 176.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.43 -62.42 4.08 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.304 1.43 . . . . 0.0 114.087 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -133.32 -53.83 0.9 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.296 1.439 . . . . 0.0 112.647 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 14.6 p -76.02 176.3 8.07 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.535 1.134 . . . . 0.0 111.335 171.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.23 163.27 16.23 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.261 -0.899 . . . . 0.0 111.617 161.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -134.22 154.81 51.04 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.441 1.496 . . . . 0.0 112.042 175.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 p -82.26 130.17 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.54 1.136 . . . . 0.0 112.52 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -145.06 170.34 16.37 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.349 1.46 . . . . 0.0 111.579 173.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -124.57 161.03 27.05 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.102 1.361 . . . . 0.0 112.082 -169.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.74 177.64 24.39 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.843 1.211 . . . . 0.0 114.324 -177.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.3 t -81.83 80.81 8.04 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.521 -0.988 . . . . 0.0 111.184 175.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -84.01 76.46 10.05 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 122.167 0.984 . . . . 0.0 110.511 171.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.6 m 60.82 32.07 20.09 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.926 1.29 . . . . 0.0 112.861 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.47 -85.34 0.84 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.799 1.666 . . . . 0.0 113.319 178.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 59.24 -131.63 51.73 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.811 1.672 . . . . 0.0 113.744 -176.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -100.52 163.92 12.14 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.775 1.23 . . . . 0.0 112.133 -176.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.0 m -129.12 -0.7 5.19 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.771 1.228 . . . . 0.0 114.112 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -143.4 162.16 36.5 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.697 1.599 . . . . 0.0 112.833 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -42.5 95.26 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.205 1.802 . . . . 0.0 111.286 177.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.14 -25.67 75.25 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 121.493 -0.755 . . . . 0.0 114.155 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -74.26 -46.71 39.68 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.006 1.403 . . . . 0.0 112.037 175.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.7 p -61.14 -31.45 71.16 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.69 -0.631 . . . . 0.0 112.339 176.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.07 -53.47 6.38 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.999 1.72 . . . . 0.0 113.05 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -58.77 -28.17 65.67 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 120.203 1.365 . . . . 0.0 114.385 -174.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -84.08 -6.28 59.38 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.086 1.354 . . . . 0.0 113.858 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.0 m -129.85 162.97 50.31 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 125.197 1.399 . . . . 0.0 114.311 -172.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.98 -9.82 14.14 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.468 2.779 . . . . 0.0 114.943 -175.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.41 0 C-N-CA 125.816 1.674 . . . . 0.0 114.593 -177.685 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.528 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -131.0 0.76 4.24 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -161.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -71.37 159.51 34.42 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.218 1.407 . . . . 0.0 112.054 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -72.84 161.76 30.32 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.431 1.093 . . . . 0.0 112.081 170.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -140.28 139.2 35.47 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.519 1.528 . . . . 0.0 111.13 177.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 75.3 m -80.69 170.55 16.17 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.754 0.821 . . . . 0.0 112.174 170.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.9 p -135.36 159.6 41.06 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.462 1.505 . . . . 0.0 111.541 168.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.0 p -79.9 130.67 66.09 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 124.701 1.2 . . . . 0.0 110.997 176.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.46 141.43 42.37 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.457 2.105 . . . . 0.0 110.993 171.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.1 pt -56.68 134.67 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.551 0.74 . . . . 0.0 112.336 -178.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.7 -8.01 57.95 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.388 1.47 . . . . 0.0 115.53 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 24.6 t-105 -77.75 152.85 33.4 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 119.728 1.764 . . . . 0.0 110.12 168.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.5 t -78.24 72.58 4.78 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 122.564 1.173 . . . . 0.0 112.178 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -66.79 154.52 91.69 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 125.67 1.588 . . . . 0.0 114.022 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -76.26 150.8 33.33 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.09 2.527 . . . . 0.0 111.627 175.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.5 t -136.84 76.86 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.099 1.36 . . . . 0.0 109.813 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.71 -28.57 0.43 Allowed 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 116.143 1.905 . . . . 0.0 116.143 -177.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.3 -169.61 24.99 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.16 0.886 . . . . 0.0 113.169 -165.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 98.0 mt -134.75 113.46 11.67 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.311 2.244 . . . . 0.0 108.404 177.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 63.1 m 61.4 29.3 18.43 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.437 1.895 . . . . 0.0 114.628 177.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -53.49 -53.57 49.56 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 126.123 1.769 . . . . 0.0 112.57 175.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.26 169.31 10.48 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.091 1.356 . . . . 0.0 112.19 174.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -108.49 5.07 24.87 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.348 1.859 . . . . 0.0 114.592 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -143.48 102.81 4.01 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.751 2.02 . . . . 0.0 110.85 -176.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.3 m -150.36 155.38 39.51 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 120.806 -1.184 . . . . 0.0 111.51 -177.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -77.71 160.99 28.08 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.771 1.228 . . . . 0.0 112.673 173.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -131.58 107.67 9.01 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.911 1.285 . . . . 0.0 110.759 -174.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -114.6 122.26 45.96 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.959 1.304 . . . . 0.0 112.462 -168.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 35.3 t -67.64 122.7 18.62 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.279 1.032 . . . . 0.0 112.008 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.34 -10.6 1.24 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -171.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 169.23 70.97 0.03 OUTLIER Glycine 0 N--CA 1.47 0.921 0 O-C-N 121.498 -0.751 . . . . 0.0 111.84 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.7 m120 60.83 1.86 0.48 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 127.953 2.501 . . . . 0.0 116.253 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 79.8 m -132.14 160.44 36.03 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.121 1.768 . . . . 0.0 110.158 163.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.7 p -101.26 91.22 4.41 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.93 1.292 . . . . 0.0 111.13 167.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -67.64 154.25 41.89 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.727 1.611 . . . . 0.0 112.319 -176.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 p -66.64 121.49 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.425 1.49 . . . . 0.0 112.351 172.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -140.05 122.48 16.09 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.451 1.5 . . . . 0.0 111.796 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -74.33 150.68 40.02 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.491 0.716 . . . . 0.0 112.02 171.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.8 174.65 13.41 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.138 1.352 . . . . 0.0 115.417 176.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 17.6 p -80.33 39.08 0.44 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.513 1.925 . . . . 0.0 114.14 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -51.51 -34.91 38.11 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.196 1.398 . . . . 0.0 113.522 178.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.1 t -144.05 -23.86 0.56 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 169.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.63 15.0 81.54 Favored Glycine 0 CA--C 1.539 1.537 0 O-C-N 120.908 -1.12 . . . . 0.0 115.675 171.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -54.26 -68.63 1.56 Allowed Glycine 0 CA--C 1.535 1.33 0 C-N-CA 126.054 1.787 . . . . 0.0 115.073 -174.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -140.31 151.14 44.82 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.889 1.276 . . . . 0.0 112.525 -172.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.8 m -117.89 0.84 12.01 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.341 1.456 . . . . 0.0 114.499 -177.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -135.96 144.77 45.59 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.193 1.797 . . . . 0.0 110.771 174.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -62.91 -35.58 80.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.873 0.869 . . . . 0.0 111.755 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.75 -11.34 77.72 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.356 0.979 . . . . 0.0 114.925 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -96.16 -37.7 10.46 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.986 1.393 . . . . 0.0 112.099 176.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.7 p -70.79 -45.91 63.82 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.194 -0.941 . . . . 0.0 112.005 171.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.21 -12.48 61.19 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -177.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -85.33 -25.53 27.09 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 119.821 1.192 . . . . 0.0 113.626 168.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -91.47 -29.0 17.26 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.844 1.258 . . . . 0.0 112.995 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.3 m -106.53 165.41 13.0 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 126.009 1.724 . . . . 0.0 112.68 175.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -79.12 -4.92 14.18 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.049 2.5 . . . . 0.0 114.775 -171.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.333 0 C-N-CA 126.823 2.154 . . . . 0.0 115.236 -178.737 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.525 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -140.78 171.0 14.71 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.921 1.688 . . . . 0.0 111.248 -174.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 48.15 47.06 19.56 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.317 1.847 . . . . 0.0 113.188 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -60.9 -34.07 74.09 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.801 1.641 . . . . 0.0 113.328 -177.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -106.13 157.71 17.35 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.624 1.57 . . . . 0.0 110.851 169.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 35.8 t -140.27 143.45 35.93 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.936 1.294 . . . . 0.0 111.149 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.4 m -132.79 146.03 51.49 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.445 1.498 . . . . 0.0 110.937 -168.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.1 m -100.49 155.94 35.79 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 125.037 1.335 . . . . 0.0 112.822 -173.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.3 157.06 62.68 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.436 2.757 . . . . 0.0 112.435 172.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.4 mp -66.06 137.22 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.832 1.253 . . . . 0.0 110.385 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.31 -4.56 67.04 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.549 1.547 . . . . 0.0 115.781 176.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.03 172.66 11.26 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 118.826 1.313 . . . . 0.0 113.048 177.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -115.77 80.75 1.49 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.127 1.371 . . . . 0.0 111.53 -175.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -67.96 155.04 92.74 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 125.275 1.43 . . . . 0.0 114.176 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.24 168.27 25.02 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 124.025 3.15 . . . . 0.0 112.594 174.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.3 t -130.54 10.85 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 125.216 1.406 . . . . 0.0 112.706 -174.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -131.12 170.16 14.91 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.575 1.95 . . . . 0.0 112.252 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.69 31.55 0.22 Allowed Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.988 1.28 . . . . 0.0 115.053 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.6 mp -90.14 85.18 6.21 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.442 1.497 . . . . 0.0 110.735 -175.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.0 m -68.3 77.39 0.26 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.711 1.604 . . . . 0.0 112.9 176.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? -129.86 73.26 1.52 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.571 2.348 . . . . 0.0 110.88 -176.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 46.33 42.47 10.48 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.407 1.883 . . . . 0.0 114.659 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -74.05 -30.31 62.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.146 1.378 . . . . 0.0 113.088 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 50.81 26.57 2.65 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.897 2.079 . . . . 0.0 114.589 -175.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.1 m -60.03 152.67 23.38 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.749 2.42 . . . . 0.0 113.026 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.6 152.21 45.68 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.378 1.471 . . . . 0.0 112.028 176.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -129.6 144.89 51.48 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.84 1.256 . . . . 0.0 111.366 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -143.78 139.91 29.63 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.304 1.442 . . . . 0.0 110.722 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 38.0 t -89.95 123.18 33.65 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.878 0.871 . . . . 0.0 111.981 173.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 29.5 mtt -79.25 -12.84 59.96 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 175.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 154.46 -39.72 0.65 Allowed Glycine 0 N--CA 1.475 1.288 0 CA-C-N 119.293 0.951 . . . . 0.0 114.974 171.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -126.61 -12.06 6.11 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 174.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 25.8 p -151.91 163.43 39.26 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.878 2.071 . . . . 0.0 110.284 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 2.4 p -119.57 151.34 38.8 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.37 1.068 . . . . 0.0 112.68 176.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -122.53 178.89 4.79 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.795 1.638 . . . . 0.0 111.668 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.1 p -115.09 122.56 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.636 1.974 . . . . 0.0 110.806 -174.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -129.33 116.69 19.46 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.133 1.373 . . . . 0.0 111.068 -169.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -57.62 117.97 4.75 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.34 1.456 . . . . 0.0 112.972 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.42 173.52 49.86 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 125.387 1.47 . . . . 0.0 114.478 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 76.4 m -78.38 84.4 4.55 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.443 -1.033 . . . . 0.0 111.159 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -50.25 -50.66 49.37 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.453 1.501 . . . . 0.0 112.703 -178.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 90.6 m -136.89 -44.68 0.58 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.08 1.752 . . . . 0.0 111.723 169.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.5 56.82 0.08 OUTLIER Glycine 0 CA--C 1.536 1.367 0 C-N-CA 126.409 1.957 . . . . 0.0 112.636 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.09 -92.62 0.5 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.826 1.203 . . . . 0.0 113.745 -173.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -110.93 158.18 19.05 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.578 1.151 . . . . 0.0 112.6 -174.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.8 t -102.7 -30.29 10.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.594 1.958 . . . . 0.0 111.87 174.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -132.3 151.09 52.0 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.319 1.848 . . . . 0.0 111.589 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 48.8 ttm -66.93 -19.01 65.65 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.54 0.736 . . . . 0.0 112.926 177.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.61 -16.35 55.38 Favored Glycine 0 CA--C 1.539 1.548 0 O-C-N 121.149 -0.969 . . . . 0.0 114.561 168.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -87.78 -25.5 23.35 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 118.894 1.347 . . . . 0.0 112.761 173.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -61.05 -59.3 5.57 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.392 -0.817 . . . . 0.0 109.752 165.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.84 -12.45 59.17 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -170.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -92.37 -25.19 18.63 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 170.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -90.79 -13.7 33.38 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.946 1.298 . . . . 0.0 113.186 175.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.5 m -129.63 159.17 70.94 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.852 1.661 . . . . 0.0 113.187 -175.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -76.59 -10.39 18.68 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 123.85 3.033 . . . . 0.0 114.63 -176.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 C-N-CA 127.017 2.246 . . . . 0.0 112.276 176.922 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.4 t0 49.9 42.15 23.8 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.514 1.926 . . . . 0.0 114.685 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.98 159.95 8.58 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.537 1.535 . . . . 0.0 113.972 177.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -61.26 119.87 9.29 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.54 1.936 . . . . 0.0 113.275 -176.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -85.68 174.6 9.27 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.089 1.356 . . . . 0.0 113.154 173.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.6 p -110.47 16.22 21.69 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.952 1.701 . . . . 0.0 114.49 -171.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -16.2 -72.93 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 130.085 3.354 . . . . 0.0 116.378 -163.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 m -143.28 151.29 54.64 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 127.195 2.198 . . . . 0.0 111.399 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.9 -27.3 7.18 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.575 2.85 . . . . 0.0 113.621 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.2 pt -136.06 -177.62 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.466 2.306 . . . . 0.0 111.014 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.39 41.64 0.3 Allowed Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.691 1.615 . . . . 0.0 114.248 172.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -59.31 143.52 49.13 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.931 2.092 . . . . 0.0 111.211 175.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.5 t -76.41 85.3 3.16 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.475 1.11 . . . . 0.0 112.116 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -63.98 155.74 76.82 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 125.155 1.382 . . . . 0.0 113.236 175.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.05 138.75 31.54 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.173 2.582 . . . . 0.0 111.076 174.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.6 t -73.39 -40.11 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.733 0.813 . . . . 0.0 111.141 175.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -69.52 161.32 29.77 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.137 1.375 . . . . 0.0 112.124 174.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.0 -126.12 1.34 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.41 1.481 . . . . 0.0 111.274 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 60.9 mt 49.27 45.48 23.43 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.771 1.628 . . . . 0.0 112.479 -177.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 65.9 m -63.22 149.66 44.94 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.964 1.706 . . . . 0.0 112.364 -177.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.97 -5.15 3.12 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.502 1.521 . . . . 0.0 114.804 -177.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.17 168.89 16.26 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.063 0.945 . . . . 0.0 112.144 169.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -105.62 5.64 31.41 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.563 1.945 . . . . 0.0 113.939 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -147.3 116.28 6.86 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.119 2.167 . . . . 0.0 110.335 -176.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.0 m -142.16 159.16 42.77 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.994 1.317 . . . . 0.0 110.775 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -76.92 147.06 37.19 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.538 1.135 . . . . 0.0 111.319 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -132.94 120.55 21.59 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.122 0.969 . . . . 0.0 111.908 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -113.63 122.88 48.54 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.709 1.204 . . . . 0.0 111.567 -175.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.7 t -70.95 115.9 10.62 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.937 0.895 . . . . 0.0 110.852 171.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.4 mmt -82.23 -16.79 48.34 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 165.99 -45.21 0.27 Allowed Glycine 0 N--CA 1.468 0.792 0 C-N-CA 124.675 1.131 . . . . 0.0 113.22 -173.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -136.55 -62.68 0.65 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.292 1.837 . . . . 0.0 110.471 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -81.13 168.43 18.59 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.3 1.04 . . . . 0.0 111.198 173.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 p -121.88 143.89 49.17 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.182 0.993 . . . . 0.0 112.993 170.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -110.48 148.88 31.19 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.778 1.631 . . . . 0.0 111.578 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 p -69.44 127.51 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 126.465 1.906 . . . . 0.0 112.254 169.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -136.02 129.86 32.66 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.085 1.354 . . . . 0.0 111.013 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.85 100.55 0.57 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.999 1.32 . . . . 0.0 112.114 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.73 179.63 50.21 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.076 1.322 . . . . 0.0 114.937 176.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 79.4 m -75.19 75.69 2.33 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.044 1.338 . . . . 0.0 112.002 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -50.18 -49.78 51.35 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.02 1.728 . . . . 0.0 113.116 177.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.4 t -146.93 1.27 0.76 Allowed 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 174.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 111.04 33.54 2.35 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.773 1.178 . . . . 0.0 115.704 173.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.32 -173.67 42.35 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.776 1.655 . . . . 0.0 114.469 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -64.81 148.66 50.84 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.858 1.263 . . . . 0.0 114.108 -173.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.1 t -100.79 -5.43 26.32 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.617 1.567 . . . . 0.0 113.549 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 89.2 mmt-85 -134.84 139.54 45.14 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.314 1.446 . . . . 0.0 111.351 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 47.4 ttm -69.15 -26.32 64.81 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -58.88 -42.81 96.86 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 121.946 -0.471 . . . . 0.0 112.589 169.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -70.06 -45.84 66.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.794 0.838 . . . . 0.0 112.968 177.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 12.9 p -66.68 -20.41 65.97 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.584 1.084 . . . . 0.0 113.355 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.14 -66.19 0.91 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.58 1.552 . . . . 0.0 111.919 168.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -60.22 -27.75 67.45 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 115.356 1.614 . . . . 0.0 115.356 -168.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -85.48 -3.16 58.77 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.576 1.15 . . . . 0.0 113.253 176.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -122.14 166.29 17.57 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 126.858 2.063 . . . . 0.0 112.671 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.71 -8.11 13.48 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.253 2.636 . . . . 0.0 114.838 -176.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.429 0 C-N-CA 125.88 1.705 . . . . 0.0 114.298 -179.53 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.538 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -143.01 166.71 23.9 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.699 1.599 . . . . 0.0 112.797 -176.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -135.3 87.61 2.34 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.383 1.873 . . . . 0.0 110.957 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -85.77 2.18 46.61 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.694 1.198 . . . . 0.0 113.853 175.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -62.18 161.4 11.2 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.635 1.574 . . . . 0.0 113.48 177.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.8 t -62.91 120.02 10.53 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.267 1.427 . . . . 0.0 112.697 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.9 m -68.39 154.44 41.8 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.548 1.539 . . . . 0.0 111.4 174.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.7 t -111.05 135.78 20.85 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 125.594 1.557 . . . . 0.0 110.803 -173.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.62 165.69 26.67 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.685 3.59 . . . . 0.0 113.546 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 63.2 mt -58.96 140.33 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.199 1.399 . . . . 0.0 110.629 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.85 25.05 47.13 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.143 0.878 . . . . 0.0 114.622 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -63.02 175.26 0.91 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.293 1.837 . . . . 0.0 115.505 -178.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.7 m -139.74 65.99 1.41 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 127.374 2.269 . . . . 0.0 110.45 178.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.8 155.61 69.9 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 124.583 1.153 . . . . 0.0 113.564 177.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.78 96.97 1.02 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.724 2.949 . . . . 0.0 113.253 -174.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.5 t -59.97 -43.87 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.316 1.046 . . . . 0.0 111.274 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -76.43 3.66 10.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.288 1.835 . . . . 0.0 114.927 173.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.76 -11.44 30.03 Favored Glycine 0 CA--C 1.541 1.698 0 C-N-CA 124.534 1.064 . . . . 0.0 115.531 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.43 -27.31 67.72 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.525 1.53 . . . . 0.0 113.228 167.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 9.2 t -76.81 165.54 24.57 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.341 1.456 . . . . 0.0 112.077 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -118.05 70.87 0.81 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.228 1.811 . . . . 0.0 110.805 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.36 158.71 19.79 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.428 1.091 . . . . 0.0 112.846 176.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -95.26 9.35 40.11 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.09 1.756 . . . . 0.0 114.577 -177.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -136.17 118.21 15.37 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.467 2.307 . . . . 0.0 110.057 -175.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.64 139.66 47.48 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.467 -0.771 . . . . 0.0 110.41 169.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.37 154.24 44.47 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.694 1.197 . . . . 0.0 112.201 -177.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -140.35 130.8 25.36 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.829 1.252 . . . . 0.0 111.069 -164.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -141.12 126.39 18.56 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.323 1.049 . . . . 0.0 111.956 -168.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 18.1 t -75.39 120.1 20.39 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.514 0.597 . . . . 0.0 112.303 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 37.5 mtm -135.73 87.11 2.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.353 1.461 . . . . 0.0 110.528 171.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.0 68.05 1.26 Allowed Glycine 0 N--CA 1.47 0.945 0 C-N-CA 124.777 1.18 . . . . 0.0 113.479 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 66.31 -2.67 0.95 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 127.759 2.424 . . . . 0.0 115.682 175.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.7 p -137.23 151.07 48.31 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.807 2.043 . . . . 0.0 110.4 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.5 p -118.88 93.94 4.27 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.848 0.859 . . . . 0.0 112.72 173.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -67.72 167.02 14.06 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.642 1.177 . . . . 0.0 112.784 170.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.21 129.0 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.736 1.614 . . . . 0.0 111.69 175.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -135.17 113.9 11.82 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.091 1.757 . . . . 0.0 110.426 -174.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -71.58 169.23 15.95 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.096 0.959 . . . . 0.0 112.667 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.42 167.39 42.6 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.064 1.316 . . . . 0.0 113.557 -176.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 8.8 t -83.47 71.74 10.29 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.489 -1.006 . . . . 0.0 112.157 -177.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -81.94 83.05 7.35 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.251 -0.906 . . . . 0.0 110.711 169.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.0 m -48.7 -35.08 13.19 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.434 1.494 . . . . 0.0 114.828 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.34 73.11 2.64 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.319 1.438 . . . . 0.0 114.948 -171.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.85 -115.8 0.5 Allowed Glycine 0 CA--C 1.53 1.0 0 CA-C-N 118.079 0.94 . . . . 0.0 114.257 171.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -129.8 175.61 8.7 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.156 1.382 . . . . 0.0 112.432 -170.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 80.8 p -123.82 -2.94 8.23 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.219 1.407 . . . . 0.0 114.76 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -140.06 144.95 37.12 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.21 1.804 . . . . 0.0 111.97 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 38.6 tpp -60.67 -31.12 70.37 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.657 1.183 . . . . 0.0 112.202 173.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.94 -14.34 70.5 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.568 1.08 . . . . 0.0 115.296 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -89.97 -43.73 10.36 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.051 1.425 . . . . 0.0 111.823 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 18.1 p -67.62 -23.03 65.32 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.42 -61.99 1.57 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.128 1.371 . . . . 0.0 111.845 170.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -62.29 -26.97 68.71 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -174.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -77.18 -6.61 53.64 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.1 m -123.43 164.91 25.32 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 126.347 1.859 . . . . 0.0 112.607 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -76.44 -17.59 16.37 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.009 2.473 . . . . 0.0 113.934 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.256 0 C-N-CA 126.081 1.801 . . . . 0.0 114.503 -177.593 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.545 0.764 0 CA-C-O 121.015 0.436 . . . . 0.0 112.028 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.4 p -115.89 135.38 54.05 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.625 1.57 . . . . 0.0 111.587 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.7 m -139.97 159.04 43.09 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.53 1.932 . . . . 0.0 109.844 -174.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 p -51.58 118.53 11.46 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 124.857 1.263 . . . . 0.0 112.322 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -78.09 175.37 11.23 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.509 2.806 . . . . 0.0 112.228 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.3 mm -58.13 133.93 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.725 1.21 . . . . 0.0 111.39 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.19 -60.79 0.66 Allowed Glycine 0 CA--C 1.531 1.037 0 C-N-CA 126.322 1.915 . . . . 0.0 111.522 -177.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -85.23 175.72 8.77 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.826 1.25 . . . . 0.0 113.24 175.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.9 m -143.19 122.64 13.14 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.874 2.07 . . . . 0.0 110.218 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.5 152.87 96.2 Favored Pre-proline 0 CA--C 1.554 1.105 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 175.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.77 121.95 8.63 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 124.389 3.393 . . . . 0.0 111.653 176.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.5 p -70.14 -27.06 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.107 0.963 . . . . 0.0 112.572 175.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -70.87 168.65 16.39 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.707 2.003 . . . . 0.0 113.328 175.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.85 148.77 16.58 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.313 1.435 . . . . 0.0 111.919 170.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 29.5 tp -150.93 79.59 1.32 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.632 1.173 . . . . 0.0 111.463 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 85.1 m -68.67 -3.94 13.85 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -68.8 -21.08 64.35 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.91 2.084 . . . . 0.0 114.289 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.7 158.3 30.5 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.712 0.768 . . . . 0.0 112.859 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -92.95 6.64 47.13 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.075 1.75 . . . . 0.0 113.175 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -144.13 167.18 23.01 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 129.488 3.115 . . . . 0.0 108.277 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.6 m -142.15 152.8 43.54 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.551 1.94 . . . . 0.0 109.635 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.9 tpp85 -127.98 146.1 50.76 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.77 1.228 . . . . 0.0 111.758 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -138.26 125.73 21.96 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.032 1.333 . . . . 0.0 110.301 -170.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -131.86 128.63 39.04 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.342 1.057 . . . . 0.0 111.564 -172.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.3 t -70.8 123.6 22.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.326 0.65 . . . . 0.0 111.681 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.1 mmt -84.97 -90.68 0.09 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.842 0.857 . . . . 0.0 110.268 170.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -94.27 -55.21 1.49 Allowed Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.74 1.162 . . . . 0.0 112.821 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -131.43 -49.2 0.99 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.518 1.527 . . . . 0.0 112.919 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 89.0 m -93.5 167.83 11.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.191 1.397 . . . . 0.0 112.353 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.6 p -121.66 103.01 8.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.102 1.361 . . . . 0.0 112.982 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -70.44 167.31 18.55 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.923 1.289 . . . . 0.0 112.73 171.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.1 p -89.73 126.36 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.592 1.557 . . . . 0.0 112.264 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -133.41 160.99 35.76 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.822 1.649 . . . . 0.0 111.052 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -127.82 80.99 1.99 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.556 1.142 . . . . 0.0 111.266 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.06 167.16 30.98 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.295 1.902 . . . . 0.0 112.776 175.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 92.6 m -85.12 72.03 10.83 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.815 1.246 . . . . 0.0 111.138 176.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -74.12 79.39 1.75 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.348 1.859 . . . . 0.0 111.104 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.6 m 55.02 31.33 15.9 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 125.726 1.61 . . . . 0.0 113.368 -177.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.13 -63.35 3.89 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 126.081 1.8 . . . . 0.0 114.154 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 51.81 -118.29 6.99 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 126.968 2.223 . . . . 0.0 114.628 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -125.89 153.21 44.52 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.296 1.438 . . . . 0.0 112.08 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.3 m -118.15 5.75 11.99 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.119 1.368 . . . . 0.0 114.054 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.2 mmt85 -134.03 140.83 46.94 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.881 2.072 . . . . 0.0 110.218 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 51.3 ttm -63.34 -30.98 72.02 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 122.929 0.492 . . . . 0.0 112.084 173.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.38 -43.3 98.51 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 121.483 -0.761 . . . . 0.0 113.086 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -65.64 -48.0 73.65 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.074 0.95 . . . . 0.0 112.537 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.1 p -67.58 -21.54 65.42 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.44 -61.91 1.85 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.326 1.45 . . . . 0.0 111.455 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -61.53 -27.88 68.93 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -172.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 -81.64 -2.76 51.44 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.563 1.145 . . . . 0.0 113.577 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -126.81 167.38 17.66 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 126.336 1.854 . . . . 0.0 112.999 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.4 -8.74 15.04 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.2 2.6 . . . . 0.0 114.693 -176.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.325 0 C-N-CA 125.968 1.747 . . . . 0.0 113.147 178.611 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 N--CA 1.474 0.729 0 CA-C-O 120.868 0.366 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.7 m -96.7 58.41 1.67 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.674 1.189 . . . . 0.0 112.185 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.4 p -67.66 160.04 28.76 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.034 1.334 . . . . 0.0 111.907 167.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.6 m -81.35 157.6 70.25 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 124.592 1.157 . . . . 0.0 112.243 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.45 177.76 8.39 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.056 2.504 . . . . 0.0 111.945 166.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.556 HD12 ' H ' ' A' ' 28' ' ' ILE . 4.1 mp -54.21 132.39 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.901 1.68 . . . . 0.0 112.066 -176.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.74 -48.5 0.94 Allowed Glycine 0 CA--C 1.533 1.164 0 C-N-CA 126.569 2.033 . . . . 0.0 113.536 175.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -89.25 -174.64 4.49 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.345 1.458 . . . . 0.0 113.496 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.5 t -135.31 -79.24 0.43 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.122 1.369 . . . . 0.0 111.929 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -153.78 162.43 26.74 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.86 1.264 . . . . 0.0 112.884 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -71.12 83.98 0.91 Allowed 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.58 2.853 . . . . 0.0 111.559 167.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.5 t -68.32 -43.99 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.412 1.085 . . . . 0.0 110.744 173.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -82.61 173.24 12.12 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.762 2.025 . . . . 0.0 111.816 175.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.43 64.99 0.97 Allowed Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.041 1.305 . . . . 0.0 112.654 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.0 mp -128.94 19.93 5.97 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.741 2.016 . . . . 0.0 111.744 175.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 80.3 m -63.4 168.63 4.34 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.339 1.856 . . . . 0.0 113.322 -174.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.429 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -110.09 14.51 22.91 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.19 1.796 . . . . 0.0 113.087 -179.338 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.64 171.97 2.37 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.626 1.57 . . . . 0.0 113.478 175.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -98.54 1.0 46.12 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.028 1.731 . . . . 0.0 114.271 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -130.04 98.98 4.92 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.245 1.818 . . . . 0.0 112.303 -169.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.9 m -72.95 100.81 3.04 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.122 1.369 . . . . 0.0 110.822 176.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -87.39 142.02 28.19 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.764 0.826 . . . . 0.0 111.941 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -126.11 150.71 48.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.88 1.672 . . . . 0.0 111.974 -176.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -147.94 148.02 30.33 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.012 1.325 . . . . 0.0 112.984 173.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 41.5 t -88.26 113.44 23.87 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.075 1.35 . . . . 0.0 111.884 173.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.0 mmt -72.63 -42.86 63.98 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 173.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.54 -84.33 0.05 OUTLIER Glycine 0 N--CA 1.471 1.008 0 C-N-CA 123.732 0.682 . . . . 0.0 113.164 -175.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -86.76 -40.08 15.34 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 176.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -130.81 169.38 15.8 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.031 2.132 . . . . 0.0 111.671 -173.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 22.7 p -117.51 155.15 30.24 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -132.39 173.9 10.81 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.85 2.46 . . . . 0.0 111.95 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.12 137.68 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 127.008 2.123 . . . . 0.0 112.358 174.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -138.12 -21.51 1.07 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.719 1.608 . . . . 0.0 114.441 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 60.7 16.37 6.61 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 171.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -149.46 173.42 29.28 Favored Glycine 0 N--CA 1.474 1.197 0 O-C-N 120.606 -1.309 . . . . 0.0 114.2 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 71.8 m -78.33 65.18 3.6 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.711 1.204 . . . . 0.0 111.644 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -55.08 -43.1 73.62 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.465 1.506 . . . . 0.0 112.74 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.8 t -142.71 -19.17 0.67 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.357 1.463 . . . . 0.0 113.744 173.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -176.68 -85.05 0.06 OUTLIER Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.595 1.093 . . . . 0.0 111.311 175.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.43 108.26 0.63 Allowed Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.005 0.812 . . . . 0.0 114.383 170.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -60.67 154.46 21.36 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.38 0.672 . . . . 0.0 111.85 165.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.5 t -80.39 -40.35 26.67 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.14 1.376 . . . . 0.0 112.456 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -143.55 157.93 44.05 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 127.016 2.126 . . . . 0.0 111.266 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 5.0 ttt -64.83 -23.63 67.29 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.216 1.007 . . . . 0.0 113.136 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.26 -21.97 64.77 Favored Glycine 0 CA--C 1.535 1.331 0 O-C-N 120.786 -1.196 . . . . 0.0 114.289 171.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -78.93 -44.66 22.14 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.892 1.346 . . . . 0.0 111.925 173.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.0 p -66.53 -22.2 66.17 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 175.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.19 -62.35 1.46 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.208 1.403 . . . . 0.0 111.769 167.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -61.0 -27.98 68.7 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 -172.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -77.69 -6.2 53.1 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.354 1.061 . . . . 0.0 113.757 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m -123.2 164.93 24.72 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 126.208 1.803 . . . . 0.0 113.313 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -79.9 -10.31 14.13 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.17 2.58 . . . . 0.0 114.314 -173.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.381 0 C-N-CA 125.966 1.746 . . . . 0.0 113.797 -178.99 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 61.6 m -120.81 -78.77 0.6 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.238 1.815 . . . . 0.0 110.853 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 70.5 m -156.17 151.58 26.83 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 127.988 2.515 . . . . 0.0 108.547 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.8 m -129.94 156.78 78.53 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 125.221 1.408 . . . . 0.0 112.042 170.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -64.34 152.1 82.79 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.24 2.627 . . . . 0.0 112.244 172.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.2 pt -66.46 149.99 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.606 0.762 . . . . 0.0 112.014 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.03 -2.76 12.06 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 125.077 1.322 . . . . 0.0 116.169 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.27 172.97 11.5 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.218 1.509 . . . . 0.0 112.755 178.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 56.5 m -133.33 92.68 3.04 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.255 1.422 . . . . 0.0 111.149 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -63.51 148.46 93.8 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 124.176 0.991 . . . . 0.0 113.496 -178.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -78.3 75.05 5.08 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.163 3.242 . . . . 0.0 111.592 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 p -59.83 -23.9 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.869 1.668 . . . . 0.0 113.432 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -109.98 7.38 23.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.876 2.471 . . . . 0.0 114.128 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.81 49.81 2.87 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.945 1.736 . . . . 0.0 115.88 -172.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.0 mp -76.26 47.49 0.46 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 126.936 2.095 . . . . 0.0 113.092 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 59.7 m -69.43 154.38 42.1 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.526 -1.358 . . . . 0.0 112.195 169.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.23 16.54 1.52 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -177.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -120.73 167.05 12.89 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.355 1.462 . . . . 0.0 113.17 -177.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -18.43 63.51 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -70.88 -29.25 65.28 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.141 1.376 . . . . 0.0 113.83 -169.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.2 m -76.95 162.93 27.18 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.509 1.524 . . . . 0.0 111.769 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.89 168.31 11.61 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.616 1.566 . . . . 0.0 113.051 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -135.53 140.23 44.58 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.157 1.383 . . . . 0.0 110.482 -171.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -142.01 134.6 28.25 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.826 0.85 . . . . 0.0 112.695 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 31.5 t -75.02 119.16 18.82 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.312 0.645 . . . . 0.0 111.88 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.2 mmt -94.87 -2.86 49.89 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.57 -54.24 0.15 Allowed Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.373 0.987 . . . . 0.0 112.81 175.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -133.78 -19.89 2.03 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 175.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -136.67 167.59 21.13 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.358 1.463 . . . . 0.0 111.325 177.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 11.1 p -121.5 109.41 14.79 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -176.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -76.64 175.18 9.56 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.321 1.048 . . . . 0.0 112.047 167.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.7 p -85.88 137.79 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 126.855 2.062 . . . . 0.0 112.336 171.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -140.23 142.3 35.83 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.268 1.427 . . . . 0.0 111.434 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -93.83 -4.78 49.52 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -165.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -135.41 172.31 22.21 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 126.231 1.872 . . . . 0.0 112.396 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 22.5 t -66.57 145.2 55.88 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 122.052 -0.676 . . . . 0.0 112.607 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.05 82.66 2.06 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.241 1.816 . . . . 0.0 109.235 171.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.4 m 55.08 27.35 9.3 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.8 1.64 . . . . 0.0 113.822 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.58 13.98 74.77 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.358 1.456 . . . . 0.0 116.175 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -43.67 -82.84 0.02 OUTLIER Glycine 0 CA--C 1.539 1.593 0 C-N-CA 127.094 2.283 . . . . 0.0 116.991 -172.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -139.84 166.57 24.27 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.215 1.406 . . . . 0.0 112.435 -170.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.3 m -134.23 -18.45 2.01 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.193 1.397 . . . . 0.0 114.215 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -115.97 153.71 31.13 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.803 1.641 . . . . 0.0 111.544 175.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.0 tpp -65.04 -39.33 93.17 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.772 0.829 . . . . 0.0 111.359 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.77 -30.05 75.83 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.372 -0.682 . . . . 0.0 114.115 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -69.92 -57.79 4.62 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 118.577 1.189 . . . . 0.0 111.369 175.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.6 p -65.89 -26.04 67.44 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.91 -61.01 1.95 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.141 1.377 . . . . 0.0 111.81 168.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -61.98 -29.61 70.37 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -172.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -75.37 -13.59 60.42 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -113.55 166.22 11.73 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 126.413 1.885 . . . . 0.0 112.613 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.38 -17.95 23.54 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.888 2.392 . . . . 0.0 113.837 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.383 0 CA-C-O 117.061 -1.966 . . . . 0.0 115.046 -178.83 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 CA--C 1.543 0.699 0 N-CA-C 111.431 0.16 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.3 t -124.5 78.31 1.66 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.201 1.001 . . . . 0.0 111.077 173.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.3 t -70.14 161.04 30.96 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.358 1.063 . . . . 0.0 111.607 170.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.3 t -81.47 134.27 51.62 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 124.414 1.086 . . . . 0.0 110.184 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -74.62 173.85 13.64 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.194 3.262 . . . . 0.0 112.933 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.9 mt -60.14 137.5 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.327 1.451 . . . . 0.0 110.903 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.67 -55.63 0.67 Allowed Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.329 1.919 . . . . 0.0 112.342 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -78.32 178.96 7.25 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.73 1.212 . . . . 0.0 113.281 174.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.2 p -138.37 92.57 2.65 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.618 1.967 . . . . 0.0 110.982 -175.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -66.12 154.9 88.87 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 124.098 0.959 . . . . 0.0 113.569 -177.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.84 151.59 51.34 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.935 2.424 . . . . 0.0 112.36 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.2 t -102.26 -20.62 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 125.136 1.374 . . . . 0.0 112.01 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.89 172.9 6.71 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 127.054 2.142 . . . . 0.0 111.657 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.87 85.77 0.07 OUTLIER Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.622 1.106 . . . . 0.0 112.616 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 tt -133.14 72.37 1.49 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.028 1.331 . . . . 0.0 111.107 -175.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 78.2 m -78.12 97.39 5.43 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.435 1.494 . . . . 0.0 111.346 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -61.55 -60.74 3.23 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.85 1.26 . . . . 0.0 112.751 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.5 167.78 21.04 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.784 0.834 . . . . 0.0 112.274 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -75.32 2.62 10.75 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.975 1.71 . . . . 0.0 114.446 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -93.29 90.05 6.64 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.355 1.862 . . . . 0.0 111.003 -173.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 m -123.14 157.02 33.86 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.506 1.522 . . . . 0.0 111.106 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.9 ttm105 -134.93 155.3 50.95 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.7 1.2 . . . . 0.0 111.79 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -135.55 134.03 39.0 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.578 1.151 . . . . 0.0 110.441 -165.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -136.46 133.59 36.75 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.969 0.908 . . . . 0.0 112.312 -171.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.8 t -72.96 132.1 43.02 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 122.161 -0.337 . . . . 0.0 111.59 174.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.1 mmt -93.47 -91.0 0.19 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.85 0.86 . . . . 0.0 109.831 167.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -97.61 -40.73 3.56 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.509 1.052 . . . . 0.0 114.636 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -146.02 -58.43 0.31 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.493 1.517 . . . . 0.0 110.966 -173.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.7 p -83.27 168.81 16.35 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.672 1.189 . . . . 0.0 112.117 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.0 p -121.11 105.99 11.13 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.495 1.118 . . . . 0.0 112.844 169.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -73.88 177.27 5.68 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.567 1.147 . . . . 0.0 112.14 173.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.2 p -88.9 134.17 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.271 1.828 . . . . 0.0 111.842 173.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -137.22 172.19 13.37 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.323 1.449 . . . . 0.0 111.107 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -127.12 108.01 10.53 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.784 1.234 . . . . 0.0 111.629 -174.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.82 168.21 36.51 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.2 1.381 . . . . 0.0 113.717 -176.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 7.9 p -58.92 129.69 43.36 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -138.18 -40.63 0.53 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.33 1.452 . . . . 0.0 113.208 -174.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.3 t -144.89 -22.4 0.5 Allowed 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -168.0 -161.73 18.38 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.867 1.699 . . . . 0.0 112.122 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -153.48 58.59 0.41 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.328 0.966 . . . . 0.0 113.876 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -70.77 -32.37 69.47 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -174.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.6 p 55.53 -3.4 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 128.868 2.867 . . . . 0.0 117.522 -171.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -131.14 135.11 47.17 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.374 1.87 . . . . 0.0 112.217 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 40.2 ttm -63.62 -33.0 74.64 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.516 1.126 . . . . 0.0 112.862 175.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.42 -22.89 77.8 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 121.456 -0.777 . . . . 0.0 113.799 174.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -83.87 -40.77 18.21 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.529 1.165 . . . . 0.0 112.33 175.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.6 p -65.14 -23.76 67.22 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.487 1.039 . . . . 0.0 113.06 173.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.52 -60.48 2.26 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.88 1.672 . . . . 0.0 111.89 170.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -61.34 -28.38 69.18 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -172.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -73.9 -8.09 54.75 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.322 1.049 . . . . 0.0 113.557 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.91 167.48 19.37 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 125.688 1.595 . . . . 0.0 114.213 -174.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.99 -9.61 16.73 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 123.172 2.581 . . . . 0.0 114.595 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.236 0 C-N-CA 125.864 1.697 . . . . 0.0 113.459 179.259 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 CA--C 1.548 0.891 0 CA-C-O 120.549 0.214 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 47.2 t -133.29 123.79 26.12 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.26 1.424 . . . . 0.0 110.654 172.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.1 m -63.31 122.26 15.76 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.52 1.528 . . . . 0.0 112.245 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.3 t -78.01 134.12 64.4 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.837 1.255 . . . . 0.0 110.716 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.54 164.81 30.0 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.196 3.264 . . . . 0.0 113.442 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.9 mm -60.3 145.24 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.844 1.257 . . . . 0.0 111.21 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.08 25.62 57.23 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.074 0.845 . . . . 0.0 114.2 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -63.54 178.21 0.6 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.701 2.001 . . . . 0.0 115.271 -178.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.0 t -139.67 48.96 1.81 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.373 1.869 . . . . 0.0 110.905 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.55 151.81 68.85 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.424 1.489 . . . . 0.0 112.968 175.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -74.79 158.25 43.12 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.231 2.62 . . . . 0.0 113.54 -170.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.77 -29.97 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.836 0.854 . . . . 0.0 112.55 177.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.41 177.51 7.09 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.415 1.486 . . . . 0.0 112.571 175.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.59 -107.29 0.29 Allowed Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.522 1.058 . . . . 0.0 112.416 172.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.1 tp -154.17 115.54 4.12 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.672 1.589 . . . . 0.0 109.751 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.5 t -68.73 173.14 5.46 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.82 1.648 . . . . 0.0 112.337 174.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.39 5.94 21.88 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.324 1.85 . . . . 0.0 114.71 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.25 156.47 12.4 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.664 1.185 . . . . 0.0 113.298 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -81.27 4.38 20.68 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.883 1.673 . . . . 0.0 115.051 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -140.55 117.65 11.22 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.944 2.097 . . . . 0.0 110.521 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.9 m -142.45 154.56 44.66 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.332 1.453 . . . . 0.0 110.777 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -100.95 151.73 21.41 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.49 1.116 . . . . 0.0 111.316 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -125.06 138.81 54.19 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.578 1.151 . . . . 0.0 111.185 -174.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -132.36 135.76 46.37 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.076 1.351 . . . . 0.0 111.051 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 38.5 t -80.19 104.7 10.93 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.901 0.48 . . . . 0.0 111.004 169.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 87.5 mmm -76.04 -18.74 59.11 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.29 -78.29 0.05 OUTLIER Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.554 1.073 . . . . 0.0 112.861 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -109.26 -3.83 16.92 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.059 1.344 . . . . 0.0 114.058 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 25.1 p -149.13 157.99 43.82 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.946 2.099 . . . . 0.0 109.895 -176.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.4 p -111.17 147.81 34.12 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 168.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.0 mtpp -140.72 167.33 22.42 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.542 1.937 . . . . 0.0 111.844 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.78 125.76 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.915 1.286 . . . . 0.0 111.884 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -146.21 166.3 26.63 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.51 1.524 . . . . 0.0 110.72 177.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -142.68 103.05 4.16 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.353 1.061 . . . . 0.0 112.104 -172.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.7 -175.94 45.32 Favored Glycine 0 CA--C 1.532 1.132 0 O-C-N 121.455 -0.778 . . . . 0.0 113.742 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 63.1 m -68.01 14.41 0.06 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 127.207 2.203 . . . . 0.0 115.163 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -60.48 99.97 0.09 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 128.133 2.573 . . . . 0.0 110.797 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 21.7 m -53.69 -61.61 2.19 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.476 1.911 . . . . 0.0 113.003 -175.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.1 93.21 1.29 Allowed Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.444 1.497 . . . . 0.0 113.47 -174.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -147.65 175.05 27.19 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.158 1.361 . . . . 0.0 113.273 175.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -121.23 -17.71 7.61 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.521 1.675 . . . . 0.0 115.521 -165.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 58.63 4.48 0.37 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.572 1.949 . . . . 0.0 116.136 -176.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -138.13 142.89 40.14 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.93 2.092 . . . . 0.0 111.266 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.6 tpp -71.62 -32.19 67.71 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.323 1.049 . . . . 0.0 112.741 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.09 -48.12 67.69 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 121.598 -0.689 . . . . 0.0 111.402 175.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -64.86 -37.31 87.22 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.466 1.506 . . . . 0.0 113.409 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.5 p -71.57 -27.34 63.08 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.925 1.239 . . . . 0.0 113.39 171.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.16 -43.27 21.89 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.821 1.249 . . . . 0.0 112.992 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -63.52 -26.62 68.79 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 120.723 1.601 . . . . 0.0 113.482 -177.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -78.89 -9.26 59.43 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.641 1.577 . . . . 0.0 113.698 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 m -131.71 167.12 23.51 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 125.015 1.326 . . . . 0.0 113.97 -173.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.39 -11.66 15.81 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.968 2.445 . . . . 0.0 114.19 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.22 0 C-N-CA 126.919 2.2 . . . . 0.0 112.552 179.431 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 . . . . . 0 N--CA 1.476 0.831 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.6 p -75.48 156.45 35.2 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.727 0.811 . . . . 0.0 112.304 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.3 m -144.89 143.42 30.58 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.917 1.287 . . . . 0.0 110.73 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.0 t -68.74 133.95 90.38 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 124.112 0.965 . . . . 0.0 110.655 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.59 -175.36 2.41 Favored 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 124.401 3.401 . . . . 0.0 112.232 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.1 pt -59.51 166.06 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.987 1.315 . . . . 0.0 113.501 175.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.36 -59.38 4.11 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.666 1.603 . . . . 0.0 112.378 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -73.35 -178.37 2.95 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.866 1.266 . . . . 0.0 112.925 170.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.4 p -126.83 133.29 50.79 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.873 1.669 . . . . 0.0 111.063 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -74.97 152.46 86.59 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 123.869 0.868 . . . . 0.0 112.659 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.44 169.44 22.41 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.713 2.942 . . . . 0.0 111.906 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.9 t -131.35 -19.84 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.732 1.213 . . . . 0.0 112.05 -171.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt 55.27 2.75 0.06 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 128.326 2.65 . . . . 0.0 116.271 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -108.25 -7.89 29.93 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.756 1.646 . . . . 0.0 115.492 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.1 mp -74.95 -66.44 0.75 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.011 1.406 . . . . 0.0 110.855 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.4 t -139.0 153.12 48.11 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.273 1.429 . . . . 0.0 112.199 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.0 mtpt -135.72 83.99 2.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.618 2.367 . . . . 0.0 109.872 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.67 174.12 10.86 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.431 1.493 . . . . 0.0 112.514 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.02 -5.62 54.4 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.63 1.572 . . . . 0.0 114.697 -174.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -85.28 -15.61 42.86 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.094 1.357 . . . . 0.0 114.348 -170.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.5 m -68.79 158.82 33.57 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.836 1.254 . . . . 0.0 111.959 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -133.22 165.3 25.11 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.487 1.515 . . . . 0.0 111.82 -176.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -114.24 133.25 55.76 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.072 1.349 . . . . 0.0 111.466 -169.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -134.96 162.42 32.48 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.86 1.264 . . . . 0.0 111.805 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.7 t -101.68 108.69 20.3 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.563 1.145 . . . . 0.0 110.856 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 16.7 mmt -73.4 -60.27 2.32 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.101 0.56 . . . . 0.0 112.264 174.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -169.59 97.44 0.12 Allowed Glycine 0 N--CA 1.469 0.894 0 C-N-CA 124.149 0.881 . . . . 0.0 112.244 -170.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 58.92 11.43 1.91 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.88 2.072 . . . . 0.0 114.994 -175.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 6.4 t -151.49 147.74 27.2 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.053 2.141 . . . . 0.0 109.078 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 13.6 p -125.19 143.67 50.83 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 170.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.4 mtpp -149.57 170.94 17.48 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.253 1.421 . . . . 0.0 112.348 -172.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.3 p -75.01 128.52 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.509 1.524 . . . . 0.0 111.008 169.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -136.5 108.48 7.15 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.528 1.131 . . . . 0.0 111.439 -175.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -64.22 147.45 52.34 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.731 1.213 . . . . 0.0 112.149 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.98 177.62 21.54 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 125.771 1.653 . . . . 0.0 113.902 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 64.7 m -73.42 146.5 45.01 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 122.004 -0.703 . . . . 0.0 111.667 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -154.69 119.88 5.0 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.321 1.449 . . . . 0.0 108.742 170.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.2 m -57.56 -49.19 77.18 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.051 0.94 . . . . 0.0 112.632 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.44 172.61 45.1 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.811 1.196 . . . . 0.0 113.536 172.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 170.56 170.12 34.46 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.473 1.035 . . . . 0.0 114.933 176.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -111.68 -22.51 11.15 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.6 p 55.38 -4.28 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 128.85 2.86 . . . . 0.0 117.714 -172.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -133.29 137.7 46.12 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.472 1.909 . . . . 0.0 111.756 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.1 tpp -64.15 -33.12 75.06 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.603 1.161 . . . . 0.0 112.072 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.21 -38.17 82.12 Favored Glycine 0 CA--C 1.531 1.086 0 O-C-N 121.582 -0.699 . . . . 0.0 112.852 176.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -68.62 -47.55 66.37 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.011 0.924 . . . . 0.0 112.52 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.3 p -62.37 -25.9 68.17 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.392 0.996 . . . . 0.0 112.773 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.72 -64.46 1.07 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.52 1.528 . . . . 0.0 111.404 171.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -63.68 -27.47 69.24 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -171.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -78.93 -2.04 38.08 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.953 0.901 . . . . 0.0 113.251 174.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.67 170.55 7.85 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 127.023 2.129 . . . . 0.0 112.347 176.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -82.54 -8.07 11.54 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.071 2.514 . . . . 0.0 114.092 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.277 0 C-N-CA 126.548 2.023 . . . . 0.0 114.265 -178.764 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 CA--C 1.545 0.777 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.4 t -140.19 153.48 46.62 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.166 1.787 . . . . 0.0 110.161 176.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.6 t -69.33 165.27 21.05 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.852 0.861 . . . . 0.0 112.168 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.3 t -145.07 133.56 10.85 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 125.619 1.568 . . . . 0.0 110.002 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.8 163.88 32.82 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.362 3.375 . . . . 0.0 113.376 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.531 HD12 ' H ' ' A' ' 28' ' ' ILE . 4.5 mp -58.93 138.43 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.161 1.384 . . . . 0.0 110.755 177.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.39 28.03 41.5 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.142 0.877 . . . . 0.0 114.472 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -63.88 176.22 0.99 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.295 1.838 . . . . 0.0 115.886 -176.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 72.5 m -131.87 63.07 1.62 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.223 2.209 . . . . 0.0 110.65 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -63.25 156.59 68.35 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 125.123 1.369 . . . . 0.0 112.841 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.26 172.47 13.99 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.2 2.6 . . . . 0.0 113.815 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 p -119.45 20.86 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 126.957 2.103 . . . . 0.0 112.178 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -57.67 164.37 2.09 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.151 2.18 . . . . 0.0 115.195 -174.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 144.94 -29.52 1.83 Allowed Glycine 0 CA--C 1.536 1.397 0 C-N-CA 126.051 1.786 . . . . 0.0 114.321 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.24 1.95 6.4 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.698 1.599 . . . . 0.0 113.956 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.6 t -62.59 138.68 58.54 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.359 1.064 . . . . 0.0 112.317 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -113.55 -7.68 13.37 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.767 1.627 . . . . 0.0 114.598 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.19 170.58 12.69 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.875 0.87 . . . . 0.0 112.401 172.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -124.1 9.92 8.72 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.986 1.714 . . . . 0.0 114.472 -175.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -88.83 74.35 8.29 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.155 1.382 . . . . 0.0 112.03 -170.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.16 133.91 55.86 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.736 0.815 . . . . 0.0 111.404 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -137.28 154.86 50.02 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.424 1.09 . . . . 0.0 111.846 -172.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -132.87 129.18 38.08 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.856 1.263 . . . . 0.0 110.454 -169.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -139.55 129.42 24.82 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.24 1.016 . . . . 0.0 111.597 -171.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 40.6 t -71.83 129.87 39.67 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.753 -0.592 . . . . 0.0 112.587 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 43.7 mtm -132.79 -80.37 0.49 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.687 1.195 . . . . 0.0 112.042 167.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -86.35 60.56 4.54 Favored Glycine 0 N--CA 1.474 1.177 0 O-C-N 121.201 -0.937 . . . . 0.0 114.353 -170.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.4 m120 59.68 14.04 3.8 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.448 1.899 . . . . 0.0 113.901 -172.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 28.2 p -144.89 160.62 41.01 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.711 2.804 . . . . 0.0 109.322 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 18.5 p -115.15 87.39 2.65 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.765 0.826 . . . . 0.0 111.879 170.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -67.24 164.32 18.53 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 122.12 0.962 . . . . 0.0 111.85 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.2 p -82.49 128.5 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.929 1.292 . . . . 0.0 111.587 174.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -131.39 154.37 48.7 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.509 1.524 . . . . 0.0 110.829 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -132.0 89.52 2.69 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.135 1.374 . . . . 0.0 110.366 -174.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.61 175.71 42.37 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.902 1.239 . . . . 0.0 112.889 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 29.5 m -66.71 141.89 57.6 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.472 0.709 . . . . 0.0 111.765 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.63 121.93 5.67 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.887 1.275 . . . . 0.0 109.097 173.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.0 m -59.18 -37.13 76.65 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.472 1.109 . . . . 0.0 113.343 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -100.1 -161.98 28.55 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 126.405 1.955 . . . . 0.0 113.623 176.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 123.74 172.01 13.65 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.988 1.756 . . . . 0.0 114.541 174.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -107.1 -18.21 13.96 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -173.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.4 t 60.47 -14.07 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 127.728 2.411 . . . . 0.0 116.496 -174.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 42.2 mmt180 -125.24 136.52 53.62 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.519 1.927 . . . . 0.0 112.094 -177.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 62.2 tpp -59.8 -38.27 81.47 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.191 1.396 . . . . 0.0 112.129 175.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.33 -29.69 65.89 Favored Glycine 0 CA--C 1.533 1.194 0 O-C-N 121.716 -0.615 . . . . 0.0 113.769 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -82.25 -41.29 20.41 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.15 0.975 . . . . 0.0 112.403 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.0 p -64.89 -23.41 67.22 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.07 0.85 . . . . 0.0 112.895 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.27 -64.03 1.11 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.481 1.512 . . . . 0.0 111.589 169.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -61.41 -28.1 69.02 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -171.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -78.46 -6.27 54.86 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.11 0.964 . . . . 0.0 113.565 174.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -122.35 170.85 7.19 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 126.625 1.97 . . . . 0.0 112.437 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.11 -7.16 17.11 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.229 2.62 . . . . 0.0 114.724 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.286 0 C-N-CA 126.747 2.117 . . . . 0.0 114.742 -178.735 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 CA--C 1.547 0.847 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.2 p -127.47 170.46 12.54 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.901 1.68 . . . . 0.0 112.542 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.7 p -90.31 161.69 15.52 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.756 1.223 . . . . 0.0 111.925 173.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.8 m -66.06 155.54 86.93 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 123.524 0.729 . . . . 0.0 112.257 176.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -64.17 156.24 60.46 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.493 2.795 . . . . 0.0 112.47 172.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 40.5 pt -61.69 143.78 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.783 0.833 . . . . 0.0 112.083 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.86 -6.73 11.41 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.116 1.341 . . . . 0.0 116.188 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -76.71 172.32 13.26 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.42 1.61 . . . . 0.0 112.243 176.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.5 t -128.97 92.98 3.49 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.856 1.262 . . . . 0.0 111.827 -174.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -61.75 152.62 75.0 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 125.158 1.383 . . . . 0.0 113.864 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.36 86.95 1.4 Allowed 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.867 3.045 . . . . 0.0 112.243 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.6 p -68.19 -29.64 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.639 1.176 . . . . 0.0 113.161 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -78.71 -68.13 0.68 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.884 1.674 . . . . 0.0 112.593 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.67 43.79 91.41 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.138 1.351 . . . . 0.0 114.498 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.0 tp -113.11 92.85 4.15 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.971 1.708 . . . . 0.0 111.174 -169.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 31.3 p -120.41 178.21 4.75 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.588 1.955 . . . . 0.0 113.502 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -127.84 -60.0 1.17 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.396 1.878 . . . . 0.0 112.099 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.05 173.23 6.76 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.636 1.174 . . . . 0.0 113.259 176.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -110.1 47.66 0.94 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.63 1.972 . . . . 0.0 113.297 -173.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -122.25 95.53 4.68 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.894 1.678 . . . . 0.0 110.788 -176.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.6 m -132.35 154.63 49.57 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.111 1.364 . . . . 0.0 110.876 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -138.78 124.21 19.38 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.808 1.243 . . . . 0.0 111.485 -174.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -76.98 140.03 40.28 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.649 1.18 . . . . 0.0 111.483 -177.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -131.36 127.42 37.56 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.87 1.268 . . . . 0.0 111.141 -176.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.7 t -65.98 122.86 18.33 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.809 0.338 . . . . 0.0 110.846 171.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 37.6 mtp -137.5 111.96 8.66 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.159 1.384 . . . . 0.0 110.327 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.05 -68.48 2.84 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.6 1.095 . . . . 0.0 112.39 -174.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -145.94 -52.22 0.25 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 8.4 p -83.82 172.62 11.99 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.295 0.952 . . . . 0.0 112.437 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.4 p -121.2 90.69 3.37 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.311 1.044 . . . . 0.0 112.75 172.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -74.12 173.59 9.88 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.358 1.063 . . . . 0.0 112.218 172.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.02 130.11 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.48 1.512 . . . . 0.0 111.26 168.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -142.99 163.63 32.27 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.161 1.784 . . . . 0.0 110.61 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -130.76 -1.36 4.24 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.39 170.55 54.88 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.416 1.007 . . . . 0.0 114.079 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 56.6 m -67.74 105.08 1.81 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.653 1.181 . . . . 0.0 111.358 177.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.44 98.88 4.07 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.574 1.15 . . . . 0.0 109.985 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.0 m -53.64 -47.36 70.4 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.676 1.59 . . . . 0.0 113.373 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.06 60.78 4.65 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.499 1.523 . . . . 0.0 114.29 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.97 164.01 35.14 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.613 1.101 . . . . 0.0 114.324 176.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -120.35 -26.72 5.36 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 59.95 5.5 0.76 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.653 1.981 . . . . 0.0 115.735 -175.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -136.63 129.75 31.21 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.647 1.979 . . . . 0.0 111.428 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 31.5 ttm -61.58 -31.23 71.27 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.732 1.213 . . . . 0.0 113.043 175.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.45 -37.02 48.02 Favored Glycine 0 CA--C 1.528 0.903 0 O-C-N 121.889 -0.507 . . . . 0.0 113.268 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -76.05 -44.49 38.89 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.731 0.812 . . . . 0.0 112.132 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.4 p -64.93 -21.75 66.88 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.58 -63.14 1.48 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.495 1.518 . . . . 0.0 111.466 170.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -61.68 -28.44 69.4 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -76.56 -5.0 45.81 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 174.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -126.07 167.15 17.77 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 125.865 1.666 . . . . 0.0 113.656 -175.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.21 -8.11 14.05 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.277 2.652 . . . . 0.0 114.531 -174.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.375 0 C-N-CA 126.106 1.812 . . . . 0.0 114.357 179.383 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 N--CA 1.472 0.667 0 CA-C-O 121.089 0.471 . . . . 0.0 112.263 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 61.3 m -71.16 154.04 42.02 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.462 0.705 . . . . 0.0 111.558 173.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.6 t -70.14 -175.73 1.02 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.267 1.027 . . . . 0.0 112.529 170.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.4 t -135.09 134.23 21.44 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 126.354 1.862 . . . . 0.0 110.03 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.36 162.8 37.66 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.074 3.183 . . . . 0.0 113.171 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.502 HD12 ' H ' ' A' ' 28' ' ' ILE . 4.2 mp -60.67 141.02 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.883 1.273 . . . . 0.0 110.593 176.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.35 26.12 40.98 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.099 0.857 . . . . 0.0 114.336 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -63.69 177.86 0.67 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.432 2.293 . . . . 0.0 116.016 -176.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.0 p -134.93 65.73 1.55 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 127.398 2.279 . . . . 0.0 111.122 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.45 154.68 53.11 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 124.983 1.313 . . . . 0.0 113.84 178.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -72.61 169.27 22.28 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.555 2.836 . . . . 0.0 112.738 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.0 t -132.48 56.06 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.518 1.527 . . . . 0.0 109.277 -177.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.4 mtmm -59.82 131.49 51.05 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.637 1.175 . . . . 0.0 110.88 172.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.08 79.98 0.12 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.905 1.24 . . . . 0.0 111.9 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.2 mt 55.18 32.97 19.53 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.11 1.764 . . . . 0.0 113.565 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 67.0 m -58.54 153.15 16.72 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.914 1.685 . . . . 0.0 113.464 -174.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.403 ' HA ' ' HE2' ' A' ' 39' ' ' LYS . 11.0 mmpt? -123.85 73.57 1.22 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.168 1.787 . . . . 0.0 111.015 -174.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -137.32 163.03 31.98 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.568 1.547 . . . . 0.0 111.781 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.1 mtp85 -129.68 12.37 5.82 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.109 1.764 . . . . 0.0 113.8 -175.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -132.52 109.46 9.8 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.528 1.931 . . . . 0.0 110.899 -175.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.6 156.82 38.33 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.231 1.012 . . . . 0.0 111.547 174.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -142.5 166.47 24.59 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.136 1.375 . . . . 0.0 111.681 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -131.08 144.6 51.55 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.344 1.058 . . . . 0.0 111.424 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -141.34 132.3 26.08 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.838 1.255 . . . . 0.0 111.005 -171.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 36.1 t -82.42 109.73 16.92 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.631 1.172 . . . . 0.0 111.766 173.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 6.9 mmt -72.33 -9.8 58.96 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 173.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.09 -37.15 0.46 Allowed Glycine 0 N--CA 1.474 1.211 0 C-N-CA 124.257 0.932 . . . . 0.0 114.76 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -141.82 -53.98 0.44 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.669 1.588 . . . . 0.0 111.248 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 36.8 t -107.7 110.3 22.11 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.462 1.505 . . . . 0.0 110.215 -175.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 21.4 p -74.97 146.95 41.26 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -128.58 171.86 11.73 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.524 1.93 . . . . 0.0 111.097 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 p -75.22 131.95 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.69 1.196 . . . . 0.0 111.019 172.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -145.11 163.47 34.21 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.575 1.15 . . . . 0.0 111.195 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -154.47 149.54 26.87 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.278 1.431 . . . . 0.0 110.229 174.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 135.16 -172.86 21.9 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.925 1.25 . . . . 0.0 113.359 -172.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 63.6 m -72.8 6.73 2.35 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 -172.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -68.36 97.46 0.75 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.472 1.909 . . . . 0.0 111.789 -177.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.8 m -55.16 -41.57 71.99 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 126.319 1.848 . . . . 0.0 114.206 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.49 58.44 4.99 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.16 1.362 . . . . 0.0 115.029 -171.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -100.83 173.7 24.84 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 125.118 1.342 . . . . 0.0 114.591 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -107.38 159.07 16.67 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.133 1.773 . . . . 0.0 111.186 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.3 p -79.59 -40.4 29.45 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 120.855 -1.153 . . . . 0.0 113.256 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.8 mmp_? -139.39 161.82 36.53 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.93 2.092 . . . . 0.0 111.627 -177.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 49.1 ttm -67.43 -29.19 68.61 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.398 0.679 . . . . 0.0 112.382 -177.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.53 -28.71 70.1 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.445 -0.642 . . . . 0.0 113.855 171.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -74.65 -50.85 16.16 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.796 1.298 . . . . 0.0 111.901 172.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.7 p -66.33 -19.76 65.9 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.73 -66.48 0.74 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.465 1.506 . . . . 0.0 111.887 164.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -60.48 -28.65 68.51 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -169.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -81.05 -7.0 59.47 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.335 1.054 . . . . 0.0 113.78 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -119.72 164.98 19.01 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 125.956 1.702 . . . . 0.0 112.723 -177.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -75.94 -6.38 17.35 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.527 2.818 . . . . 0.0 115.089 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.237 0 C-N-CA 126.075 1.798 . . . . 0.0 113.429 177.47 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 120.74 0.305 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.9 m -71.0 135.15 47.68 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.394 0.677 . . . . 0.0 111.516 178.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.1 t -74.06 167.21 21.99 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.452 0.701 . . . . 0.0 111.842 169.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.1 t -84.63 132.86 45.36 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 124.698 1.199 . . . . 0.0 109.789 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.85 179.98 5.74 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 124.525 3.484 . . . . 0.0 112.67 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.9 mm -56.49 147.95 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 126.038 1.735 . . . . 0.0 112.414 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.48 -60.02 1.07 Allowed Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.919 1.723 . . . . 0.0 111.918 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -81.77 -178.71 7.09 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.047 1.339 . . . . 0.0 112.654 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.0 t -147.41 174.88 11.27 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.082 1.753 . . . . 0.0 110.627 172.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -83.64 111.29 30.9 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 125.275 1.43 . . . . 0.0 113.266 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -74.93 158.56 42.4 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.978 2.452 . . . . 0.0 111.559 168.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.1 t -107.11 -35.12 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.835 1.254 . . . . 0.0 111.543 173.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -63.07 152.52 36.84 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.597 1.159 . . . . 0.0 112.4 175.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.29 -6.88 62.29 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.039 1.304 . . . . 0.0 116.21 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.8 mp -78.96 32.55 0.21 Allowed 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 119.308 1.554 . . . . 0.0 112.566 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 57.0 m -66.17 12.83 0.06 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 128.85 2.86 . . . . 0.0 115.428 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 61.03 9.07 2.17 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 129.164 2.986 . . . . 0.0 115.607 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.6 169.66 13.83 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.778 1.631 . . . . 0.0 113.324 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.1 mtm180 -116.75 -8.68 11.37 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -173.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -77.99 -25.83 48.26 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.3 m -62.52 147.2 49.67 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.885 1.274 . . . . 0.0 111.635 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -87.86 159.03 18.56 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.338 1.055 . . . . 0.0 111.322 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -119.66 123.86 44.88 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.258 1.023 . . . . 0.0 110.879 -172.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -119.42 130.17 55.15 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.246 1.018 . . . . 0.0 111.129 -171.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 41.8 t -73.42 97.08 2.47 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.679 0.792 . . . . 0.0 111.653 176.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 15.4 mmt -72.52 80.6 1.07 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.692 1.597 . . . . 0.0 110.668 169.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.43 -63.22 3.37 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.497 1.522 . . . . 0.0 114.456 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -123.63 -53.81 1.77 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.336 1.454 . . . . 0.0 112.408 -173.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 9.6 m -101.98 171.64 7.39 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.316 1.446 . . . . 0.0 111.018 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 11.0 p -120.6 158.82 26.55 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.027 0.931 . . . . 0.0 113.372 172.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -150.07 172.99 14.38 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 126.126 1.77 . . . . 0.0 111.239 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.3 p -76.96 125.62 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.506 1.523 . . . . 0.0 111.974 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -145.09 111.62 5.74 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.544 1.138 . . . . 0.0 111.206 -178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -75.88 98.39 4.19 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.254 -0.904 . . . . 0.0 110.901 169.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.69 167.95 38.1 Favored Glycine 0 CA--C 1.533 1.186 0 O-C-N 121.107 -0.996 . . . . 0.0 114.36 174.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.4 m -72.69 101.6 3.11 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.023 1.329 . . . . 0.0 111.335 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -133.42 97.41 3.95 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.75 1.22 . . . . 0.0 109.716 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.7 m -49.47 -49.31 46.03 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.111 1.764 . . . . 0.0 113.618 -175.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.48 77.4 0.95 Allowed Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.317 1.437 . . . . 0.0 112.784 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -131.13 175.63 19.43 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.431 1.491 . . . . 0.0 114.491 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -130.39 134.67 47.31 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.841 1.256 . . . . 0.0 112.014 -173.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 65.4 p -79.56 -8.47 59.19 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -129.12 138.42 51.8 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.574 1.549 . . . . 0.0 112.282 -176.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 61.4 tpp -65.45 -33.5 76.09 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.574 1.15 . . . . 0.0 112.056 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.45 -37.02 85.18 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 121.71 -0.619 . . . . 0.0 112.922 175.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 82.0 mm-40 -72.01 -46.37 57.43 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.294 1.037 . . . . 0.0 112.22 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.8 p -63.54 -24.21 67.71 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.07 0.85 . . . . 0.0 113.046 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.62 -64.13 1.25 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.481 1.513 . . . . 0.0 112.045 170.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -62.69 -28.18 69.76 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -169.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -81.43 -6.35 58.85 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.4 164.14 17.22 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 126.198 1.799 . . . . 0.0 112.786 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.56 -17.18 16.44 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.66 2.24 . . . . 0.0 113.854 -173.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.381 0 C-N-CA 126.587 2.042 . . . . 0.0 115.074 -179.705 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 120.9 0.381 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.0 t -69.75 128.21 35.61 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.467 0.707 . . . . 0.0 111.287 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 50.6 p -136.38 169.38 17.76 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.501 1.521 . . . . 0.0 112.281 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.6 t -69.24 133.93 89.37 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.96 0.904 . . . . 0.0 110.169 177.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.8 158.65 56.99 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.128 3.219 . . . . 0.0 112.516 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.7 mt -63.63 136.07 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.936 0.895 . . . . 0.0 109.817 177.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.42 -10.56 63.74 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.523 1.535 . . . . 0.0 115.456 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.27 172.22 11.57 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.535 1.667 . . . . 0.0 112.853 172.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.0 t -107.65 91.55 3.7 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.093 1.357 . . . . 0.0 110.437 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -56.73 115.36 10.0 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 125.071 1.349 . . . . 0.0 113.32 -176.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.86 94.57 1.07 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.481 2.788 . . . . 0.0 111.739 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 p -70.83 -24.42 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 124.337 1.055 . . . . 0.0 113.0 175.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -62.76 154.02 30.96 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.69 1.596 . . . . 0.0 111.78 173.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.62 31.87 62.36 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 123.726 0.679 . . . . 0.0 114.538 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.8 tp -74.05 59.97 0.75 Allowed 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.947 1.699 . . . . 0.0 112.583 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 31.8 p -149.7 173.74 13.36 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.457 1.903 . . . . 0.0 112.555 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.25 78.31 1.78 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.55 1.94 . . . . 0.0 110.984 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.74 178.55 4.11 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.787 0.804 . . . . 0.0 112.29 168.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -12.31 59.87 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.814 1.646 . . . . 0.0 113.429 171.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -126.63 105.03 8.42 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.708 2.803 . . . . 0.0 108.896 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.4 m -128.77 158.63 38.12 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.501 1.92 . . . . 0.0 110.313 -175.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -114.07 162.08 16.92 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.476 1.111 . . . . 0.0 112.834 170.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -146.98 127.83 14.41 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.999 1.32 . . . . 0.0 110.051 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -132.4 137.88 47.49 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.757 1.223 . . . . 0.0 111.701 -174.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 35.4 t -79.68 115.89 19.54 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.164 0.986 . . . . 0.0 111.792 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 96.3 mmm -90.25 -10.95 42.38 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.846 1.258 . . . . 0.0 114.22 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.54 -87.94 0.08 OUTLIER Glycine 0 N--CA 1.469 0.869 0 C-N-CA 124.536 1.065 . . . . 0.0 111.807 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -86.54 -31.6 21.17 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 171.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.5 p -125.98 166.33 17.13 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.732 2.013 . . . . 0.0 111.74 -170.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.5 p -113.87 153.3 29.43 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 167.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.7 ttpt -124.39 165.72 17.24 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.549 1.94 . . . . 0.0 110.513 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.2 p -69.98 135.72 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.273 1.029 . . . . 0.0 111.609 171.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -144.15 177.37 8.63 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.167 1.787 . . . . 0.0 110.515 174.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -136.38 156.79 48.13 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.982 0.913 . . . . 0.0 112.353 175.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.45 175.93 10.71 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.665 1.126 . . . . 0.0 113.969 -170.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 76.9 m -91.96 85.32 5.52 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.557 1.143 . . . . 0.0 110.375 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -70.08 84.82 0.53 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.01 1.324 . . . . 0.0 111.268 -178.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 m 61.7 7.07 1.77 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 126.612 1.965 . . . . 0.0 114.018 -174.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.78 149.44 9.47 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 127.212 2.339 . . . . 0.0 113.295 -174.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.12 -91.36 0.08 OUTLIER Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.491 1.044 . . . . 0.0 112.513 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -135.31 157.41 46.97 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.346 1.058 . . . . 0.0 113.162 -174.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.9 m -123.29 5.53 9.11 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.153 1.781 . . . . 0.0 113.092 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 -138.47 139.38 38.8 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.968 2.107 . . . . 0.0 111.0 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 30.0 tpp -59.35 -35.47 73.94 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.788 1.235 . . . . 0.0 112.14 172.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.09 -24.85 73.36 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 121.196 -0.94 . . . . 0.0 114.383 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -80.32 -46.28 16.4 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.641 1.221 . . . . 0.0 111.952 175.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.6 p -64.17 -25.03 67.9 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.28 -61.62 1.76 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.59 1.556 . . . . 0.0 111.855 171.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -61.56 -27.37 68.58 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -173.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -79.68 -4.82 53.48 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.442 1.097 . . . . 0.0 113.702 174.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m -125.61 166.43 21.09 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 126.431 1.892 . . . . 0.0 113.077 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.29 -13.76 16.76 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.772 2.314 . . . . 0.0 114.05 -176.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.214 0 C-N-CA 126.507 2.003 . . . . 0.0 112.95 179.611 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 CA--C 1.546 0.808 0 CA-C-O 120.788 0.328 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.2 m -68.28 75.77 0.25 Allowed 'General case' 0 CA--C 1.549 0.915 0 O-C-N 120.647 -1.283 . . . . 0.0 112.223 174.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.4 m -125.15 139.39 53.8 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.384 2.274 . . . . 0.0 109.624 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.8 t -72.89 136.25 80.09 Favored Pre-proline 0 N--CA 1.477 0.876 0 O-C-N 121.694 -0.629 . . . . 0.0 110.376 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.6 150.34 88.37 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.658 2.905 . . . . 0.0 112.22 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.49 HD12 ' H ' ' A' ' 28' ' ' ILE . 5.4 mp -61.66 133.43 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.357 1.063 . . . . 0.0 110.181 -178.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.58 -12.87 63.92 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.712 1.625 . . . . 0.0 115.415 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -73.51 159.87 32.53 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.76 1.78 . . . . 0.0 112.529 174.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.4 m -82.79 76.05 9.66 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.301 1.04 . . . . 0.0 111.749 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -54.21 111.87 3.3 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 125.586 1.554 . . . . 0.0 113.457 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.18 113.09 3.34 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.241 2.627 . . . . 0.0 111.954 -176.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.7 p -76.4 -25.1 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.002 0.921 . . . . 0.0 113.171 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 pmtp? -66.74 168.16 10.02 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.101 1.36 . . . . 0.0 113.798 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.71 166.56 39.44 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.6 1.572 . . . . 0.0 112.566 174.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.0 tp -146.75 74.04 1.34 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.744 1.217 . . . . 0.0 110.987 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 76.2 m -63.68 165.56 8.13 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.474 1.11 . . . . 0.0 112.375 176.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm 60.13 -0.91 0.21 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.177 2.591 . . . . 0.0 116.505 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.18 160.4 26.96 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.023 1.329 . . . . 0.0 113.121 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.9 ptt85 -80.95 -0.74 40.71 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.276 1.43 . . . . 0.0 114.81 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -137.33 137.24 38.73 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.073 2.149 . . . . 0.0 109.781 -176.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.5 m -141.65 144.53 34.19 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.664 1.985 . . . . 0.0 110.098 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -123.66 157.02 34.77 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.504 1.521 . . . . 0.0 110.547 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -143.95 137.89 28.1 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.895 0.878 . . . . 0.0 111.217 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -141.0 131.33 25.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.467 1.107 . . . . 0.0 111.541 -177.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 15.2 t -77.47 126.32 30.72 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.018 0.927 . . . . 0.0 111.911 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 96.6 mmm -108.7 0.3 20.48 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.191 1.397 . . . . 0.0 113.828 -174.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.39 -78.37 0.14 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 125.33 1.443 . . . . 0.0 111.79 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -115.11 -1.04 13.12 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.017 1.327 . . . . 0.0 113.567 177.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 38.7 t -149.07 156.4 42.17 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.252 1.821 . . . . 0.0 110.038 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.2 p -119.87 103.93 9.76 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.34 1.056 . . . . 0.0 113.005 176.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -70.52 165.97 21.55 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.245 1.018 . . . . 0.0 111.408 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -77.37 139.04 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.756 1.222 . . . . 0.0 111.647 168.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -138.74 172.17 13.26 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.722 2.009 . . . . 0.0 110.335 173.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.6 mp0 -134.44 123.66 24.38 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.906 1.282 . . . . 0.0 110.665 -173.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.06 173.26 49.67 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.627 1.108 . . . . 0.0 113.322 -170.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 75.9 m -82.91 85.72 7.08 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.466 1.106 . . . . 0.0 111.527 -177.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -73.95 93.91 2.27 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.116 0.966 . . . . 0.0 110.508 174.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 59.6 p 54.29 -0.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 128.972 2.909 . . . . 0.0 117.972 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.64 153.67 30.32 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 127.247 2.356 . . . . 0.0 113.359 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.61 -86.76 0.1 OUTLIER Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.333 0.968 . . . . 0.0 113.376 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -132.65 162.76 30.52 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.319 1.448 . . . . 0.0 112.371 -175.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 74.0 m -126.59 -3.88 6.61 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -137.98 147.83 44.61 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.262 1.825 . . . . 0.0 110.306 172.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 32.7 ttm -62.52 -32.29 73.2 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 122.62 0.368 . . . . 0.0 111.934 177.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -58.72 -33.75 74.11 Favored Glycine 0 CA--C 1.533 1.163 0 O-C-N 121.446 -0.783 . . . . 0.0 114.126 175.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -72.41 -50.34 27.09 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.434 1.117 . . . . 0.0 111.799 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.3 p -65.5 -30.07 70.8 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.37 -58.63 3.34 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.706 1.202 . . . . 0.0 112.192 173.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -60.68 -30.05 69.69 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -171.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 -82.27 -22.57 35.69 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.194 0.998 . . . . 0.0 113.57 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m -97.03 168.66 9.9 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 125.717 1.607 . . . . 0.0 112.208 176.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.71 -7.44 15.65 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.017 2.478 . . . . 0.0 114.617 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.29 0 C-N-CA 126.264 1.888 . . . . 0.0 113.862 -178.401 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.1 m -61.81 128.42 36.13 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.751 1.22 . . . . 0.0 111.953 170.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.6 t -145.66 164.92 30.25 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.161 1.384 . . . . 0.0 111.243 171.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.4 m -71.72 154.9 92.83 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 125.46 1.504 . . . . 0.0 112.546 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -69.94 155.64 64.85 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.906 2.404 . . . . 0.0 110.662 174.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.9 mt -61.28 134.98 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.86 0.864 . . . . 0.0 110.634 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.04 51.17 47.2 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.032 1.301 . . . . 0.0 114.006 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 37.7 p90 -76.65 -177.76 4.41 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.808 1.643 . . . . 0.0 112.528 177.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.9 m -133.54 93.09 3.08 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.473 1.909 . . . . 0.0 110.142 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -57.32 115.78 11.73 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 124.536 1.134 . . . . 0.0 113.629 -173.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.6 105.81 2.13 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.649 2.899 . . . . 0.0 111.651 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.6 t -130.64 75.76 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.126 1.37 . . . . 0.0 109.622 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -149.82 176.11 11.02 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.825 2.05 . . . . 0.0 111.656 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.15 65.67 3.23 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.58 1.086 . . . . 0.0 114.146 172.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.408 ' H ' HD23 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -62.26 -3.76 1.48 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -177.651 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 67.1 m -61.17 164.26 5.42 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.952 1.701 . . . . 0.0 113.526 177.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -127.55 74.98 1.56 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.79 1.636 . . . . 0.0 111.638 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.94 165.9 16.8 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.87 0.868 . . . . 0.0 112.378 172.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -77.83 1.47 20.22 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.623 1.569 . . . . 0.0 114.12 176.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -143.2 164.67 29.55 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.746 2.818 . . . . 0.0 108.398 175.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.1 m -132.98 151.91 52.01 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.281 1.832 . . . . 0.0 110.479 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -85.24 150.69 24.62 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.752 1.221 . . . . 0.0 112.151 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -132.95 129.28 38.06 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.527 1.131 . . . . 0.0 110.935 -177.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -125.87 130.62 51.71 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.259 1.024 . . . . 0.0 111.707 -172.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.7 t -70.15 119.16 13.93 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.99 0.516 . . . . 0.0 111.116 171.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 81.8 mmm -118.05 94.37 4.48 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.293 1.837 . . . . 0.0 109.086 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.74 -65.07 4.19 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.728 1.156 . . . . 0.0 113.678 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -133.97 -59.76 0.83 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.376 1.47 . . . . 0.0 112.043 -172.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 p -96.91 168.17 10.64 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.198 1.799 . . . . 0.0 111.458 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 14.3 p -109.49 150.25 28.4 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 172.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -133.34 162.6 31.39 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.973 1.709 . . . . 0.0 112.684 -175.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 p -78.86 126.29 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 125.884 1.673 . . . . 0.0 111.724 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -145.98 103.4 3.74 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.191 0.996 . . . . 0.0 111.308 -178.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -62.88 111.69 2.25 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.044 1.338 . . . . 0.0 110.826 172.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.47 -156.88 26.94 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.096 0.855 . . . . 0.0 113.863 -175.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 78.0 m -134.31 114.65 13.21 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.048 2.139 . . . . 0.0 109.959 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -124.94 92.14 3.58 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.661 1.985 . . . . 0.0 109.329 -178.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 m 50.07 35.94 11.01 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.589 1.955 . . . . 0.0 114.19 174.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.08 23.0 78.53 Favored Glycine 0 CA--C 1.539 1.567 0 O-C-N 120.865 -1.147 . . . . 0.0 115.678 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.99 174.26 5.74 Favored Glycine 0 CA--C 1.542 1.757 0 C-N-CA 125.232 1.396 . . . . 0.0 116.184 -176.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -62.87 139.32 58.72 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 -159.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.5 m -74.64 -19.04 60.45 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.904 1.681 . . . . 0.0 114.828 176.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -137.96 154.66 49.36 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.247 1.819 . . . . 0.0 112.061 -176.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 49.3 ttm -75.48 -29.79 59.69 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.15 -29.54 75.59 Favored Glycine 0 CA--C 1.533 1.184 0 O-C-N 121.385 -0.822 . . . . 0.0 113.047 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -74.52 -48.33 27.68 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.874 1.67 . . . . 0.0 111.838 173.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.9 p -66.27 -25.98 67.13 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.284 0.947 . . . . 0.0 113.426 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.09 -59.16 2.85 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.377 1.471 . . . . 0.0 111.791 173.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -61.92 -28.3 69.43 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 -172.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -78.57 -6.7 56.26 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.461 1.104 . . . . 0.0 113.765 175.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -129.16 168.69 15.24 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 125.845 1.658 . . . . 0.0 113.346 -175.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -74.52 -19.25 19.29 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.756 2.304 . . . . 0.0 113.555 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.657 1.599 . . . . 0.0 114.287 -179.391 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.7 t -73.82 94.87 2.33 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.113 0.965 . . . . 0.0 110.452 167.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.5 p -80.99 175.18 10.91 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.259 1.424 . . . . 0.0 111.843 170.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.9 t -118.66 134.62 23.51 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 125.357 1.463 . . . . 0.0 109.866 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -78.05 -170.37 0.95 Allowed 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 124.685 3.59 . . . . 0.0 112.614 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.1 pt -55.24 165.39 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 126.341 1.856 . . . . 0.0 114.021 175.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.06 -61.23 4.76 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.803 1.668 . . . . 0.0 111.936 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -78.45 -179.45 6.35 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.057 1.343 . . . . 0.0 112.85 170.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.7 t -145.45 177.06 9.13 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.211 1.804 . . . . 0.0 110.201 164.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -84.87 112.31 41.97 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 125.062 1.345 . . . . 0.0 112.15 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.05 122.6 8.57 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.61 2.873 . . . . 0.0 112.542 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -78.89 -25.33 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.405 1.082 . . . . 0.0 113.414 174.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -66.9 154.99 39.63 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.458 1.503 . . . . 0.0 112.663 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.6 50.96 0.04 OUTLIER Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.933 1.254 . . . . 0.0 114.445 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.87 60.71 2.35 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.245 1.418 . . . . 0.0 111.991 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 83.3 m -117.44 155.57 29.45 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.224 1.81 . . . . 0.0 111.661 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.43 24.9 1.9 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.752 1.621 . . . . 0.0 113.944 -171.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.51 168.71 13.26 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.852 1.661 . . . . 0.0 112.279 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -73.38 0.99 10.58 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.526 1.93 . . . . 0.0 115.787 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -84.72 83.23 8.1 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.6 1.56 . . . . 0.0 111.987 -173.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.51 156.98 44.76 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.584 1.554 . . . . 0.0 111.317 -173.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 24.3 ttp180 -145.54 162.64 36.95 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.742 1.217 . . . . 0.0 111.77 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -123.28 111.58 16.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.284 1.034 . . . . 0.0 111.377 -167.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -108.8 122.73 47.79 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.763 0.825 . . . . 0.0 111.729 -171.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.4 t -69.77 111.72 5.72 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.939 1.296 . . . . 0.0 111.4 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 57.7 mtp -138.26 84.35 2.03 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.943 2.097 . . . . 0.0 110.394 -175.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.4 64.01 1.41 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.245 0.926 . . . . 0.0 114.111 175.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 56.74 22.93 7.37 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 126.331 1.853 . . . . 0.0 114.485 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 9.8 t -149.48 153.0 36.57 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 128.479 2.711 . . . . 0.0 108.102 172.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 7.1 p -114.51 121.55 43.84 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.026 0.931 . . . . 0.0 111.497 165.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -100.44 160.92 13.96 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.582 1.553 . . . . 0.0 111.039 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.7 p -74.76 129.05 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.629 0.772 . . . . 0.0 110.834 166.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -134.94 149.33 50.22 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.693 0.797 . . . . 0.0 111.597 171.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -88.47 154.7 20.15 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.685 1.194 . . . . 0.0 110.928 173.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.26 -176.84 33.64 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-O 122.21 0.894 . . . . 0.0 114.81 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 65.3 m -94.82 23.09 5.74 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.335 1.454 . . . . 0.0 114.504 -171.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -40.18 -44.37 1.83 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 127.019 2.128 . . . . 0.0 115.419 -170.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 98.0 m -155.28 82.65 1.06 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.857 1.663 . . . . 0.0 109.224 174.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -51.72 101.99 0.07 OUTLIER Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.526 1.536 . . . . 0.0 114.862 -176.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -126.74 -90.31 0.74 Allowed Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.764 1.65 . . . . 0.0 114.008 -175.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -121.77 116.69 24.95 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.641 1.177 . . . . 0.0 113.234 -164.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.7 m -84.71 -2.34 57.44 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -127.96 139.14 52.75 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.584 1.554 . . . . 0.0 111.378 174.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 38.9 ttm -69.45 -26.41 64.58 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.61 -33.69 72.1 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 121.798 -0.564 . . . . 0.0 112.96 172.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -74.19 -48.0 31.9 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.068 0.947 . . . . 0.0 111.835 173.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.6 p -63.79 -24.24 67.68 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.36 -65.38 0.93 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.661 1.584 . . . . 0.0 112.226 168.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -61.46 -28.7 69.47 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -168.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -84.11 -5.99 59.33 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.142 0.977 . . . . 0.0 113.474 177.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.45 169.84 6.35 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 126.373 1.869 . . . . 0.0 112.257 177.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -77.59 -8.81 17.2 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.056 2.504 . . . . 0.0 113.765 -178.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.311 0 C-N-CA 127.57 2.51 . . . . 0.0 112.615 177.424 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 71.8 m -65.03 134.58 54.17 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.712 0.805 . . . . 0.0 111.473 173.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.7 p -129.46 173.43 10.57 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.934 1.694 . . . . 0.0 111.287 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.6 t -58.18 134.74 84.49 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 124.39 1.076 . . . . 0.0 110.863 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -65.92 155.94 66.86 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 124.488 3.459 . . . . 0.0 112.658 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.1 pt -57.37 135.42 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.738 0.815 . . . . 0.0 112.368 -178.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.47 -13.45 22.12 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.451 1.5 . . . . 0.0 116.075 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -75.55 146.06 40.77 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 119.833 1.816 . . . . 0.0 112.252 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.0 t -90.93 96.12 10.47 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.445 1.098 . . . . 0.0 111.717 -175.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -57.72 142.99 77.26 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 124.611 1.164 . . . . 0.0 113.791 -176.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.47 81.0 2.9 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.913 3.075 . . . . 0.0 112.677 -171.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 p -61.07 -28.4 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 125.169 1.388 . . . . 0.0 113.114 -178.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -83.08 -4.91 58.85 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.083 2.153 . . . . 0.0 114.576 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.3 -139.35 6.58 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.365 1.459 . . . . 0.0 112.789 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.5 mt 65.22 11.21 7.05 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 127.051 2.14 . . . . 0.0 115.419 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 16.7 t -73.45 150.73 41.44 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.04 1.336 . . . . 0.0 112.777 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.6 37.87 0.36 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.958 2.503 . . . . 0.0 113.593 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.16 159.7 25.71 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.107 -0.996 . . . . 0.0 113.088 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -86.03 0.38 53.52 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.703 1.601 . . . . 0.0 114.88 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -144.26 122.24 12.07 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.183 2.193 . . . . 0.0 109.705 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.457 HG22 ' H ' ' A' ' 44' ' ' ARG . 1.9 m -148.31 167.57 24.83 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.969 1.308 . . . . 0.0 111.445 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.457 ' H ' HG22 ' A' ' 43' ' ' THR . 17.0 ttm180 -129.61 159.95 34.79 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.707 1.603 . . . . 0.0 111.513 -176.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -126.63 103.74 7.73 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.942 0.897 . . . . 0.0 111.953 -166.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -103.76 122.54 45.29 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.89 0.876 . . . . 0.0 112.346 -169.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.8 t -71.18 103.93 2.93 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.371 1.068 . . . . 0.0 110.794 171.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -136.07 111.21 8.96 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.499 1.92 . . . . 0.0 110.944 -177.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.46 53.78 5.37 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 123.945 0.783 . . . . 0.0 112.8 -170.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 63.24 -11.0 0.1 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 129.328 3.051 . . . . 0.0 116.896 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 48.4 t -126.9 158.24 37.28 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.884 2.074 . . . . 0.0 110.213 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.9 p -108.2 150.76 26.83 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 174.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -141.35 169.47 17.54 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.017 1.327 . . . . 0.0 111.798 172.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.26 126.16 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.006 1.322 . . . . 0.0 111.406 171.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -144.2 165.08 28.84 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.232 1.413 . . . . 0.0 111.217 174.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -126.49 104.79 8.33 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.037 1.335 . . . . 0.0 110.603 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.94 -178.31 36.96 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.466 1.508 . . . . 0.0 111.932 -176.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 77.8 m -99.36 103.35 15.15 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.625 1.17 . . . . 0.0 111.167 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -121.7 86.9 2.66 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.969 1.308 . . . . 0.0 110.402 -178.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.264 1.3 t 49.43 14.67 0.11 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 129.012 2.925 . . . . 0.0 117.182 174.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.88 33.72 45.17 Favored Glycine 0 CA--C 1.537 1.426 0 O-C-N 120.302 -1.499 . . . . 0.0 114.241 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.37 176.24 6.58 Favored Glycine 0 CA--C 1.543 1.812 0 C-N-CA 124.923 1.249 . . . . 0.0 115.564 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -70.07 147.59 49.84 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -162.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -89.38 -30.04 18.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.656 1.182 . . . . 0.0 113.158 174.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -91.17 135.51 33.73 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.84 1.256 . . . . 0.0 111.651 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 38.1 ttm -69.09 -25.32 64.37 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.432 0.693 . . . . 0.0 112.551 176.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.35 -46.86 75.23 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.585 0.612 . . . . 0.0 111.967 171.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.25 -47.05 86.07 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.149 0.98 . . . . 0.0 112.553 176.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.2 p -65.32 -23.48 67.02 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.67 -67.47 0.76 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.0 1.32 . . . . 0.0 111.643 168.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.08 -26.3 68.2 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -168.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -86.05 -4.86 59.26 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.024 0.93 . . . . 0.0 113.381 175.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.37 166.5 10.85 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 126.174 1.79 . . . . 0.0 112.077 176.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.86 -8.76 16.87 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.217 2.612 . . . . 0.0 114.426 -175.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.231 0 C-N-CA 126.493 1.997 . . . . 0.0 114.714 179.459 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 CA--C 1.546 0.792 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.9 t -69.39 149.94 47.83 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 119.175 0.898 . . . . 0.0 112.842 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.9 p -131.52 166.6 21.01 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.316 1.846 . . . . 0.0 112.15 -177.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.6 m -69.82 155.08 94.1 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.345 1.058 . . . . 0.0 112.341 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.7 156.14 67.22 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.934 2.423 . . . . 0.0 111.777 173.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 74.4 mt -66.92 136.15 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.034 0.934 . . . . 0.0 110.049 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.26 -0.84 83.17 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.216 1.388 . . . . 0.0 115.746 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.91 174.99 7.0 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.135 1.467 . . . . 0.0 112.693 175.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.9 t -128.31 92.23 3.4 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.926 1.29 . . . . 0.0 111.033 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.59 148.48 90.73 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 124.85 1.26 . . . . 0.0 113.798 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.442 ' HG2' ' CD1' ' A' ' 55' ' ' TYR . 69.0 Cg_endo -70.98 169.33 20.73 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.762 2.975 . . . . 0.0 113.336 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.8 t -108.57 94.96 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.075 1.75 . . . . 0.0 109.366 -172.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.19 172.27 7.01 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.111 2.164 . . . . 0.0 112.831 -175.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.1 -18.85 0.73 Allowed Glycine 0 CA--C 1.536 1.364 0 N-CA-C 115.916 1.126 . . . . 0.0 115.916 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.8 mp -80.83 61.78 4.6 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 119.171 1.486 . . . . 0.0 110.941 178.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.7 t -71.19 3.22 3.73 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 126.564 1.946 . . . . 0.0 114.189 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -65.42 -21.88 66.71 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.318 1.847 . . . . 0.0 113.884 177.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.24 168.81 11.59 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.491 1.117 . . . . 0.0 112.772 171.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -115.03 17.11 16.98 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.214 1.805 . . . . 0.0 113.732 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -138.26 123.38 19.16 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.543 2.337 . . . . 0.0 109.679 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -137.27 164.23 29.05 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.526 1.931 . . . . 0.0 110.149 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -133.5 171.7 13.73 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.675 1.19 . . . . 0.0 112.835 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -136.72 110.36 8.05 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.938 1.295 . . . . 0.0 110.394 -163.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -99.02 134.62 41.59 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.184 0.994 . . . . 0.0 111.219 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.9 t -69.14 128.44 36.66 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.924 -0.485 . . . . 0.0 110.947 171.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 98.7 mmm -114.68 81.55 1.58 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.581 1.952 . . . . 0.0 109.78 176.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.43 -62.42 4.08 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.304 1.43 . . . . 0.0 114.087 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -133.32 -53.83 0.9 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.296 1.439 . . . . 0.0 112.647 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 14.6 p -76.02 176.3 8.07 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.535 1.134 . . . . 0.0 111.335 171.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.23 163.27 16.23 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.261 -0.899 . . . . 0.0 111.617 161.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -134.22 154.81 51.04 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.441 1.496 . . . . 0.0 112.042 175.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 p -82.26 130.17 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.54 1.136 . . . . 0.0 112.52 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.442 ' CD1' ' HG2' ' A' ' 33' ' ' PRO . 68.1 m-85 -145.06 170.34 16.37 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.349 1.46 . . . . 0.0 111.579 173.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -124.57 161.03 27.05 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.102 1.361 . . . . 0.0 112.082 -169.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.74 177.64 24.39 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.843 1.211 . . . . 0.0 114.324 -177.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.3 t -81.83 80.81 8.04 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.521 -0.988 . . . . 0.0 111.184 175.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -84.01 76.46 10.05 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 122.167 0.984 . . . . 0.0 110.511 171.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.6 m 60.82 32.07 20.09 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.926 1.29 . . . . 0.0 112.861 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.47 -85.34 0.84 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.799 1.666 . . . . 0.0 113.319 178.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 59.24 -131.63 51.73 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.811 1.672 . . . . 0.0 113.744 -176.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -100.52 163.92 12.14 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.775 1.23 . . . . 0.0 112.133 -176.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.0 m -129.12 -0.7 5.19 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.771 1.228 . . . . 0.0 114.112 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -143.4 162.16 36.5 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.697 1.599 . . . . 0.0 112.833 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -42.5 95.26 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.205 1.802 . . . . 0.0 111.286 177.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.14 -25.67 75.25 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 121.493 -0.755 . . . . 0.0 114.155 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -74.26 -46.71 39.68 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.006 1.403 . . . . 0.0 112.037 175.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.7 p -61.14 -31.45 71.16 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.69 -0.631 . . . . 0.0 112.339 176.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.07 -53.47 6.38 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.999 1.72 . . . . 0.0 113.05 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -58.77 -28.17 65.67 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 120.203 1.365 . . . . 0.0 114.385 -174.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -84.08 -6.28 59.38 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.086 1.354 . . . . 0.0 113.858 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.0 m -129.85 162.97 50.31 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 125.197 1.399 . . . . 0.0 114.311 -172.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.98 -9.82 14.14 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.468 2.779 . . . . 0.0 114.943 -175.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.41 0 C-N-CA 125.816 1.674 . . . . 0.0 114.593 -177.685 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 120.495 0.188 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 75.3 m -80.69 170.55 16.17 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.754 0.821 . . . . 0.0 112.174 170.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.9 p -135.36 159.6 41.06 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.462 1.505 . . . . 0.0 111.541 168.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.0 p -79.9 130.67 66.09 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 124.701 1.2 . . . . 0.0 110.997 176.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.46 141.43 42.37 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.457 2.105 . . . . 0.0 110.993 171.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.1 pt -56.68 134.67 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.551 0.74 . . . . 0.0 112.336 -178.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.7 -8.01 57.95 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.388 1.47 . . . . 0.0 115.53 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 24.6 t-105 -77.75 152.85 33.4 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 119.728 1.764 . . . . 0.0 110.12 168.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.5 t -78.24 72.58 4.78 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 122.564 1.173 . . . . 0.0 112.178 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -66.79 154.52 91.69 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 125.67 1.588 . . . . 0.0 114.022 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -76.26 150.8 33.33 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.09 2.527 . . . . 0.0 111.627 175.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.5 t -136.84 76.86 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.099 1.36 . . . . 0.0 109.813 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.71 -28.57 0.43 Allowed 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 116.143 1.905 . . . . 0.0 116.143 -177.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.3 -169.61 24.99 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.16 0.886 . . . . 0.0 113.169 -165.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 98.0 mt -134.75 113.46 11.67 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.311 2.244 . . . . 0.0 108.404 177.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 63.1 m 61.4 29.3 18.43 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.437 1.895 . . . . 0.0 114.628 177.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -53.49 -53.57 49.56 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 126.123 1.769 . . . . 0.0 112.57 175.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.26 169.31 10.48 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.091 1.356 . . . . 0.0 112.19 174.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -108.49 5.07 24.87 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.348 1.859 . . . . 0.0 114.592 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -143.48 102.81 4.01 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.751 2.02 . . . . 0.0 110.85 -176.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.467 HG21 HG22 ' A' ' 54' ' ' VAL . 23.3 m -150.36 155.38 39.51 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 120.806 -1.184 . . . . 0.0 111.51 -177.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -77.71 160.99 28.08 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.771 1.228 . . . . 0.0 112.673 173.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -131.58 107.67 9.01 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.911 1.285 . . . . 0.0 110.759 -174.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -114.6 122.26 45.96 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.959 1.304 . . . . 0.0 112.462 -168.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 35.3 t -67.64 122.7 18.62 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.279 1.032 . . . . 0.0 112.008 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.34 -10.6 1.24 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -171.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 169.23 70.97 0.03 OUTLIER Glycine 0 N--CA 1.47 0.921 0 O-C-N 121.498 -0.751 . . . . 0.0 111.84 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.7 m120 60.83 1.86 0.48 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 127.953 2.501 . . . . 0.0 116.253 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 79.8 m -132.14 160.44 36.03 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.121 1.768 . . . . 0.0 110.158 163.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.7 p -101.26 91.22 4.41 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.93 1.292 . . . . 0.0 111.13 167.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -67.64 154.25 41.89 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.727 1.611 . . . . 0.0 112.319 -176.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.467 HG22 HG21 ' A' ' 43' ' ' THR . 8.9 p -66.64 121.49 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.425 1.49 . . . . 0.0 112.351 172.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -140.05 122.48 16.09 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.451 1.5 . . . . 0.0 111.796 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -74.33 150.68 40.02 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.491 0.716 . . . . 0.0 112.02 171.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.8 174.65 13.41 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.138 1.352 . . . . 0.0 115.417 176.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 17.6 p -80.33 39.08 0.44 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.513 1.925 . . . . 0.0 114.14 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -51.51 -34.91 38.11 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.196 1.398 . . . . 0.0 113.522 178.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.1 t -144.05 -23.86 0.56 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 169.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.63 15.0 81.54 Favored Glycine 0 CA--C 1.539 1.537 0 O-C-N 120.908 -1.12 . . . . 0.0 115.675 171.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -54.26 -68.63 1.56 Allowed Glycine 0 CA--C 1.535 1.33 0 C-N-CA 126.054 1.787 . . . . 0.0 115.073 -174.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -140.31 151.14 44.82 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.889 1.276 . . . . 0.0 112.525 -172.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.8 m -117.89 0.84 12.01 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.341 1.456 . . . . 0.0 114.499 -177.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -135.96 144.77 45.59 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.193 1.797 . . . . 0.0 110.771 174.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -62.91 -35.58 80.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.873 0.869 . . . . 0.0 111.755 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.75 -11.34 77.72 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.356 0.979 . . . . 0.0 114.925 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -96.16 -37.7 10.46 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.986 1.393 . . . . 0.0 112.099 176.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.7 p -70.79 -45.91 63.82 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.194 -0.941 . . . . 0.0 112.005 171.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.21 -12.48 61.19 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -177.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -85.33 -25.53 27.09 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 119.821 1.192 . . . . 0.0 113.626 168.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -91.47 -29.0 17.26 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.844 1.258 . . . . 0.0 112.995 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.3 m -106.53 165.41 13.0 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 126.009 1.724 . . . . 0.0 112.68 175.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -79.12 -4.92 14.18 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.049 2.5 . . . . 0.0 114.775 -171.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.333 0 C-N-CA 126.823 2.154 . . . . 0.0 115.236 -178.737 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 CA--C 1.541 0.611 0 CA-C-O 121.079 0.466 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 35.8 t -140.27 143.45 35.93 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.936 1.294 . . . . 0.0 111.149 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.4 m -132.79 146.03 51.49 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.445 1.498 . . . . 0.0 110.937 -168.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.1 m -100.49 155.94 35.79 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 125.037 1.335 . . . . 0.0 112.822 -173.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.3 157.06 62.68 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.436 2.757 . . . . 0.0 112.435 172.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.461 HD12 ' H ' ' A' ' 28' ' ' ILE . 5.4 mp -66.06 137.22 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.832 1.253 . . . . 0.0 110.385 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.31 -4.56 67.04 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.549 1.547 . . . . 0.0 115.781 176.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.03 172.66 11.26 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 118.826 1.313 . . . . 0.0 113.048 177.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -115.77 80.75 1.49 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.127 1.371 . . . . 0.0 111.53 -175.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -67.96 155.04 92.74 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 125.275 1.43 . . . . 0.0 114.176 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.24 168.27 25.02 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 124.025 3.15 . . . . 0.0 112.594 174.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.3 t -130.54 10.85 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 125.216 1.406 . . . . 0.0 112.706 -174.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -131.12 170.16 14.91 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.575 1.95 . . . . 0.0 112.252 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.69 31.55 0.22 Allowed Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.988 1.28 . . . . 0.0 115.053 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.6 mp -90.14 85.18 6.21 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.442 1.497 . . . . 0.0 110.735 -175.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.0 m -68.3 77.39 0.26 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.711 1.604 . . . . 0.0 112.9 176.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? -129.86 73.26 1.52 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.571 2.348 . . . . 0.0 110.88 -176.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 46.33 42.47 10.48 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.407 1.883 . . . . 0.0 114.659 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -74.05 -30.31 62.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.146 1.378 . . . . 0.0 113.088 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 50.81 26.57 2.65 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.897 2.079 . . . . 0.0 114.589 -175.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.1 m -60.03 152.67 23.38 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.749 2.42 . . . . 0.0 113.026 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.6 152.21 45.68 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.378 1.471 . . . . 0.0 112.028 176.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -129.6 144.89 51.48 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.84 1.256 . . . . 0.0 111.366 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -143.78 139.91 29.63 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.304 1.442 . . . . 0.0 110.722 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 38.0 t -89.95 123.18 33.65 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.878 0.871 . . . . 0.0 111.981 173.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 29.5 mtt -79.25 -12.84 59.96 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 175.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 154.46 -39.72 0.65 Allowed Glycine 0 N--CA 1.475 1.288 0 CA-C-N 119.293 0.951 . . . . 0.0 114.974 171.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -126.61 -12.06 6.11 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 174.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 25.8 p -151.91 163.43 39.26 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.878 2.071 . . . . 0.0 110.284 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 2.4 p -119.57 151.34 38.8 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.37 1.068 . . . . 0.0 112.68 176.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -122.53 178.89 4.79 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.795 1.638 . . . . 0.0 111.668 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.1 p -115.09 122.56 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.636 1.974 . . . . 0.0 110.806 -174.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -129.33 116.69 19.46 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.133 1.373 . . . . 0.0 111.068 -169.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -57.62 117.97 4.75 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.34 1.456 . . . . 0.0 112.972 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.42 173.52 49.86 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 125.387 1.47 . . . . 0.0 114.478 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 76.4 m -78.38 84.4 4.55 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.443 -1.033 . . . . 0.0 111.159 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -50.25 -50.66 49.37 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.453 1.501 . . . . 0.0 112.703 -178.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 90.6 m -136.89 -44.68 0.58 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.08 1.752 . . . . 0.0 111.723 169.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.5 56.82 0.08 OUTLIER Glycine 0 CA--C 1.536 1.367 0 C-N-CA 126.409 1.957 . . . . 0.0 112.636 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.09 -92.62 0.5 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.826 1.203 . . . . 0.0 113.745 -173.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -110.93 158.18 19.05 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.578 1.151 . . . . 0.0 112.6 -174.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.8 t -102.7 -30.29 10.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.594 1.958 . . . . 0.0 111.87 174.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -132.3 151.09 52.0 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.319 1.848 . . . . 0.0 111.589 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 48.8 ttm -66.93 -19.01 65.65 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.54 0.736 . . . . 0.0 112.926 177.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.61 -16.35 55.38 Favored Glycine 0 CA--C 1.539 1.548 0 O-C-N 121.149 -0.969 . . . . 0.0 114.561 168.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -87.78 -25.5 23.35 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 118.894 1.347 . . . . 0.0 112.761 173.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -61.05 -59.3 5.57 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.392 -0.817 . . . . 0.0 109.752 165.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.84 -12.45 59.17 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -170.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -92.37 -25.19 18.63 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 170.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -90.79 -13.7 33.38 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.946 1.298 . . . . 0.0 113.186 175.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.5 m -129.63 159.17 70.94 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.852 1.661 . . . . 0.0 113.187 -175.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -76.59 -10.39 18.68 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 123.85 3.033 . . . . 0.0 114.63 -176.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 C-N-CA 127.017 2.246 . . . . 0.0 112.276 176.922 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 CA--C 1.55 0.946 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.6 p -110.47 16.22 21.69 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.952 1.701 . . . . 0.0 114.49 -171.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -16.2 -72.93 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 130.085 3.354 . . . . 0.0 116.378 -163.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 m -143.28 151.29 54.64 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 127.195 2.198 . . . . 0.0 111.399 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.9 -27.3 7.18 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.575 2.85 . . . . 0.0 113.621 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.2 pt -136.06 -177.62 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.466 2.306 . . . . 0.0 111.014 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.39 41.64 0.3 Allowed Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.691 1.615 . . . . 0.0 114.248 172.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -59.31 143.52 49.13 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.931 2.092 . . . . 0.0 111.211 175.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.5 t -76.41 85.3 3.16 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.475 1.11 . . . . 0.0 112.116 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -63.98 155.74 76.82 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 125.155 1.382 . . . . 0.0 113.236 175.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.05 138.75 31.54 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.173 2.582 . . . . 0.0 111.076 174.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.6 t -73.39 -40.11 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.733 0.813 . . . . 0.0 111.141 175.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -69.52 161.32 29.77 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.137 1.375 . . . . 0.0 112.124 174.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.0 -126.12 1.34 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.41 1.481 . . . . 0.0 111.274 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 60.9 mt 49.27 45.48 23.43 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.771 1.628 . . . . 0.0 112.479 -177.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 65.9 m -63.22 149.66 44.94 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.964 1.706 . . . . 0.0 112.364 -177.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.97 -5.15 3.12 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.502 1.521 . . . . 0.0 114.804 -177.03 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.17 168.89 16.26 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.063 0.945 . . . . 0.0 112.144 169.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -105.62 5.64 31.41 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.563 1.945 . . . . 0.0 113.939 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -147.3 116.28 6.86 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.119 2.167 . . . . 0.0 110.335 -176.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.0 m -142.16 159.16 42.77 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.994 1.317 . . . . 0.0 110.775 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -76.92 147.06 37.19 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.538 1.135 . . . . 0.0 111.319 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -132.94 120.55 21.59 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.122 0.969 . . . . 0.0 111.908 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -113.63 122.88 48.54 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.709 1.204 . . . . 0.0 111.567 -175.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.7 t -70.95 115.9 10.62 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.937 0.895 . . . . 0.0 110.852 171.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.4 mmt -82.23 -16.79 48.34 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 165.99 -45.21 0.27 Allowed Glycine 0 N--CA 1.468 0.792 0 C-N-CA 124.675 1.131 . . . . 0.0 113.22 -173.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -136.55 -62.68 0.65 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.292 1.837 . . . . 0.0 110.471 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -81.13 168.43 18.59 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.3 1.04 . . . . 0.0 111.198 173.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 p -121.88 143.89 49.17 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.182 0.993 . . . . 0.0 112.993 170.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -110.48 148.88 31.19 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.778 1.631 . . . . 0.0 111.578 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 p -69.44 127.51 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 126.465 1.906 . . . . 0.0 112.254 169.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -136.02 129.86 32.66 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.085 1.354 . . . . 0.0 111.013 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.85 100.55 0.57 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.999 1.32 . . . . 0.0 112.114 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.73 179.63 50.21 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.076 1.322 . . . . 0.0 114.937 176.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 79.4 m -75.19 75.69 2.33 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.044 1.338 . . . . 0.0 112.002 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -50.18 -49.78 51.35 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.02 1.728 . . . . 0.0 113.116 177.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.4 t -146.93 1.27 0.76 Allowed 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 174.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 111.04 33.54 2.35 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.773 1.178 . . . . 0.0 115.704 173.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.32 -173.67 42.35 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.776 1.655 . . . . 0.0 114.469 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -64.81 148.66 50.84 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.858 1.263 . . . . 0.0 114.108 -173.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.1 t -100.79 -5.43 26.32 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.617 1.567 . . . . 0.0 113.549 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 89.2 mmt-85 -134.84 139.54 45.14 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.314 1.446 . . . . 0.0 111.351 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 47.4 ttm -69.15 -26.32 64.81 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -58.88 -42.81 96.86 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 121.946 -0.471 . . . . 0.0 112.589 169.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -70.06 -45.84 66.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.794 0.838 . . . . 0.0 112.968 177.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 12.9 p -66.68 -20.41 65.97 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.584 1.084 . . . . 0.0 113.355 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.14 -66.19 0.91 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.58 1.552 . . . . 0.0 111.919 168.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -60.22 -27.75 67.45 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 115.356 1.614 . . . . 0.0 115.356 -168.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -85.48 -3.16 58.77 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.576 1.15 . . . . 0.0 113.253 176.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -122.14 166.29 17.57 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 126.858 2.063 . . . . 0.0 112.671 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.71 -8.11 13.48 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.253 2.636 . . . . 0.0 114.838 -176.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.429 0 C-N-CA 125.88 1.705 . . . . 0.0 114.298 -179.53 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 . . . . . 0 CA--C 1.544 0.726 0 CA-C-O 122.265 1.031 . . . . 0.0 113.48 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.8 t -62.91 120.02 10.53 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.267 1.427 . . . . 0.0 112.697 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.9 m -68.39 154.44 41.8 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.548 1.539 . . . . 0.0 111.4 174.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.7 t -111.05 135.78 20.85 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 125.594 1.557 . . . . 0.0 110.803 -173.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.62 165.69 26.67 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.685 3.59 . . . . 0.0 113.546 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 63.2 mt -58.96 140.33 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.199 1.399 . . . . 0.0 110.629 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.85 25.05 47.13 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.143 0.878 . . . . 0.0 114.622 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -63.02 175.26 0.91 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.293 1.837 . . . . 0.0 115.505 -178.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.7 m -139.74 65.99 1.41 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 127.374 2.269 . . . . 0.0 110.45 178.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.8 155.61 69.9 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 124.583 1.153 . . . . 0.0 113.564 177.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.78 96.97 1.02 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.724 2.949 . . . . 0.0 113.253 -174.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.5 t -59.97 -43.87 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.316 1.046 . . . . 0.0 111.274 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -76.43 3.66 10.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.288 1.835 . . . . 0.0 114.927 173.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.76 -11.44 30.03 Favored Glycine 0 CA--C 1.541 1.698 0 C-N-CA 124.534 1.064 . . . . 0.0 115.531 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.43 -27.31 67.72 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.525 1.53 . . . . 0.0 113.228 167.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 9.2 t -76.81 165.54 24.57 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.341 1.456 . . . . 0.0 112.077 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -118.05 70.87 0.81 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.228 1.811 . . . . 0.0 110.805 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.36 158.71 19.79 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.428 1.091 . . . . 0.0 112.846 176.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -95.26 9.35 40.11 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.09 1.756 . . . . 0.0 114.577 -177.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -136.17 118.21 15.37 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.467 2.307 . . . . 0.0 110.057 -175.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.64 139.66 47.48 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.467 -0.771 . . . . 0.0 110.41 169.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.37 154.24 44.47 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.694 1.197 . . . . 0.0 112.201 -177.099 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -140.35 130.8 25.36 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.829 1.252 . . . . 0.0 111.069 -164.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -141.12 126.39 18.56 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.323 1.049 . . . . 0.0 111.956 -168.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 18.1 t -75.39 120.1 20.39 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.514 0.597 . . . . 0.0 112.303 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 37.5 mtm -135.73 87.11 2.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.353 1.461 . . . . 0.0 110.528 171.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.0 68.05 1.26 Allowed Glycine 0 N--CA 1.47 0.945 0 C-N-CA 124.777 1.18 . . . . 0.0 113.479 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 66.31 -2.67 0.95 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 127.759 2.424 . . . . 0.0 115.682 175.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.7 p -137.23 151.07 48.31 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.807 2.043 . . . . 0.0 110.4 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.5 p -118.88 93.94 4.27 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.848 0.859 . . . . 0.0 112.72 173.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -67.72 167.02 14.06 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.642 1.177 . . . . 0.0 112.784 170.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.21 129.0 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.736 1.614 . . . . 0.0 111.69 175.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -135.17 113.9 11.82 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.091 1.757 . . . . 0.0 110.426 -174.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -71.58 169.23 15.95 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.096 0.959 . . . . 0.0 112.667 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.42 167.39 42.6 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.064 1.316 . . . . 0.0 113.557 -176.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 8.8 t -83.47 71.74 10.29 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.489 -1.006 . . . . 0.0 112.157 -177.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -81.94 83.05 7.35 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.251 -0.906 . . . . 0.0 110.711 169.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.0 m -48.7 -35.08 13.19 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.434 1.494 . . . . 0.0 114.828 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.34 73.11 2.64 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.319 1.438 . . . . 0.0 114.948 -171.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.85 -115.8 0.5 Allowed Glycine 0 CA--C 1.53 1.0 0 CA-C-N 118.079 0.94 . . . . 0.0 114.257 171.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -129.8 175.61 8.7 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.156 1.382 . . . . 0.0 112.432 -170.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 80.8 p -123.82 -2.94 8.23 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.219 1.407 . . . . 0.0 114.76 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -140.06 144.95 37.12 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.21 1.804 . . . . 0.0 111.97 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 38.6 tpp -60.67 -31.12 70.37 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.657 1.183 . . . . 0.0 112.202 173.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.94 -14.34 70.5 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.568 1.08 . . . . 0.0 115.296 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -89.97 -43.73 10.36 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.051 1.425 . . . . 0.0 111.823 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 18.1 p -67.62 -23.03 65.32 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.42 -61.99 1.57 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.128 1.371 . . . . 0.0 111.845 170.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -62.29 -26.97 68.71 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -174.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -77.18 -6.61 53.64 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.1 m -123.43 164.91 25.32 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 126.347 1.859 . . . . 0.0 112.607 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -76.44 -17.59 16.37 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.009 2.473 . . . . 0.0 113.934 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.256 0 C-N-CA 126.081 1.801 . . . . 0.0 114.503 -177.593 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.474 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -67.28 134.46 51.64 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.245 1.018 . . . . 0.0 111.875 176.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -114.06 -6.75 13.1 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -176.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -72.05 157.97 36.82 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.05 0.94 . . . . 0.0 112.259 174.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.31 178.4 8.12 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.065 1.746 . . . . 0.0 112.028 173.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.4 p -115.89 135.38 54.05 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.625 1.57 . . . . 0.0 111.587 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.7 m -139.97 159.04 43.09 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.53 1.932 . . . . 0.0 109.844 -174.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 p -51.58 118.53 11.46 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 124.857 1.263 . . . . 0.0 112.322 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -78.09 175.37 11.23 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.509 2.806 . . . . 0.0 112.228 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.3 mm -58.13 133.93 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.725 1.21 . . . . 0.0 111.39 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.19 -60.79 0.66 Allowed Glycine 0 CA--C 1.531 1.037 0 C-N-CA 126.322 1.915 . . . . 0.0 111.522 -177.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -85.23 175.72 8.77 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.826 1.25 . . . . 0.0 113.24 175.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.9 m -143.19 122.64 13.14 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.874 2.07 . . . . 0.0 110.218 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.5 152.87 96.2 Favored Pre-proline 0 CA--C 1.554 1.105 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 175.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.77 121.95 8.63 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 124.389 3.393 . . . . 0.0 111.653 176.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.5 p -70.14 -27.06 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.107 0.963 . . . . 0.0 112.572 175.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -70.87 168.65 16.39 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.707 2.003 . . . . 0.0 113.328 175.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.85 148.77 16.58 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.313 1.435 . . . . 0.0 111.919 170.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 29.5 tp -150.93 79.59 1.32 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.632 1.173 . . . . 0.0 111.463 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 85.1 m -68.67 -3.94 13.85 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -68.8 -21.08 64.35 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.91 2.084 . . . . 0.0 114.289 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.7 158.3 30.5 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.712 0.768 . . . . 0.0 112.859 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -92.95 6.64 47.13 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.075 1.75 . . . . 0.0 113.175 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -144.13 167.18 23.01 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 129.488 3.115 . . . . 0.0 108.277 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.6 m -142.15 152.8 43.54 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.551 1.94 . . . . 0.0 109.635 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.9 tpp85 -127.98 146.1 50.76 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.77 1.228 . . . . 0.0 111.758 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -138.26 125.73 21.96 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.032 1.333 . . . . 0.0 110.301 -170.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -131.86 128.63 39.04 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.342 1.057 . . . . 0.0 111.564 -172.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.3 t -70.8 123.6 22.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.326 0.65 . . . . 0.0 111.681 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.1 mmt -84.97 -90.68 0.09 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.842 0.857 . . . . 0.0 110.268 170.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -94.27 -55.21 1.49 Allowed Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.74 1.162 . . . . 0.0 112.821 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -131.43 -49.2 0.99 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.518 1.527 . . . . 0.0 112.919 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 89.0 m -93.5 167.83 11.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.191 1.397 . . . . 0.0 112.353 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.6 p -121.66 103.01 8.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.102 1.361 . . . . 0.0 112.982 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -70.44 167.31 18.55 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.923 1.289 . . . . 0.0 112.73 171.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.1 p -89.73 126.36 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.592 1.557 . . . . 0.0 112.264 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -133.41 160.99 35.76 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.822 1.649 . . . . 0.0 111.052 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -127.82 80.99 1.99 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.556 1.142 . . . . 0.0 111.266 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.06 167.16 30.98 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.295 1.902 . . . . 0.0 112.776 175.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 92.6 m -85.12 72.03 10.83 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.815 1.246 . . . . 0.0 111.138 176.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -74.12 79.39 1.75 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.348 1.859 . . . . 0.0 111.104 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.6 m 55.02 31.33 15.9 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 125.726 1.61 . . . . 0.0 113.368 -177.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.13 -63.35 3.89 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 126.081 1.8 . . . . 0.0 114.154 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 51.81 -118.29 6.99 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 126.968 2.223 . . . . 0.0 114.628 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -125.89 153.21 44.52 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.296 1.438 . . . . 0.0 112.08 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.3 m -118.15 5.75 11.99 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.119 1.368 . . . . 0.0 114.054 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.2 mmt85 -134.03 140.83 46.94 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.881 2.072 . . . . 0.0 110.218 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 51.3 ttm -63.34 -30.98 72.02 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 122.929 0.492 . . . . 0.0 112.084 173.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.38 -43.3 98.51 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 121.483 -0.761 . . . . 0.0 113.086 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -65.64 -48.0 73.65 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.074 0.95 . . . . 0.0 112.537 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.1 p -67.58 -21.54 65.42 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.44 -61.91 1.85 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.326 1.45 . . . . 0.0 111.455 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -61.53 -27.88 68.93 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -172.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 -81.64 -2.76 51.44 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.563 1.145 . . . . 0.0 113.577 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -126.81 167.38 17.66 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 126.336 1.854 . . . . 0.0 112.999 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.4 -8.74 15.04 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.2 2.6 . . . . 0.0 114.693 -176.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.325 0 C-N-CA 125.968 1.747 . . . . 0.0 113.147 178.611 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.53 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -72.27 167.19 20.92 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.996 0.918 . . . . 0.0 112.19 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -82.65 -33.18 27.88 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.459 1.504 . . . . 0.0 111.939 171.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -77.68 174.8 10.55 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.095 1.358 . . . . 0.0 112.945 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -119.23 155.01 32.49 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.802 1.641 . . . . 0.0 111.33 173.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.7 m -96.7 58.41 1.67 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.674 1.189 . . . . 0.0 112.185 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.4 p -67.66 160.04 28.76 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.034 1.334 . . . . 0.0 111.907 167.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.6 m -81.35 157.6 70.25 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 124.592 1.157 . . . . 0.0 112.243 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.45 177.76 8.39 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.056 2.504 . . . . 0.0 111.945 166.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.556 HD12 ' H ' ' A' ' 28' ' ' ILE . 4.1 mp -54.21 132.39 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.901 1.68 . . . . 0.0 112.066 -176.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.74 -48.5 0.94 Allowed Glycine 0 CA--C 1.533 1.164 0 C-N-CA 126.569 2.033 . . . . 0.0 113.536 175.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -89.25 -174.64 4.49 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.345 1.458 . . . . 0.0 113.496 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.5 t -135.31 -79.24 0.43 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.122 1.369 . . . . 0.0 111.929 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -153.78 162.43 26.74 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.86 1.264 . . . . 0.0 112.884 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -71.12 83.98 0.91 Allowed 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.58 2.853 . . . . 0.0 111.559 167.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.5 t -68.32 -43.99 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.412 1.085 . . . . 0.0 110.744 173.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -82.61 173.24 12.12 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.762 2.025 . . . . 0.0 111.816 175.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.43 64.99 0.97 Allowed Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.041 1.305 . . . . 0.0 112.654 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.0 mp -128.94 19.93 5.97 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.741 2.016 . . . . 0.0 111.744 175.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 80.3 m -63.4 168.63 4.34 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.339 1.856 . . . . 0.0 113.322 -174.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.429 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -110.09 14.51 22.91 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.19 1.796 . . . . 0.0 113.087 -179.338 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.64 171.97 2.37 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.626 1.57 . . . . 0.0 113.478 175.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -98.54 1.0 46.12 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.028 1.731 . . . . 0.0 114.271 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -130.04 98.98 4.92 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.245 1.818 . . . . 0.0 112.303 -169.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.9 m -72.95 100.81 3.04 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.122 1.369 . . . . 0.0 110.822 176.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -87.39 142.02 28.19 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.764 0.826 . . . . 0.0 111.941 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -126.11 150.71 48.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.88 1.672 . . . . 0.0 111.974 -176.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -147.94 148.02 30.33 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.012 1.325 . . . . 0.0 112.984 173.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 41.5 t -88.26 113.44 23.87 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.075 1.35 . . . . 0.0 111.884 173.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.0 mmt -72.63 -42.86 63.98 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 173.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.54 -84.33 0.05 OUTLIER Glycine 0 N--CA 1.471 1.008 0 C-N-CA 123.732 0.682 . . . . 0.0 113.164 -175.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -86.76 -40.08 15.34 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 176.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -130.81 169.38 15.8 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.031 2.132 . . . . 0.0 111.671 -173.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 22.7 p -117.51 155.15 30.24 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -132.39 173.9 10.81 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.85 2.46 . . . . 0.0 111.95 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.12 137.68 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 127.008 2.123 . . . . 0.0 112.358 174.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -138.12 -21.51 1.07 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.719 1.608 . . . . 0.0 114.441 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 60.7 16.37 6.61 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 171.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -149.46 173.42 29.28 Favored Glycine 0 N--CA 1.474 1.197 0 O-C-N 120.606 -1.309 . . . . 0.0 114.2 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 71.8 m -78.33 65.18 3.6 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.711 1.204 . . . . 0.0 111.644 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -55.08 -43.1 73.62 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.465 1.506 . . . . 0.0 112.74 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.8 t -142.71 -19.17 0.67 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.357 1.463 . . . . 0.0 113.744 173.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -176.68 -85.05 0.06 OUTLIER Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.595 1.093 . . . . 0.0 111.311 175.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.43 108.26 0.63 Allowed Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.005 0.812 . . . . 0.0 114.383 170.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -60.67 154.46 21.36 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.38 0.672 . . . . 0.0 111.85 165.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.5 t -80.39 -40.35 26.67 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.14 1.376 . . . . 0.0 112.456 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -143.55 157.93 44.05 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 127.016 2.126 . . . . 0.0 111.266 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 5.0 ttt -64.83 -23.63 67.29 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.216 1.007 . . . . 0.0 113.136 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.26 -21.97 64.77 Favored Glycine 0 CA--C 1.535 1.331 0 O-C-N 120.786 -1.196 . . . . 0.0 114.289 171.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -78.93 -44.66 22.14 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.892 1.346 . . . . 0.0 111.925 173.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.0 p -66.53 -22.2 66.17 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 175.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.19 -62.35 1.46 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.208 1.403 . . . . 0.0 111.769 167.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -61.0 -27.98 68.7 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 -172.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -77.69 -6.2 53.1 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.354 1.061 . . . . 0.0 113.757 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m -123.2 164.93 24.72 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 126.208 1.803 . . . . 0.0 113.313 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -79.9 -10.31 14.13 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.17 2.58 . . . . 0.0 114.314 -173.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.381 0 C-N-CA 125.966 1.746 . . . . 0.0 113.797 -178.99 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -80.13 84.65 5.8 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.055 1.342 . . . . 0.0 113.64 -172.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -61.57 177.69 0.38 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.199 1.399 . . . . 0.0 111.815 163.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -56.94 147.04 24.85 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 120.838 -1.164 . . . . 0.0 112.621 170.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -112.95 -28.28 7.77 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 61.6 m -120.81 -78.77 0.6 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.238 1.815 . . . . 0.0 110.853 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 70.5 m -156.17 151.58 26.83 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 127.988 2.515 . . . . 0.0 108.547 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.8 m -129.94 156.78 78.53 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 125.221 1.408 . . . . 0.0 112.042 170.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -64.34 152.1 82.79 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.24 2.627 . . . . 0.0 112.244 172.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.2 pt -66.46 149.99 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.606 0.762 . . . . 0.0 112.014 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.03 -2.76 12.06 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 125.077 1.322 . . . . 0.0 116.169 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.27 172.97 11.5 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.218 1.509 . . . . 0.0 112.755 178.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 56.5 m -133.33 92.68 3.04 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.255 1.422 . . . . 0.0 111.149 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -63.51 148.46 93.8 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 124.176 0.991 . . . . 0.0 113.496 -178.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -78.3 75.05 5.08 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.163 3.242 . . . . 0.0 111.592 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 p -59.83 -23.9 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.869 1.668 . . . . 0.0 113.432 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -109.98 7.38 23.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.876 2.471 . . . . 0.0 114.128 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.81 49.81 2.87 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.945 1.736 . . . . 0.0 115.88 -172.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.0 mp -76.26 47.49 0.46 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 126.936 2.095 . . . . 0.0 113.092 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 59.7 m -69.43 154.38 42.1 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.526 -1.358 . . . . 0.0 112.195 169.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.23 16.54 1.52 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -177.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -120.73 167.05 12.89 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.355 1.462 . . . . 0.0 113.17 -177.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -18.43 63.51 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -70.88 -29.25 65.28 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.141 1.376 . . . . 0.0 113.83 -169.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.2 m -76.95 162.93 27.18 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.509 1.524 . . . . 0.0 111.769 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.89 168.31 11.61 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.616 1.566 . . . . 0.0 113.051 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -135.53 140.23 44.58 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.157 1.383 . . . . 0.0 110.482 -171.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -142.01 134.6 28.25 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.826 0.85 . . . . 0.0 112.695 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 31.5 t -75.02 119.16 18.82 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.312 0.645 . . . . 0.0 111.88 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.2 mmt -94.87 -2.86 49.89 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.57 -54.24 0.15 Allowed Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.373 0.987 . . . . 0.0 112.81 175.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -133.78 -19.89 2.03 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 175.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -136.67 167.59 21.13 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.358 1.463 . . . . 0.0 111.325 177.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 11.1 p -121.5 109.41 14.79 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -176.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -76.64 175.18 9.56 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.321 1.048 . . . . 0.0 112.047 167.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.7 p -85.88 137.79 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 126.855 2.062 . . . . 0.0 112.336 171.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -140.23 142.3 35.83 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.268 1.427 . . . . 0.0 111.434 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -93.83 -4.78 49.52 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -165.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -135.41 172.31 22.21 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 126.231 1.872 . . . . 0.0 112.396 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 22.5 t -66.57 145.2 55.88 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 122.052 -0.676 . . . . 0.0 112.607 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.05 82.66 2.06 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.241 1.816 . . . . 0.0 109.235 171.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.4 m 55.08 27.35 9.3 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.8 1.64 . . . . 0.0 113.822 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.58 13.98 74.77 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.358 1.456 . . . . 0.0 116.175 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -43.67 -82.84 0.02 OUTLIER Glycine 0 CA--C 1.539 1.593 0 C-N-CA 127.094 2.283 . . . . 0.0 116.991 -172.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -139.84 166.57 24.27 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.215 1.406 . . . . 0.0 112.435 -170.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.3 m -134.23 -18.45 2.01 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.193 1.397 . . . . 0.0 114.215 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -115.97 153.71 31.13 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.803 1.641 . . . . 0.0 111.544 175.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.0 tpp -65.04 -39.33 93.17 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.772 0.829 . . . . 0.0 111.359 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.77 -30.05 75.83 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.372 -0.682 . . . . 0.0 114.115 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -69.92 -57.79 4.62 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 118.577 1.189 . . . . 0.0 111.369 175.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.6 p -65.89 -26.04 67.44 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.91 -61.01 1.95 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.141 1.377 . . . . 0.0 111.81 168.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -61.98 -29.61 70.37 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -172.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -75.37 -13.59 60.42 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -113.55 166.22 11.73 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 126.413 1.885 . . . . 0.0 112.613 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.38 -17.95 23.54 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.888 2.392 . . . . 0.0 113.837 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.383 0 CA-C-O 117.061 -1.966 . . . . 0.0 115.046 -178.83 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.527 0 N-CA-C 111.801 -0.52 . . . . 0.0 111.801 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -126.69 161.59 27.77 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.707 1.603 . . . . 0.0 111.976 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -118.04 123.01 44.61 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.177 1.791 . . . . 0.0 111.382 -173.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -71.55 -23.34 61.74 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.02 0.928 . . . . 0.0 113.287 177.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -150.68 169.47 21.53 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.7 2.0 . . . . 0.0 111.431 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.3 t -124.5 78.31 1.66 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.201 1.001 . . . . 0.0 111.077 173.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.3 t -70.14 161.04 30.96 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.358 1.063 . . . . 0.0 111.607 170.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.3 t -81.47 134.27 51.62 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 124.414 1.086 . . . . 0.0 110.184 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -74.62 173.85 13.64 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.194 3.262 . . . . 0.0 112.933 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.9 mt -60.14 137.5 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.327 1.451 . . . . 0.0 110.903 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.67 -55.63 0.67 Allowed Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.329 1.919 . . . . 0.0 112.342 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -78.32 178.96 7.25 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.73 1.212 . . . . 0.0 113.281 174.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.2 p -138.37 92.57 2.65 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.618 1.967 . . . . 0.0 110.982 -175.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -66.12 154.9 88.87 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 124.098 0.959 . . . . 0.0 113.569 -177.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.84 151.59 51.34 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.935 2.424 . . . . 0.0 112.36 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.2 t -102.26 -20.62 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 125.136 1.374 . . . . 0.0 112.01 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.89 172.9 6.71 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 127.054 2.142 . . . . 0.0 111.657 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.87 85.77 0.07 OUTLIER Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.622 1.106 . . . . 0.0 112.616 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 tt -133.14 72.37 1.49 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.028 1.331 . . . . 0.0 111.107 -175.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 78.2 m -78.12 97.39 5.43 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.435 1.494 . . . . 0.0 111.346 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -61.55 -60.74 3.23 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.85 1.26 . . . . 0.0 112.751 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.5 167.78 21.04 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.784 0.834 . . . . 0.0 112.274 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -75.32 2.62 10.75 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.975 1.71 . . . . 0.0 114.446 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -93.29 90.05 6.64 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.355 1.862 . . . . 0.0 111.003 -173.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 m -123.14 157.02 33.86 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.506 1.522 . . . . 0.0 111.106 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.9 ttm105 -134.93 155.3 50.95 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.7 1.2 . . . . 0.0 111.79 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -135.55 134.03 39.0 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.578 1.151 . . . . 0.0 110.441 -165.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -136.46 133.59 36.75 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.969 0.908 . . . . 0.0 112.312 -171.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.8 t -72.96 132.1 43.02 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 122.161 -0.337 . . . . 0.0 111.59 174.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.1 mmt -93.47 -91.0 0.19 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.85 0.86 . . . . 0.0 109.831 167.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -97.61 -40.73 3.56 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.509 1.052 . . . . 0.0 114.636 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -146.02 -58.43 0.31 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.493 1.517 . . . . 0.0 110.966 -173.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.7 p -83.27 168.81 16.35 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.672 1.189 . . . . 0.0 112.117 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.0 p -121.11 105.99 11.13 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.495 1.118 . . . . 0.0 112.844 169.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -73.88 177.27 5.68 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.567 1.147 . . . . 0.0 112.14 173.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.2 p -88.9 134.17 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.271 1.828 . . . . 0.0 111.842 173.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -137.22 172.19 13.37 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.323 1.449 . . . . 0.0 111.107 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -127.12 108.01 10.53 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.784 1.234 . . . . 0.0 111.629 -174.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.82 168.21 36.51 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.2 1.381 . . . . 0.0 113.717 -176.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 7.9 p -58.92 129.69 43.36 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -138.18 -40.63 0.53 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.33 1.452 . . . . 0.0 113.208 -174.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.3 t -144.89 -22.4 0.5 Allowed 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -168.0 -161.73 18.38 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.867 1.699 . . . . 0.0 112.122 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -153.48 58.59 0.41 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.328 0.966 . . . . 0.0 113.876 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -70.77 -32.37 69.47 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -174.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.6 p 55.53 -3.4 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 128.868 2.867 . . . . 0.0 117.522 -171.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -131.14 135.11 47.17 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.374 1.87 . . . . 0.0 112.217 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 40.2 ttm -63.62 -33.0 74.64 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.516 1.126 . . . . 0.0 112.862 175.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.42 -22.89 77.8 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 121.456 -0.777 . . . . 0.0 113.799 174.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -83.87 -40.77 18.21 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.529 1.165 . . . . 0.0 112.33 175.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.6 p -65.14 -23.76 67.22 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.487 1.039 . . . . 0.0 113.06 173.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.52 -60.48 2.26 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.88 1.672 . . . . 0.0 111.89 170.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -61.34 -28.38 69.18 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -172.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -73.9 -8.09 54.75 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.322 1.049 . . . . 0.0 113.557 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.91 167.48 19.37 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 125.688 1.595 . . . . 0.0 114.213 -174.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.99 -9.61 16.73 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 123.172 2.581 . . . . 0.0 114.595 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.236 0 C-N-CA 125.864 1.697 . . . . 0.0 113.459 179.259 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.51 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -127.58 80.87 1.98 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.605 1.162 . . . . 0.0 111.216 -157.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -78.38 80.85 4.76 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.138 1.375 . . . . 0.0 111.079 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -61.99 -38.23 87.8 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.183 0.993 . . . . 0.0 112.361 175.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -156.06 -178.79 7.57 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.982 2.113 . . . . 0.0 111.395 173.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 47.2 t -133.29 123.79 26.12 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.26 1.424 . . . . 0.0 110.654 172.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.1 m -63.31 122.26 15.76 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.52 1.528 . . . . 0.0 112.245 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.3 t -78.01 134.12 64.4 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.837 1.255 . . . . 0.0 110.716 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.54 164.81 30.0 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.196 3.264 . . . . 0.0 113.442 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.9 mm -60.3 145.24 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.844 1.257 . . . . 0.0 111.21 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.08 25.62 57.23 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.074 0.845 . . . . 0.0 114.2 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -63.54 178.21 0.6 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.701 2.001 . . . . 0.0 115.271 -178.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.0 t -139.67 48.96 1.81 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.373 1.869 . . . . 0.0 110.905 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.55 151.81 68.85 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.424 1.489 . . . . 0.0 112.968 175.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -74.79 158.25 43.12 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.231 2.62 . . . . 0.0 113.54 -170.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.77 -29.97 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.836 0.854 . . . . 0.0 112.55 177.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.41 177.51 7.09 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.415 1.486 . . . . 0.0 112.571 175.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.59 -107.29 0.29 Allowed Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.522 1.058 . . . . 0.0 112.416 172.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.1 tp -154.17 115.54 4.12 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.672 1.589 . . . . 0.0 109.751 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.5 t -68.73 173.14 5.46 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.82 1.648 . . . . 0.0 112.337 174.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.39 5.94 21.88 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.324 1.85 . . . . 0.0 114.71 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.25 156.47 12.4 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.664 1.185 . . . . 0.0 113.298 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -81.27 4.38 20.68 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.883 1.673 . . . . 0.0 115.051 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -140.55 117.65 11.22 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.944 2.097 . . . . 0.0 110.521 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.9 m -142.45 154.56 44.66 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.332 1.453 . . . . 0.0 110.777 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -100.95 151.73 21.41 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.49 1.116 . . . . 0.0 111.316 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -125.06 138.81 54.19 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.578 1.151 . . . . 0.0 111.185 -174.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -132.36 135.76 46.37 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.076 1.351 . . . . 0.0 111.051 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 38.5 t -80.19 104.7 10.93 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.901 0.48 . . . . 0.0 111.004 169.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 87.5 mmm -76.04 -18.74 59.11 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.29 -78.29 0.05 OUTLIER Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.554 1.073 . . . . 0.0 112.861 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -109.26 -3.83 16.92 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.059 1.344 . . . . 0.0 114.058 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 25.1 p -149.13 157.99 43.82 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.946 2.099 . . . . 0.0 109.895 -176.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.4 p -111.17 147.81 34.12 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 168.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.0 mtpp -140.72 167.33 22.42 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.542 1.937 . . . . 0.0 111.844 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.78 125.76 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.915 1.286 . . . . 0.0 111.884 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -146.21 166.3 26.63 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.51 1.524 . . . . 0.0 110.72 177.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -142.68 103.05 4.16 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.353 1.061 . . . . 0.0 112.104 -172.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.7 -175.94 45.32 Favored Glycine 0 CA--C 1.532 1.132 0 O-C-N 121.455 -0.778 . . . . 0.0 113.742 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 63.1 m -68.01 14.41 0.06 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 127.207 2.203 . . . . 0.0 115.163 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -60.48 99.97 0.09 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 128.133 2.573 . . . . 0.0 110.797 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 21.7 m -53.69 -61.61 2.19 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.476 1.911 . . . . 0.0 113.003 -175.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.1 93.21 1.29 Allowed Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.444 1.497 . . . . 0.0 113.47 -174.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -147.65 175.05 27.19 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.158 1.361 . . . . 0.0 113.273 175.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -121.23 -17.71 7.61 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.521 1.675 . . . . 0.0 115.521 -165.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 58.63 4.48 0.37 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.572 1.949 . . . . 0.0 116.136 -176.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -138.13 142.89 40.14 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.93 2.092 . . . . 0.0 111.266 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.6 tpp -71.62 -32.19 67.71 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.323 1.049 . . . . 0.0 112.741 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.09 -48.12 67.69 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 121.598 -0.689 . . . . 0.0 111.402 175.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -64.86 -37.31 87.22 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.466 1.506 . . . . 0.0 113.409 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.5 p -71.57 -27.34 63.08 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.925 1.239 . . . . 0.0 113.39 171.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.16 -43.27 21.89 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.821 1.249 . . . . 0.0 112.992 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -63.52 -26.62 68.79 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 120.723 1.601 . . . . 0.0 113.482 -177.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -78.89 -9.26 59.43 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.641 1.577 . . . . 0.0 113.698 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 m -131.71 167.12 23.51 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 125.015 1.326 . . . . 0.0 113.97 -173.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.39 -11.66 15.81 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.968 2.445 . . . . 0.0 114.19 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.22 0 C-N-CA 126.919 2.2 . . . . 0.0 112.552 179.431 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.641 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -65.87 -21.51 66.46 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -171.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -67.85 -19.04 65.0 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -176.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -114.76 116.23 28.31 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.996 1.319 . . . . 0.0 111.312 172.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -78.02 -16.87 57.73 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.6 p -75.48 156.45 35.2 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.727 0.811 . . . . 0.0 112.304 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.3 m -144.89 143.42 30.58 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.917 1.287 . . . . 0.0 110.73 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.0 t -68.74 133.95 90.38 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 124.112 0.965 . . . . 0.0 110.655 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.59 -175.36 2.41 Favored 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 124.401 3.401 . . . . 0.0 112.232 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.1 pt -59.51 166.06 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.987 1.315 . . . . 0.0 113.501 175.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.36 -59.38 4.11 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.666 1.603 . . . . 0.0 112.378 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -73.35 -178.37 2.95 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.866 1.266 . . . . 0.0 112.925 170.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.4 p -126.83 133.29 50.79 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.873 1.669 . . . . 0.0 111.063 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -74.97 152.46 86.59 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 123.869 0.868 . . . . 0.0 112.659 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.44 169.44 22.41 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.713 2.942 . . . . 0.0 111.906 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.9 t -131.35 -19.84 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.732 1.213 . . . . 0.0 112.05 -171.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt 55.27 2.75 0.06 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 128.326 2.65 . . . . 0.0 116.271 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -108.25 -7.89 29.93 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.756 1.646 . . . . 0.0 115.492 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.1 mp -74.95 -66.44 0.75 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.011 1.406 . . . . 0.0 110.855 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.4 t -139.0 153.12 48.11 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.273 1.429 . . . . 0.0 112.199 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.0 mtpt -135.72 83.99 2.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.618 2.367 . . . . 0.0 109.872 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.67 174.12 10.86 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.431 1.493 . . . . 0.0 112.514 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.02 -5.62 54.4 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.63 1.572 . . . . 0.0 114.697 -174.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -85.28 -15.61 42.86 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.094 1.357 . . . . 0.0 114.348 -170.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.5 m -68.79 158.82 33.57 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.836 1.254 . . . . 0.0 111.959 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -133.22 165.3 25.11 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.487 1.515 . . . . 0.0 111.82 -176.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -114.24 133.25 55.76 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.072 1.349 . . . . 0.0 111.466 -169.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -134.96 162.42 32.48 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.86 1.264 . . . . 0.0 111.805 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.7 t -101.68 108.69 20.3 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.563 1.145 . . . . 0.0 110.856 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 16.7 mmt -73.4 -60.27 2.32 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.101 0.56 . . . . 0.0 112.264 174.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -169.59 97.44 0.12 Allowed Glycine 0 N--CA 1.469 0.894 0 C-N-CA 124.149 0.881 . . . . 0.0 112.244 -170.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 58.92 11.43 1.91 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.88 2.072 . . . . 0.0 114.994 -175.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 6.4 t -151.49 147.74 27.2 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.053 2.141 . . . . 0.0 109.078 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 13.6 p -125.19 143.67 50.83 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 170.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.4 mtpp -149.57 170.94 17.48 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.253 1.421 . . . . 0.0 112.348 -172.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.3 p -75.01 128.52 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.509 1.524 . . . . 0.0 111.008 169.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -136.5 108.48 7.15 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.528 1.131 . . . . 0.0 111.439 -175.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -64.22 147.45 52.34 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.731 1.213 . . . . 0.0 112.149 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.98 177.62 21.54 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 125.771 1.653 . . . . 0.0 113.902 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 64.7 m -73.42 146.5 45.01 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 122.004 -0.703 . . . . 0.0 111.667 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -154.69 119.88 5.0 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.321 1.449 . . . . 0.0 108.742 170.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.2 m -57.56 -49.19 77.18 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.051 0.94 . . . . 0.0 112.632 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.44 172.61 45.1 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.811 1.196 . . . . 0.0 113.536 172.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 170.56 170.12 34.46 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.473 1.035 . . . . 0.0 114.933 176.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -111.68 -22.51 11.15 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.6 p 55.38 -4.28 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 128.85 2.86 . . . . 0.0 117.714 -172.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -133.29 137.7 46.12 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.472 1.909 . . . . 0.0 111.756 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.1 tpp -64.15 -33.12 75.06 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.603 1.161 . . . . 0.0 112.072 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.21 -38.17 82.12 Favored Glycine 0 CA--C 1.531 1.086 0 O-C-N 121.582 -0.699 . . . . 0.0 112.852 176.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -68.62 -47.55 66.37 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.011 0.924 . . . . 0.0 112.52 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.3 p -62.37 -25.9 68.17 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.392 0.996 . . . . 0.0 112.773 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.72 -64.46 1.07 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.52 1.528 . . . . 0.0 111.404 171.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -63.68 -27.47 69.24 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -171.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -78.93 -2.04 38.08 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.953 0.901 . . . . 0.0 113.251 174.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.67 170.55 7.85 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 127.023 2.129 . . . . 0.0 112.347 176.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -82.54 -8.07 11.54 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.071 2.514 . . . . 0.0 114.092 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.277 0 C-N-CA 126.548 2.023 . . . . 0.0 114.265 -178.764 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.575 0 N-CA-C 112.207 -0.357 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -70.79 168.94 15.64 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.489 1.515 . . . . 0.0 113.612 175.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -129.48 109.19 10.85 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.432 1.893 . . . . 0.0 109.884 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -64.58 155.91 31.61 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.929 0.892 . . . . 0.0 112.567 178.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -146.92 177.25 9.28 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.149 1.38 . . . . 0.0 112.803 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.4 t -140.19 153.48 46.62 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.166 1.787 . . . . 0.0 110.161 176.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.6 t -69.33 165.27 21.05 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.852 0.861 . . . . 0.0 112.168 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.3 t -145.07 133.56 10.85 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 125.619 1.568 . . . . 0.0 110.002 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.8 163.88 32.82 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.362 3.375 . . . . 0.0 113.376 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.531 HD12 ' H ' ' A' ' 28' ' ' ILE . 4.5 mp -58.93 138.43 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.161 1.384 . . . . 0.0 110.755 177.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.39 28.03 41.5 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.142 0.877 . . . . 0.0 114.472 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -63.88 176.22 0.99 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.295 1.838 . . . . 0.0 115.886 -176.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 72.5 m -131.87 63.07 1.62 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.223 2.209 . . . . 0.0 110.65 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -63.25 156.59 68.35 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 125.123 1.369 . . . . 0.0 112.841 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.26 172.47 13.99 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.2 2.6 . . . . 0.0 113.815 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 p -119.45 20.86 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 126.957 2.103 . . . . 0.0 112.178 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -57.67 164.37 2.09 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.151 2.18 . . . . 0.0 115.195 -174.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 144.94 -29.52 1.83 Allowed Glycine 0 CA--C 1.536 1.397 0 C-N-CA 126.051 1.786 . . . . 0.0 114.321 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.24 1.95 6.4 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.698 1.599 . . . . 0.0 113.956 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.6 t -62.59 138.68 58.54 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.359 1.064 . . . . 0.0 112.317 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -113.55 -7.68 13.37 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.767 1.627 . . . . 0.0 114.598 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.19 170.58 12.69 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.875 0.87 . . . . 0.0 112.401 172.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -124.1 9.92 8.72 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.986 1.714 . . . . 0.0 114.472 -175.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -88.83 74.35 8.29 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.155 1.382 . . . . 0.0 112.03 -170.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.16 133.91 55.86 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.736 0.815 . . . . 0.0 111.404 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -137.28 154.86 50.02 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.424 1.09 . . . . 0.0 111.846 -172.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -132.87 129.18 38.08 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.856 1.263 . . . . 0.0 110.454 -169.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -139.55 129.42 24.82 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.24 1.016 . . . . 0.0 111.597 -171.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 40.6 t -71.83 129.87 39.67 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.753 -0.592 . . . . 0.0 112.587 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 43.7 mtm -132.79 -80.37 0.49 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.687 1.195 . . . . 0.0 112.042 167.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -86.35 60.56 4.54 Favored Glycine 0 N--CA 1.474 1.177 0 O-C-N 121.201 -0.937 . . . . 0.0 114.353 -170.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.4 m120 59.68 14.04 3.8 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.448 1.899 . . . . 0.0 113.901 -172.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 28.2 p -144.89 160.62 41.01 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.711 2.804 . . . . 0.0 109.322 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 18.5 p -115.15 87.39 2.65 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.765 0.826 . . . . 0.0 111.879 170.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -67.24 164.32 18.53 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 122.12 0.962 . . . . 0.0 111.85 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.2 p -82.49 128.5 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.929 1.292 . . . . 0.0 111.587 174.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -131.39 154.37 48.7 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.509 1.524 . . . . 0.0 110.829 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -132.0 89.52 2.69 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.135 1.374 . . . . 0.0 110.366 -174.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.61 175.71 42.37 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.902 1.239 . . . . 0.0 112.889 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 29.5 m -66.71 141.89 57.6 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.472 0.709 . . . . 0.0 111.765 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.63 121.93 5.67 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.887 1.275 . . . . 0.0 109.097 173.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.0 m -59.18 -37.13 76.65 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.472 1.109 . . . . 0.0 113.343 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -100.1 -161.98 28.55 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 126.405 1.955 . . . . 0.0 113.623 176.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 123.74 172.01 13.65 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.988 1.756 . . . . 0.0 114.541 174.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -107.1 -18.21 13.96 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -173.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.4 t 60.47 -14.07 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 127.728 2.411 . . . . 0.0 116.496 -174.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 42.2 mmt180 -125.24 136.52 53.62 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.519 1.927 . . . . 0.0 112.094 -177.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 62.2 tpp -59.8 -38.27 81.47 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.191 1.396 . . . . 0.0 112.129 175.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.33 -29.69 65.89 Favored Glycine 0 CA--C 1.533 1.194 0 O-C-N 121.716 -0.615 . . . . 0.0 113.769 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -82.25 -41.29 20.41 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.15 0.975 . . . . 0.0 112.403 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.0 p -64.89 -23.41 67.22 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.07 0.85 . . . . 0.0 112.895 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.27 -64.03 1.11 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.481 1.512 . . . . 0.0 111.589 169.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -61.41 -28.1 69.02 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -171.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -78.46 -6.27 54.86 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.11 0.964 . . . . 0.0 113.565 174.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -122.35 170.85 7.19 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 126.625 1.97 . . . . 0.0 112.437 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.11 -7.16 17.11 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.229 2.62 . . . . 0.0 114.724 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.286 0 C-N-CA 126.747 2.117 . . . . 0.0 114.742 -178.735 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.642 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -68.9 -23.43 64.19 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -169.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -125.18 23.22 7.72 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 126.37 1.868 . . . . 0.0 113.112 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -58.82 120.42 8.97 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.507 1.923 . . . . 0.0 112.636 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -146.18 172.51 13.33 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.816 1.646 . . . . 0.0 112.145 172.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.2 p -127.47 170.46 12.54 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.901 1.68 . . . . 0.0 112.542 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.7 p -90.31 161.69 15.52 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.756 1.223 . . . . 0.0 111.925 173.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.8 m -66.06 155.54 86.93 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 123.524 0.729 . . . . 0.0 112.257 176.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -64.17 156.24 60.46 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.493 2.795 . . . . 0.0 112.47 172.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 40.5 pt -61.69 143.78 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.783 0.833 . . . . 0.0 112.083 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.86 -6.73 11.41 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.116 1.341 . . . . 0.0 116.188 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -76.71 172.32 13.26 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.42 1.61 . . . . 0.0 112.243 176.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.5 t -128.97 92.98 3.49 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.856 1.262 . . . . 0.0 111.827 -174.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -61.75 152.62 75.0 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 125.158 1.383 . . . . 0.0 113.864 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.36 86.95 1.4 Allowed 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.867 3.045 . . . . 0.0 112.243 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.6 p -68.19 -29.64 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.639 1.176 . . . . 0.0 113.161 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -78.71 -68.13 0.68 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.884 1.674 . . . . 0.0 112.593 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.67 43.79 91.41 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.138 1.351 . . . . 0.0 114.498 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.0 tp -113.11 92.85 4.15 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.971 1.708 . . . . 0.0 111.174 -169.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 31.3 p -120.41 178.21 4.75 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.588 1.955 . . . . 0.0 113.502 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -127.84 -60.0 1.17 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.396 1.878 . . . . 0.0 112.099 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.05 173.23 6.76 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.636 1.174 . . . . 0.0 113.259 176.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -110.1 47.66 0.94 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.63 1.972 . . . . 0.0 113.297 -173.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -122.25 95.53 4.68 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.894 1.678 . . . . 0.0 110.788 -176.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.6 m -132.35 154.63 49.57 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.111 1.364 . . . . 0.0 110.876 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -138.78 124.21 19.38 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.808 1.243 . . . . 0.0 111.485 -174.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -76.98 140.03 40.28 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.649 1.18 . . . . 0.0 111.483 -177.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -131.36 127.42 37.56 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.87 1.268 . . . . 0.0 111.141 -176.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.7 t -65.98 122.86 18.33 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.809 0.338 . . . . 0.0 110.846 171.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 37.6 mtp -137.5 111.96 8.66 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.159 1.384 . . . . 0.0 110.327 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.05 -68.48 2.84 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.6 1.095 . . . . 0.0 112.39 -174.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -145.94 -52.22 0.25 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 8.4 p -83.82 172.62 11.99 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.295 0.952 . . . . 0.0 112.437 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.4 p -121.2 90.69 3.37 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.311 1.044 . . . . 0.0 112.75 172.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -74.12 173.59 9.88 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.358 1.063 . . . . 0.0 112.218 172.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.02 130.11 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.48 1.512 . . . . 0.0 111.26 168.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -142.99 163.63 32.27 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.161 1.784 . . . . 0.0 110.61 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -130.76 -1.36 4.24 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.39 170.55 54.88 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.416 1.007 . . . . 0.0 114.079 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 56.6 m -67.74 105.08 1.81 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.653 1.181 . . . . 0.0 111.358 177.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.44 98.88 4.07 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.574 1.15 . . . . 0.0 109.985 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.0 m -53.64 -47.36 70.4 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.676 1.59 . . . . 0.0 113.373 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.06 60.78 4.65 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.499 1.523 . . . . 0.0 114.29 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.97 164.01 35.14 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.613 1.101 . . . . 0.0 114.324 176.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -120.35 -26.72 5.36 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 59.95 5.5 0.76 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.653 1.981 . . . . 0.0 115.735 -175.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -136.63 129.75 31.21 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.647 1.979 . . . . 0.0 111.428 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 31.5 ttm -61.58 -31.23 71.27 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.732 1.213 . . . . 0.0 113.043 175.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.45 -37.02 48.02 Favored Glycine 0 CA--C 1.528 0.903 0 O-C-N 121.889 -0.507 . . . . 0.0 113.268 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -76.05 -44.49 38.89 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.731 0.812 . . . . 0.0 112.132 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.4 p -64.93 -21.75 66.88 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.58 -63.14 1.48 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.495 1.518 . . . . 0.0 111.466 170.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -61.68 -28.44 69.4 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -76.56 -5.0 45.81 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 174.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -126.07 167.15 17.77 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 125.865 1.666 . . . . 0.0 113.656 -175.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.21 -8.11 14.05 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.277 2.652 . . . . 0.0 114.531 -174.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.375 0 C-N-CA 126.106 1.812 . . . . 0.0 114.357 179.383 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.496 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -82.0 -19.64 40.08 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -174.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -85.0 165.13 17.82 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.292 1.437 . . . . 0.0 112.292 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -76.05 74.29 2.92 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.497 1.519 . . . . 0.0 111.749 176.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -141.65 157.09 45.51 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.621 1.568 . . . . 0.0 112.263 175.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 61.3 m -71.16 154.04 42.02 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.462 0.705 . . . . 0.0 111.558 173.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.6 t -70.14 -175.73 1.02 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.267 1.027 . . . . 0.0 112.529 170.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.4 t -135.09 134.23 21.44 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 126.354 1.862 . . . . 0.0 110.03 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.36 162.8 37.66 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.074 3.183 . . . . 0.0 113.171 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.502 HD12 ' H ' ' A' ' 28' ' ' ILE . 4.2 mp -60.67 141.02 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.883 1.273 . . . . 0.0 110.593 176.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.35 26.12 40.98 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.099 0.857 . . . . 0.0 114.336 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -63.69 177.86 0.67 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.432 2.293 . . . . 0.0 116.016 -176.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.0 p -134.93 65.73 1.55 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 127.398 2.279 . . . . 0.0 111.122 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.45 154.68 53.11 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 124.983 1.313 . . . . 0.0 113.84 178.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -72.61 169.27 22.28 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.555 2.836 . . . . 0.0 112.738 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.0 t -132.48 56.06 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.518 1.527 . . . . 0.0 109.277 -177.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.4 mtmm -59.82 131.49 51.05 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.637 1.175 . . . . 0.0 110.88 172.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.08 79.98 0.12 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.905 1.24 . . . . 0.0 111.9 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.2 mt 55.18 32.97 19.53 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.11 1.764 . . . . 0.0 113.565 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 67.0 m -58.54 153.15 16.72 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.914 1.685 . . . . 0.0 113.464 -174.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.403 ' HA ' ' HE2' ' A' ' 39' ' ' LYS . 11.0 mmpt? -123.85 73.57 1.22 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.168 1.787 . . . . 0.0 111.015 -174.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -137.32 163.03 31.98 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.568 1.547 . . . . 0.0 111.781 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.1 mtp85 -129.68 12.37 5.82 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.109 1.764 . . . . 0.0 113.8 -175.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -132.52 109.46 9.8 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.528 1.931 . . . . 0.0 110.899 -175.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.6 156.82 38.33 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.231 1.012 . . . . 0.0 111.547 174.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -142.5 166.47 24.59 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.136 1.375 . . . . 0.0 111.681 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -131.08 144.6 51.55 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.344 1.058 . . . . 0.0 111.424 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -141.34 132.3 26.08 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.838 1.255 . . . . 0.0 111.005 -171.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 36.1 t -82.42 109.73 16.92 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.631 1.172 . . . . 0.0 111.766 173.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 6.9 mmt -72.33 -9.8 58.96 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 173.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.09 -37.15 0.46 Allowed Glycine 0 N--CA 1.474 1.211 0 C-N-CA 124.257 0.932 . . . . 0.0 114.76 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -141.82 -53.98 0.44 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.669 1.588 . . . . 0.0 111.248 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 36.8 t -107.7 110.3 22.11 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.462 1.505 . . . . 0.0 110.215 -175.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 21.4 p -74.97 146.95 41.26 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -128.58 171.86 11.73 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.524 1.93 . . . . 0.0 111.097 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 p -75.22 131.95 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.69 1.196 . . . . 0.0 111.019 172.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -145.11 163.47 34.21 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.575 1.15 . . . . 0.0 111.195 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -154.47 149.54 26.87 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.278 1.431 . . . . 0.0 110.229 174.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 135.16 -172.86 21.9 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.925 1.25 . . . . 0.0 113.359 -172.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 63.6 m -72.8 6.73 2.35 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 -172.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -68.36 97.46 0.75 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.472 1.909 . . . . 0.0 111.789 -177.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.8 m -55.16 -41.57 71.99 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 126.319 1.848 . . . . 0.0 114.206 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.49 58.44 4.99 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.16 1.362 . . . . 0.0 115.029 -171.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -100.83 173.7 24.84 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 125.118 1.342 . . . . 0.0 114.591 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -107.38 159.07 16.67 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.133 1.773 . . . . 0.0 111.186 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.3 p -79.59 -40.4 29.45 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 120.855 -1.153 . . . . 0.0 113.256 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.8 mmp_? -139.39 161.82 36.53 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.93 2.092 . . . . 0.0 111.627 -177.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 49.1 ttm -67.43 -29.19 68.61 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.398 0.679 . . . . 0.0 112.382 -177.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.53 -28.71 70.1 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.445 -0.642 . . . . 0.0 113.855 171.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -74.65 -50.85 16.16 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.796 1.298 . . . . 0.0 111.901 172.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.7 p -66.33 -19.76 65.9 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.73 -66.48 0.74 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.465 1.506 . . . . 0.0 111.887 164.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -60.48 -28.65 68.51 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -169.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -81.05 -7.0 59.47 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.335 1.054 . . . . 0.0 113.78 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -119.72 164.98 19.01 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 125.956 1.702 . . . . 0.0 112.723 -177.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -75.94 -6.38 17.35 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.527 2.818 . . . . 0.0 115.089 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.237 0 C-N-CA 126.075 1.798 . . . . 0.0 113.429 177.47 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.575 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -136.2 96.82 3.46 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.112 1.365 . . . . 0.0 110.656 -167.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -66.72 -37.14 84.09 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.809 1.243 . . . . 0.0 113.341 -176.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -111.28 173.53 6.3 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.286 1.834 . . . . 0.0 111.771 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -129.15 148.34 51.09 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.468 1.507 . . . . 0.0 111.15 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.9 m -71.0 135.15 47.68 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.394 0.677 . . . . 0.0 111.516 178.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.1 t -74.06 167.21 21.99 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.452 0.701 . . . . 0.0 111.842 169.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.1 t -84.63 132.86 45.36 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 124.698 1.199 . . . . 0.0 109.789 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.85 179.98 5.74 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 124.525 3.484 . . . . 0.0 112.67 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.9 mm -56.49 147.95 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 126.038 1.735 . . . . 0.0 112.414 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.48 -60.02 1.07 Allowed Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.919 1.723 . . . . 0.0 111.918 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -81.77 -178.71 7.09 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.047 1.339 . . . . 0.0 112.654 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.0 t -147.41 174.88 11.27 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.082 1.753 . . . . 0.0 110.627 172.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -83.64 111.29 30.9 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 125.275 1.43 . . . . 0.0 113.266 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -74.93 158.56 42.4 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.978 2.452 . . . . 0.0 111.559 168.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.1 t -107.11 -35.12 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.835 1.254 . . . . 0.0 111.543 173.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -63.07 152.52 36.84 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.597 1.159 . . . . 0.0 112.4 175.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.29 -6.88 62.29 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.039 1.304 . . . . 0.0 116.21 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.8 mp -78.96 32.55 0.21 Allowed 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 119.308 1.554 . . . . 0.0 112.566 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 57.0 m -66.17 12.83 0.06 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 128.85 2.86 . . . . 0.0 115.428 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 61.03 9.07 2.17 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 129.164 2.986 . . . . 0.0 115.607 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.6 169.66 13.83 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.778 1.631 . . . . 0.0 113.324 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.1 mtm180 -116.75 -8.68 11.37 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -173.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -77.99 -25.83 48.26 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.3 m -62.52 147.2 49.67 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.885 1.274 . . . . 0.0 111.635 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -87.86 159.03 18.56 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.338 1.055 . . . . 0.0 111.322 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -119.66 123.86 44.88 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.258 1.023 . . . . 0.0 110.879 -172.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -119.42 130.17 55.15 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.246 1.018 . . . . 0.0 111.129 -171.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 41.8 t -73.42 97.08 2.47 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.679 0.792 . . . . 0.0 111.653 176.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 15.4 mmt -72.52 80.6 1.07 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.692 1.597 . . . . 0.0 110.668 169.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.43 -63.22 3.37 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.497 1.522 . . . . 0.0 114.456 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -123.63 -53.81 1.77 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.336 1.454 . . . . 0.0 112.408 -173.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 9.6 m -101.98 171.64 7.39 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.316 1.446 . . . . 0.0 111.018 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 11.0 p -120.6 158.82 26.55 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.027 0.931 . . . . 0.0 113.372 172.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -150.07 172.99 14.38 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 126.126 1.77 . . . . 0.0 111.239 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.3 p -76.96 125.62 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.506 1.523 . . . . 0.0 111.974 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -145.09 111.62 5.74 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.544 1.138 . . . . 0.0 111.206 -178.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -75.88 98.39 4.19 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.254 -0.904 . . . . 0.0 110.901 169.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.69 167.95 38.1 Favored Glycine 0 CA--C 1.533 1.186 0 O-C-N 121.107 -0.996 . . . . 0.0 114.36 174.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.4 m -72.69 101.6 3.11 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.023 1.329 . . . . 0.0 111.335 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -133.42 97.41 3.95 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.75 1.22 . . . . 0.0 109.716 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.7 m -49.47 -49.31 46.03 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.111 1.764 . . . . 0.0 113.618 -175.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.48 77.4 0.95 Allowed Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.317 1.437 . . . . 0.0 112.784 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -131.13 175.63 19.43 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.431 1.491 . . . . 0.0 114.491 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -130.39 134.67 47.31 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.841 1.256 . . . . 0.0 112.014 -173.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 65.4 p -79.56 -8.47 59.19 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -129.12 138.42 51.8 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.574 1.549 . . . . 0.0 112.282 -176.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 61.4 tpp -65.45 -33.5 76.09 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.574 1.15 . . . . 0.0 112.056 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.45 -37.02 85.18 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 121.71 -0.619 . . . . 0.0 112.922 175.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 82.0 mm-40 -72.01 -46.37 57.43 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.294 1.037 . . . . 0.0 112.22 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.8 p -63.54 -24.21 67.71 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.07 0.85 . . . . 0.0 113.046 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.62 -64.13 1.25 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.481 1.513 . . . . 0.0 112.045 170.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -62.69 -28.18 69.76 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -169.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -81.43 -6.35 58.85 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.4 164.14 17.22 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 126.198 1.799 . . . . 0.0 112.786 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.56 -17.18 16.44 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.66 2.24 . . . . 0.0 113.854 -173.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.381 0 C-N-CA 126.587 2.042 . . . . 0.0 115.074 -179.705 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.556 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -98.55 9.48 43.13 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.054 1.742 . . . . 0.0 114.972 -170.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -58.14 161.41 4.18 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.855 1.662 . . . . 0.0 112.782 175.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -64.57 149.79 48.12 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.841 0.856 . . . . 0.0 111.892 172.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -138.57 168.26 20.16 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.974 1.71 . . . . 0.0 111.414 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.0 t -69.75 128.21 35.61 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.467 0.707 . . . . 0.0 111.287 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 50.6 p -136.38 169.38 17.76 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.501 1.521 . . . . 0.0 112.281 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.6 t -69.24 133.93 89.37 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.96 0.904 . . . . 0.0 110.169 177.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.8 158.65 56.99 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.128 3.219 . . . . 0.0 112.516 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.7 mt -63.63 136.07 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.936 0.895 . . . . 0.0 109.817 177.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.42 -10.56 63.74 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.523 1.535 . . . . 0.0 115.456 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.27 172.22 11.57 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.535 1.667 . . . . 0.0 112.853 172.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.0 t -107.65 91.55 3.7 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.093 1.357 . . . . 0.0 110.437 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -56.73 115.36 10.0 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 125.071 1.349 . . . . 0.0 113.32 -176.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.86 94.57 1.07 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.481 2.788 . . . . 0.0 111.739 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 p -70.83 -24.42 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 124.337 1.055 . . . . 0.0 113.0 175.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -62.76 154.02 30.96 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.69 1.596 . . . . 0.0 111.78 173.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.62 31.87 62.36 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 123.726 0.679 . . . . 0.0 114.538 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.8 tp -74.05 59.97 0.75 Allowed 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.947 1.699 . . . . 0.0 112.583 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 31.8 p -149.7 173.74 13.36 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.457 1.903 . . . . 0.0 112.555 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.25 78.31 1.78 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.55 1.94 . . . . 0.0 110.984 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.74 178.55 4.11 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.787 0.804 . . . . 0.0 112.29 168.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -12.31 59.87 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.814 1.646 . . . . 0.0 113.429 171.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -126.63 105.03 8.42 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.708 2.803 . . . . 0.0 108.896 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.4 m -128.77 158.63 38.12 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.501 1.92 . . . . 0.0 110.313 -175.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -114.07 162.08 16.92 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.476 1.111 . . . . 0.0 112.834 170.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -146.98 127.83 14.41 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.999 1.32 . . . . 0.0 110.051 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -132.4 137.88 47.49 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.757 1.223 . . . . 0.0 111.701 -174.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 35.4 t -79.68 115.89 19.54 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.164 0.986 . . . . 0.0 111.792 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 96.3 mmm -90.25 -10.95 42.38 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.846 1.258 . . . . 0.0 114.22 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.54 -87.94 0.08 OUTLIER Glycine 0 N--CA 1.469 0.869 0 C-N-CA 124.536 1.065 . . . . 0.0 111.807 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -86.54 -31.6 21.17 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 171.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.5 p -125.98 166.33 17.13 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.732 2.013 . . . . 0.0 111.74 -170.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.5 p -113.87 153.3 29.43 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 167.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.7 ttpt -124.39 165.72 17.24 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.549 1.94 . . . . 0.0 110.513 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.2 p -69.98 135.72 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.273 1.029 . . . . 0.0 111.609 171.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -144.15 177.37 8.63 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.167 1.787 . . . . 0.0 110.515 174.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -136.38 156.79 48.13 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.982 0.913 . . . . 0.0 112.353 175.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.45 175.93 10.71 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.665 1.126 . . . . 0.0 113.969 -170.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 76.9 m -91.96 85.32 5.52 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.557 1.143 . . . . 0.0 110.375 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -70.08 84.82 0.53 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.01 1.324 . . . . 0.0 111.268 -178.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 m 61.7 7.07 1.77 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 126.612 1.965 . . . . 0.0 114.018 -174.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.78 149.44 9.47 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 127.212 2.339 . . . . 0.0 113.295 -174.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.12 -91.36 0.08 OUTLIER Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.491 1.044 . . . . 0.0 112.513 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -135.31 157.41 46.97 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.346 1.058 . . . . 0.0 113.162 -174.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.9 m -123.29 5.53 9.11 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.153 1.781 . . . . 0.0 113.092 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 -138.47 139.38 38.8 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.968 2.107 . . . . 0.0 111.0 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 30.0 tpp -59.35 -35.47 73.94 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.788 1.235 . . . . 0.0 112.14 172.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.09 -24.85 73.36 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 121.196 -0.94 . . . . 0.0 114.383 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -80.32 -46.28 16.4 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.641 1.221 . . . . 0.0 111.952 175.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.6 p -64.17 -25.03 67.9 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.28 -61.62 1.76 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.59 1.556 . . . . 0.0 111.855 171.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -61.56 -27.37 68.58 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -173.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -79.68 -4.82 53.48 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.442 1.097 . . . . 0.0 113.702 174.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m -125.61 166.43 21.09 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 126.431 1.892 . . . . 0.0 113.077 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.29 -13.76 16.76 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.772 2.314 . . . . 0.0 114.05 -176.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.214 0 C-N-CA 126.507 2.003 . . . . 0.0 112.95 179.611 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.521 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -132.22 80.01 1.89 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.526 1.13 . . . . 0.0 110.928 -165.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.65 18.03 2.62 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 127.109 2.164 . . . . 0.0 114.885 -175.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -65.82 145.39 56.02 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.297 1.439 . . . . 0.0 111.403 172.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -134.58 -162.57 1.27 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.132 1.773 . . . . 0.0 110.724 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.2 m -68.28 75.77 0.25 Allowed 'General case' 0 CA--C 1.549 0.915 0 O-C-N 120.647 -1.283 . . . . 0.0 112.223 174.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.4 m -125.15 139.39 53.8 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.384 2.274 . . . . 0.0 109.624 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.8 t -72.89 136.25 80.09 Favored Pre-proline 0 N--CA 1.477 0.876 0 O-C-N 121.694 -0.629 . . . . 0.0 110.376 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.6 150.34 88.37 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.658 2.905 . . . . 0.0 112.22 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.49 HD12 ' H ' ' A' ' 28' ' ' ILE . 5.4 mp -61.66 133.43 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.357 1.063 . . . . 0.0 110.181 -178.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.58 -12.87 63.92 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.712 1.625 . . . . 0.0 115.415 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -73.51 159.87 32.53 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.76 1.78 . . . . 0.0 112.529 174.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.4 m -82.79 76.05 9.66 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.301 1.04 . . . . 0.0 111.749 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -54.21 111.87 3.3 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 125.586 1.554 . . . . 0.0 113.457 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.18 113.09 3.34 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.241 2.627 . . . . 0.0 111.954 -176.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.7 p -76.4 -25.1 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.002 0.921 . . . . 0.0 113.171 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 pmtp? -66.74 168.16 10.02 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.101 1.36 . . . . 0.0 113.798 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.71 166.56 39.44 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.6 1.572 . . . . 0.0 112.566 174.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.0 tp -146.75 74.04 1.34 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.744 1.217 . . . . 0.0 110.987 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 76.2 m -63.68 165.56 8.13 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.474 1.11 . . . . 0.0 112.375 176.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm 60.13 -0.91 0.21 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.177 2.591 . . . . 0.0 116.505 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.18 160.4 26.96 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.023 1.329 . . . . 0.0 113.121 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.9 ptt85 -80.95 -0.74 40.71 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.276 1.43 . . . . 0.0 114.81 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -137.33 137.24 38.73 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.073 2.149 . . . . 0.0 109.781 -176.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.5 m -141.65 144.53 34.19 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.664 1.985 . . . . 0.0 110.098 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -123.66 157.02 34.77 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.504 1.521 . . . . 0.0 110.547 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -143.95 137.89 28.1 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.895 0.878 . . . . 0.0 111.217 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -141.0 131.33 25.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.467 1.107 . . . . 0.0 111.541 -177.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 15.2 t -77.47 126.32 30.72 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.018 0.927 . . . . 0.0 111.911 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 96.6 mmm -108.7 0.3 20.48 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.191 1.397 . . . . 0.0 113.828 -174.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.39 -78.37 0.14 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 125.33 1.443 . . . . 0.0 111.79 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -115.11 -1.04 13.12 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.017 1.327 . . . . 0.0 113.567 177.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 38.7 t -149.07 156.4 42.17 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.252 1.821 . . . . 0.0 110.038 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.2 p -119.87 103.93 9.76 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.34 1.056 . . . . 0.0 113.005 176.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -70.52 165.97 21.55 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.245 1.018 . . . . 0.0 111.408 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -77.37 139.04 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.756 1.222 . . . . 0.0 111.647 168.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -138.74 172.17 13.26 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.722 2.009 . . . . 0.0 110.335 173.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.6 mp0 -134.44 123.66 24.38 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.906 1.282 . . . . 0.0 110.665 -173.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.06 173.26 49.67 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.627 1.108 . . . . 0.0 113.322 -170.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 75.9 m -82.91 85.72 7.08 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.466 1.106 . . . . 0.0 111.527 -177.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -73.95 93.91 2.27 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.116 0.966 . . . . 0.0 110.508 174.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 59.6 p 54.29 -0.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 128.972 2.909 . . . . 0.0 117.972 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.64 153.67 30.32 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 127.247 2.356 . . . . 0.0 113.359 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.61 -86.76 0.1 OUTLIER Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.333 0.968 . . . . 0.0 113.376 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -132.65 162.76 30.52 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.319 1.448 . . . . 0.0 112.371 -175.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 74.0 m -126.59 -3.88 6.61 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -137.98 147.83 44.61 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.262 1.825 . . . . 0.0 110.306 172.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 32.7 ttm -62.52 -32.29 73.2 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 122.62 0.368 . . . . 0.0 111.934 177.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -58.72 -33.75 74.11 Favored Glycine 0 CA--C 1.533 1.163 0 O-C-N 121.446 -0.783 . . . . 0.0 114.126 175.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -72.41 -50.34 27.09 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.434 1.117 . . . . 0.0 111.799 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.3 p -65.5 -30.07 70.8 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.37 -58.63 3.34 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.706 1.202 . . . . 0.0 112.192 173.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -60.68 -30.05 69.69 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -171.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 -82.27 -22.57 35.69 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.194 0.998 . . . . 0.0 113.57 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m -97.03 168.66 9.9 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 125.717 1.607 . . . . 0.0 112.208 176.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.71 -7.44 15.65 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.017 2.478 . . . . 0.0 114.617 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.29 0 C-N-CA 126.264 1.888 . . . . 0.0 113.862 -178.401 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.429 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -151.48 165.36 34.42 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.066 1.746 . . . . 0.0 111.783 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -84.57 102.62 13.02 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.066 1.346 . . . . 0.0 111.413 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.1 -5.16 38.01 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.498 1.519 . . . . 0.0 114.178 178.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -134.22 163.64 29.16 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.346 1.858 . . . . 0.0 112.987 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.1 m -61.81 128.42 36.13 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.751 1.22 . . . . 0.0 111.953 170.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.6 t -145.66 164.92 30.25 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.161 1.384 . . . . 0.0 111.243 171.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.4 m -71.72 154.9 92.83 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 125.46 1.504 . . . . 0.0 112.546 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -69.94 155.64 64.85 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.906 2.404 . . . . 0.0 110.662 174.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.9 mt -61.28 134.98 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.86 0.864 . . . . 0.0 110.634 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.04 51.17 47.2 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.032 1.301 . . . . 0.0 114.006 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 37.7 p90 -76.65 -177.76 4.41 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.808 1.643 . . . . 0.0 112.528 177.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.9 m -133.54 93.09 3.08 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.473 1.909 . . . . 0.0 110.142 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -57.32 115.78 11.73 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 124.536 1.134 . . . . 0.0 113.629 -173.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.6 105.81 2.13 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.649 2.899 . . . . 0.0 111.651 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.6 t -130.64 75.76 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.126 1.37 . . . . 0.0 109.622 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -149.82 176.11 11.02 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.825 2.05 . . . . 0.0 111.656 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.15 65.67 3.23 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.58 1.086 . . . . 0.0 114.146 172.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.408 ' H ' HD23 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -62.26 -3.76 1.48 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -177.651 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 67.1 m -61.17 164.26 5.42 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.952 1.701 . . . . 0.0 113.526 177.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -127.55 74.98 1.56 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.79 1.636 . . . . 0.0 111.638 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.94 165.9 16.8 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.87 0.868 . . . . 0.0 112.378 172.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -77.83 1.47 20.22 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.623 1.569 . . . . 0.0 114.12 176.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -143.2 164.67 29.55 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.746 2.818 . . . . 0.0 108.398 175.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.1 m -132.98 151.91 52.01 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.281 1.832 . . . . 0.0 110.479 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -85.24 150.69 24.62 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.752 1.221 . . . . 0.0 112.151 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -132.95 129.28 38.06 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.527 1.131 . . . . 0.0 110.935 -177.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -125.87 130.62 51.71 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.259 1.024 . . . . 0.0 111.707 -172.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.7 t -70.15 119.16 13.93 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.99 0.516 . . . . 0.0 111.116 171.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 81.8 mmm -118.05 94.37 4.48 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.293 1.837 . . . . 0.0 109.086 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.74 -65.07 4.19 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.728 1.156 . . . . 0.0 113.678 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -133.97 -59.76 0.83 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.376 1.47 . . . . 0.0 112.043 -172.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 p -96.91 168.17 10.64 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.198 1.799 . . . . 0.0 111.458 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 14.3 p -109.49 150.25 28.4 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 172.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -133.34 162.6 31.39 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.973 1.709 . . . . 0.0 112.684 -175.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 p -78.86 126.29 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 125.884 1.673 . . . . 0.0 111.724 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -145.98 103.4 3.74 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.191 0.996 . . . . 0.0 111.308 -178.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -62.88 111.69 2.25 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.044 1.338 . . . . 0.0 110.826 172.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.47 -156.88 26.94 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.096 0.855 . . . . 0.0 113.863 -175.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 78.0 m -134.31 114.65 13.21 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.048 2.139 . . . . 0.0 109.959 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -124.94 92.14 3.58 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.661 1.985 . . . . 0.0 109.329 -178.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 m 50.07 35.94 11.01 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.589 1.955 . . . . 0.0 114.19 174.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.08 23.0 78.53 Favored Glycine 0 CA--C 1.539 1.567 0 O-C-N 120.865 -1.147 . . . . 0.0 115.678 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.99 174.26 5.74 Favored Glycine 0 CA--C 1.542 1.757 0 C-N-CA 125.232 1.396 . . . . 0.0 116.184 -176.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -62.87 139.32 58.72 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 -159.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.5 m -74.64 -19.04 60.45 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.904 1.681 . . . . 0.0 114.828 176.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -137.96 154.66 49.36 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.247 1.819 . . . . 0.0 112.061 -176.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 49.3 ttm -75.48 -29.79 59.69 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.15 -29.54 75.59 Favored Glycine 0 CA--C 1.533 1.184 0 O-C-N 121.385 -0.822 . . . . 0.0 113.047 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -74.52 -48.33 27.68 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.874 1.67 . . . . 0.0 111.838 173.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.9 p -66.27 -25.98 67.13 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.284 0.947 . . . . 0.0 113.426 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.09 -59.16 2.85 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.377 1.471 . . . . 0.0 111.791 173.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -61.92 -28.3 69.43 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 -172.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -78.57 -6.7 56.26 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.461 1.104 . . . . 0.0 113.765 175.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -129.16 168.69 15.24 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 125.845 1.658 . . . . 0.0 113.346 -175.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -74.52 -19.25 19.29 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.756 2.304 . . . . 0.0 113.555 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.657 1.599 . . . . 0.0 114.287 -179.391 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.548 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -73.48 157.66 36.39 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.318 1.047 . . . . 0.0 112.522 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -127.42 145.44 50.82 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.165 1.786 . . . . 0.0 111.669 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -91.62 87.81 6.49 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.07 1.348 . . . . 0.0 110.977 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -106.8 -44.61 4.4 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.372 1.069 . . . . 0.0 112.908 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.7 t -73.82 94.87 2.33 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.113 0.965 . . . . 0.0 110.452 167.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.5 p -80.99 175.18 10.91 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.259 1.424 . . . . 0.0 111.843 170.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.9 t -118.66 134.62 23.51 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 125.357 1.463 . . . . 0.0 109.866 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -78.05 -170.37 0.95 Allowed 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 124.685 3.59 . . . . 0.0 112.614 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.1 pt -55.24 165.39 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 126.341 1.856 . . . . 0.0 114.021 175.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.06 -61.23 4.76 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.803 1.668 . . . . 0.0 111.936 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -78.45 -179.45 6.35 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.057 1.343 . . . . 0.0 112.85 170.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.7 t -145.45 177.06 9.13 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.211 1.804 . . . . 0.0 110.201 164.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -84.87 112.31 41.97 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 125.062 1.345 . . . . 0.0 112.15 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.05 122.6 8.57 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.61 2.873 . . . . 0.0 112.542 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -78.89 -25.33 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.405 1.082 . . . . 0.0 113.414 174.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -66.9 154.99 39.63 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.458 1.503 . . . . 0.0 112.663 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.6 50.96 0.04 OUTLIER Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.933 1.254 . . . . 0.0 114.445 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.87 60.71 2.35 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.245 1.418 . . . . 0.0 111.991 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 83.3 m -117.44 155.57 29.45 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.224 1.81 . . . . 0.0 111.661 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.43 24.9 1.9 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.752 1.621 . . . . 0.0 113.944 -171.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.51 168.71 13.26 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.852 1.661 . . . . 0.0 112.279 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -73.38 0.99 10.58 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.526 1.93 . . . . 0.0 115.787 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -84.72 83.23 8.1 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.6 1.56 . . . . 0.0 111.987 -173.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.51 156.98 44.76 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.584 1.554 . . . . 0.0 111.317 -173.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 24.3 ttp180 -145.54 162.64 36.95 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.742 1.217 . . . . 0.0 111.77 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -123.28 111.58 16.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.284 1.034 . . . . 0.0 111.377 -167.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -108.8 122.73 47.79 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.763 0.825 . . . . 0.0 111.729 -171.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.4 t -69.77 111.72 5.72 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.939 1.296 . . . . 0.0 111.4 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 57.7 mtp -138.26 84.35 2.03 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.943 2.097 . . . . 0.0 110.394 -175.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.4 64.01 1.41 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.245 0.926 . . . . 0.0 114.111 175.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 56.74 22.93 7.37 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 126.331 1.853 . . . . 0.0 114.485 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 9.8 t -149.48 153.0 36.57 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 128.479 2.711 . . . . 0.0 108.102 172.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 7.1 p -114.51 121.55 43.84 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.026 0.931 . . . . 0.0 111.497 165.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -100.44 160.92 13.96 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.582 1.553 . . . . 0.0 111.039 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.7 p -74.76 129.05 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.629 0.772 . . . . 0.0 110.834 166.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -134.94 149.33 50.22 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.693 0.797 . . . . 0.0 111.597 171.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -88.47 154.7 20.15 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.685 1.194 . . . . 0.0 110.928 173.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.26 -176.84 33.64 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-O 122.21 0.894 . . . . 0.0 114.81 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 65.3 m -94.82 23.09 5.74 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.335 1.454 . . . . 0.0 114.504 -171.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -40.18 -44.37 1.83 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 127.019 2.128 . . . . 0.0 115.419 -170.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 98.0 m -155.28 82.65 1.06 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.857 1.663 . . . . 0.0 109.224 174.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -51.72 101.99 0.07 OUTLIER Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.526 1.536 . . . . 0.0 114.862 -176.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -126.74 -90.31 0.74 Allowed Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.764 1.65 . . . . 0.0 114.008 -175.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -121.77 116.69 24.95 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.641 1.177 . . . . 0.0 113.234 -164.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.7 m -84.71 -2.34 57.44 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -127.96 139.14 52.75 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.584 1.554 . . . . 0.0 111.378 174.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 38.9 ttm -69.45 -26.41 64.58 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.61 -33.69 72.1 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 121.798 -0.564 . . . . 0.0 112.96 172.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -74.19 -48.0 31.9 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.068 0.947 . . . . 0.0 111.835 173.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.6 p -63.79 -24.24 67.68 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.36 -65.38 0.93 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.661 1.584 . . . . 0.0 112.226 168.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -61.46 -28.7 69.47 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -168.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -84.11 -5.99 59.33 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.142 0.977 . . . . 0.0 113.474 177.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.45 169.84 6.35 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 126.373 1.869 . . . . 0.0 112.257 177.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -77.59 -8.81 17.2 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.056 2.504 . . . . 0.0 113.765 -178.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.311 0 C-N-CA 127.57 2.51 . . . . 0.0 112.615 177.424 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.523 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -82.61 104.36 12.82 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.776 1.23 . . . . 0.0 112.522 -175.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -65.03 -30.87 71.88 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.015 1.326 . . . . 0.0 113.919 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -82.52 113.82 20.51 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.599 1.56 . . . . 0.0 110.778 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -142.05 166.98 23.22 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.731 1.213 . . . . 0.0 112.894 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 71.8 m -65.03 134.58 54.17 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.712 0.805 . . . . 0.0 111.473 173.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.7 p -129.46 173.43 10.57 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.934 1.694 . . . . 0.0 111.287 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.6 t -58.18 134.74 84.49 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 124.39 1.076 . . . . 0.0 110.863 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -65.92 155.94 66.86 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 124.488 3.459 . . . . 0.0 112.658 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.1 pt -57.37 135.42 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.738 0.815 . . . . 0.0 112.368 -178.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.47 -13.45 22.12 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.451 1.5 . . . . 0.0 116.075 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -75.55 146.06 40.77 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 119.833 1.816 . . . . 0.0 112.252 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.0 t -90.93 96.12 10.47 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.445 1.098 . . . . 0.0 111.717 -175.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -57.72 142.99 77.26 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 124.611 1.164 . . . . 0.0 113.791 -176.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.47 81.0 2.9 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.913 3.075 . . . . 0.0 112.677 -171.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 p -61.07 -28.4 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 125.169 1.388 . . . . 0.0 113.114 -178.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -83.08 -4.91 58.85 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.083 2.153 . . . . 0.0 114.576 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.3 -139.35 6.58 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.365 1.459 . . . . 0.0 112.789 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.5 mt 65.22 11.21 7.05 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 127.051 2.14 . . . . 0.0 115.419 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 16.7 t -73.45 150.73 41.44 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.04 1.336 . . . . 0.0 112.777 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.6 37.87 0.36 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.958 2.503 . . . . 0.0 113.593 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.16 159.7 25.71 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.107 -0.996 . . . . 0.0 113.088 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -86.03 0.38 53.52 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.703 1.601 . . . . 0.0 114.88 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -144.26 122.24 12.07 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.183 2.193 . . . . 0.0 109.705 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.457 HG22 ' H ' ' A' ' 44' ' ' ARG . 1.9 m -148.31 167.57 24.83 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.969 1.308 . . . . 0.0 111.445 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.457 ' H ' HG22 ' A' ' 43' ' ' THR . 17.0 ttm180 -129.61 159.95 34.79 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.707 1.603 . . . . 0.0 111.513 -176.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -126.63 103.74 7.73 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.942 0.897 . . . . 0.0 111.953 -166.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -103.76 122.54 45.29 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.89 0.876 . . . . 0.0 112.346 -169.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.8 t -71.18 103.93 2.93 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.371 1.068 . . . . 0.0 110.794 171.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -136.07 111.21 8.96 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.499 1.92 . . . . 0.0 110.944 -177.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.46 53.78 5.37 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 123.945 0.783 . . . . 0.0 112.8 -170.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 63.24 -11.0 0.1 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 129.328 3.051 . . . . 0.0 116.896 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 48.4 t -126.9 158.24 37.28 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.884 2.074 . . . . 0.0 110.213 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.9 p -108.2 150.76 26.83 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 174.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -141.35 169.47 17.54 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.017 1.327 . . . . 0.0 111.798 172.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.26 126.16 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.006 1.322 . . . . 0.0 111.406 171.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -144.2 165.08 28.84 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.232 1.413 . . . . 0.0 111.217 174.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -126.49 104.79 8.33 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.037 1.335 . . . . 0.0 110.603 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.94 -178.31 36.96 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.466 1.508 . . . . 0.0 111.932 -176.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 77.8 m -99.36 103.35 15.15 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.625 1.17 . . . . 0.0 111.167 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -121.7 86.9 2.66 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.969 1.308 . . . . 0.0 110.402 -178.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.264 1.3 t 49.43 14.67 0.11 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 129.012 2.925 . . . . 0.0 117.182 174.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.88 33.72 45.17 Favored Glycine 0 CA--C 1.537 1.426 0 O-C-N 120.302 -1.499 . . . . 0.0 114.241 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.37 176.24 6.58 Favored Glycine 0 CA--C 1.543 1.812 0 C-N-CA 124.923 1.249 . . . . 0.0 115.564 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -70.07 147.59 49.84 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -162.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -89.38 -30.04 18.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.656 1.182 . . . . 0.0 113.158 174.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -91.17 135.51 33.73 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.84 1.256 . . . . 0.0 111.651 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 38.1 ttm -69.09 -25.32 64.37 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.432 0.693 . . . . 0.0 112.551 176.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.35 -46.86 75.23 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.585 0.612 . . . . 0.0 111.967 171.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.25 -47.05 86.07 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.149 0.98 . . . . 0.0 112.553 176.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.2 p -65.32 -23.48 67.02 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.67 -67.47 0.76 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.0 1.32 . . . . 0.0 111.643 168.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.08 -26.3 68.2 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -168.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -86.05 -4.86 59.26 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.024 0.93 . . . . 0.0 113.381 175.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.37 166.5 10.85 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 126.174 1.79 . . . . 0.0 112.077 176.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.86 -8.76 16.87 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.217 2.612 . . . . 0.0 114.426 -175.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.231 0 C-N-CA 126.493 1.997 . . . . 0.0 114.714 179.459 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.476 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -149.33 153.45 37.48 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.417 1.487 . . . . 0.0 110.843 173.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.1 tptm 49.3 29.78 2.87 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.914 2.086 . . . . 0.0 114.218 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -66.28 108.84 2.45 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.674 1.99 . . . . 0.0 113.081 -173.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -80.94 -17.24 51.16 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.9 t -69.39 149.94 47.83 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 119.175 0.898 . . . . 0.0 112.842 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.9 p -131.52 166.6 21.01 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.316 1.846 . . . . 0.0 112.15 -177.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.6 m -69.82 155.08 94.1 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.345 1.058 . . . . 0.0 112.341 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.7 156.14 67.22 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.934 2.423 . . . . 0.0 111.777 173.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 74.4 mt -66.92 136.15 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.034 0.934 . . . . 0.0 110.049 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.26 -0.84 83.17 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.216 1.388 . . . . 0.0 115.746 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.91 174.99 7.0 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.135 1.467 . . . . 0.0 112.693 175.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.9 t -128.31 92.23 3.4 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.926 1.29 . . . . 0.0 111.033 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.59 148.48 90.73 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 124.85 1.26 . . . . 0.0 113.798 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.442 ' HG2' ' CD1' ' A' ' 55' ' ' TYR . 69.0 Cg_endo -70.98 169.33 20.73 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.762 2.975 . . . . 0.0 113.336 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.8 t -108.57 94.96 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.075 1.75 . . . . 0.0 109.366 -172.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.19 172.27 7.01 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.111 2.164 . . . . 0.0 112.831 -175.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.1 -18.85 0.73 Allowed Glycine 0 CA--C 1.536 1.364 0 N-CA-C 115.916 1.126 . . . . 0.0 115.916 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.8 mp -80.83 61.78 4.6 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 119.171 1.486 . . . . 0.0 110.941 178.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.7 t -71.19 3.22 3.73 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 126.564 1.946 . . . . 0.0 114.189 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -65.42 -21.88 66.71 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.318 1.847 . . . . 0.0 113.884 177.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.24 168.81 11.59 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.491 1.117 . . . . 0.0 112.772 171.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -115.03 17.11 16.98 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.214 1.805 . . . . 0.0 113.732 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -138.26 123.38 19.16 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.543 2.337 . . . . 0.0 109.679 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -137.27 164.23 29.05 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.526 1.931 . . . . 0.0 110.149 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -133.5 171.7 13.73 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.675 1.19 . . . . 0.0 112.835 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -136.72 110.36 8.05 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.938 1.295 . . . . 0.0 110.394 -163.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -99.02 134.62 41.59 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.184 0.994 . . . . 0.0 111.219 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.9 t -69.14 128.44 36.66 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.924 -0.485 . . . . 0.0 110.947 171.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 98.7 mmm -114.68 81.55 1.58 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.581 1.952 . . . . 0.0 109.78 176.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.43 -62.42 4.08 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.304 1.43 . . . . 0.0 114.087 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -133.32 -53.83 0.9 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.296 1.439 . . . . 0.0 112.647 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 14.6 p -76.02 176.3 8.07 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.535 1.134 . . . . 0.0 111.335 171.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.23 163.27 16.23 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.261 -0.899 . . . . 0.0 111.617 161.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -134.22 154.81 51.04 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.441 1.496 . . . . 0.0 112.042 175.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 p -82.26 130.17 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.54 1.136 . . . . 0.0 112.52 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.442 ' CD1' ' HG2' ' A' ' 33' ' ' PRO . 68.1 m-85 -145.06 170.34 16.37 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.349 1.46 . . . . 0.0 111.579 173.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -124.57 161.03 27.05 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.102 1.361 . . . . 0.0 112.082 -169.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.74 177.64 24.39 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.843 1.211 . . . . 0.0 114.324 -177.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.3 t -81.83 80.81 8.04 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.521 -0.988 . . . . 0.0 111.184 175.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -84.01 76.46 10.05 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 122.167 0.984 . . . . 0.0 110.511 171.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.6 m 60.82 32.07 20.09 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.926 1.29 . . . . 0.0 112.861 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.47 -85.34 0.84 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.799 1.666 . . . . 0.0 113.319 178.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 59.24 -131.63 51.73 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.811 1.672 . . . . 0.0 113.744 -176.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -100.52 163.92 12.14 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.775 1.23 . . . . 0.0 112.133 -176.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.0 m -129.12 -0.7 5.19 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.771 1.228 . . . . 0.0 114.112 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -143.4 162.16 36.5 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.697 1.599 . . . . 0.0 112.833 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -42.5 95.26 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.205 1.802 . . . . 0.0 111.286 177.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.14 -25.67 75.25 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 121.493 -0.755 . . . . 0.0 114.155 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -74.26 -46.71 39.68 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.006 1.403 . . . . 0.0 112.037 175.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.7 p -61.14 -31.45 71.16 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.69 -0.631 . . . . 0.0 112.339 176.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.07 -53.47 6.38 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.999 1.72 . . . . 0.0 113.05 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -58.77 -28.17 65.67 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 120.203 1.365 . . . . 0.0 114.385 -174.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -84.08 -6.28 59.38 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.086 1.354 . . . . 0.0 113.858 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.0 m -129.85 162.97 50.31 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 125.197 1.399 . . . . 0.0 114.311 -172.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.98 -9.82 14.14 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.468 2.779 . . . . 0.0 114.943 -175.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.41 0 C-N-CA 125.816 1.674 . . . . 0.0 114.593 -177.685 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.528 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -131.0 0.76 4.24 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -161.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -71.37 159.51 34.42 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.218 1.407 . . . . 0.0 112.054 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -72.84 161.76 30.32 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.431 1.093 . . . . 0.0 112.081 170.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -140.28 139.2 35.47 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.519 1.528 . . . . 0.0 111.13 177.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 75.3 m -80.69 170.55 16.17 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.754 0.821 . . . . 0.0 112.174 170.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.9 p -135.36 159.6 41.06 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.462 1.505 . . . . 0.0 111.541 168.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.0 p -79.9 130.67 66.09 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 124.701 1.2 . . . . 0.0 110.997 176.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.46 141.43 42.37 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.457 2.105 . . . . 0.0 110.993 171.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.1 pt -56.68 134.67 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.551 0.74 . . . . 0.0 112.336 -178.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.7 -8.01 57.95 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.388 1.47 . . . . 0.0 115.53 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 24.6 t-105 -77.75 152.85 33.4 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 119.728 1.764 . . . . 0.0 110.12 168.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.5 t -78.24 72.58 4.78 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 122.564 1.173 . . . . 0.0 112.178 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -66.79 154.52 91.69 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 125.67 1.588 . . . . 0.0 114.022 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -76.26 150.8 33.33 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.09 2.527 . . . . 0.0 111.627 175.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.5 t -136.84 76.86 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.099 1.36 . . . . 0.0 109.813 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.71 -28.57 0.43 Allowed 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 116.143 1.905 . . . . 0.0 116.143 -177.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.3 -169.61 24.99 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.16 0.886 . . . . 0.0 113.169 -165.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 98.0 mt -134.75 113.46 11.67 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.311 2.244 . . . . 0.0 108.404 177.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 63.1 m 61.4 29.3 18.43 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.437 1.895 . . . . 0.0 114.628 177.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -53.49 -53.57 49.56 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 126.123 1.769 . . . . 0.0 112.57 175.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.26 169.31 10.48 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.091 1.356 . . . . 0.0 112.19 174.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -108.49 5.07 24.87 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.348 1.859 . . . . 0.0 114.592 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -143.48 102.81 4.01 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.751 2.02 . . . . 0.0 110.85 -176.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.467 HG21 HG22 ' A' ' 54' ' ' VAL . 23.3 m -150.36 155.38 39.51 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 120.806 -1.184 . . . . 0.0 111.51 -177.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -77.71 160.99 28.08 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.771 1.228 . . . . 0.0 112.673 173.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -131.58 107.67 9.01 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.911 1.285 . . . . 0.0 110.759 -174.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -114.6 122.26 45.96 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.959 1.304 . . . . 0.0 112.462 -168.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 35.3 t -67.64 122.7 18.62 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.279 1.032 . . . . 0.0 112.008 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.34 -10.6 1.24 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -171.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 169.23 70.97 0.03 OUTLIER Glycine 0 N--CA 1.47 0.921 0 O-C-N 121.498 -0.751 . . . . 0.0 111.84 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.7 m120 60.83 1.86 0.48 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 127.953 2.501 . . . . 0.0 116.253 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 79.8 m -132.14 160.44 36.03 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.121 1.768 . . . . 0.0 110.158 163.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.7 p -101.26 91.22 4.41 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.93 1.292 . . . . 0.0 111.13 167.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -67.64 154.25 41.89 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.727 1.611 . . . . 0.0 112.319 -176.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.467 HG22 HG21 ' A' ' 43' ' ' THR . 8.9 p -66.64 121.49 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.425 1.49 . . . . 0.0 112.351 172.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -140.05 122.48 16.09 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.451 1.5 . . . . 0.0 111.796 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -74.33 150.68 40.02 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.491 0.716 . . . . 0.0 112.02 171.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.8 174.65 13.41 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.138 1.352 . . . . 0.0 115.417 176.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 17.6 p -80.33 39.08 0.44 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.513 1.925 . . . . 0.0 114.14 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -51.51 -34.91 38.11 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.196 1.398 . . . . 0.0 113.522 178.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.1 t -144.05 -23.86 0.56 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 169.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.63 15.0 81.54 Favored Glycine 0 CA--C 1.539 1.537 0 O-C-N 120.908 -1.12 . . . . 0.0 115.675 171.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -54.26 -68.63 1.56 Allowed Glycine 0 CA--C 1.535 1.33 0 C-N-CA 126.054 1.787 . . . . 0.0 115.073 -174.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -140.31 151.14 44.82 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.889 1.276 . . . . 0.0 112.525 -172.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.8 m -117.89 0.84 12.01 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.341 1.456 . . . . 0.0 114.499 -177.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -135.96 144.77 45.59 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.193 1.797 . . . . 0.0 110.771 174.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -62.91 -35.58 80.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.873 0.869 . . . . 0.0 111.755 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.75 -11.34 77.72 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.356 0.979 . . . . 0.0 114.925 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -96.16 -37.7 10.46 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.986 1.393 . . . . 0.0 112.099 176.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.7 p -70.79 -45.91 63.82 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.194 -0.941 . . . . 0.0 112.005 171.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.21 -12.48 61.19 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -177.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -85.33 -25.53 27.09 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 119.821 1.192 . . . . 0.0 113.626 168.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -91.47 -29.0 17.26 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.844 1.258 . . . . 0.0 112.995 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.3 m -106.53 165.41 13.0 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 126.009 1.724 . . . . 0.0 112.68 175.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -79.12 -4.92 14.18 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.049 2.5 . . . . 0.0 114.775 -171.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.333 0 C-N-CA 126.823 2.154 . . . . 0.0 115.236 -178.737 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.525 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -140.78 171.0 14.71 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.921 1.688 . . . . 0.0 111.248 -174.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 48.15 47.06 19.56 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.317 1.847 . . . . 0.0 113.188 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -60.9 -34.07 74.09 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.801 1.641 . . . . 0.0 113.328 -177.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -106.13 157.71 17.35 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.624 1.57 . . . . 0.0 110.851 169.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 35.8 t -140.27 143.45 35.93 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.936 1.294 . . . . 0.0 111.149 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.4 m -132.79 146.03 51.49 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.445 1.498 . . . . 0.0 110.937 -168.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.1 m -100.49 155.94 35.79 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 125.037 1.335 . . . . 0.0 112.822 -173.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.3 157.06 62.68 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.436 2.757 . . . . 0.0 112.435 172.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.461 HD12 ' H ' ' A' ' 28' ' ' ILE . 5.4 mp -66.06 137.22 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.832 1.253 . . . . 0.0 110.385 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.31 -4.56 67.04 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.549 1.547 . . . . 0.0 115.781 176.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.03 172.66 11.26 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 118.826 1.313 . . . . 0.0 113.048 177.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -115.77 80.75 1.49 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.127 1.371 . . . . 0.0 111.53 -175.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -67.96 155.04 92.74 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 125.275 1.43 . . . . 0.0 114.176 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.24 168.27 25.02 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 124.025 3.15 . . . . 0.0 112.594 174.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.3 t -130.54 10.85 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 125.216 1.406 . . . . 0.0 112.706 -174.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -131.12 170.16 14.91 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.575 1.95 . . . . 0.0 112.252 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.69 31.55 0.22 Allowed Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.988 1.28 . . . . 0.0 115.053 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.6 mp -90.14 85.18 6.21 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.442 1.497 . . . . 0.0 110.735 -175.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.0 m -68.3 77.39 0.26 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.711 1.604 . . . . 0.0 112.9 176.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? -129.86 73.26 1.52 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.571 2.348 . . . . 0.0 110.88 -176.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 46.33 42.47 10.48 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.407 1.883 . . . . 0.0 114.659 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -74.05 -30.31 62.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.146 1.378 . . . . 0.0 113.088 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 50.81 26.57 2.65 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.897 2.079 . . . . 0.0 114.589 -175.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.1 m -60.03 152.67 23.38 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.749 2.42 . . . . 0.0 113.026 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.6 152.21 45.68 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.378 1.471 . . . . 0.0 112.028 176.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -129.6 144.89 51.48 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.84 1.256 . . . . 0.0 111.366 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -143.78 139.91 29.63 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.304 1.442 . . . . 0.0 110.722 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 38.0 t -89.95 123.18 33.65 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.878 0.871 . . . . 0.0 111.981 173.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 29.5 mtt -79.25 -12.84 59.96 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 175.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 154.46 -39.72 0.65 Allowed Glycine 0 N--CA 1.475 1.288 0 CA-C-N 119.293 0.951 . . . . 0.0 114.974 171.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -126.61 -12.06 6.11 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 174.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 25.8 p -151.91 163.43 39.26 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.878 2.071 . . . . 0.0 110.284 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 2.4 p -119.57 151.34 38.8 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.37 1.068 . . . . 0.0 112.68 176.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -122.53 178.89 4.79 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.795 1.638 . . . . 0.0 111.668 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.1 p -115.09 122.56 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.636 1.974 . . . . 0.0 110.806 -174.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -129.33 116.69 19.46 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.133 1.373 . . . . 0.0 111.068 -169.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -57.62 117.97 4.75 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.34 1.456 . . . . 0.0 112.972 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.42 173.52 49.86 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 125.387 1.47 . . . . 0.0 114.478 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 76.4 m -78.38 84.4 4.55 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.443 -1.033 . . . . 0.0 111.159 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -50.25 -50.66 49.37 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.453 1.501 . . . . 0.0 112.703 -178.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 90.6 m -136.89 -44.68 0.58 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.08 1.752 . . . . 0.0 111.723 169.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.5 56.82 0.08 OUTLIER Glycine 0 CA--C 1.536 1.367 0 C-N-CA 126.409 1.957 . . . . 0.0 112.636 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.09 -92.62 0.5 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.826 1.203 . . . . 0.0 113.745 -173.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -110.93 158.18 19.05 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.578 1.151 . . . . 0.0 112.6 -174.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.8 t -102.7 -30.29 10.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.594 1.958 . . . . 0.0 111.87 174.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -132.3 151.09 52.0 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.319 1.848 . . . . 0.0 111.589 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 48.8 ttm -66.93 -19.01 65.65 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.54 0.736 . . . . 0.0 112.926 177.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.61 -16.35 55.38 Favored Glycine 0 CA--C 1.539 1.548 0 O-C-N 121.149 -0.969 . . . . 0.0 114.561 168.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -87.78 -25.5 23.35 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 118.894 1.347 . . . . 0.0 112.761 173.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -61.05 -59.3 5.57 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.392 -0.817 . . . . 0.0 109.752 165.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.84 -12.45 59.17 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -170.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -92.37 -25.19 18.63 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 170.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -90.79 -13.7 33.38 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.946 1.298 . . . . 0.0 113.186 175.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.5 m -129.63 159.17 70.94 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.852 1.661 . . . . 0.0 113.187 -175.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -76.59 -10.39 18.68 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 123.85 3.033 . . . . 0.0 114.63 -176.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 C-N-CA 127.017 2.246 . . . . 0.0 112.276 176.922 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.4 t0 49.9 42.15 23.8 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.514 1.926 . . . . 0.0 114.685 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.98 159.95 8.58 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.537 1.535 . . . . 0.0 113.972 177.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -61.26 119.87 9.29 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.54 1.936 . . . . 0.0 113.275 -176.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -85.68 174.6 9.27 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.089 1.356 . . . . 0.0 113.154 173.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.6 p -110.47 16.22 21.69 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.952 1.701 . . . . 0.0 114.49 -171.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -16.2 -72.93 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 130.085 3.354 . . . . 0.0 116.378 -163.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 m -143.28 151.29 54.64 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 127.195 2.198 . . . . 0.0 111.399 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.9 -27.3 7.18 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.575 2.85 . . . . 0.0 113.621 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.2 pt -136.06 -177.62 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.466 2.306 . . . . 0.0 111.014 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.39 41.64 0.3 Allowed Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.691 1.615 . . . . 0.0 114.248 172.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -59.31 143.52 49.13 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.931 2.092 . . . . 0.0 111.211 175.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.5 t -76.41 85.3 3.16 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.475 1.11 . . . . 0.0 112.116 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -63.98 155.74 76.82 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 125.155 1.382 . . . . 0.0 113.236 175.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.05 138.75 31.54 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.173 2.582 . . . . 0.0 111.076 174.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.6 t -73.39 -40.11 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.733 0.813 . . . . 0.0 111.141 175.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -69.52 161.32 29.77 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.137 1.375 . . . . 0.0 112.124 174.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.0 -126.12 1.34 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.41 1.481 . . . . 0.0 111.274 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 60.9 mt 49.27 45.48 23.43 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.771 1.628 . . . . 0.0 112.479 -177.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 65.9 m -63.22 149.66 44.94 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.964 1.706 . . . . 0.0 112.364 -177.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.97 -5.15 3.12 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.502 1.521 . . . . 0.0 114.804 -177.03 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.17 168.89 16.26 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.063 0.945 . . . . 0.0 112.144 169.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -105.62 5.64 31.41 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.563 1.945 . . . . 0.0 113.939 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -147.3 116.28 6.86 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.119 2.167 . . . . 0.0 110.335 -176.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.0 m -142.16 159.16 42.77 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.994 1.317 . . . . 0.0 110.775 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -76.92 147.06 37.19 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.538 1.135 . . . . 0.0 111.319 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -132.94 120.55 21.59 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.122 0.969 . . . . 0.0 111.908 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -113.63 122.88 48.54 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.709 1.204 . . . . 0.0 111.567 -175.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.7 t -70.95 115.9 10.62 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.937 0.895 . . . . 0.0 110.852 171.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.4 mmt -82.23 -16.79 48.34 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 165.99 -45.21 0.27 Allowed Glycine 0 N--CA 1.468 0.792 0 C-N-CA 124.675 1.131 . . . . 0.0 113.22 -173.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -136.55 -62.68 0.65 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.292 1.837 . . . . 0.0 110.471 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -81.13 168.43 18.59 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.3 1.04 . . . . 0.0 111.198 173.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 p -121.88 143.89 49.17 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.182 0.993 . . . . 0.0 112.993 170.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -110.48 148.88 31.19 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.778 1.631 . . . . 0.0 111.578 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 p -69.44 127.51 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 126.465 1.906 . . . . 0.0 112.254 169.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -136.02 129.86 32.66 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.085 1.354 . . . . 0.0 111.013 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.85 100.55 0.57 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.999 1.32 . . . . 0.0 112.114 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.73 179.63 50.21 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.076 1.322 . . . . 0.0 114.937 176.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 79.4 m -75.19 75.69 2.33 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.044 1.338 . . . . 0.0 112.002 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -50.18 -49.78 51.35 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.02 1.728 . . . . 0.0 113.116 177.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.4 t -146.93 1.27 0.76 Allowed 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 174.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 111.04 33.54 2.35 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.773 1.178 . . . . 0.0 115.704 173.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.32 -173.67 42.35 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.776 1.655 . . . . 0.0 114.469 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -64.81 148.66 50.84 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.858 1.263 . . . . 0.0 114.108 -173.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.1 t -100.79 -5.43 26.32 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.617 1.567 . . . . 0.0 113.549 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 89.2 mmt-85 -134.84 139.54 45.14 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.314 1.446 . . . . 0.0 111.351 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 47.4 ttm -69.15 -26.32 64.81 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -58.88 -42.81 96.86 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 121.946 -0.471 . . . . 0.0 112.589 169.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -70.06 -45.84 66.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.794 0.838 . . . . 0.0 112.968 177.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 12.9 p -66.68 -20.41 65.97 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.584 1.084 . . . . 0.0 113.355 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.14 -66.19 0.91 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.58 1.552 . . . . 0.0 111.919 168.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -60.22 -27.75 67.45 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 115.356 1.614 . . . . 0.0 115.356 -168.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -85.48 -3.16 58.77 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.576 1.15 . . . . 0.0 113.253 176.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -122.14 166.29 17.57 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 126.858 2.063 . . . . 0.0 112.671 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.71 -8.11 13.48 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.253 2.636 . . . . 0.0 114.838 -176.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.429 0 C-N-CA 125.88 1.705 . . . . 0.0 114.298 -179.53 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.538 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -143.01 166.71 23.9 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.699 1.599 . . . . 0.0 112.797 -176.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -135.3 87.61 2.34 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.383 1.873 . . . . 0.0 110.957 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -85.77 2.18 46.61 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.694 1.198 . . . . 0.0 113.853 175.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -62.18 161.4 11.2 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.635 1.574 . . . . 0.0 113.48 177.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.8 t -62.91 120.02 10.53 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.267 1.427 . . . . 0.0 112.697 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.9 m -68.39 154.44 41.8 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.548 1.539 . . . . 0.0 111.4 174.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.7 t -111.05 135.78 20.85 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 125.594 1.557 . . . . 0.0 110.803 -173.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.62 165.69 26.67 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.685 3.59 . . . . 0.0 113.546 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 63.2 mt -58.96 140.33 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.199 1.399 . . . . 0.0 110.629 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.85 25.05 47.13 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.143 0.878 . . . . 0.0 114.622 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -63.02 175.26 0.91 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.293 1.837 . . . . 0.0 115.505 -178.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.7 m -139.74 65.99 1.41 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 127.374 2.269 . . . . 0.0 110.45 178.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.8 155.61 69.9 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 124.583 1.153 . . . . 0.0 113.564 177.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.78 96.97 1.02 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.724 2.949 . . . . 0.0 113.253 -174.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.5 t -59.97 -43.87 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.316 1.046 . . . . 0.0 111.274 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -76.43 3.66 10.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.288 1.835 . . . . 0.0 114.927 173.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.76 -11.44 30.03 Favored Glycine 0 CA--C 1.541 1.698 0 C-N-CA 124.534 1.064 . . . . 0.0 115.531 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.43 -27.31 67.72 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.525 1.53 . . . . 0.0 113.228 167.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 9.2 t -76.81 165.54 24.57 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.341 1.456 . . . . 0.0 112.077 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -118.05 70.87 0.81 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.228 1.811 . . . . 0.0 110.805 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.36 158.71 19.79 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.428 1.091 . . . . 0.0 112.846 176.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -95.26 9.35 40.11 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.09 1.756 . . . . 0.0 114.577 -177.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -136.17 118.21 15.37 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.467 2.307 . . . . 0.0 110.057 -175.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.64 139.66 47.48 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.467 -0.771 . . . . 0.0 110.41 169.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.37 154.24 44.47 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.694 1.197 . . . . 0.0 112.201 -177.099 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -140.35 130.8 25.36 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.829 1.252 . . . . 0.0 111.069 -164.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -141.12 126.39 18.56 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.323 1.049 . . . . 0.0 111.956 -168.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 18.1 t -75.39 120.1 20.39 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.514 0.597 . . . . 0.0 112.303 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 37.5 mtm -135.73 87.11 2.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.353 1.461 . . . . 0.0 110.528 171.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.0 68.05 1.26 Allowed Glycine 0 N--CA 1.47 0.945 0 C-N-CA 124.777 1.18 . . . . 0.0 113.479 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 66.31 -2.67 0.95 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 127.759 2.424 . . . . 0.0 115.682 175.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.7 p -137.23 151.07 48.31 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.807 2.043 . . . . 0.0 110.4 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.5 p -118.88 93.94 4.27 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.848 0.859 . . . . 0.0 112.72 173.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -67.72 167.02 14.06 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.642 1.177 . . . . 0.0 112.784 170.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.21 129.0 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.736 1.614 . . . . 0.0 111.69 175.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -135.17 113.9 11.82 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.091 1.757 . . . . 0.0 110.426 -174.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -71.58 169.23 15.95 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.096 0.959 . . . . 0.0 112.667 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.42 167.39 42.6 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.064 1.316 . . . . 0.0 113.557 -176.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 8.8 t -83.47 71.74 10.29 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.489 -1.006 . . . . 0.0 112.157 -177.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -81.94 83.05 7.35 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.251 -0.906 . . . . 0.0 110.711 169.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.0 m -48.7 -35.08 13.19 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.434 1.494 . . . . 0.0 114.828 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.34 73.11 2.64 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.319 1.438 . . . . 0.0 114.948 -171.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.85 -115.8 0.5 Allowed Glycine 0 CA--C 1.53 1.0 0 CA-C-N 118.079 0.94 . . . . 0.0 114.257 171.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -129.8 175.61 8.7 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.156 1.382 . . . . 0.0 112.432 -170.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 80.8 p -123.82 -2.94 8.23 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.219 1.407 . . . . 0.0 114.76 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -140.06 144.95 37.12 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.21 1.804 . . . . 0.0 111.97 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 38.6 tpp -60.67 -31.12 70.37 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.657 1.183 . . . . 0.0 112.202 173.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.94 -14.34 70.5 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.568 1.08 . . . . 0.0 115.296 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -89.97 -43.73 10.36 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.051 1.425 . . . . 0.0 111.823 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 18.1 p -67.62 -23.03 65.32 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.42 -61.99 1.57 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.128 1.371 . . . . 0.0 111.845 170.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -62.29 -26.97 68.71 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -174.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -77.18 -6.61 53.64 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.1 m -123.43 164.91 25.32 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 126.347 1.859 . . . . 0.0 112.607 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -76.44 -17.59 16.37 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.009 2.473 . . . . 0.0 113.934 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.256 0 C-N-CA 126.081 1.801 . . . . 0.0 114.503 -177.593 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.545 0.764 0 CA-C-O 121.015 0.436 . . . . 0.0 112.028 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.4 p -115.89 135.38 54.05 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.625 1.57 . . . . 0.0 111.587 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.7 m -139.97 159.04 43.09 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.53 1.932 . . . . 0.0 109.844 -174.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 p -51.58 118.53 11.46 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 124.857 1.263 . . . . 0.0 112.322 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -78.09 175.37 11.23 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.509 2.806 . . . . 0.0 112.228 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.3 mm -58.13 133.93 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.725 1.21 . . . . 0.0 111.39 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.19 -60.79 0.66 Allowed Glycine 0 CA--C 1.531 1.037 0 C-N-CA 126.322 1.915 . . . . 0.0 111.522 -177.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -85.23 175.72 8.77 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.826 1.25 . . . . 0.0 113.24 175.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.9 m -143.19 122.64 13.14 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.874 2.07 . . . . 0.0 110.218 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.5 152.87 96.2 Favored Pre-proline 0 CA--C 1.554 1.105 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 175.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.77 121.95 8.63 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 124.389 3.393 . . . . 0.0 111.653 176.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.5 p -70.14 -27.06 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.107 0.963 . . . . 0.0 112.572 175.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -70.87 168.65 16.39 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.707 2.003 . . . . 0.0 113.328 175.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.85 148.77 16.58 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.313 1.435 . . . . 0.0 111.919 170.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 29.5 tp -150.93 79.59 1.32 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.632 1.173 . . . . 0.0 111.463 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 85.1 m -68.67 -3.94 13.85 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -68.8 -21.08 64.35 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.91 2.084 . . . . 0.0 114.289 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.7 158.3 30.5 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.712 0.768 . . . . 0.0 112.859 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -92.95 6.64 47.13 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.075 1.75 . . . . 0.0 113.175 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -144.13 167.18 23.01 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 129.488 3.115 . . . . 0.0 108.277 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.6 m -142.15 152.8 43.54 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.551 1.94 . . . . 0.0 109.635 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.9 tpp85 -127.98 146.1 50.76 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.77 1.228 . . . . 0.0 111.758 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -138.26 125.73 21.96 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.032 1.333 . . . . 0.0 110.301 -170.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -131.86 128.63 39.04 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.342 1.057 . . . . 0.0 111.564 -172.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.3 t -70.8 123.6 22.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.326 0.65 . . . . 0.0 111.681 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.1 mmt -84.97 -90.68 0.09 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.842 0.857 . . . . 0.0 110.268 170.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -94.27 -55.21 1.49 Allowed Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.74 1.162 . . . . 0.0 112.821 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -131.43 -49.2 0.99 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.518 1.527 . . . . 0.0 112.919 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 89.0 m -93.5 167.83 11.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.191 1.397 . . . . 0.0 112.353 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.6 p -121.66 103.01 8.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.102 1.361 . . . . 0.0 112.982 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -70.44 167.31 18.55 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.923 1.289 . . . . 0.0 112.73 171.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.1 p -89.73 126.36 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.592 1.557 . . . . 0.0 112.264 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -133.41 160.99 35.76 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.822 1.649 . . . . 0.0 111.052 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -127.82 80.99 1.99 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.556 1.142 . . . . 0.0 111.266 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.06 167.16 30.98 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.295 1.902 . . . . 0.0 112.776 175.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 92.6 m -85.12 72.03 10.83 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.815 1.246 . . . . 0.0 111.138 176.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -74.12 79.39 1.75 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.348 1.859 . . . . 0.0 111.104 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.6 m 55.02 31.33 15.9 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 125.726 1.61 . . . . 0.0 113.368 -177.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.13 -63.35 3.89 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 126.081 1.8 . . . . 0.0 114.154 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 51.81 -118.29 6.99 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 126.968 2.223 . . . . 0.0 114.628 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -125.89 153.21 44.52 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.296 1.438 . . . . 0.0 112.08 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.3 m -118.15 5.75 11.99 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.119 1.368 . . . . 0.0 114.054 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.2 mmt85 -134.03 140.83 46.94 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.881 2.072 . . . . 0.0 110.218 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 51.3 ttm -63.34 -30.98 72.02 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 122.929 0.492 . . . . 0.0 112.084 173.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.38 -43.3 98.51 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 121.483 -0.761 . . . . 0.0 113.086 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -65.64 -48.0 73.65 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.074 0.95 . . . . 0.0 112.537 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.1 p -67.58 -21.54 65.42 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.44 -61.91 1.85 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.326 1.45 . . . . 0.0 111.455 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -61.53 -27.88 68.93 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -172.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 -81.64 -2.76 51.44 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.563 1.145 . . . . 0.0 113.577 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -126.81 167.38 17.66 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 126.336 1.854 . . . . 0.0 112.999 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.4 -8.74 15.04 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.2 2.6 . . . . 0.0 114.693 -176.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.325 0 C-N-CA 125.968 1.747 . . . . 0.0 113.147 178.611 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 N--CA 1.474 0.729 0 CA-C-O 120.868 0.366 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.7 m -96.7 58.41 1.67 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.674 1.189 . . . . 0.0 112.185 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.4 p -67.66 160.04 28.76 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.034 1.334 . . . . 0.0 111.907 167.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.6 m -81.35 157.6 70.25 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 124.592 1.157 . . . . 0.0 112.243 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.45 177.76 8.39 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.056 2.504 . . . . 0.0 111.945 166.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.556 HD12 ' H ' ' A' ' 28' ' ' ILE . 4.1 mp -54.21 132.39 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.901 1.68 . . . . 0.0 112.066 -176.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.74 -48.5 0.94 Allowed Glycine 0 CA--C 1.533 1.164 0 C-N-CA 126.569 2.033 . . . . 0.0 113.536 175.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -89.25 -174.64 4.49 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.345 1.458 . . . . 0.0 113.496 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.5 t -135.31 -79.24 0.43 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.122 1.369 . . . . 0.0 111.929 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -153.78 162.43 26.74 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.86 1.264 . . . . 0.0 112.884 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -71.12 83.98 0.91 Allowed 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.58 2.853 . . . . 0.0 111.559 167.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.5 t -68.32 -43.99 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.412 1.085 . . . . 0.0 110.744 173.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -82.61 173.24 12.12 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.762 2.025 . . . . 0.0 111.816 175.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.43 64.99 0.97 Allowed Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.041 1.305 . . . . 0.0 112.654 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.0 mp -128.94 19.93 5.97 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.741 2.016 . . . . 0.0 111.744 175.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 80.3 m -63.4 168.63 4.34 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.339 1.856 . . . . 0.0 113.322 -174.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -110.09 14.51 22.91 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.19 1.796 . . . . 0.0 113.087 -179.338 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.64 171.97 2.37 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.626 1.57 . . . . 0.0 113.478 175.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -98.54 1.0 46.12 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.028 1.731 . . . . 0.0 114.271 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -130.04 98.98 4.92 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.245 1.818 . . . . 0.0 112.303 -169.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.9 m -72.95 100.81 3.04 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.122 1.369 . . . . 0.0 110.822 176.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -87.39 142.02 28.19 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.764 0.826 . . . . 0.0 111.941 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -126.11 150.71 48.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.88 1.672 . . . . 0.0 111.974 -176.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -147.94 148.02 30.33 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.012 1.325 . . . . 0.0 112.984 173.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 41.5 t -88.26 113.44 23.87 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.075 1.35 . . . . 0.0 111.884 173.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.0 mmt -72.63 -42.86 63.98 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 173.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.54 -84.33 0.05 OUTLIER Glycine 0 N--CA 1.471 1.008 0 C-N-CA 123.732 0.682 . . . . 0.0 113.164 -175.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -86.76 -40.08 15.34 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 176.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -130.81 169.38 15.8 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.031 2.132 . . . . 0.0 111.671 -173.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 22.7 p -117.51 155.15 30.24 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -132.39 173.9 10.81 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.85 2.46 . . . . 0.0 111.95 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.12 137.68 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 127.008 2.123 . . . . 0.0 112.358 174.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -138.12 -21.51 1.07 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.719 1.608 . . . . 0.0 114.441 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 60.7 16.37 6.61 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 171.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -149.46 173.42 29.28 Favored Glycine 0 N--CA 1.474 1.197 0 O-C-N 120.606 -1.309 . . . . 0.0 114.2 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 71.8 m -78.33 65.18 3.6 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.711 1.204 . . . . 0.0 111.644 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -55.08 -43.1 73.62 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.465 1.506 . . . . 0.0 112.74 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.8 t -142.71 -19.17 0.67 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.357 1.463 . . . . 0.0 113.744 173.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -176.68 -85.05 0.06 OUTLIER Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.595 1.093 . . . . 0.0 111.311 175.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.43 108.26 0.63 Allowed Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.005 0.812 . . . . 0.0 114.383 170.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -60.67 154.46 21.36 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.38 0.672 . . . . 0.0 111.85 165.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.5 t -80.39 -40.35 26.67 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.14 1.376 . . . . 0.0 112.456 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -143.55 157.93 44.05 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 127.016 2.126 . . . . 0.0 111.266 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 5.0 ttt -64.83 -23.63 67.29 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.216 1.007 . . . . 0.0 113.136 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.26 -21.97 64.77 Favored Glycine 0 CA--C 1.535 1.331 0 O-C-N 120.786 -1.196 . . . . 0.0 114.289 171.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -78.93 -44.66 22.14 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.892 1.346 . . . . 0.0 111.925 173.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.0 p -66.53 -22.2 66.17 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 175.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.19 -62.35 1.46 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.208 1.403 . . . . 0.0 111.769 167.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -61.0 -27.98 68.7 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 -172.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -77.69 -6.2 53.1 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.354 1.061 . . . . 0.0 113.757 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m -123.2 164.93 24.72 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 126.208 1.803 . . . . 0.0 113.313 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -79.9 -10.31 14.13 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.17 2.58 . . . . 0.0 114.314 -173.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.381 0 C-N-CA 125.966 1.746 . . . . 0.0 113.797 -178.99 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 . . . . . 0 N--CA 1.48 1.027 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 61.6 m -120.81 -78.77 0.6 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.238 1.815 . . . . 0.0 110.853 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 70.5 m -156.17 151.58 26.83 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 127.988 2.515 . . . . 0.0 108.547 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.8 m -129.94 156.78 78.53 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 125.221 1.408 . . . . 0.0 112.042 170.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -64.34 152.1 82.79 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.24 2.627 . . . . 0.0 112.244 172.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.2 pt -66.46 149.99 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.606 0.762 . . . . 0.0 112.014 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.03 -2.76 12.06 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 125.077 1.322 . . . . 0.0 116.169 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.27 172.97 11.5 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.218 1.509 . . . . 0.0 112.755 178.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 56.5 m -133.33 92.68 3.04 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.255 1.422 . . . . 0.0 111.149 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -63.51 148.46 93.8 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 124.176 0.991 . . . . 0.0 113.496 -178.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -78.3 75.05 5.08 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.163 3.242 . . . . 0.0 111.592 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 p -59.83 -23.9 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.869 1.668 . . . . 0.0 113.432 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -109.98 7.38 23.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.876 2.471 . . . . 0.0 114.128 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.81 49.81 2.87 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.945 1.736 . . . . 0.0 115.88 -172.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.0 mp -76.26 47.49 0.46 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 126.936 2.095 . . . . 0.0 113.092 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 59.7 m -69.43 154.38 42.1 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.526 -1.358 . . . . 0.0 112.195 169.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.23 16.54 1.52 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -177.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -120.73 167.05 12.89 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.355 1.462 . . . . 0.0 113.17 -177.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -18.43 63.51 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -70.88 -29.25 65.28 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.141 1.376 . . . . 0.0 113.83 -169.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.2 m -76.95 162.93 27.18 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.509 1.524 . . . . 0.0 111.769 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.89 168.31 11.61 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.616 1.566 . . . . 0.0 113.051 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -135.53 140.23 44.58 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.157 1.383 . . . . 0.0 110.482 -171.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -142.01 134.6 28.25 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.826 0.85 . . . . 0.0 112.695 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 31.5 t -75.02 119.16 18.82 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.312 0.645 . . . . 0.0 111.88 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.2 mmt -94.87 -2.86 49.89 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.57 -54.24 0.15 Allowed Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.373 0.987 . . . . 0.0 112.81 175.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -133.78 -19.89 2.03 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 175.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -136.67 167.59 21.13 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.358 1.463 . . . . 0.0 111.325 177.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 11.1 p -121.5 109.41 14.79 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -176.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -76.64 175.18 9.56 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.321 1.048 . . . . 0.0 112.047 167.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.7 p -85.88 137.79 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 126.855 2.062 . . . . 0.0 112.336 171.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -140.23 142.3 35.83 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.268 1.427 . . . . 0.0 111.434 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -93.83 -4.78 49.52 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -165.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -135.41 172.31 22.21 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 126.231 1.872 . . . . 0.0 112.396 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 22.5 t -66.57 145.2 55.88 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 122.052 -0.676 . . . . 0.0 112.607 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.05 82.66 2.06 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.241 1.816 . . . . 0.0 109.235 171.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.4 m 55.08 27.35 9.3 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.8 1.64 . . . . 0.0 113.822 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.58 13.98 74.77 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.358 1.456 . . . . 0.0 116.175 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -43.67 -82.84 0.02 OUTLIER Glycine 0 CA--C 1.539 1.593 0 C-N-CA 127.094 2.283 . . . . 0.0 116.991 -172.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -139.84 166.57 24.27 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.215 1.406 . . . . 0.0 112.435 -170.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.3 m -134.23 -18.45 2.01 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.193 1.397 . . . . 0.0 114.215 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -115.97 153.71 31.13 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.803 1.641 . . . . 0.0 111.544 175.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.0 tpp -65.04 -39.33 93.17 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.772 0.829 . . . . 0.0 111.359 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.77 -30.05 75.83 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.372 -0.682 . . . . 0.0 114.115 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -69.92 -57.79 4.62 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 118.577 1.189 . . . . 0.0 111.369 175.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.6 p -65.89 -26.04 67.44 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.91 -61.01 1.95 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.141 1.377 . . . . 0.0 111.81 168.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -61.98 -29.61 70.37 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -172.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -75.37 -13.59 60.42 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -113.55 166.22 11.73 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 126.413 1.885 . . . . 0.0 112.613 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.38 -17.95 23.54 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.888 2.392 . . . . 0.0 113.837 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.383 0 CA-C-O 117.061 -1.966 . . . . 0.0 115.046 -178.83 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 . . . . . 0 CA--C 1.543 0.699 0 N-CA-C 111.431 0.16 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.3 t -124.5 78.31 1.66 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.201 1.001 . . . . 0.0 111.077 173.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.3 t -70.14 161.04 30.96 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.358 1.063 . . . . 0.0 111.607 170.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.3 t -81.47 134.27 51.62 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 124.414 1.086 . . . . 0.0 110.184 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -74.62 173.85 13.64 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.194 3.262 . . . . 0.0 112.933 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.9 mt -60.14 137.5 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.327 1.451 . . . . 0.0 110.903 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.67 -55.63 0.67 Allowed Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.329 1.919 . . . . 0.0 112.342 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -78.32 178.96 7.25 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.73 1.212 . . . . 0.0 113.281 174.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.2 p -138.37 92.57 2.65 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.618 1.967 . . . . 0.0 110.982 -175.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -66.12 154.9 88.87 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 124.098 0.959 . . . . 0.0 113.569 -177.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.84 151.59 51.34 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.935 2.424 . . . . 0.0 112.36 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.2 t -102.26 -20.62 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 125.136 1.374 . . . . 0.0 112.01 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.89 172.9 6.71 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 127.054 2.142 . . . . 0.0 111.657 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.87 85.77 0.07 OUTLIER Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.622 1.106 . . . . 0.0 112.616 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 tt -133.14 72.37 1.49 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.028 1.331 . . . . 0.0 111.107 -175.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 78.2 m -78.12 97.39 5.43 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.435 1.494 . . . . 0.0 111.346 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -61.55 -60.74 3.23 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.85 1.26 . . . . 0.0 112.751 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.5 167.78 21.04 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.784 0.834 . . . . 0.0 112.274 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -75.32 2.62 10.75 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.975 1.71 . . . . 0.0 114.446 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -93.29 90.05 6.64 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.355 1.862 . . . . 0.0 111.003 -173.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 m -123.14 157.02 33.86 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.506 1.522 . . . . 0.0 111.106 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.9 ttm105 -134.93 155.3 50.95 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.7 1.2 . . . . 0.0 111.79 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -135.55 134.03 39.0 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.578 1.151 . . . . 0.0 110.441 -165.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -136.46 133.59 36.75 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.969 0.908 . . . . 0.0 112.312 -171.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.8 t -72.96 132.1 43.02 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 122.161 -0.337 . . . . 0.0 111.59 174.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.1 mmt -93.47 -91.0 0.19 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.85 0.86 . . . . 0.0 109.831 167.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -97.61 -40.73 3.56 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.509 1.052 . . . . 0.0 114.636 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -146.02 -58.43 0.31 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.493 1.517 . . . . 0.0 110.966 -173.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.7 p -83.27 168.81 16.35 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.672 1.189 . . . . 0.0 112.117 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.0 p -121.11 105.99 11.13 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.495 1.118 . . . . 0.0 112.844 169.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -73.88 177.27 5.68 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.567 1.147 . . . . 0.0 112.14 173.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.2 p -88.9 134.17 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.271 1.828 . . . . 0.0 111.842 173.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -137.22 172.19 13.37 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.323 1.449 . . . . 0.0 111.107 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -127.12 108.01 10.53 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.784 1.234 . . . . 0.0 111.629 -174.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.82 168.21 36.51 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.2 1.381 . . . . 0.0 113.717 -176.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 7.9 p -58.92 129.69 43.36 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -138.18 -40.63 0.53 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.33 1.452 . . . . 0.0 113.208 -174.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.3 t -144.89 -22.4 0.5 Allowed 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -168.0 -161.73 18.38 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.867 1.699 . . . . 0.0 112.122 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -153.48 58.59 0.41 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.328 0.966 . . . . 0.0 113.876 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -70.77 -32.37 69.47 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -174.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.6 p 55.53 -3.4 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 128.868 2.867 . . . . 0.0 117.522 -171.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -131.14 135.11 47.17 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.374 1.87 . . . . 0.0 112.217 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 40.2 ttm -63.62 -33.0 74.64 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.516 1.126 . . . . 0.0 112.862 175.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.42 -22.89 77.8 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 121.456 -0.777 . . . . 0.0 113.799 174.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -83.87 -40.77 18.21 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.529 1.165 . . . . 0.0 112.33 175.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.6 p -65.14 -23.76 67.22 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.487 1.039 . . . . 0.0 113.06 173.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.52 -60.48 2.26 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.88 1.672 . . . . 0.0 111.89 170.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -61.34 -28.38 69.18 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -172.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -73.9 -8.09 54.75 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.322 1.049 . . . . 0.0 113.557 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.91 167.48 19.37 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 125.688 1.595 . . . . 0.0 114.213 -174.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.99 -9.61 16.73 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 123.172 2.581 . . . . 0.0 114.595 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.236 0 C-N-CA 125.864 1.697 . . . . 0.0 113.459 179.259 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 CA--C 1.548 0.891 0 CA-C-O 120.549 0.214 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 47.2 t -133.29 123.79 26.12 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.26 1.424 . . . . 0.0 110.654 172.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.1 m -63.31 122.26 15.76 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.52 1.528 . . . . 0.0 112.245 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.3 t -78.01 134.12 64.4 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.837 1.255 . . . . 0.0 110.716 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.54 164.81 30.0 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.196 3.264 . . . . 0.0 113.442 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.9 mm -60.3 145.24 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.844 1.257 . . . . 0.0 111.21 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.08 25.62 57.23 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.074 0.845 . . . . 0.0 114.2 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -63.54 178.21 0.6 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.701 2.001 . . . . 0.0 115.271 -178.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.0 t -139.67 48.96 1.81 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.373 1.869 . . . . 0.0 110.905 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.55 151.81 68.85 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.424 1.489 . . . . 0.0 112.968 175.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -74.79 158.25 43.12 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.231 2.62 . . . . 0.0 113.54 -170.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.77 -29.97 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.836 0.854 . . . . 0.0 112.55 177.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.41 177.51 7.09 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.415 1.486 . . . . 0.0 112.571 175.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.59 -107.29 0.29 Allowed Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.522 1.058 . . . . 0.0 112.416 172.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.1 tp -154.17 115.54 4.12 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.672 1.589 . . . . 0.0 109.751 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.5 t -68.73 173.14 5.46 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.82 1.648 . . . . 0.0 112.337 174.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.39 5.94 21.88 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.324 1.85 . . . . 0.0 114.71 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.25 156.47 12.4 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.664 1.185 . . . . 0.0 113.298 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -81.27 4.38 20.68 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.883 1.673 . . . . 0.0 115.051 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -140.55 117.65 11.22 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.944 2.097 . . . . 0.0 110.521 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.9 m -142.45 154.56 44.66 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.332 1.453 . . . . 0.0 110.777 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -100.95 151.73 21.41 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.49 1.116 . . . . 0.0 111.316 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -125.06 138.81 54.19 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.578 1.151 . . . . 0.0 111.185 -174.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -132.36 135.76 46.37 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.076 1.351 . . . . 0.0 111.051 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 38.5 t -80.19 104.7 10.93 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.901 0.48 . . . . 0.0 111.004 169.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 87.5 mmm -76.04 -18.74 59.11 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.29 -78.29 0.05 OUTLIER Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.554 1.073 . . . . 0.0 112.861 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -109.26 -3.83 16.92 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.059 1.344 . . . . 0.0 114.058 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 25.1 p -149.13 157.99 43.82 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.946 2.099 . . . . 0.0 109.895 -176.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.4 p -111.17 147.81 34.12 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 168.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.0 mtpp -140.72 167.33 22.42 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.542 1.937 . . . . 0.0 111.844 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.78 125.76 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.915 1.286 . . . . 0.0 111.884 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -146.21 166.3 26.63 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.51 1.524 . . . . 0.0 110.72 177.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -142.68 103.05 4.16 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.353 1.061 . . . . 0.0 112.104 -172.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.7 -175.94 45.32 Favored Glycine 0 CA--C 1.532 1.132 0 O-C-N 121.455 -0.778 . . . . 0.0 113.742 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 63.1 m -68.01 14.41 0.06 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 127.207 2.203 . . . . 0.0 115.163 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -60.48 99.97 0.09 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 128.133 2.573 . . . . 0.0 110.797 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 21.7 m -53.69 -61.61 2.19 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.476 1.911 . . . . 0.0 113.003 -175.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.1 93.21 1.29 Allowed Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.444 1.497 . . . . 0.0 113.47 -174.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -147.65 175.05 27.19 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.158 1.361 . . . . 0.0 113.273 175.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -121.23 -17.71 7.61 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.521 1.675 . . . . 0.0 115.521 -165.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 58.63 4.48 0.37 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.572 1.949 . . . . 0.0 116.136 -176.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -138.13 142.89 40.14 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.93 2.092 . . . . 0.0 111.266 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.6 tpp -71.62 -32.19 67.71 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.323 1.049 . . . . 0.0 112.741 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.09 -48.12 67.69 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 121.598 -0.689 . . . . 0.0 111.402 175.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -64.86 -37.31 87.22 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.466 1.506 . . . . 0.0 113.409 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.5 p -71.57 -27.34 63.08 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.925 1.239 . . . . 0.0 113.39 171.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.16 -43.27 21.89 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.821 1.249 . . . . 0.0 112.992 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -63.52 -26.62 68.79 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 120.723 1.601 . . . . 0.0 113.482 -177.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -78.89 -9.26 59.43 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.641 1.577 . . . . 0.0 113.698 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 m -131.71 167.12 23.51 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 125.015 1.326 . . . . 0.0 113.97 -173.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.39 -11.66 15.81 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.968 2.445 . . . . 0.0 114.19 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.22 0 C-N-CA 126.919 2.2 . . . . 0.0 112.552 179.431 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 . . . . . 0 N--CA 1.476 0.831 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.6 p -75.48 156.45 35.2 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.727 0.811 . . . . 0.0 112.304 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.3 m -144.89 143.42 30.58 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.917 1.287 . . . . 0.0 110.73 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.0 t -68.74 133.95 90.38 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 124.112 0.965 . . . . 0.0 110.655 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.59 -175.36 2.41 Favored 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 124.401 3.401 . . . . 0.0 112.232 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.1 pt -59.51 166.06 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.987 1.315 . . . . 0.0 113.501 175.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.36 -59.38 4.11 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.666 1.603 . . . . 0.0 112.378 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -73.35 -178.37 2.95 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.866 1.266 . . . . 0.0 112.925 170.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.4 p -126.83 133.29 50.79 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.873 1.669 . . . . 0.0 111.063 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -74.97 152.46 86.59 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 123.869 0.868 . . . . 0.0 112.659 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.44 169.44 22.41 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.713 2.942 . . . . 0.0 111.906 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.9 t -131.35 -19.84 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.732 1.213 . . . . 0.0 112.05 -171.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt 55.27 2.75 0.06 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 128.326 2.65 . . . . 0.0 116.271 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -108.25 -7.89 29.93 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.756 1.646 . . . . 0.0 115.492 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.1 mp -74.95 -66.44 0.75 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.011 1.406 . . . . 0.0 110.855 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.4 t -139.0 153.12 48.11 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.273 1.429 . . . . 0.0 112.199 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.0 mtpt -135.72 83.99 2.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.618 2.367 . . . . 0.0 109.872 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.67 174.12 10.86 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.431 1.493 . . . . 0.0 112.514 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.02 -5.62 54.4 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.63 1.572 . . . . 0.0 114.697 -174.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -85.28 -15.61 42.86 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.094 1.357 . . . . 0.0 114.348 -170.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.5 m -68.79 158.82 33.57 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.836 1.254 . . . . 0.0 111.959 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -133.22 165.3 25.11 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.487 1.515 . . . . 0.0 111.82 -176.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -114.24 133.25 55.76 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.072 1.349 . . . . 0.0 111.466 -169.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -134.96 162.42 32.48 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.86 1.264 . . . . 0.0 111.805 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.7 t -101.68 108.69 20.3 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.563 1.145 . . . . 0.0 110.856 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 16.7 mmt -73.4 -60.27 2.32 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.101 0.56 . . . . 0.0 112.264 174.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -169.59 97.44 0.12 Allowed Glycine 0 N--CA 1.469 0.894 0 C-N-CA 124.149 0.881 . . . . 0.0 112.244 -170.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 58.92 11.43 1.91 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.88 2.072 . . . . 0.0 114.994 -175.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 6.4 t -151.49 147.74 27.2 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.053 2.141 . . . . 0.0 109.078 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 13.6 p -125.19 143.67 50.83 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 170.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.4 mtpp -149.57 170.94 17.48 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.253 1.421 . . . . 0.0 112.348 -172.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.3 p -75.01 128.52 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.509 1.524 . . . . 0.0 111.008 169.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -136.5 108.48 7.15 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.528 1.131 . . . . 0.0 111.439 -175.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -64.22 147.45 52.34 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.731 1.213 . . . . 0.0 112.149 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.98 177.62 21.54 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 125.771 1.653 . . . . 0.0 113.902 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 64.7 m -73.42 146.5 45.01 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 122.004 -0.703 . . . . 0.0 111.667 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -154.69 119.88 5.0 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.321 1.449 . . . . 0.0 108.742 170.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.2 m -57.56 -49.19 77.18 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.051 0.94 . . . . 0.0 112.632 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.44 172.61 45.1 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.811 1.196 . . . . 0.0 113.536 172.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 170.56 170.12 34.46 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.473 1.035 . . . . 0.0 114.933 176.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -111.68 -22.51 11.15 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.6 p 55.38 -4.28 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 128.85 2.86 . . . . 0.0 117.714 -172.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -133.29 137.7 46.12 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.472 1.909 . . . . 0.0 111.756 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.1 tpp -64.15 -33.12 75.06 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.603 1.161 . . . . 0.0 112.072 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.21 -38.17 82.12 Favored Glycine 0 CA--C 1.531 1.086 0 O-C-N 121.582 -0.699 . . . . 0.0 112.852 176.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -68.62 -47.55 66.37 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.011 0.924 . . . . 0.0 112.52 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.3 p -62.37 -25.9 68.17 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.392 0.996 . . . . 0.0 112.773 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.72 -64.46 1.07 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.52 1.528 . . . . 0.0 111.404 171.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -63.68 -27.47 69.24 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -171.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -78.93 -2.04 38.08 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.953 0.901 . . . . 0.0 113.251 174.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.67 170.55 7.85 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 127.023 2.129 . . . . 0.0 112.347 176.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -82.54 -8.07 11.54 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.071 2.514 . . . . 0.0 114.092 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.277 0 C-N-CA 126.548 2.023 . . . . 0.0 114.265 -178.764 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 CA--C 1.545 0.777 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.4 t -140.19 153.48 46.62 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.166 1.787 . . . . 0.0 110.161 176.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.6 t -69.33 165.27 21.05 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.852 0.861 . . . . 0.0 112.168 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.3 t -145.07 133.56 10.85 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 125.619 1.568 . . . . 0.0 110.002 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.8 163.88 32.82 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.362 3.375 . . . . 0.0 113.376 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.531 HD12 ' H ' ' A' ' 28' ' ' ILE . 4.5 mp -58.93 138.43 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.161 1.384 . . . . 0.0 110.755 177.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.39 28.03 41.5 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.142 0.877 . . . . 0.0 114.472 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -63.88 176.22 0.99 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.295 1.838 . . . . 0.0 115.886 -176.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 72.5 m -131.87 63.07 1.62 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.223 2.209 . . . . 0.0 110.65 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -63.25 156.59 68.35 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 125.123 1.369 . . . . 0.0 112.841 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.26 172.47 13.99 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.2 2.6 . . . . 0.0 113.815 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 p -119.45 20.86 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 126.957 2.103 . . . . 0.0 112.178 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -57.67 164.37 2.09 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.151 2.18 . . . . 0.0 115.195 -174.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 144.94 -29.52 1.83 Allowed Glycine 0 CA--C 1.536 1.397 0 C-N-CA 126.051 1.786 . . . . 0.0 114.321 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.24 1.95 6.4 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.698 1.599 . . . . 0.0 113.956 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.6 t -62.59 138.68 58.54 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.359 1.064 . . . . 0.0 112.317 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -113.55 -7.68 13.37 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.767 1.627 . . . . 0.0 114.598 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.19 170.58 12.69 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.875 0.87 . . . . 0.0 112.401 172.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -124.1 9.92 8.72 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.986 1.714 . . . . 0.0 114.472 -175.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -88.83 74.35 8.29 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.155 1.382 . . . . 0.0 112.03 -170.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.16 133.91 55.86 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.736 0.815 . . . . 0.0 111.404 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -137.28 154.86 50.02 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.424 1.09 . . . . 0.0 111.846 -172.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -132.87 129.18 38.08 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.856 1.263 . . . . 0.0 110.454 -169.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -139.55 129.42 24.82 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.24 1.016 . . . . 0.0 111.597 -171.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 40.6 t -71.83 129.87 39.67 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.753 -0.592 . . . . 0.0 112.587 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 43.7 mtm -132.79 -80.37 0.49 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.687 1.195 . . . . 0.0 112.042 167.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -86.35 60.56 4.54 Favored Glycine 0 N--CA 1.474 1.177 0 O-C-N 121.201 -0.937 . . . . 0.0 114.353 -170.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.4 m120 59.68 14.04 3.8 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.448 1.899 . . . . 0.0 113.901 -172.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 28.2 p -144.89 160.62 41.01 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.711 2.804 . . . . 0.0 109.322 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 18.5 p -115.15 87.39 2.65 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.765 0.826 . . . . 0.0 111.879 170.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -67.24 164.32 18.53 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 122.12 0.962 . . . . 0.0 111.85 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.2 p -82.49 128.5 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.929 1.292 . . . . 0.0 111.587 174.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -131.39 154.37 48.7 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.509 1.524 . . . . 0.0 110.829 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -132.0 89.52 2.69 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.135 1.374 . . . . 0.0 110.366 -174.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.61 175.71 42.37 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.902 1.239 . . . . 0.0 112.889 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 29.5 m -66.71 141.89 57.6 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.472 0.709 . . . . 0.0 111.765 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.63 121.93 5.67 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.887 1.275 . . . . 0.0 109.097 173.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.0 m -59.18 -37.13 76.65 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.472 1.109 . . . . 0.0 113.343 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -100.1 -161.98 28.55 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 126.405 1.955 . . . . 0.0 113.623 176.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 123.74 172.01 13.65 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.988 1.756 . . . . 0.0 114.541 174.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -107.1 -18.21 13.96 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -173.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.4 t 60.47 -14.07 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 127.728 2.411 . . . . 0.0 116.496 -174.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 42.2 mmt180 -125.24 136.52 53.62 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.519 1.927 . . . . 0.0 112.094 -177.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 62.2 tpp -59.8 -38.27 81.47 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.191 1.396 . . . . 0.0 112.129 175.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.33 -29.69 65.89 Favored Glycine 0 CA--C 1.533 1.194 0 O-C-N 121.716 -0.615 . . . . 0.0 113.769 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -82.25 -41.29 20.41 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.15 0.975 . . . . 0.0 112.403 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.0 p -64.89 -23.41 67.22 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.07 0.85 . . . . 0.0 112.895 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.27 -64.03 1.11 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.481 1.512 . . . . 0.0 111.589 169.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -61.41 -28.1 69.02 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -171.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -78.46 -6.27 54.86 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.11 0.964 . . . . 0.0 113.565 174.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -122.35 170.85 7.19 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 126.625 1.97 . . . . 0.0 112.437 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.11 -7.16 17.11 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.229 2.62 . . . . 0.0 114.724 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.286 0 C-N-CA 126.747 2.117 . . . . 0.0 114.742 -178.735 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 . . . . . 0 CA--C 1.547 0.847 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.2 p -127.47 170.46 12.54 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.901 1.68 . . . . 0.0 112.542 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.7 p -90.31 161.69 15.52 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.756 1.223 . . . . 0.0 111.925 173.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.8 m -66.06 155.54 86.93 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 123.524 0.729 . . . . 0.0 112.257 176.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -64.17 156.24 60.46 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.493 2.795 . . . . 0.0 112.47 172.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 40.5 pt -61.69 143.78 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.783 0.833 . . . . 0.0 112.083 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.86 -6.73 11.41 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.116 1.341 . . . . 0.0 116.188 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -76.71 172.32 13.26 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.42 1.61 . . . . 0.0 112.243 176.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.5 t -128.97 92.98 3.49 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.856 1.262 . . . . 0.0 111.827 -174.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -61.75 152.62 75.0 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 125.158 1.383 . . . . 0.0 113.864 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.36 86.95 1.4 Allowed 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.867 3.045 . . . . 0.0 112.243 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.6 p -68.19 -29.64 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.639 1.176 . . . . 0.0 113.161 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -78.71 -68.13 0.68 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.884 1.674 . . . . 0.0 112.593 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.67 43.79 91.41 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.138 1.351 . . . . 0.0 114.498 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.0 tp -113.11 92.85 4.15 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.971 1.708 . . . . 0.0 111.174 -169.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 31.3 p -120.41 178.21 4.75 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.588 1.955 . . . . 0.0 113.502 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -127.84 -60.0 1.17 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.396 1.878 . . . . 0.0 112.099 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.05 173.23 6.76 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.636 1.174 . . . . 0.0 113.259 176.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -110.1 47.66 0.94 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.63 1.972 . . . . 0.0 113.297 -173.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -122.25 95.53 4.68 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.894 1.678 . . . . 0.0 110.788 -176.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.6 m -132.35 154.63 49.57 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.111 1.364 . . . . 0.0 110.876 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -138.78 124.21 19.38 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.808 1.243 . . . . 0.0 111.485 -174.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -76.98 140.03 40.28 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.649 1.18 . . . . 0.0 111.483 -177.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -131.36 127.42 37.56 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.87 1.268 . . . . 0.0 111.141 -176.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.7 t -65.98 122.86 18.33 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.809 0.338 . . . . 0.0 110.846 171.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 37.6 mtp -137.5 111.96 8.66 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.159 1.384 . . . . 0.0 110.327 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.05 -68.48 2.84 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.6 1.095 . . . . 0.0 112.39 -174.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -145.94 -52.22 0.25 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 8.4 p -83.82 172.62 11.99 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.295 0.952 . . . . 0.0 112.437 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.4 p -121.2 90.69 3.37 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.311 1.044 . . . . 0.0 112.75 172.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -74.12 173.59 9.88 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.358 1.063 . . . . 0.0 112.218 172.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.02 130.11 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.48 1.512 . . . . 0.0 111.26 168.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -142.99 163.63 32.27 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.161 1.784 . . . . 0.0 110.61 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -130.76 -1.36 4.24 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.39 170.55 54.88 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.416 1.007 . . . . 0.0 114.079 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 56.6 m -67.74 105.08 1.81 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.653 1.181 . . . . 0.0 111.358 177.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.44 98.88 4.07 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.574 1.15 . . . . 0.0 109.985 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.0 m -53.64 -47.36 70.4 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.676 1.59 . . . . 0.0 113.373 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.06 60.78 4.65 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.499 1.523 . . . . 0.0 114.29 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.97 164.01 35.14 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.613 1.101 . . . . 0.0 114.324 176.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -120.35 -26.72 5.36 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 59.95 5.5 0.76 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.653 1.981 . . . . 0.0 115.735 -175.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -136.63 129.75 31.21 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.647 1.979 . . . . 0.0 111.428 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 31.5 ttm -61.58 -31.23 71.27 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.732 1.213 . . . . 0.0 113.043 175.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.45 -37.02 48.02 Favored Glycine 0 CA--C 1.528 0.903 0 O-C-N 121.889 -0.507 . . . . 0.0 113.268 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -76.05 -44.49 38.89 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.731 0.812 . . . . 0.0 112.132 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.4 p -64.93 -21.75 66.88 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.58 -63.14 1.48 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.495 1.518 . . . . 0.0 111.466 170.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -61.68 -28.44 69.4 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -76.56 -5.0 45.81 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 174.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -126.07 167.15 17.77 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 125.865 1.666 . . . . 0.0 113.656 -175.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.21 -8.11 14.05 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.277 2.652 . . . . 0.0 114.531 -174.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.375 0 C-N-CA 126.106 1.812 . . . . 0.0 114.357 179.383 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 N--CA 1.472 0.667 0 CA-C-O 121.089 0.471 . . . . 0.0 112.263 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 61.3 m -71.16 154.04 42.02 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.462 0.705 . . . . 0.0 111.558 173.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.6 t -70.14 -175.73 1.02 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.267 1.027 . . . . 0.0 112.529 170.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.4 t -135.09 134.23 21.44 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 126.354 1.862 . . . . 0.0 110.03 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.36 162.8 37.66 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.074 3.183 . . . . 0.0 113.171 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.502 HD12 ' H ' ' A' ' 28' ' ' ILE . 4.2 mp -60.67 141.02 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.883 1.273 . . . . 0.0 110.593 176.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.35 26.12 40.98 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.099 0.857 . . . . 0.0 114.336 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -63.69 177.86 0.67 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.432 2.293 . . . . 0.0 116.016 -176.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.0 p -134.93 65.73 1.55 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 127.398 2.279 . . . . 0.0 111.122 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.45 154.68 53.11 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 124.983 1.313 . . . . 0.0 113.84 178.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -72.61 169.27 22.28 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.555 2.836 . . . . 0.0 112.738 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.0 t -132.48 56.06 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.518 1.527 . . . . 0.0 109.277 -177.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.4 mtmm -59.82 131.49 51.05 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.637 1.175 . . . . 0.0 110.88 172.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.08 79.98 0.12 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.905 1.24 . . . . 0.0 111.9 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.2 mt 55.18 32.97 19.53 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.11 1.764 . . . . 0.0 113.565 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 67.0 m -58.54 153.15 16.72 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.914 1.685 . . . . 0.0 113.464 -174.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.403 ' HA ' ' HE2' ' A' ' 39' ' ' LYS . 11.0 mmpt? -123.85 73.57 1.22 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.168 1.787 . . . . 0.0 111.015 -174.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -137.32 163.03 31.98 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.568 1.547 . . . . 0.0 111.781 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.1 mtp85 -129.68 12.37 5.82 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.109 1.764 . . . . 0.0 113.8 -175.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -132.52 109.46 9.8 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.528 1.931 . . . . 0.0 110.899 -175.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.6 156.82 38.33 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.231 1.012 . . . . 0.0 111.547 174.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -142.5 166.47 24.59 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.136 1.375 . . . . 0.0 111.681 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -131.08 144.6 51.55 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.344 1.058 . . . . 0.0 111.424 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -141.34 132.3 26.08 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.838 1.255 . . . . 0.0 111.005 -171.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 36.1 t -82.42 109.73 16.92 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.631 1.172 . . . . 0.0 111.766 173.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 6.9 mmt -72.33 -9.8 58.96 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 173.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.09 -37.15 0.46 Allowed Glycine 0 N--CA 1.474 1.211 0 C-N-CA 124.257 0.932 . . . . 0.0 114.76 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -141.82 -53.98 0.44 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.669 1.588 . . . . 0.0 111.248 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 36.8 t -107.7 110.3 22.11 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.462 1.505 . . . . 0.0 110.215 -175.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 21.4 p -74.97 146.95 41.26 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -128.58 171.86 11.73 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.524 1.93 . . . . 0.0 111.097 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 p -75.22 131.95 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.69 1.196 . . . . 0.0 111.019 172.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -145.11 163.47 34.21 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.575 1.15 . . . . 0.0 111.195 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -154.47 149.54 26.87 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.278 1.431 . . . . 0.0 110.229 174.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 135.16 -172.86 21.9 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.925 1.25 . . . . 0.0 113.359 -172.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 63.6 m -72.8 6.73 2.35 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 -172.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -68.36 97.46 0.75 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.472 1.909 . . . . 0.0 111.789 -177.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.8 m -55.16 -41.57 71.99 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 126.319 1.848 . . . . 0.0 114.206 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.49 58.44 4.99 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.16 1.362 . . . . 0.0 115.029 -171.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -100.83 173.7 24.84 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 125.118 1.342 . . . . 0.0 114.591 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -107.38 159.07 16.67 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.133 1.773 . . . . 0.0 111.186 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.3 p -79.59 -40.4 29.45 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 120.855 -1.153 . . . . 0.0 113.256 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.8 mmp_? -139.39 161.82 36.53 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.93 2.092 . . . . 0.0 111.627 -177.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 49.1 ttm -67.43 -29.19 68.61 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.398 0.679 . . . . 0.0 112.382 -177.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.53 -28.71 70.1 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.445 -0.642 . . . . 0.0 113.855 171.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -74.65 -50.85 16.16 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.796 1.298 . . . . 0.0 111.901 172.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.7 p -66.33 -19.76 65.9 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.73 -66.48 0.74 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.465 1.506 . . . . 0.0 111.887 164.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -60.48 -28.65 68.51 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -169.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -81.05 -7.0 59.47 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.335 1.054 . . . . 0.0 113.78 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -119.72 164.98 19.01 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 125.956 1.702 . . . . 0.0 112.723 -177.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -75.94 -6.38 17.35 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.527 2.818 . . . . 0.0 115.089 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.237 0 C-N-CA 126.075 1.798 . . . . 0.0 113.429 177.47 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 . . . . . 0 N--CA 1.473 0.721 0 CA-C-O 120.74 0.305 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.9 m -71.0 135.15 47.68 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.394 0.677 . . . . 0.0 111.516 178.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.1 t -74.06 167.21 21.99 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.452 0.701 . . . . 0.0 111.842 169.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.1 t -84.63 132.86 45.36 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 124.698 1.199 . . . . 0.0 109.789 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.85 179.98 5.74 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 124.525 3.484 . . . . 0.0 112.67 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.9 mm -56.49 147.95 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 126.038 1.735 . . . . 0.0 112.414 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.48 -60.02 1.07 Allowed Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.919 1.723 . . . . 0.0 111.918 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -81.77 -178.71 7.09 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.047 1.339 . . . . 0.0 112.654 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.0 t -147.41 174.88 11.27 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.082 1.753 . . . . 0.0 110.627 172.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -83.64 111.29 30.9 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 125.275 1.43 . . . . 0.0 113.266 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -74.93 158.56 42.4 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.978 2.452 . . . . 0.0 111.559 168.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.1 t -107.11 -35.12 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.835 1.254 . . . . 0.0 111.543 173.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -63.07 152.52 36.84 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.597 1.159 . . . . 0.0 112.4 175.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.29 -6.88 62.29 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.039 1.304 . . . . 0.0 116.21 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.8 mp -78.96 32.55 0.21 Allowed 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 119.308 1.554 . . . . 0.0 112.566 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 57.0 m -66.17 12.83 0.06 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 128.85 2.86 . . . . 0.0 115.428 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 61.03 9.07 2.17 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 129.164 2.986 . . . . 0.0 115.607 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.6 169.66 13.83 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.778 1.631 . . . . 0.0 113.324 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.1 mtm180 -116.75 -8.68 11.37 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -173.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -77.99 -25.83 48.26 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.3 m -62.52 147.2 49.67 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.885 1.274 . . . . 0.0 111.635 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -87.86 159.03 18.56 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.338 1.055 . . . . 0.0 111.322 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -119.66 123.86 44.88 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.258 1.023 . . . . 0.0 110.879 -172.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -119.42 130.17 55.15 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.246 1.018 . . . . 0.0 111.129 -171.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 41.8 t -73.42 97.08 2.47 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.679 0.792 . . . . 0.0 111.653 176.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 15.4 mmt -72.52 80.6 1.07 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.692 1.597 . . . . 0.0 110.668 169.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.43 -63.22 3.37 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.497 1.522 . . . . 0.0 114.456 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -123.63 -53.81 1.77 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.336 1.454 . . . . 0.0 112.408 -173.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 9.6 m -101.98 171.64 7.39 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.316 1.446 . . . . 0.0 111.018 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 11.0 p -120.6 158.82 26.55 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.027 0.931 . . . . 0.0 113.372 172.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -150.07 172.99 14.38 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 126.126 1.77 . . . . 0.0 111.239 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.3 p -76.96 125.62 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.506 1.523 . . . . 0.0 111.974 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -145.09 111.62 5.74 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.544 1.138 . . . . 0.0 111.206 -178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -75.88 98.39 4.19 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.254 -0.904 . . . . 0.0 110.901 169.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.69 167.95 38.1 Favored Glycine 0 CA--C 1.533 1.186 0 O-C-N 121.107 -0.996 . . . . 0.0 114.36 174.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.4 m -72.69 101.6 3.11 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.023 1.329 . . . . 0.0 111.335 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -133.42 97.41 3.95 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.75 1.22 . . . . 0.0 109.716 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.7 m -49.47 -49.31 46.03 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.111 1.764 . . . . 0.0 113.618 -175.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.48 77.4 0.95 Allowed Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.317 1.437 . . . . 0.0 112.784 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -131.13 175.63 19.43 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.431 1.491 . . . . 0.0 114.491 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -130.39 134.67 47.31 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.841 1.256 . . . . 0.0 112.014 -173.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 65.4 p -79.56 -8.47 59.19 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -129.12 138.42 51.8 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.574 1.549 . . . . 0.0 112.282 -176.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 61.4 tpp -65.45 -33.5 76.09 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.574 1.15 . . . . 0.0 112.056 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.45 -37.02 85.18 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 121.71 -0.619 . . . . 0.0 112.922 175.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 82.0 mm-40 -72.01 -46.37 57.43 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.294 1.037 . . . . 0.0 112.22 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.8 p -63.54 -24.21 67.71 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.07 0.85 . . . . 0.0 113.046 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.62 -64.13 1.25 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.481 1.513 . . . . 0.0 112.045 170.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -62.69 -28.18 69.76 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -169.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -81.43 -6.35 58.85 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.4 164.14 17.22 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 126.198 1.799 . . . . 0.0 112.786 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.56 -17.18 16.44 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.66 2.24 . . . . 0.0 113.854 -173.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.381 0 C-N-CA 126.587 2.042 . . . . 0.0 115.074 -179.705 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 120.9 0.381 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.0 t -69.75 128.21 35.61 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.467 0.707 . . . . 0.0 111.287 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 50.6 p -136.38 169.38 17.76 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.501 1.521 . . . . 0.0 112.281 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.6 t -69.24 133.93 89.37 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.96 0.904 . . . . 0.0 110.169 177.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.8 158.65 56.99 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.128 3.219 . . . . 0.0 112.516 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.7 mt -63.63 136.07 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.936 0.895 . . . . 0.0 109.817 177.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.42 -10.56 63.74 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.523 1.535 . . . . 0.0 115.456 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.27 172.22 11.57 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.535 1.667 . . . . 0.0 112.853 172.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.0 t -107.65 91.55 3.7 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.093 1.357 . . . . 0.0 110.437 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -56.73 115.36 10.0 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 125.071 1.349 . . . . 0.0 113.32 -176.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.86 94.57 1.07 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.481 2.788 . . . . 0.0 111.739 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 p -70.83 -24.42 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 124.337 1.055 . . . . 0.0 113.0 175.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -62.76 154.02 30.96 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.69 1.596 . . . . 0.0 111.78 173.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.62 31.87 62.36 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 123.726 0.679 . . . . 0.0 114.538 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.8 tp -74.05 59.97 0.75 Allowed 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.947 1.699 . . . . 0.0 112.583 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 31.8 p -149.7 173.74 13.36 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.457 1.903 . . . . 0.0 112.555 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.25 78.31 1.78 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.55 1.94 . . . . 0.0 110.984 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.74 178.55 4.11 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.787 0.804 . . . . 0.0 112.29 168.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -12.31 59.87 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.814 1.646 . . . . 0.0 113.429 171.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -126.63 105.03 8.42 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.708 2.803 . . . . 0.0 108.896 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.4 m -128.77 158.63 38.12 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.501 1.92 . . . . 0.0 110.313 -175.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -114.07 162.08 16.92 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.476 1.111 . . . . 0.0 112.834 170.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -146.98 127.83 14.41 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.999 1.32 . . . . 0.0 110.051 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -132.4 137.88 47.49 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.757 1.223 . . . . 0.0 111.701 -174.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 35.4 t -79.68 115.89 19.54 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.164 0.986 . . . . 0.0 111.792 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 96.3 mmm -90.25 -10.95 42.38 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.846 1.258 . . . . 0.0 114.22 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.54 -87.94 0.08 OUTLIER Glycine 0 N--CA 1.469 0.869 0 C-N-CA 124.536 1.065 . . . . 0.0 111.807 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -86.54 -31.6 21.17 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 171.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.5 p -125.98 166.33 17.13 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.732 2.013 . . . . 0.0 111.74 -170.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.5 p -113.87 153.3 29.43 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 167.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.7 ttpt -124.39 165.72 17.24 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.549 1.94 . . . . 0.0 110.513 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.2 p -69.98 135.72 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.273 1.029 . . . . 0.0 111.609 171.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -144.15 177.37 8.63 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.167 1.787 . . . . 0.0 110.515 174.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -136.38 156.79 48.13 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.982 0.913 . . . . 0.0 112.353 175.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.45 175.93 10.71 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.665 1.126 . . . . 0.0 113.969 -170.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 76.9 m -91.96 85.32 5.52 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.557 1.143 . . . . 0.0 110.375 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -70.08 84.82 0.53 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.01 1.324 . . . . 0.0 111.268 -178.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 m 61.7 7.07 1.77 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 126.612 1.965 . . . . 0.0 114.018 -174.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.78 149.44 9.47 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 127.212 2.339 . . . . 0.0 113.295 -174.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.12 -91.36 0.08 OUTLIER Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.491 1.044 . . . . 0.0 112.513 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -135.31 157.41 46.97 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.346 1.058 . . . . 0.0 113.162 -174.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.9 m -123.29 5.53 9.11 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.153 1.781 . . . . 0.0 113.092 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 -138.47 139.38 38.8 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.968 2.107 . . . . 0.0 111.0 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 30.0 tpp -59.35 -35.47 73.94 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.788 1.235 . . . . 0.0 112.14 172.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.09 -24.85 73.36 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 121.196 -0.94 . . . . 0.0 114.383 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -80.32 -46.28 16.4 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.641 1.221 . . . . 0.0 111.952 175.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.6 p -64.17 -25.03 67.9 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.28 -61.62 1.76 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.59 1.556 . . . . 0.0 111.855 171.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -61.56 -27.37 68.58 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -173.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -79.68 -4.82 53.48 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.442 1.097 . . . . 0.0 113.702 174.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m -125.61 166.43 21.09 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 126.431 1.892 . . . . 0.0 113.077 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.29 -13.76 16.76 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.772 2.314 . . . . 0.0 114.05 -176.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.214 0 C-N-CA 126.507 2.003 . . . . 0.0 112.95 179.611 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 CA--C 1.546 0.808 0 CA-C-O 120.788 0.328 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.2 m -68.28 75.77 0.25 Allowed 'General case' 0 CA--C 1.549 0.915 0 O-C-N 120.647 -1.283 . . . . 0.0 112.223 174.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.4 m -125.15 139.39 53.8 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.384 2.274 . . . . 0.0 109.624 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.8 t -72.89 136.25 80.09 Favored Pre-proline 0 N--CA 1.477 0.876 0 O-C-N 121.694 -0.629 . . . . 0.0 110.376 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.6 150.34 88.37 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.658 2.905 . . . . 0.0 112.22 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.49 HD12 ' H ' ' A' ' 28' ' ' ILE . 5.4 mp -61.66 133.43 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.357 1.063 . . . . 0.0 110.181 -178.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.58 -12.87 63.92 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.712 1.625 . . . . 0.0 115.415 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -73.51 159.87 32.53 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.76 1.78 . . . . 0.0 112.529 174.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.4 m -82.79 76.05 9.66 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.301 1.04 . . . . 0.0 111.749 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -54.21 111.87 3.3 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 125.586 1.554 . . . . 0.0 113.457 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.18 113.09 3.34 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.241 2.627 . . . . 0.0 111.954 -176.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.7 p -76.4 -25.1 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.002 0.921 . . . . 0.0 113.171 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 pmtp? -66.74 168.16 10.02 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.101 1.36 . . . . 0.0 113.798 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.71 166.56 39.44 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.6 1.572 . . . . 0.0 112.566 174.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.0 tp -146.75 74.04 1.34 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.744 1.217 . . . . 0.0 110.987 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 76.2 m -63.68 165.56 8.13 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.474 1.11 . . . . 0.0 112.375 176.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm 60.13 -0.91 0.21 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.177 2.591 . . . . 0.0 116.505 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.18 160.4 26.96 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.023 1.329 . . . . 0.0 113.121 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.9 ptt85 -80.95 -0.74 40.71 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.276 1.43 . . . . 0.0 114.81 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -137.33 137.24 38.73 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.073 2.149 . . . . 0.0 109.781 -176.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.5 m -141.65 144.53 34.19 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.664 1.985 . . . . 0.0 110.098 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -123.66 157.02 34.77 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.504 1.521 . . . . 0.0 110.547 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -143.95 137.89 28.1 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.895 0.878 . . . . 0.0 111.217 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -141.0 131.33 25.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.467 1.107 . . . . 0.0 111.541 -177.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 15.2 t -77.47 126.32 30.72 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.018 0.927 . . . . 0.0 111.911 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 96.6 mmm -108.7 0.3 20.48 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.191 1.397 . . . . 0.0 113.828 -174.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.39 -78.37 0.14 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 125.33 1.443 . . . . 0.0 111.79 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -115.11 -1.04 13.12 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.017 1.327 . . . . 0.0 113.567 177.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 38.7 t -149.07 156.4 42.17 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.252 1.821 . . . . 0.0 110.038 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.2 p -119.87 103.93 9.76 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.34 1.056 . . . . 0.0 113.005 176.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -70.52 165.97 21.55 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.245 1.018 . . . . 0.0 111.408 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -77.37 139.04 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.756 1.222 . . . . 0.0 111.647 168.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -138.74 172.17 13.26 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.722 2.009 . . . . 0.0 110.335 173.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.6 mp0 -134.44 123.66 24.38 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.906 1.282 . . . . 0.0 110.665 -173.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.06 173.26 49.67 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.627 1.108 . . . . 0.0 113.322 -170.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 75.9 m -82.91 85.72 7.08 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.466 1.106 . . . . 0.0 111.527 -177.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -73.95 93.91 2.27 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.116 0.966 . . . . 0.0 110.508 174.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 59.6 p 54.29 -0.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 128.972 2.909 . . . . 0.0 117.972 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.64 153.67 30.32 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 127.247 2.356 . . . . 0.0 113.359 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.61 -86.76 0.1 OUTLIER Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.333 0.968 . . . . 0.0 113.376 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -132.65 162.76 30.52 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.319 1.448 . . . . 0.0 112.371 -175.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 74.0 m -126.59 -3.88 6.61 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -137.98 147.83 44.61 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.262 1.825 . . . . 0.0 110.306 172.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 32.7 ttm -62.52 -32.29 73.2 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 122.62 0.368 . . . . 0.0 111.934 177.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -58.72 -33.75 74.11 Favored Glycine 0 CA--C 1.533 1.163 0 O-C-N 121.446 -0.783 . . . . 0.0 114.126 175.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -72.41 -50.34 27.09 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.434 1.117 . . . . 0.0 111.799 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.3 p -65.5 -30.07 70.8 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.37 -58.63 3.34 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.706 1.202 . . . . 0.0 112.192 173.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -60.68 -30.05 69.69 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -171.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 -82.27 -22.57 35.69 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.194 0.998 . . . . 0.0 113.57 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m -97.03 168.66 9.9 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 125.717 1.607 . . . . 0.0 112.208 176.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.71 -7.44 15.65 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.017 2.478 . . . . 0.0 114.617 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.29 0 C-N-CA 126.264 1.888 . . . . 0.0 113.862 -178.401 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.1 m -61.81 128.42 36.13 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.751 1.22 . . . . 0.0 111.953 170.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.6 t -145.66 164.92 30.25 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.161 1.384 . . . . 0.0 111.243 171.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.4 m -71.72 154.9 92.83 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 125.46 1.504 . . . . 0.0 112.546 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -69.94 155.64 64.85 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.906 2.404 . . . . 0.0 110.662 174.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.9 mt -61.28 134.98 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.86 0.864 . . . . 0.0 110.634 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.04 51.17 47.2 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.032 1.301 . . . . 0.0 114.006 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 37.7 p90 -76.65 -177.76 4.41 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.808 1.643 . . . . 0.0 112.528 177.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.9 m -133.54 93.09 3.08 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.473 1.909 . . . . 0.0 110.142 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -57.32 115.78 11.73 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 124.536 1.134 . . . . 0.0 113.629 -173.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.6 105.81 2.13 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.649 2.899 . . . . 0.0 111.651 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.6 t -130.64 75.76 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.126 1.37 . . . . 0.0 109.622 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -149.82 176.11 11.02 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.825 2.05 . . . . 0.0 111.656 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.15 65.67 3.23 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.58 1.086 . . . . 0.0 114.146 172.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.408 ' H ' HD23 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -62.26 -3.76 1.48 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -177.651 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 67.1 m -61.17 164.26 5.42 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.952 1.701 . . . . 0.0 113.526 177.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -127.55 74.98 1.56 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.79 1.636 . . . . 0.0 111.638 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.94 165.9 16.8 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.87 0.868 . . . . 0.0 112.378 172.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -77.83 1.47 20.22 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.623 1.569 . . . . 0.0 114.12 176.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -143.2 164.67 29.55 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.746 2.818 . . . . 0.0 108.398 175.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.1 m -132.98 151.91 52.01 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.281 1.832 . . . . 0.0 110.479 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -85.24 150.69 24.62 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.752 1.221 . . . . 0.0 112.151 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -132.95 129.28 38.06 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.527 1.131 . . . . 0.0 110.935 -177.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -125.87 130.62 51.71 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.259 1.024 . . . . 0.0 111.707 -172.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.7 t -70.15 119.16 13.93 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.99 0.516 . . . . 0.0 111.116 171.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 81.8 mmm -118.05 94.37 4.48 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.293 1.837 . . . . 0.0 109.086 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.74 -65.07 4.19 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.728 1.156 . . . . 0.0 113.678 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -133.97 -59.76 0.83 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.376 1.47 . . . . 0.0 112.043 -172.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 p -96.91 168.17 10.64 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.198 1.799 . . . . 0.0 111.458 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 14.3 p -109.49 150.25 28.4 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 172.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -133.34 162.6 31.39 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.973 1.709 . . . . 0.0 112.684 -175.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 p -78.86 126.29 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 125.884 1.673 . . . . 0.0 111.724 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -145.98 103.4 3.74 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.191 0.996 . . . . 0.0 111.308 -178.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -62.88 111.69 2.25 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.044 1.338 . . . . 0.0 110.826 172.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.47 -156.88 26.94 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.096 0.855 . . . . 0.0 113.863 -175.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 78.0 m -134.31 114.65 13.21 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.048 2.139 . . . . 0.0 109.959 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -124.94 92.14 3.58 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.661 1.985 . . . . 0.0 109.329 -178.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 m 50.07 35.94 11.01 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.589 1.955 . . . . 0.0 114.19 174.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.08 23.0 78.53 Favored Glycine 0 CA--C 1.539 1.567 0 O-C-N 120.865 -1.147 . . . . 0.0 115.678 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.99 174.26 5.74 Favored Glycine 0 CA--C 1.542 1.757 0 C-N-CA 125.232 1.396 . . . . 0.0 116.184 -176.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -62.87 139.32 58.72 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 -159.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.5 m -74.64 -19.04 60.45 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.904 1.681 . . . . 0.0 114.828 176.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -137.96 154.66 49.36 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.247 1.819 . . . . 0.0 112.061 -176.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 49.3 ttm -75.48 -29.79 59.69 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.15 -29.54 75.59 Favored Glycine 0 CA--C 1.533 1.184 0 O-C-N 121.385 -0.822 . . . . 0.0 113.047 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -74.52 -48.33 27.68 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.874 1.67 . . . . 0.0 111.838 173.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.9 p -66.27 -25.98 67.13 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.284 0.947 . . . . 0.0 113.426 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.09 -59.16 2.85 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.377 1.471 . . . . 0.0 111.791 173.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -61.92 -28.3 69.43 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 -172.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -78.57 -6.7 56.26 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.461 1.104 . . . . 0.0 113.765 175.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -129.16 168.69 15.24 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 125.845 1.658 . . . . 0.0 113.346 -175.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -74.52 -19.25 19.29 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.756 2.304 . . . . 0.0 113.555 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.657 1.599 . . . . 0.0 114.287 -179.391 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 . . . . . 0 N--CA 1.476 0.87 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.7 t -73.82 94.87 2.33 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.113 0.965 . . . . 0.0 110.452 167.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.5 p -80.99 175.18 10.91 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.259 1.424 . . . . 0.0 111.843 170.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.9 t -118.66 134.62 23.51 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 125.357 1.463 . . . . 0.0 109.866 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -78.05 -170.37 0.95 Allowed 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 124.685 3.59 . . . . 0.0 112.614 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.1 pt -55.24 165.39 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 126.341 1.856 . . . . 0.0 114.021 175.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.06 -61.23 4.76 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.803 1.668 . . . . 0.0 111.936 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -78.45 -179.45 6.35 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.057 1.343 . . . . 0.0 112.85 170.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.7 t -145.45 177.06 9.13 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.211 1.804 . . . . 0.0 110.201 164.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -84.87 112.31 41.97 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 125.062 1.345 . . . . 0.0 112.15 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.05 122.6 8.57 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.61 2.873 . . . . 0.0 112.542 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -78.89 -25.33 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.405 1.082 . . . . 0.0 113.414 174.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -66.9 154.99 39.63 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.458 1.503 . . . . 0.0 112.663 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.6 50.96 0.04 OUTLIER Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.933 1.254 . . . . 0.0 114.445 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.87 60.71 2.35 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.245 1.418 . . . . 0.0 111.991 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 83.3 m -117.44 155.57 29.45 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.224 1.81 . . . . 0.0 111.661 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.43 24.9 1.9 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.752 1.621 . . . . 0.0 113.944 -171.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.51 168.71 13.26 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.852 1.661 . . . . 0.0 112.279 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -73.38 0.99 10.58 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.526 1.93 . . . . 0.0 115.787 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -84.72 83.23 8.1 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.6 1.56 . . . . 0.0 111.987 -173.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.51 156.98 44.76 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.584 1.554 . . . . 0.0 111.317 -173.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 24.3 ttp180 -145.54 162.64 36.95 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.742 1.217 . . . . 0.0 111.77 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -123.28 111.58 16.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.284 1.034 . . . . 0.0 111.377 -167.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -108.8 122.73 47.79 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.763 0.825 . . . . 0.0 111.729 -171.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.4 t -69.77 111.72 5.72 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.939 1.296 . . . . 0.0 111.4 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 57.7 mtp -138.26 84.35 2.03 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.943 2.097 . . . . 0.0 110.394 -175.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.4 64.01 1.41 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.245 0.926 . . . . 0.0 114.111 175.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 56.74 22.93 7.37 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 126.331 1.853 . . . . 0.0 114.485 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 9.8 t -149.48 153.0 36.57 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 128.479 2.711 . . . . 0.0 108.102 172.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 7.1 p -114.51 121.55 43.84 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.026 0.931 . . . . 0.0 111.497 165.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -100.44 160.92 13.96 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.582 1.553 . . . . 0.0 111.039 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.7 p -74.76 129.05 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.629 0.772 . . . . 0.0 110.834 166.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -134.94 149.33 50.22 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.693 0.797 . . . . 0.0 111.597 171.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -88.47 154.7 20.15 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.685 1.194 . . . . 0.0 110.928 173.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.26 -176.84 33.64 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-O 122.21 0.894 . . . . 0.0 114.81 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 65.3 m -94.82 23.09 5.74 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.335 1.454 . . . . 0.0 114.504 -171.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -40.18 -44.37 1.83 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 127.019 2.128 . . . . 0.0 115.419 -170.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 98.0 m -155.28 82.65 1.06 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.857 1.663 . . . . 0.0 109.224 174.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -51.72 101.99 0.07 OUTLIER Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.526 1.536 . . . . 0.0 114.862 -176.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -126.74 -90.31 0.74 Allowed Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.764 1.65 . . . . 0.0 114.008 -175.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -121.77 116.69 24.95 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.641 1.177 . . . . 0.0 113.234 -164.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.7 m -84.71 -2.34 57.44 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -127.96 139.14 52.75 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.584 1.554 . . . . 0.0 111.378 174.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 38.9 ttm -69.45 -26.41 64.58 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.61 -33.69 72.1 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 121.798 -0.564 . . . . 0.0 112.96 172.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -74.19 -48.0 31.9 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.068 0.947 . . . . 0.0 111.835 173.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.6 p -63.79 -24.24 67.68 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.36 -65.38 0.93 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.661 1.584 . . . . 0.0 112.226 168.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -61.46 -28.7 69.47 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -168.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -84.11 -5.99 59.33 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.142 0.977 . . . . 0.0 113.474 177.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.45 169.84 6.35 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 126.373 1.869 . . . . 0.0 112.257 177.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -77.59 -8.81 17.2 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.056 2.504 . . . . 0.0 113.765 -178.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.311 0 C-N-CA 127.57 2.51 . . . . 0.0 112.615 177.424 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 71.8 m -65.03 134.58 54.17 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.712 0.805 . . . . 0.0 111.473 173.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.7 p -129.46 173.43 10.57 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.934 1.694 . . . . 0.0 111.287 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.6 t -58.18 134.74 84.49 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 124.39 1.076 . . . . 0.0 110.863 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -65.92 155.94 66.86 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 124.488 3.459 . . . . 0.0 112.658 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.1 pt -57.37 135.42 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.738 0.815 . . . . 0.0 112.368 -178.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.47 -13.45 22.12 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.451 1.5 . . . . 0.0 116.075 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -75.55 146.06 40.77 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 119.833 1.816 . . . . 0.0 112.252 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.0 t -90.93 96.12 10.47 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.445 1.098 . . . . 0.0 111.717 -175.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -57.72 142.99 77.26 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 124.611 1.164 . . . . 0.0 113.791 -176.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.47 81.0 2.9 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.913 3.075 . . . . 0.0 112.677 -171.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 p -61.07 -28.4 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 125.169 1.388 . . . . 0.0 113.114 -178.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -83.08 -4.91 58.85 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.083 2.153 . . . . 0.0 114.576 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.3 -139.35 6.58 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.365 1.459 . . . . 0.0 112.789 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.5 mt 65.22 11.21 7.05 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 127.051 2.14 . . . . 0.0 115.419 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 16.7 t -73.45 150.73 41.44 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.04 1.336 . . . . 0.0 112.777 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.6 37.87 0.36 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.958 2.503 . . . . 0.0 113.593 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.16 159.7 25.71 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.107 -0.996 . . . . 0.0 113.088 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -86.03 0.38 53.52 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.703 1.601 . . . . 0.0 114.88 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -144.26 122.24 12.07 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.183 2.193 . . . . 0.0 109.705 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.457 HG22 ' H ' ' A' ' 44' ' ' ARG . 1.9 m -148.31 167.57 24.83 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.969 1.308 . . . . 0.0 111.445 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.457 ' H ' HG22 ' A' ' 43' ' ' THR . 17.0 ttm180 -129.61 159.95 34.79 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.707 1.603 . . . . 0.0 111.513 -176.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -126.63 103.74 7.73 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.942 0.897 . . . . 0.0 111.953 -166.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -103.76 122.54 45.29 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.89 0.876 . . . . 0.0 112.346 -169.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.8 t -71.18 103.93 2.93 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.371 1.068 . . . . 0.0 110.794 171.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -136.07 111.21 8.96 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.499 1.92 . . . . 0.0 110.944 -177.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.46 53.78 5.37 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 123.945 0.783 . . . . 0.0 112.8 -170.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 63.24 -11.0 0.1 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 129.328 3.051 . . . . 0.0 116.896 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 48.4 t -126.9 158.24 37.28 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.884 2.074 . . . . 0.0 110.213 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.9 p -108.2 150.76 26.83 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 174.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -141.35 169.47 17.54 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.017 1.327 . . . . 0.0 111.798 172.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.26 126.16 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.006 1.322 . . . . 0.0 111.406 171.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -144.2 165.08 28.84 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.232 1.413 . . . . 0.0 111.217 174.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -126.49 104.79 8.33 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.037 1.335 . . . . 0.0 110.603 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.94 -178.31 36.96 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.466 1.508 . . . . 0.0 111.932 -176.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 77.8 m -99.36 103.35 15.15 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.625 1.17 . . . . 0.0 111.167 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -121.7 86.9 2.66 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.969 1.308 . . . . 0.0 110.402 -178.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.264 1.3 t 49.43 14.67 0.11 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 129.012 2.925 . . . . 0.0 117.182 174.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.88 33.72 45.17 Favored Glycine 0 CA--C 1.537 1.426 0 O-C-N 120.302 -1.499 . . . . 0.0 114.241 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.37 176.24 6.58 Favored Glycine 0 CA--C 1.543 1.812 0 C-N-CA 124.923 1.249 . . . . 0.0 115.564 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -70.07 147.59 49.84 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -162.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -89.38 -30.04 18.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.656 1.182 . . . . 0.0 113.158 174.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -91.17 135.51 33.73 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.84 1.256 . . . . 0.0 111.651 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 38.1 ttm -69.09 -25.32 64.37 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.432 0.693 . . . . 0.0 112.551 176.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.35 -46.86 75.23 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.585 0.612 . . . . 0.0 111.967 171.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.25 -47.05 86.07 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.149 0.98 . . . . 0.0 112.553 176.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.2 p -65.32 -23.48 67.02 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.67 -67.47 0.76 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.0 1.32 . . . . 0.0 111.643 168.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.08 -26.3 68.2 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -168.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -86.05 -4.86 59.26 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.024 0.93 . . . . 0.0 113.381 175.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.37 166.5 10.85 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 126.174 1.79 . . . . 0.0 112.077 176.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.86 -8.76 16.87 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.217 2.612 . . . . 0.0 114.426 -175.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.231 0 C-N-CA 126.493 1.997 . . . . 0.0 114.714 179.459 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 CA--C 1.546 0.792 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.9 t -69.39 149.94 47.83 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 119.175 0.898 . . . . 0.0 112.842 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.9 p -131.52 166.6 21.01 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.316 1.846 . . . . 0.0 112.15 -177.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.6 m -69.82 155.08 94.1 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.345 1.058 . . . . 0.0 112.341 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.7 156.14 67.22 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.934 2.423 . . . . 0.0 111.777 173.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 74.4 mt -66.92 136.15 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.034 0.934 . . . . 0.0 110.049 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.26 -0.84 83.17 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.216 1.388 . . . . 0.0 115.746 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.91 174.99 7.0 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.135 1.467 . . . . 0.0 112.693 175.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.9 t -128.31 92.23 3.4 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.926 1.29 . . . . 0.0 111.033 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.59 148.48 90.73 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 124.85 1.26 . . . . 0.0 113.798 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.442 ' HG2' ' CD1' ' A' ' 55' ' ' TYR . 69.0 Cg_endo -70.98 169.33 20.73 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.762 2.975 . . . . 0.0 113.336 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.8 t -108.57 94.96 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.075 1.75 . . . . 0.0 109.366 -172.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.19 172.27 7.01 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.111 2.164 . . . . 0.0 112.831 -175.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.1 -18.85 0.73 Allowed Glycine 0 CA--C 1.536 1.364 0 N-CA-C 115.916 1.126 . . . . 0.0 115.916 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.8 mp -80.83 61.78 4.6 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 119.171 1.486 . . . . 0.0 110.941 178.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.7 t -71.19 3.22 3.73 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 126.564 1.946 . . . . 0.0 114.189 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -65.42 -21.88 66.71 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.318 1.847 . . . . 0.0 113.884 177.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.24 168.81 11.59 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.491 1.117 . . . . 0.0 112.772 171.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -115.03 17.11 16.98 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.214 1.805 . . . . 0.0 113.732 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -138.26 123.38 19.16 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.543 2.337 . . . . 0.0 109.679 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -137.27 164.23 29.05 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.526 1.931 . . . . 0.0 110.149 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -133.5 171.7 13.73 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.675 1.19 . . . . 0.0 112.835 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -136.72 110.36 8.05 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.938 1.295 . . . . 0.0 110.394 -163.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -99.02 134.62 41.59 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.184 0.994 . . . . 0.0 111.219 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.9 t -69.14 128.44 36.66 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.924 -0.485 . . . . 0.0 110.947 171.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 98.7 mmm -114.68 81.55 1.58 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.581 1.952 . . . . 0.0 109.78 176.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.43 -62.42 4.08 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.304 1.43 . . . . 0.0 114.087 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -133.32 -53.83 0.9 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.296 1.439 . . . . 0.0 112.647 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 14.6 p -76.02 176.3 8.07 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.535 1.134 . . . . 0.0 111.335 171.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.23 163.27 16.23 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.261 -0.899 . . . . 0.0 111.617 161.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -134.22 154.81 51.04 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.441 1.496 . . . . 0.0 112.042 175.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 p -82.26 130.17 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.54 1.136 . . . . 0.0 112.52 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.442 ' CD1' ' HG2' ' A' ' 33' ' ' PRO . 68.1 m-85 -145.06 170.34 16.37 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.349 1.46 . . . . 0.0 111.579 173.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -124.57 161.03 27.05 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.102 1.361 . . . . 0.0 112.082 -169.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.74 177.64 24.39 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.843 1.211 . . . . 0.0 114.324 -177.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.3 t -81.83 80.81 8.04 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.521 -0.988 . . . . 0.0 111.184 175.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -84.01 76.46 10.05 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 122.167 0.984 . . . . 0.0 110.511 171.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.6 m 60.82 32.07 20.09 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.926 1.29 . . . . 0.0 112.861 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.47 -85.34 0.84 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.799 1.666 . . . . 0.0 113.319 178.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 59.24 -131.63 51.73 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.811 1.672 . . . . 0.0 113.744 -176.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -100.52 163.92 12.14 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.775 1.23 . . . . 0.0 112.133 -176.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.0 m -129.12 -0.7 5.19 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.771 1.228 . . . . 0.0 114.112 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -143.4 162.16 36.5 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.697 1.599 . . . . 0.0 112.833 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -42.5 95.26 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.205 1.802 . . . . 0.0 111.286 177.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.14 -25.67 75.25 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 121.493 -0.755 . . . . 0.0 114.155 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -74.26 -46.71 39.68 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.006 1.403 . . . . 0.0 112.037 175.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.7 p -61.14 -31.45 71.16 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.69 -0.631 . . . . 0.0 112.339 176.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.07 -53.47 6.38 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.999 1.72 . . . . 0.0 113.05 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -58.77 -28.17 65.67 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 120.203 1.365 . . . . 0.0 114.385 -174.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -84.08 -6.28 59.38 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.086 1.354 . . . . 0.0 113.858 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.0 m -129.85 162.97 50.31 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 125.197 1.399 . . . . 0.0 114.311 -172.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.98 -9.82 14.14 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.468 2.779 . . . . 0.0 114.943 -175.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.41 0 C-N-CA 125.816 1.674 . . . . 0.0 114.593 -177.685 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 120.495 0.188 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 75.3 m -80.69 170.55 16.17 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.754 0.821 . . . . 0.0 112.174 170.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.9 p -135.36 159.6 41.06 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.462 1.505 . . . . 0.0 111.541 168.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.0 p -79.9 130.67 66.09 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 124.701 1.2 . . . . 0.0 110.997 176.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.46 141.43 42.37 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.457 2.105 . . . . 0.0 110.993 171.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.1 pt -56.68 134.67 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.551 0.74 . . . . 0.0 112.336 -178.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.7 -8.01 57.95 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.388 1.47 . . . . 0.0 115.53 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 24.6 t-105 -77.75 152.85 33.4 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 119.728 1.764 . . . . 0.0 110.12 168.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.5 t -78.24 72.58 4.78 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 122.564 1.173 . . . . 0.0 112.178 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -66.79 154.52 91.69 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 125.67 1.588 . . . . 0.0 114.022 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -76.26 150.8 33.33 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.09 2.527 . . . . 0.0 111.627 175.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.5 t -136.84 76.86 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.099 1.36 . . . . 0.0 109.813 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.71 -28.57 0.43 Allowed 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 116.143 1.905 . . . . 0.0 116.143 -177.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.3 -169.61 24.99 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.16 0.886 . . . . 0.0 113.169 -165.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 98.0 mt -134.75 113.46 11.67 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.311 2.244 . . . . 0.0 108.404 177.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 63.1 m 61.4 29.3 18.43 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.437 1.895 . . . . 0.0 114.628 177.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -53.49 -53.57 49.56 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 126.123 1.769 . . . . 0.0 112.57 175.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.26 169.31 10.48 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.091 1.356 . . . . 0.0 112.19 174.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -108.49 5.07 24.87 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.348 1.859 . . . . 0.0 114.592 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -143.48 102.81 4.01 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.751 2.02 . . . . 0.0 110.85 -176.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.467 HG21 HG22 ' A' ' 54' ' ' VAL . 23.3 m -150.36 155.38 39.51 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 120.806 -1.184 . . . . 0.0 111.51 -177.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -77.71 160.99 28.08 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.771 1.228 . . . . 0.0 112.673 173.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -131.58 107.67 9.01 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.911 1.285 . . . . 0.0 110.759 -174.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -114.6 122.26 45.96 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.959 1.304 . . . . 0.0 112.462 -168.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 35.3 t -67.64 122.7 18.62 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.279 1.032 . . . . 0.0 112.008 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.34 -10.6 1.24 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -171.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 169.23 70.97 0.03 OUTLIER Glycine 0 N--CA 1.47 0.921 0 O-C-N 121.498 -0.751 . . . . 0.0 111.84 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.7 m120 60.83 1.86 0.48 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 127.953 2.501 . . . . 0.0 116.253 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 79.8 m -132.14 160.44 36.03 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.121 1.768 . . . . 0.0 110.158 163.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.7 p -101.26 91.22 4.41 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.93 1.292 . . . . 0.0 111.13 167.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -67.64 154.25 41.89 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.727 1.611 . . . . 0.0 112.319 -176.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.467 HG22 HG21 ' A' ' 43' ' ' THR . 8.9 p -66.64 121.49 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.425 1.49 . . . . 0.0 112.351 172.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -140.05 122.48 16.09 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.451 1.5 . . . . 0.0 111.796 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -74.33 150.68 40.02 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.491 0.716 . . . . 0.0 112.02 171.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.8 174.65 13.41 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.138 1.352 . . . . 0.0 115.417 176.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 17.6 p -80.33 39.08 0.44 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.513 1.925 . . . . 0.0 114.14 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -51.51 -34.91 38.11 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.196 1.398 . . . . 0.0 113.522 178.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.1 t -144.05 -23.86 0.56 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 169.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.63 15.0 81.54 Favored Glycine 0 CA--C 1.539 1.537 0 O-C-N 120.908 -1.12 . . . . 0.0 115.675 171.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -54.26 -68.63 1.56 Allowed Glycine 0 CA--C 1.535 1.33 0 C-N-CA 126.054 1.787 . . . . 0.0 115.073 -174.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -140.31 151.14 44.82 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.889 1.276 . . . . 0.0 112.525 -172.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.8 m -117.89 0.84 12.01 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.341 1.456 . . . . 0.0 114.499 -177.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -135.96 144.77 45.59 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.193 1.797 . . . . 0.0 110.771 174.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -62.91 -35.58 80.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.873 0.869 . . . . 0.0 111.755 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.75 -11.34 77.72 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.356 0.979 . . . . 0.0 114.925 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -96.16 -37.7 10.46 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.986 1.393 . . . . 0.0 112.099 176.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.7 p -70.79 -45.91 63.82 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.194 -0.941 . . . . 0.0 112.005 171.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.21 -12.48 61.19 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -177.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -85.33 -25.53 27.09 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 119.821 1.192 . . . . 0.0 113.626 168.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -91.47 -29.0 17.26 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.844 1.258 . . . . 0.0 112.995 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.3 m -106.53 165.41 13.0 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 126.009 1.724 . . . . 0.0 112.68 175.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -79.12 -4.92 14.18 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.049 2.5 . . . . 0.0 114.775 -171.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.333 0 C-N-CA 126.823 2.154 . . . . 0.0 115.236 -178.737 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 CA--C 1.541 0.611 0 CA-C-O 121.079 0.466 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 35.8 t -140.27 143.45 35.93 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.936 1.294 . . . . 0.0 111.149 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.4 m -132.79 146.03 51.49 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.445 1.498 . . . . 0.0 110.937 -168.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.1 m -100.49 155.94 35.79 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 125.037 1.335 . . . . 0.0 112.822 -173.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.3 157.06 62.68 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.436 2.757 . . . . 0.0 112.435 172.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.461 HD12 ' H ' ' A' ' 28' ' ' ILE . 5.4 mp -66.06 137.22 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.832 1.253 . . . . 0.0 110.385 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.31 -4.56 67.04 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.549 1.547 . . . . 0.0 115.781 176.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.03 172.66 11.26 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 118.826 1.313 . . . . 0.0 113.048 177.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -115.77 80.75 1.49 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.127 1.371 . . . . 0.0 111.53 -175.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -67.96 155.04 92.74 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 125.275 1.43 . . . . 0.0 114.176 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.24 168.27 25.02 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 124.025 3.15 . . . . 0.0 112.594 174.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.3 t -130.54 10.85 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 125.216 1.406 . . . . 0.0 112.706 -174.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -131.12 170.16 14.91 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.575 1.95 . . . . 0.0 112.252 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.69 31.55 0.22 Allowed Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.988 1.28 . . . . 0.0 115.053 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.6 mp -90.14 85.18 6.21 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.442 1.497 . . . . 0.0 110.735 -175.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.0 m -68.3 77.39 0.26 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.711 1.604 . . . . 0.0 112.9 176.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? -129.86 73.26 1.52 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.571 2.348 . . . . 0.0 110.88 -176.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 46.33 42.47 10.48 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.407 1.883 . . . . 0.0 114.659 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -74.05 -30.31 62.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.146 1.378 . . . . 0.0 113.088 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 50.81 26.57 2.65 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.897 2.079 . . . . 0.0 114.589 -175.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.1 m -60.03 152.67 23.38 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.749 2.42 . . . . 0.0 113.026 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.6 152.21 45.68 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.378 1.471 . . . . 0.0 112.028 176.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -129.6 144.89 51.48 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.84 1.256 . . . . 0.0 111.366 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -143.78 139.91 29.63 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.304 1.442 . . . . 0.0 110.722 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 38.0 t -89.95 123.18 33.65 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.878 0.871 . . . . 0.0 111.981 173.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 29.5 mtt -79.25 -12.84 59.96 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 175.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 154.46 -39.72 0.65 Allowed Glycine 0 N--CA 1.475 1.288 0 CA-C-N 119.293 0.951 . . . . 0.0 114.974 171.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -126.61 -12.06 6.11 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 174.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 25.8 p -151.91 163.43 39.26 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.878 2.071 . . . . 0.0 110.284 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 2.4 p -119.57 151.34 38.8 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.37 1.068 . . . . 0.0 112.68 176.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -122.53 178.89 4.79 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.795 1.638 . . . . 0.0 111.668 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.1 p -115.09 122.56 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.636 1.974 . . . . 0.0 110.806 -174.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -129.33 116.69 19.46 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.133 1.373 . . . . 0.0 111.068 -169.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -57.62 117.97 4.75 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.34 1.456 . . . . 0.0 112.972 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.42 173.52 49.86 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 125.387 1.47 . . . . 0.0 114.478 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 76.4 m -78.38 84.4 4.55 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.443 -1.033 . . . . 0.0 111.159 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -50.25 -50.66 49.37 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.453 1.501 . . . . 0.0 112.703 -178.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 90.6 m -136.89 -44.68 0.58 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.08 1.752 . . . . 0.0 111.723 169.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.5 56.82 0.08 OUTLIER Glycine 0 CA--C 1.536 1.367 0 C-N-CA 126.409 1.957 . . . . 0.0 112.636 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.09 -92.62 0.5 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.826 1.203 . . . . 0.0 113.745 -173.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -110.93 158.18 19.05 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.578 1.151 . . . . 0.0 112.6 -174.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.8 t -102.7 -30.29 10.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.594 1.958 . . . . 0.0 111.87 174.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -132.3 151.09 52.0 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.319 1.848 . . . . 0.0 111.589 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 48.8 ttm -66.93 -19.01 65.65 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.54 0.736 . . . . 0.0 112.926 177.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.61 -16.35 55.38 Favored Glycine 0 CA--C 1.539 1.548 0 O-C-N 121.149 -0.969 . . . . 0.0 114.561 168.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -87.78 -25.5 23.35 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 118.894 1.347 . . . . 0.0 112.761 173.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -61.05 -59.3 5.57 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.392 -0.817 . . . . 0.0 109.752 165.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.84 -12.45 59.17 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -170.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -92.37 -25.19 18.63 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 170.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -90.79 -13.7 33.38 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.946 1.298 . . . . 0.0 113.186 175.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.5 m -129.63 159.17 70.94 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.852 1.661 . . . . 0.0 113.187 -175.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -76.59 -10.39 18.68 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 123.85 3.033 . . . . 0.0 114.63 -176.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 C-N-CA 127.017 2.246 . . . . 0.0 112.276 176.922 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 CA--C 1.55 0.946 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.6 p -110.47 16.22 21.69 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.952 1.701 . . . . 0.0 114.49 -171.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -16.2 -72.93 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 130.085 3.354 . . . . 0.0 116.378 -163.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 m -143.28 151.29 54.64 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 127.195 2.198 . . . . 0.0 111.399 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.9 -27.3 7.18 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.575 2.85 . . . . 0.0 113.621 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.2 pt -136.06 -177.62 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.466 2.306 . . . . 0.0 111.014 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.39 41.64 0.3 Allowed Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.691 1.615 . . . . 0.0 114.248 172.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -59.31 143.52 49.13 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.931 2.092 . . . . 0.0 111.211 175.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.5 t -76.41 85.3 3.16 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.475 1.11 . . . . 0.0 112.116 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -63.98 155.74 76.82 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 125.155 1.382 . . . . 0.0 113.236 175.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.05 138.75 31.54 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.173 2.582 . . . . 0.0 111.076 174.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.6 t -73.39 -40.11 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.733 0.813 . . . . 0.0 111.141 175.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -69.52 161.32 29.77 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.137 1.375 . . . . 0.0 112.124 174.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.0 -126.12 1.34 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.41 1.481 . . . . 0.0 111.274 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 60.9 mt 49.27 45.48 23.43 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.771 1.628 . . . . 0.0 112.479 -177.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 65.9 m -63.22 149.66 44.94 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.964 1.706 . . . . 0.0 112.364 -177.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.97 -5.15 3.12 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.502 1.521 . . . . 0.0 114.804 -177.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.17 168.89 16.26 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.063 0.945 . . . . 0.0 112.144 169.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -105.62 5.64 31.41 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.563 1.945 . . . . 0.0 113.939 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -147.3 116.28 6.86 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.119 2.167 . . . . 0.0 110.335 -176.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.0 m -142.16 159.16 42.77 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.994 1.317 . . . . 0.0 110.775 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -76.92 147.06 37.19 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.538 1.135 . . . . 0.0 111.319 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -132.94 120.55 21.59 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.122 0.969 . . . . 0.0 111.908 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -113.63 122.88 48.54 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.709 1.204 . . . . 0.0 111.567 -175.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.7 t -70.95 115.9 10.62 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.937 0.895 . . . . 0.0 110.852 171.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.4 mmt -82.23 -16.79 48.34 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 165.99 -45.21 0.27 Allowed Glycine 0 N--CA 1.468 0.792 0 C-N-CA 124.675 1.131 . . . . 0.0 113.22 -173.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -136.55 -62.68 0.65 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.292 1.837 . . . . 0.0 110.471 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -81.13 168.43 18.59 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.3 1.04 . . . . 0.0 111.198 173.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 p -121.88 143.89 49.17 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.182 0.993 . . . . 0.0 112.993 170.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -110.48 148.88 31.19 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.778 1.631 . . . . 0.0 111.578 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 p -69.44 127.51 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 126.465 1.906 . . . . 0.0 112.254 169.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -136.02 129.86 32.66 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.085 1.354 . . . . 0.0 111.013 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.85 100.55 0.57 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.999 1.32 . . . . 0.0 112.114 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.73 179.63 50.21 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.076 1.322 . . . . 0.0 114.937 176.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 79.4 m -75.19 75.69 2.33 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.044 1.338 . . . . 0.0 112.002 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -50.18 -49.78 51.35 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.02 1.728 . . . . 0.0 113.116 177.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.4 t -146.93 1.27 0.76 Allowed 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 174.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 111.04 33.54 2.35 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.773 1.178 . . . . 0.0 115.704 173.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.32 -173.67 42.35 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.776 1.655 . . . . 0.0 114.469 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -64.81 148.66 50.84 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.858 1.263 . . . . 0.0 114.108 -173.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.1 t -100.79 -5.43 26.32 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.617 1.567 . . . . 0.0 113.549 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 89.2 mmt-85 -134.84 139.54 45.14 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.314 1.446 . . . . 0.0 111.351 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 47.4 ttm -69.15 -26.32 64.81 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -58.88 -42.81 96.86 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 121.946 -0.471 . . . . 0.0 112.589 169.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -70.06 -45.84 66.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.794 0.838 . . . . 0.0 112.968 177.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 12.9 p -66.68 -20.41 65.97 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.584 1.084 . . . . 0.0 113.355 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.14 -66.19 0.91 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.58 1.552 . . . . 0.0 111.919 168.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -60.22 -27.75 67.45 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 115.356 1.614 . . . . 0.0 115.356 -168.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -85.48 -3.16 58.77 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.576 1.15 . . . . 0.0 113.253 176.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -122.14 166.29 17.57 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 126.858 2.063 . . . . 0.0 112.671 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.71 -8.11 13.48 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.253 2.636 . . . . 0.0 114.838 -176.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.429 0 C-N-CA 125.88 1.705 . . . . 0.0 114.298 -179.53 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 . . . . . 0 CA--C 1.544 0.726 0 CA-C-O 122.265 1.031 . . . . 0.0 113.48 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.8 t -62.91 120.02 10.53 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.267 1.427 . . . . 0.0 112.697 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.9 m -68.39 154.44 41.8 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.548 1.539 . . . . 0.0 111.4 174.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.7 t -111.05 135.78 20.85 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 125.594 1.557 . . . . 0.0 110.803 -173.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.62 165.69 26.67 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.685 3.59 . . . . 0.0 113.546 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 63.2 mt -58.96 140.33 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.199 1.399 . . . . 0.0 110.629 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.85 25.05 47.13 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.143 0.878 . . . . 0.0 114.622 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -63.02 175.26 0.91 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.293 1.837 . . . . 0.0 115.505 -178.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.7 m -139.74 65.99 1.41 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 127.374 2.269 . . . . 0.0 110.45 178.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.8 155.61 69.9 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 124.583 1.153 . . . . 0.0 113.564 177.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.78 96.97 1.02 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.724 2.949 . . . . 0.0 113.253 -174.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.5 t -59.97 -43.87 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.316 1.046 . . . . 0.0 111.274 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -76.43 3.66 10.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.288 1.835 . . . . 0.0 114.927 173.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.76 -11.44 30.03 Favored Glycine 0 CA--C 1.541 1.698 0 C-N-CA 124.534 1.064 . . . . 0.0 115.531 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.43 -27.31 67.72 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.525 1.53 . . . . 0.0 113.228 167.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 9.2 t -76.81 165.54 24.57 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.341 1.456 . . . . 0.0 112.077 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -118.05 70.87 0.81 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.228 1.811 . . . . 0.0 110.805 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.36 158.71 19.79 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.428 1.091 . . . . 0.0 112.846 176.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -95.26 9.35 40.11 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.09 1.756 . . . . 0.0 114.577 -177.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -136.17 118.21 15.37 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.467 2.307 . . . . 0.0 110.057 -175.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.64 139.66 47.48 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.467 -0.771 . . . . 0.0 110.41 169.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.37 154.24 44.47 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.694 1.197 . . . . 0.0 112.201 -177.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -140.35 130.8 25.36 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.829 1.252 . . . . 0.0 111.069 -164.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -141.12 126.39 18.56 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.323 1.049 . . . . 0.0 111.956 -168.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 18.1 t -75.39 120.1 20.39 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.514 0.597 . . . . 0.0 112.303 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 37.5 mtm -135.73 87.11 2.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.353 1.461 . . . . 0.0 110.528 171.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.0 68.05 1.26 Allowed Glycine 0 N--CA 1.47 0.945 0 C-N-CA 124.777 1.18 . . . . 0.0 113.479 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 66.31 -2.67 0.95 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 127.759 2.424 . . . . 0.0 115.682 175.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.7 p -137.23 151.07 48.31 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.807 2.043 . . . . 0.0 110.4 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.5 p -118.88 93.94 4.27 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.848 0.859 . . . . 0.0 112.72 173.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -67.72 167.02 14.06 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.642 1.177 . . . . 0.0 112.784 170.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.21 129.0 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.736 1.614 . . . . 0.0 111.69 175.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -135.17 113.9 11.82 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.091 1.757 . . . . 0.0 110.426 -174.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -71.58 169.23 15.95 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.096 0.959 . . . . 0.0 112.667 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.42 167.39 42.6 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.064 1.316 . . . . 0.0 113.557 -176.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 8.8 t -83.47 71.74 10.29 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.489 -1.006 . . . . 0.0 112.157 -177.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -81.94 83.05 7.35 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.251 -0.906 . . . . 0.0 110.711 169.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.0 m -48.7 -35.08 13.19 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.434 1.494 . . . . 0.0 114.828 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.34 73.11 2.64 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.319 1.438 . . . . 0.0 114.948 -171.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.85 -115.8 0.5 Allowed Glycine 0 CA--C 1.53 1.0 0 CA-C-N 118.079 0.94 . . . . 0.0 114.257 171.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -129.8 175.61 8.7 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.156 1.382 . . . . 0.0 112.432 -170.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 80.8 p -123.82 -2.94 8.23 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.219 1.407 . . . . 0.0 114.76 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -140.06 144.95 37.12 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.21 1.804 . . . . 0.0 111.97 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 38.6 tpp -60.67 -31.12 70.37 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.657 1.183 . . . . 0.0 112.202 173.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.94 -14.34 70.5 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.568 1.08 . . . . 0.0 115.296 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -89.97 -43.73 10.36 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.051 1.425 . . . . 0.0 111.823 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 18.1 p -67.62 -23.03 65.32 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.42 -61.99 1.57 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.128 1.371 . . . . 0.0 111.845 170.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -62.29 -26.97 68.71 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -174.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -77.18 -6.61 53.64 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.1 m -123.43 164.91 25.32 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 126.347 1.859 . . . . 0.0 112.607 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -76.44 -17.59 16.37 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.009 2.473 . . . . 0.0 113.934 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.256 0 C-N-CA 126.081 1.801 . . . . 0.0 114.503 -177.593 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.474 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -67.28 134.46 51.64 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.245 1.018 . . . . 0.0 111.875 176.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -114.06 -6.75 13.1 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -176.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -72.05 157.97 36.82 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.05 0.94 . . . . 0.0 112.259 174.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.31 178.4 8.12 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.065 1.746 . . . . 0.0 112.028 173.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 6.4 p -115.89 135.38 54.05 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.625 1.57 . . . . 0.0 111.587 174.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.7 m -139.97 159.04 43.09 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 126.53 1.932 . . . . 0.0 109.844 -174.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 p -51.58 118.53 11.46 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 124.857 1.263 . . . . 0.0 112.322 176.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -78.09 175.37 11.23 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 123.509 2.806 . . . . 0.0 112.228 177.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.3 mm -58.13 133.93 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.725 1.21 . . . . 0.0 111.39 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 128.19 -60.79 0.66 Allowed Glycine 0 CA--C 1.531 1.037 0 C-N-CA 126.322 1.915 . . . . 0.0 111.522 -177.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -85.23 175.72 8.77 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.826 1.25 . . . . 0.0 113.24 175.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.9 m -143.19 122.64 13.14 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.874 2.07 . . . . 0.0 110.218 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.5 152.87 96.2 Favored Pre-proline 0 CA--C 1.554 1.105 0 N-CA-C 113.294 0.85 . . . . 0.0 113.294 175.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.77 121.95 8.63 Favored 'Trans proline' 0 CA--C 1.538 0.699 0 C-N-CA 124.389 3.393 . . . . 0.0 111.653 176.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.5 p -70.14 -27.06 30.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.107 0.963 . . . . 0.0 112.572 175.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -70.87 168.65 16.39 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.707 2.003 . . . . 0.0 113.328 175.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.85 148.77 16.58 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.313 1.435 . . . . 0.0 111.919 170.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 29.5 tp -150.93 79.59 1.32 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.632 1.173 . . . . 0.0 111.463 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 85.1 m -68.67 -3.94 13.85 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -68.8 -21.08 64.35 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.91 2.084 . . . . 0.0 114.289 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.7 158.3 30.5 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.712 0.768 . . . . 0.0 112.859 178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -92.95 6.64 47.13 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.075 1.75 . . . . 0.0 113.175 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -144.13 167.18 23.01 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 129.488 3.115 . . . . 0.0 108.277 177.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.6 m -142.15 152.8 43.54 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.551 1.94 . . . . 0.0 109.635 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.9 tpp85 -127.98 146.1 50.76 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.77 1.228 . . . . 0.0 111.758 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -138.26 125.73 21.96 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.032 1.333 . . . . 0.0 110.301 -170.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -131.86 128.63 39.04 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.342 1.057 . . . . 0.0 111.564 -172.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.3 t -70.8 123.6 22.32 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.326 0.65 . . . . 0.0 111.681 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.1 mmt -84.97 -90.68 0.09 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.842 0.857 . . . . 0.0 110.268 170.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -94.27 -55.21 1.49 Allowed Glycine 0 CA--C 1.531 1.042 0 C-N-CA 124.74 1.162 . . . . 0.0 112.821 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -131.43 -49.2 0.99 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.518 1.527 . . . . 0.0 112.919 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 89.0 m -93.5 167.83 11.44 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.191 1.397 . . . . 0.0 112.353 177.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.6 p -121.66 103.01 8.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.102 1.361 . . . . 0.0 112.982 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -70.44 167.31 18.55 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.923 1.289 . . . . 0.0 112.73 171.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.1 p -89.73 126.36 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 125.592 1.557 . . . . 0.0 112.264 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 19.6 m-85 -133.41 160.99 35.76 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.822 1.649 . . . . 0.0 111.052 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -127.82 80.99 1.99 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.556 1.142 . . . . 0.0 111.266 -174.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.06 167.16 30.98 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 126.295 1.902 . . . . 0.0 112.776 175.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 92.6 m -85.12 72.03 10.83 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.815 1.246 . . . . 0.0 111.138 176.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -74.12 79.39 1.75 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.348 1.859 . . . . 0.0 111.104 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.6 m 55.02 31.33 15.9 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 125.726 1.61 . . . . 0.0 113.368 -177.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 79.13 -63.35 3.89 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 126.081 1.8 . . . . 0.0 114.154 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 51.81 -118.29 6.99 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 126.968 2.223 . . . . 0.0 114.628 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -125.89 153.21 44.52 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.296 1.438 . . . . 0.0 112.08 -177.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 50.3 m -118.15 5.75 11.99 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.119 1.368 . . . . 0.0 114.054 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 21.2 mmt85 -134.03 140.83 46.94 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.881 2.072 . . . . 0.0 110.218 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 51.3 ttm -63.34 -30.98 72.02 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 122.929 0.492 . . . . 0.0 112.084 173.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.38 -43.3 98.51 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 121.483 -0.761 . . . . 0.0 113.086 173.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -65.64 -48.0 73.65 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.074 0.95 . . . . 0.0 112.537 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.1 p -67.58 -21.54 65.42 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.44 -61.91 1.85 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.326 1.45 . . . . 0.0 111.455 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -61.53 -27.88 68.93 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -172.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 -81.64 -2.76 51.44 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.563 1.145 . . . . 0.0 113.577 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -126.81 167.38 17.66 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 126.336 1.854 . . . . 0.0 112.999 -178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.4 -8.74 15.04 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.2 2.6 . . . . 0.0 114.693 -176.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.325 0 C-N-CA 125.968 1.747 . . . . 0.0 113.147 178.611 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.53 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -72.27 167.19 20.92 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 123.996 0.918 . . . . 0.0 112.19 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -82.65 -33.18 27.88 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.459 1.504 . . . . 0.0 111.939 171.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -77.68 174.8 10.55 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.095 1.358 . . . . 0.0 112.945 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -119.23 155.01 32.49 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.802 1.641 . . . . 0.0 111.33 173.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 51.7 m -96.7 58.41 1.67 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.674 1.189 . . . . 0.0 112.185 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 23.4 p -67.66 160.04 28.76 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.034 1.334 . . . . 0.0 111.907 167.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.6 m -81.35 157.6 70.25 Favored Pre-proline 0 N--CA 1.479 1.006 0 C-N-CA 124.592 1.157 . . . . 0.0 112.243 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.45 177.76 8.39 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.056 2.504 . . . . 0.0 111.945 166.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.556 HD12 ' H ' ' A' ' 28' ' ' ILE . 4.1 mp -54.21 132.39 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.901 1.68 . . . . 0.0 112.066 -176.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.74 -48.5 0.94 Allowed Glycine 0 CA--C 1.533 1.164 0 C-N-CA 126.569 2.033 . . . . 0.0 113.536 175.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -89.25 -174.64 4.49 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.345 1.458 . . . . 0.0 113.496 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.5 t -135.31 -79.24 0.43 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.122 1.369 . . . . 0.0 111.929 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -153.78 162.43 26.74 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.86 1.264 . . . . 0.0 112.884 178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -71.12 83.98 0.91 Allowed 'Trans proline' 0 CA--C 1.543 0.966 0 C-N-CA 123.58 2.853 . . . . 0.0 111.559 167.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.5 t -68.32 -43.99 84.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.412 1.085 . . . . 0.0 110.744 173.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -82.61 173.24 12.12 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.762 2.025 . . . . 0.0 111.816 175.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.43 64.99 0.97 Allowed Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.041 1.305 . . . . 0.0 112.654 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.0 mp -128.94 19.93 5.97 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 126.741 2.016 . . . . 0.0 111.744 175.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 80.3 m -63.4 168.63 4.34 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.339 1.856 . . . . 0.0 113.322 -174.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -110.09 14.51 22.91 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.19 1.796 . . . . 0.0 113.087 -179.338 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.64 171.97 2.37 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.626 1.57 . . . . 0.0 113.478 175.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -98.54 1.0 46.12 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.028 1.731 . . . . 0.0 114.271 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -130.04 98.98 4.92 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.245 1.818 . . . . 0.0 112.303 -169.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.9 m -72.95 100.81 3.04 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.122 1.369 . . . . 0.0 110.822 176.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -87.39 142.02 28.19 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.764 0.826 . . . . 0.0 111.941 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -126.11 150.71 48.02 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.88 1.672 . . . . 0.0 111.974 -176.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -147.94 148.02 30.33 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.012 1.325 . . . . 0.0 112.984 173.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 41.5 t -88.26 113.44 23.87 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.075 1.35 . . . . 0.0 111.884 173.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 7.0 mmt -72.63 -42.86 63.98 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 173.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.54 -84.33 0.05 OUTLIER Glycine 0 N--CA 1.471 1.008 0 C-N-CA 123.732 0.682 . . . . 0.0 113.164 -175.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -86.76 -40.08 15.34 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 176.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -130.81 169.38 15.8 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 127.031 2.132 . . . . 0.0 111.671 -173.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 22.7 p -117.51 155.15 30.24 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt -132.39 173.9 10.81 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 127.85 2.46 . . . . 0.0 111.95 -178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.5 p -84.12 137.68 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 127.008 2.123 . . . . 0.0 112.358 174.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 76.8 m-85 -138.12 -21.51 1.07 Allowed 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.719 1.608 . . . . 0.0 114.441 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 60.7 16.37 6.61 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 171.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -149.46 173.42 29.28 Favored Glycine 0 N--CA 1.474 1.197 0 O-C-N 120.606 -1.309 . . . . 0.0 114.2 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 71.8 m -78.33 65.18 3.6 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.711 1.204 . . . . 0.0 111.644 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -55.08 -43.1 73.62 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.465 1.506 . . . . 0.0 112.74 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.8 t -142.71 -19.17 0.67 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.357 1.463 . . . . 0.0 113.744 173.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -176.68 -85.05 0.06 OUTLIER Glycine 0 CA--C 1.529 0.928 0 C-N-CA 124.595 1.093 . . . . 0.0 111.311 175.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 143.43 108.26 0.63 Allowed Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.005 0.812 . . . . 0.0 114.383 170.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -60.67 154.46 21.36 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.38 0.672 . . . . 0.0 111.85 165.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.5 t -80.39 -40.35 26.67 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.14 1.376 . . . . 0.0 112.456 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -143.55 157.93 44.05 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 127.016 2.126 . . . . 0.0 111.266 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 5.0 ttt -64.83 -23.63 67.29 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.216 1.007 . . . . 0.0 113.136 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.26 -21.97 64.77 Favored Glycine 0 CA--C 1.535 1.331 0 O-C-N 120.786 -1.196 . . . . 0.0 114.289 171.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -78.93 -44.66 22.14 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.892 1.346 . . . . 0.0 111.925 173.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.0 p -66.53 -22.2 66.17 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 175.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.19 -62.35 1.46 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.208 1.403 . . . . 0.0 111.769 167.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -61.0 -27.98 68.7 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 114.841 1.422 . . . . 0.0 114.841 -172.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -77.69 -6.2 53.1 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.354 1.061 . . . . 0.0 113.757 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m -123.2 164.93 24.72 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 126.208 1.803 . . . . 0.0 113.313 -177.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -79.9 -10.31 14.13 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.17 2.58 . . . . 0.0 114.314 -173.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.381 0 C-N-CA 125.966 1.746 . . . . 0.0 113.797 -178.99 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -80.13 84.65 5.8 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.055 1.342 . . . . 0.0 113.64 -172.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -61.57 177.69 0.38 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.199 1.399 . . . . 0.0 111.815 163.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -56.94 147.04 24.85 Favored 'General case' 0 CA--C 1.548 0.875 0 O-C-N 120.838 -1.164 . . . . 0.0 112.621 170.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -112.95 -28.28 7.77 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 61.6 m -120.81 -78.77 0.6 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.238 1.815 . . . . 0.0 110.853 177.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 70.5 m -156.17 151.58 26.83 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 127.988 2.515 . . . . 0.0 108.547 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.8 m -129.94 156.78 78.53 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 125.221 1.408 . . . . 0.0 112.042 170.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -64.34 152.1 82.79 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.24 2.627 . . . . 0.0 112.244 172.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 45.2 pt -66.46 149.99 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.606 0.762 . . . . 0.0 112.014 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 70.03 -2.76 12.06 Favored Glycine 0 CA--C 1.54 1.609 0 C-N-CA 125.077 1.322 . . . . 0.0 116.169 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.27 172.97 11.5 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.218 1.509 . . . . 0.0 112.755 178.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 56.5 m -133.33 92.68 3.04 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.255 1.422 . . . . 0.0 111.149 -176.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -63.51 148.46 93.8 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 124.176 0.991 . . . . 0.0 113.496 -178.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -78.3 75.05 5.08 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.163 3.242 . . . . 0.0 111.592 -178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.4 p -59.83 -23.9 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.869 1.668 . . . . 0.0 113.432 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -109.98 7.38 23.73 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.876 2.471 . . . . 0.0 114.128 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -76.81 49.81 2.87 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.945 1.736 . . . . 0.0 115.88 -172.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.0 mp -76.26 47.49 0.46 Allowed 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 126.936 2.095 . . . . 0.0 113.092 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 59.7 m -69.43 154.38 42.1 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 120.526 -1.358 . . . . 0.0 112.195 169.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.23 16.54 1.52 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -177.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -120.73 167.05 12.89 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.355 1.462 . . . . 0.0 113.17 -177.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.22 -18.43 63.51 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.346 1.61 . . . . 0.0 115.346 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -70.88 -29.25 65.28 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.141 1.376 . . . . 0.0 113.83 -169.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.2 m -76.95 162.93 27.18 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.509 1.524 . . . . 0.0 111.769 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.89 168.31 11.61 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.616 1.566 . . . . 0.0 113.051 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -135.53 140.23 44.58 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.157 1.383 . . . . 0.0 110.482 -171.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -142.01 134.6 28.25 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.826 0.85 . . . . 0.0 112.695 -175.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 31.5 t -75.02 119.16 18.82 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.312 0.645 . . . . 0.0 111.88 178.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 4.2 mmt -94.87 -2.86 49.89 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 173.57 -54.24 0.15 Allowed Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.373 0.987 . . . . 0.0 112.81 175.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -133.78 -19.89 2.03 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 175.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -136.67 167.59 21.13 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.358 1.463 . . . . 0.0 111.325 177.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 11.1 p -121.5 109.41 14.79 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -176.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -76.64 175.18 9.56 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.321 1.048 . . . . 0.0 112.047 167.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.7 p -85.88 137.79 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 126.855 2.062 . . . . 0.0 112.336 171.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -140.23 142.3 35.83 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.268 1.427 . . . . 0.0 111.434 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -93.83 -4.78 49.52 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -165.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -135.41 172.31 22.21 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 126.231 1.872 . . . . 0.0 112.396 176.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 22.5 t -66.57 145.2 55.88 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 122.052 -0.676 . . . . 0.0 112.607 -178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -131.05 82.66 2.06 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.241 1.816 . . . . 0.0 109.235 171.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.4 m 55.08 27.35 9.3 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.8 1.64 . . . . 0.0 113.822 175.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.58 13.98 74.77 Favored Glycine 0 CA--C 1.54 1.645 0 C-N-CA 125.358 1.456 . . . . 0.0 116.175 176.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -43.67 -82.84 0.02 OUTLIER Glycine 0 CA--C 1.539 1.593 0 C-N-CA 127.094 2.283 . . . . 0.0 116.991 -172.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -139.84 166.57 24.27 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.215 1.406 . . . . 0.0 112.435 -170.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.3 m -134.23 -18.45 2.01 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.193 1.397 . . . . 0.0 114.215 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -115.97 153.71 31.13 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.803 1.641 . . . . 0.0 111.544 175.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.0 tpp -65.04 -39.33 93.17 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.772 0.829 . . . . 0.0 111.359 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.77 -30.05 75.83 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.372 -0.682 . . . . 0.0 114.115 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 64.5 mt-10 -69.92 -57.79 4.62 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 118.577 1.189 . . . . 0.0 111.369 175.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 19.6 p -65.89 -26.04 67.44 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -176.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.91 -61.01 1.95 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.141 1.377 . . . . 0.0 111.81 168.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -61.98 -29.61 70.37 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -172.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -75.37 -13.59 60.42 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -113.55 166.22 11.73 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 126.413 1.885 . . . . 0.0 112.613 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.38 -17.95 23.54 Favored 'Trans proline' 0 CA--C 1.544 0.988 0 C-N-CA 122.888 2.392 . . . . 0.0 113.837 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.383 0 CA-C-O 117.061 -1.966 . . . . 0.0 115.046 -178.83 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.527 0 N-CA-C 111.801 -0.52 . . . . 0.0 111.801 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -126.69 161.59 27.77 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.707 1.603 . . . . 0.0 111.976 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -118.04 123.01 44.61 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.177 1.791 . . . . 0.0 111.382 -173.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -71.55 -23.34 61.74 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.02 0.928 . . . . 0.0 113.287 177.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -150.68 169.47 21.53 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.7 2.0 . . . . 0.0 111.431 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.3 t -124.5 78.31 1.66 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.201 1.001 . . . . 0.0 111.077 173.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 13.3 t -70.14 161.04 30.96 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.358 1.063 . . . . 0.0 111.607 170.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.3 t -81.47 134.27 51.62 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 124.414 1.086 . . . . 0.0 110.184 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -74.62 173.85 13.64 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 124.194 3.262 . . . . 0.0 112.933 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 64.9 mt -60.14 137.5 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.327 1.451 . . . . 0.0 110.903 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 122.67 -55.63 0.67 Allowed Glycine 0 CA--C 1.531 1.032 0 C-N-CA 126.329 1.919 . . . . 0.0 112.342 178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -78.32 178.96 7.25 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.73 1.212 . . . . 0.0 113.281 174.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.2 p -138.37 92.57 2.65 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.618 1.967 . . . . 0.0 110.982 -175.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -66.12 154.9 88.87 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 124.098 0.959 . . . . 0.0 113.569 -177.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.84 151.59 51.34 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.935 2.424 . . . . 0.0 112.36 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 54.2 t -102.26 -20.62 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 125.136 1.374 . . . . 0.0 112.01 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.89 172.9 6.71 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 127.054 2.142 . . . . 0.0 111.657 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 179.87 85.77 0.07 OUTLIER Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.622 1.106 . . . . 0.0 112.616 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 tt -133.14 72.37 1.49 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.028 1.331 . . . . 0.0 111.107 -175.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 78.2 m -78.12 97.39 5.43 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.435 1.494 . . . . 0.0 111.346 177.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -61.55 -60.74 3.23 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.85 1.26 . . . . 0.0 112.751 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.5 167.78 21.04 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.784 0.834 . . . . 0.0 112.274 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 -75.32 2.62 10.75 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.975 1.71 . . . . 0.0 114.446 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -93.29 90.05 6.64 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.355 1.862 . . . . 0.0 111.003 -173.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 m -123.14 157.02 33.86 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.506 1.522 . . . . 0.0 111.106 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.9 ttm105 -134.93 155.3 50.95 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.7 1.2 . . . . 0.0 111.79 -177.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -135.55 134.03 39.0 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.578 1.151 . . . . 0.0 110.441 -165.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -136.46 133.59 36.75 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.969 0.908 . . . . 0.0 112.312 -171.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.8 t -72.96 132.1 43.02 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 122.161 -0.337 . . . . 0.0 111.59 174.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.1 mmt -93.47 -91.0 0.19 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.85 0.86 . . . . 0.0 109.831 167.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -97.61 -40.73 3.56 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 124.509 1.052 . . . . 0.0 114.636 -178.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -146.02 -58.43 0.31 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.493 1.517 . . . . 0.0 110.966 -173.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.7 p -83.27 168.81 16.35 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.672 1.189 . . . . 0.0 112.117 174.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.0 p -121.11 105.99 11.13 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.495 1.118 . . . . 0.0 112.844 169.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.6 ttmt -73.88 177.27 5.68 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.567 1.147 . . . . 0.0 112.14 173.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.2 p -88.9 134.17 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.271 1.828 . . . . 0.0 111.842 173.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -137.22 172.19 13.37 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.323 1.449 . . . . 0.0 111.107 178.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -127.12 108.01 10.53 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.784 1.234 . . . . 0.0 111.629 -174.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.82 168.21 36.51 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.2 1.381 . . . . 0.0 113.717 -176.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 7.9 p -58.92 129.69 43.36 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -138.18 -40.63 0.53 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.33 1.452 . . . . 0.0 113.208 -174.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.3 t -144.89 -22.4 0.5 Allowed 'General case' 0 N--CA 1.484 1.259 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -168.0 -161.73 18.38 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.867 1.699 . . . . 0.0 112.122 -179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -153.48 58.59 0.41 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.328 0.966 . . . . 0.0 113.876 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -70.77 -32.37 69.47 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -174.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.6 p 55.53 -3.4 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 128.868 2.867 . . . . 0.0 117.522 -171.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -131.14 135.11 47.17 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.374 1.87 . . . . 0.0 112.217 -177.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 40.2 ttm -63.62 -33.0 74.64 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.516 1.126 . . . . 0.0 112.862 175.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.42 -22.89 77.8 Favored Glycine 0 CA--C 1.533 1.203 0 O-C-N 121.456 -0.777 . . . . 0.0 113.799 174.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -83.87 -40.77 18.21 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.529 1.165 . . . . 0.0 112.33 175.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 15.6 p -65.14 -23.76 67.22 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 119.487 1.039 . . . . 0.0 113.06 173.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.52 -60.48 2.26 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.88 1.672 . . . . 0.0 111.89 170.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -61.34 -28.38 69.18 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -172.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 54.4 m-80 -73.9 -8.09 54.75 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.322 1.049 . . . . 0.0 113.557 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -128.91 167.48 19.37 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 125.688 1.595 . . . . 0.0 114.213 -174.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -77.99 -9.61 16.73 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 123.172 2.581 . . . . 0.0 114.595 -178.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.236 0 C-N-CA 125.864 1.697 . . . . 0.0 113.459 179.259 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.51 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -127.58 80.87 1.98 Allowed 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.605 1.162 . . . . 0.0 111.216 -157.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -78.38 80.85 4.76 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.138 1.375 . . . . 0.0 111.079 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -61.99 -38.23 87.8 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.183 0.993 . . . . 0.0 112.361 175.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -156.06 -178.79 7.57 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.982 2.113 . . . . 0.0 111.395 173.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 47.2 t -133.29 123.79 26.12 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.26 1.424 . . . . 0.0 110.654 172.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.1 m -63.31 122.26 15.76 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.52 1.528 . . . . 0.0 112.245 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.3 t -78.01 134.12 64.4 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.837 1.255 . . . . 0.0 110.716 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.54 164.81 30.0 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.196 3.264 . . . . 0.0 113.442 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.9 mm -60.3 145.24 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.844 1.257 . . . . 0.0 111.21 176.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.08 25.62 57.23 Favored Glycine 0 CA--C 1.538 1.471 0 C-N-CA 124.074 0.845 . . . . 0.0 114.2 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -63.54 178.21 0.6 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.701 2.001 . . . . 0.0 115.271 -178.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.0 t -139.67 48.96 1.81 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.373 1.869 . . . . 0.0 110.905 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.55 151.81 68.85 Favored Pre-proline 0 CA--C 1.553 1.076 0 C-N-CA 125.424 1.489 . . . . 0.0 112.968 175.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -74.79 158.25 43.12 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 123.231 2.62 . . . . 0.0 113.54 -170.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.9 p -79.77 -29.97 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 123.836 0.854 . . . . 0.0 112.55 177.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.41 177.51 7.09 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.415 1.486 . . . . 0.0 112.571 175.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -80.59 -107.29 0.29 Allowed Glycine 0 CA--C 1.536 1.37 0 C-N-CA 124.522 1.058 . . . . 0.0 112.416 172.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 17.1 tp -154.17 115.54 4.12 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.672 1.589 . . . . 0.0 109.751 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.5 t -68.73 173.14 5.46 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.82 1.648 . . . . 0.0 112.337 174.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.39 5.94 21.88 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 126.324 1.85 . . . . 0.0 114.71 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.25 156.47 12.4 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.664 1.185 . . . . 0.0 113.298 177.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -81.27 4.38 20.68 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.883 1.673 . . . . 0.0 115.051 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -140.55 117.65 11.22 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.944 2.097 . . . . 0.0 110.521 -178.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.9 m -142.45 154.56 44.66 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.332 1.453 . . . . 0.0 110.777 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.9 ttt180 -100.95 151.73 21.41 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.49 1.116 . . . . 0.0 111.316 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -125.06 138.81 54.19 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.578 1.151 . . . . 0.0 111.185 -174.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -132.36 135.76 46.37 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.076 1.351 . . . . 0.0 111.051 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 38.5 t -80.19 104.7 10.93 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 122.901 0.48 . . . . 0.0 111.004 169.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 87.5 mmm -76.04 -18.74 59.11 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -177.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -177.29 -78.29 0.05 OUTLIER Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.554 1.073 . . . . 0.0 112.861 178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -109.26 -3.83 16.92 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.059 1.344 . . . . 0.0 114.058 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 25.1 p -149.13 157.99 43.82 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.946 2.099 . . . . 0.0 109.895 -176.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.4 p -111.17 147.81 34.12 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 168.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 9.0 mtpp -140.72 167.33 22.42 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.542 1.937 . . . . 0.0 111.844 -176.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.9 p -80.78 125.76 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.915 1.286 . . . . 0.0 111.884 175.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -146.21 166.3 26.63 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.51 1.524 . . . . 0.0 110.72 177.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -142.68 103.05 4.16 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.353 1.061 . . . . 0.0 112.104 -172.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.7 -175.94 45.32 Favored Glycine 0 CA--C 1.532 1.132 0 O-C-N 121.455 -0.778 . . . . 0.0 113.742 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 63.1 m -68.01 14.41 0.06 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 127.207 2.203 . . . . 0.0 115.163 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -60.48 99.97 0.09 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 128.133 2.573 . . . . 0.0 110.797 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 21.7 m -53.69 -61.61 2.19 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.476 1.911 . . . . 0.0 113.003 -175.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -79.1 93.21 1.29 Allowed Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.444 1.497 . . . . 0.0 113.47 -174.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -147.65 175.05 27.19 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.158 1.361 . . . . 0.0 113.273 175.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -121.23 -17.71 7.61 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 115.521 1.675 . . . . 0.0 115.521 -165.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 58.63 4.48 0.37 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.572 1.949 . . . . 0.0 116.136 -176.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -138.13 142.89 40.14 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.93 2.092 . . . . 0.0 111.266 177.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.6 tpp -71.62 -32.19 67.71 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.323 1.049 . . . . 0.0 112.741 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.09 -48.12 67.69 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 121.598 -0.689 . . . . 0.0 111.402 175.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -64.86 -37.31 87.22 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.466 1.506 . . . . 0.0 113.409 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.5 p -71.57 -27.34 63.08 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.925 1.239 . . . . 0.0 113.39 171.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.16 -43.27 21.89 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.821 1.249 . . . . 0.0 112.992 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -63.52 -26.62 68.79 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 120.723 1.601 . . . . 0.0 113.482 -177.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -78.89 -9.26 59.43 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.641 1.577 . . . . 0.0 113.698 174.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.7 m -131.71 167.12 23.51 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 125.015 1.326 . . . . 0.0 113.97 -173.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -78.39 -11.66 15.81 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 122.968 2.445 . . . . 0.0 114.19 -178.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.22 0 C-N-CA 126.919 2.2 . . . . 0.0 112.552 179.431 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.641 0 N-CA-C 110.95 -0.86 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -65.87 -21.51 66.46 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.357 1.614 . . . . 0.0 115.357 -171.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -67.85 -19.04 65.0 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -176.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -114.76 116.23 28.31 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.996 1.319 . . . . 0.0 111.312 172.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -78.02 -16.87 57.73 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.6 p -75.48 156.45 35.2 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.727 0.811 . . . . 0.0 112.304 175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 22.3 m -144.89 143.42 30.58 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.917 1.287 . . . . 0.0 110.73 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.0 t -68.74 133.95 90.38 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 124.112 0.965 . . . . 0.0 110.655 178.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.59 -175.36 2.41 Favored 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 124.401 3.401 . . . . 0.0 112.232 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 48.1 pt -59.51 166.06 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.987 1.315 . . . . 0.0 113.501 175.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.36 -59.38 4.11 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.666 1.603 . . . . 0.0 112.378 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -73.35 -178.37 2.95 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.866 1.266 . . . . 0.0 112.925 170.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.4 p -126.83 133.29 50.79 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.873 1.669 . . . . 0.0 111.063 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -74.97 152.46 86.59 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 123.869 0.868 . . . . 0.0 112.659 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.44 169.44 22.41 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.713 2.942 . . . . 0.0 111.906 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.9 t -131.35 -19.84 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 124.732 1.213 . . . . 0.0 112.05 -171.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt 55.27 2.75 0.06 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 128.326 2.65 . . . . 0.0 116.271 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -108.25 -7.89 29.93 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.756 1.646 . . . . 0.0 115.492 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.1 mp -74.95 -66.44 0.75 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.011 1.406 . . . . 0.0 110.855 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.4 t -139.0 153.12 48.11 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.273 1.429 . . . . 0.0 112.199 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 28.0 mtpt -135.72 83.99 2.05 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.618 2.367 . . . . 0.0 109.872 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.67 174.12 10.86 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.431 1.493 . . . . 0.0 112.514 178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.02 -5.62 54.4 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.63 1.572 . . . . 0.0 114.697 -174.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -85.28 -15.61 42.86 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.094 1.357 . . . . 0.0 114.348 -170.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 3.5 m -68.79 158.82 33.57 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 124.836 1.254 . . . . 0.0 111.959 178.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -133.22 165.3 25.11 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.487 1.515 . . . . 0.0 111.82 -176.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -114.24 133.25 55.76 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.072 1.349 . . . . 0.0 111.466 -169.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 14.8 m-85 -134.96 162.42 32.48 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 124.86 1.264 . . . . 0.0 111.805 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.7 t -101.68 108.69 20.3 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.563 1.145 . . . . 0.0 110.856 174.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 16.7 mmt -73.4 -60.27 2.32 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.101 0.56 . . . . 0.0 112.264 174.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -169.59 97.44 0.12 Allowed Glycine 0 N--CA 1.469 0.894 0 C-N-CA 124.149 0.881 . . . . 0.0 112.244 -170.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 58.92 11.43 1.91 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.88 2.072 . . . . 0.0 114.994 -175.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 6.4 t -151.49 147.74 27.2 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.053 2.141 . . . . 0.0 109.078 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 13.6 p -125.19 143.67 50.83 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 170.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 6.4 mtpp -149.57 170.94 17.48 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.253 1.421 . . . . 0.0 112.348 -172.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.3 p -75.01 128.52 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.509 1.524 . . . . 0.0 111.008 169.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -136.5 108.48 7.15 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.528 1.131 . . . . 0.0 111.439 -175.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -64.22 147.45 52.34 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.731 1.213 . . . . 0.0 112.149 176.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.98 177.62 21.54 Favored Glycine 0 CA--C 1.538 1.489 0 C-N-CA 125.771 1.653 . . . . 0.0 113.902 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 64.7 m -73.42 146.5 45.01 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 122.004 -0.703 . . . . 0.0 111.667 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -154.69 119.88 5.0 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.321 1.449 . . . . 0.0 108.742 170.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.2 m -57.56 -49.19 77.18 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.051 0.94 . . . . 0.0 112.632 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -86.44 172.61 45.1 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.811 1.196 . . . . 0.0 113.536 172.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 170.56 170.12 34.46 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.473 1.035 . . . . 0.0 114.933 176.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -111.68 -22.51 11.15 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 -178.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.6 p 55.38 -4.28 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 128.85 2.86 . . . . 0.0 117.714 -172.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -133.29 137.7 46.12 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.472 1.909 . . . . 0.0 111.756 -178.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.1 tpp -64.15 -33.12 75.06 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.603 1.161 . . . . 0.0 112.072 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.21 -38.17 82.12 Favored Glycine 0 CA--C 1.531 1.086 0 O-C-N 121.582 -0.699 . . . . 0.0 112.852 176.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 72.0 mm-40 -68.62 -47.55 66.37 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.011 0.924 . . . . 0.0 112.52 175.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.3 p -62.37 -25.9 68.17 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 119.392 0.996 . . . . 0.0 112.773 -179.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.72 -64.46 1.07 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.52 1.528 . . . . 0.0 111.404 171.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -63.68 -27.47 69.24 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.728 1.381 . . . . 0.0 114.728 -171.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -78.93 -2.04 38.08 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.953 0.901 . . . . 0.0 113.251 174.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.67 170.55 7.85 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 127.023 2.129 . . . . 0.0 112.347 176.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -82.54 -8.07 11.54 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.071 2.514 . . . . 0.0 114.092 -179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.277 0 C-N-CA 126.548 2.023 . . . . 0.0 114.265 -178.764 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.575 0 N-CA-C 112.207 -0.357 . . . . 0.0 112.207 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -70.79 168.94 15.64 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.489 1.515 . . . . 0.0 113.612 175.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -129.48 109.19 10.85 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.432 1.893 . . . . 0.0 109.884 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -64.58 155.91 31.61 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.929 0.892 . . . . 0.0 112.567 178.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -146.92 177.25 9.28 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.149 1.38 . . . . 0.0 112.803 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 42.4 t -140.19 153.48 46.62 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.166 1.787 . . . . 0.0 110.161 176.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.6 t -69.33 165.27 21.05 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.852 0.861 . . . . 0.0 112.168 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.3 t -145.07 133.56 10.85 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 125.619 1.568 . . . . 0.0 110.002 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.8 163.88 32.82 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.362 3.375 . . . . 0.0 113.376 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.531 HD12 ' H ' ' A' ' 28' ' ' ILE . 4.5 mp -58.93 138.43 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.161 1.384 . . . . 0.0 110.755 177.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.39 28.03 41.5 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.142 0.877 . . . . 0.0 114.472 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -63.88 176.22 0.99 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.295 1.838 . . . . 0.0 115.886 -176.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 72.5 m -131.87 63.07 1.62 Allowed 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.223 2.209 . . . . 0.0 110.65 176.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -63.25 156.59 68.35 Favored Pre-proline 0 CA--C 1.554 1.106 0 C-N-CA 125.123 1.369 . . . . 0.0 112.841 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -71.26 172.47 13.99 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.2 2.6 . . . . 0.0 113.815 177.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.8 p -119.45 20.86 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 126.957 2.103 . . . . 0.0 112.178 -175.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -57.67 164.37 2.09 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 127.151 2.18 . . . . 0.0 115.195 -174.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 144.94 -29.52 1.83 Allowed Glycine 0 CA--C 1.536 1.397 0 C-N-CA 126.051 1.786 . . . . 0.0 114.321 174.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.24 1.95 6.4 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.698 1.599 . . . . 0.0 113.956 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.6 t -62.59 138.68 58.54 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.359 1.064 . . . . 0.0 112.317 -179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -113.55 -7.68 13.37 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.767 1.627 . . . . 0.0 114.598 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.19 170.58 12.69 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.875 0.87 . . . . 0.0 112.401 172.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -124.1 9.92 8.72 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.986 1.714 . . . . 0.0 114.472 -175.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -88.83 74.35 8.29 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.155 1.382 . . . . 0.0 112.03 -170.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.16 133.91 55.86 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.736 0.815 . . . . 0.0 111.404 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.1 tpt180 -137.28 154.86 50.02 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.424 1.09 . . . . 0.0 111.846 -172.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -132.87 129.18 38.08 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.856 1.263 . . . . 0.0 110.454 -169.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -139.55 129.42 24.82 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.24 1.016 . . . . 0.0 111.597 -171.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 40.6 t -71.83 129.87 39.67 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.753 -0.592 . . . . 0.0 112.587 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 43.7 mtm -132.79 -80.37 0.49 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.687 1.195 . . . . 0.0 112.042 167.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -86.35 60.56 4.54 Favored Glycine 0 N--CA 1.474 1.177 0 O-C-N 121.201 -0.937 . . . . 0.0 114.353 -170.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.4 m120 59.68 14.04 3.8 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.448 1.899 . . . . 0.0 113.901 -172.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 28.2 p -144.89 160.62 41.01 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 128.711 2.804 . . . . 0.0 109.322 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 18.5 p -115.15 87.39 2.65 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.765 0.826 . . . . 0.0 111.879 170.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 2.5 mtpp -67.24 164.32 18.53 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 122.12 0.962 . . . . 0.0 111.85 172.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.2 p -82.49 128.5 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.929 1.292 . . . . 0.0 111.587 174.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -131.39 154.37 48.7 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.509 1.524 . . . . 0.0 110.829 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -132.0 89.52 2.69 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.135 1.374 . . . . 0.0 110.366 -174.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.61 175.71 42.37 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.902 1.239 . . . . 0.0 112.889 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 29.5 m -66.71 141.89 57.6 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.472 0.709 . . . . 0.0 111.765 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -154.63 121.93 5.67 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.887 1.275 . . . . 0.0 109.097 173.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.0 m -59.18 -37.13 76.65 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.472 1.109 . . . . 0.0 113.343 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -100.1 -161.98 28.55 Favored Glycine 0 CA--C 1.539 1.543 0 C-N-CA 126.405 1.955 . . . . 0.0 113.623 176.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 123.74 172.01 13.65 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.988 1.756 . . . . 0.0 114.541 174.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -107.1 -18.21 13.96 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -173.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.4 t 60.47 -14.07 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 127.728 2.411 . . . . 0.0 116.496 -174.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 42.2 mmt180 -125.24 136.52 53.62 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.519 1.927 . . . . 0.0 112.094 -177.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 62.2 tpp -59.8 -38.27 81.47 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.191 1.396 . . . . 0.0 112.129 175.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.33 -29.69 65.89 Favored Glycine 0 CA--C 1.533 1.194 0 O-C-N 121.716 -0.615 . . . . 0.0 113.769 178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -82.25 -41.29 20.41 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.15 0.975 . . . . 0.0 112.403 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.0 p -64.89 -23.41 67.22 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 119.07 0.85 . . . . 0.0 112.895 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.27 -64.03 1.11 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.481 1.512 . . . . 0.0 111.589 169.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.4 ptp180 -61.41 -28.1 69.02 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -171.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -78.46 -6.27 54.86 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.11 0.964 . . . . 0.0 113.565 174.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -122.35 170.85 7.19 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 126.625 1.97 . . . . 0.0 112.437 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.11 -7.16 17.11 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 123.229 2.62 . . . . 0.0 114.724 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.286 0 C-N-CA 126.747 2.117 . . . . 0.0 114.742 -178.735 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.642 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -68.9 -23.43 64.19 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 115.048 1.499 . . . . 0.0 115.048 -169.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -125.18 23.22 7.72 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 126.37 1.868 . . . . 0.0 113.112 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.1 tp10 -58.82 120.42 8.97 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.507 1.923 . . . . 0.0 112.636 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -146.18 172.51 13.33 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.816 1.646 . . . . 0.0 112.145 172.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 15.2 p -127.47 170.46 12.54 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.901 1.68 . . . . 0.0 112.542 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 27.7 p -90.31 161.69 15.52 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.756 1.223 . . . . 0.0 111.925 173.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.8 m -66.06 155.54 86.93 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 123.524 0.729 . . . . 0.0 112.257 176.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -64.17 156.24 60.46 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.493 2.795 . . . . 0.0 112.47 172.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 40.5 pt -61.69 143.78 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 123.783 0.833 . . . . 0.0 112.083 178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 72.86 -6.73 11.41 Favored Glycine 0 CA--C 1.54 1.605 0 C-N-CA 125.116 1.341 . . . . 0.0 116.188 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -76.71 172.32 13.26 Favored 'General case' 0 CA--C 1.547 0.834 0 CA-C-N 119.42 1.61 . . . . 0.0 112.243 176.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.5 t -128.97 92.98 3.49 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.856 1.262 . . . . 0.0 111.827 -174.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -61.75 152.62 75.0 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 125.158 1.383 . . . . 0.0 113.864 -176.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.36 86.95 1.4 Allowed 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.867 3.045 . . . . 0.0 112.243 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 9.6 p -68.19 -29.64 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.639 1.176 . . . . 0.0 113.161 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -78.71 -68.13 0.68 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.884 1.674 . . . . 0.0 112.593 179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 56.67 43.79 91.41 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 125.138 1.351 . . . . 0.0 114.498 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.0 tp -113.11 92.85 4.15 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.971 1.708 . . . . 0.0 111.174 -169.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 31.3 p -120.41 178.21 4.75 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.588 1.955 . . . . 0.0 113.502 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -127.84 -60.0 1.17 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.396 1.878 . . . . 0.0 112.099 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.05 173.23 6.76 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.636 1.174 . . . . 0.0 113.259 176.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -110.1 47.66 0.94 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 126.63 1.972 . . . . 0.0 113.297 -173.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -122.25 95.53 4.68 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.894 1.678 . . . . 0.0 110.788 -176.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.6 m -132.35 154.63 49.57 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.111 1.364 . . . . 0.0 110.876 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -138.78 124.21 19.38 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.808 1.243 . . . . 0.0 111.485 -174.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -76.98 140.03 40.28 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.649 1.18 . . . . 0.0 111.483 -177.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -131.36 127.42 37.56 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.87 1.268 . . . . 0.0 111.141 -176.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 45.7 t -65.98 122.86 18.33 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 120.809 0.338 . . . . 0.0 110.846 171.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 37.6 mtp -137.5 111.96 8.66 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.159 1.384 . . . . 0.0 110.327 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.05 -68.48 2.84 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.6 1.095 . . . . 0.0 112.39 -174.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -145.94 -52.22 0.25 Allowed 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 177.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 8.4 p -83.82 172.62 11.99 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.295 0.952 . . . . 0.0 112.437 176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.4 p -121.2 90.69 3.37 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.311 1.044 . . . . 0.0 112.75 172.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 13.1 ttmt -74.12 173.59 9.88 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.358 1.063 . . . . 0.0 112.218 172.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.02 130.11 36.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 125.48 1.512 . . . . 0.0 111.26 168.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -142.99 163.63 32.27 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.161 1.784 . . . . 0.0 110.61 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -130.76 -1.36 4.24 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.39 170.55 54.88 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.416 1.007 . . . . 0.0 114.079 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 56.6 m -67.74 105.08 1.81 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.653 1.181 . . . . 0.0 111.358 177.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.44 98.88 4.07 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.574 1.15 . . . . 0.0 109.985 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 19.0 m -53.64 -47.36 70.4 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.676 1.59 . . . . 0.0 113.373 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.06 60.78 4.65 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.499 1.523 . . . . 0.0 114.29 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -86.97 164.01 35.14 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.613 1.101 . . . . 0.0 114.324 176.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -120.35 -26.72 5.36 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -178.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 59.95 5.5 0.76 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.653 1.981 . . . . 0.0 115.735 -175.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -136.63 129.75 31.21 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.647 1.979 . . . . 0.0 111.428 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 31.5 ttm -61.58 -31.23 71.27 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.732 1.213 . . . . 0.0 113.043 175.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -74.45 -37.02 48.02 Favored Glycine 0 CA--C 1.528 0.903 0 O-C-N 121.889 -0.507 . . . . 0.0 113.268 178.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -76.05 -44.49 38.89 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.731 0.812 . . . . 0.0 112.132 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.4 p -64.93 -21.75 66.88 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.58 -63.14 1.48 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.495 1.518 . . . . 0.0 111.466 170.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -61.68 -28.44 69.4 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 114.785 1.402 . . . . 0.0 114.785 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -76.56 -5.0 45.81 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 174.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -126.07 167.15 17.77 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 125.865 1.666 . . . . 0.0 113.656 -175.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.21 -8.11 14.05 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.277 2.652 . . . . 0.0 114.531 -174.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.375 0 C-N-CA 126.106 1.812 . . . . 0.0 114.357 179.383 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.496 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -82.0 -19.64 40.08 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -174.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -85.0 165.13 17.82 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.292 1.437 . . . . 0.0 112.292 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -76.05 74.29 2.92 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.497 1.519 . . . . 0.0 111.749 176.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -141.65 157.09 45.51 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.621 1.568 . . . . 0.0 112.263 175.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 61.3 m -71.16 154.04 42.02 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.462 0.705 . . . . 0.0 111.558 173.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 5.6 t -70.14 -175.73 1.02 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.267 1.027 . . . . 0.0 112.529 170.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.4 t -135.09 134.23 21.44 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 126.354 1.862 . . . . 0.0 110.03 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.36 162.8 37.66 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.074 3.183 . . . . 0.0 113.171 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.502 HD12 ' H ' ' A' ' 28' ' ' ILE . 4.2 mp -60.67 141.02 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.883 1.273 . . . . 0.0 110.593 176.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.35 26.12 40.98 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.099 0.857 . . . . 0.0 114.336 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -63.69 177.86 0.67 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.432 2.293 . . . . 0.0 116.016 -176.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.0 p -134.93 65.73 1.55 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 127.398 2.279 . . . . 0.0 111.122 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.45 154.68 53.11 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 124.983 1.313 . . . . 0.0 113.84 178.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -72.61 169.27 22.28 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.555 2.836 . . . . 0.0 112.738 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 4.0 t -132.48 56.06 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.518 1.527 . . . . 0.0 109.277 -177.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.4 mtmm -59.82 131.49 51.05 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.637 1.175 . . . . 0.0 110.88 172.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.08 79.98 0.12 Allowed Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.905 1.24 . . . . 0.0 111.9 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.2 mt 55.18 32.97 19.53 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.11 1.764 . . . . 0.0 113.565 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 67.0 m -58.54 153.15 16.72 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.914 1.685 . . . . 0.0 113.464 -174.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.403 ' HA ' ' HE2' ' A' ' 39' ' ' LYS . 11.0 mmpt? -123.85 73.57 1.22 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.168 1.787 . . . . 0.0 111.015 -174.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -137.32 163.03 31.98 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.568 1.547 . . . . 0.0 111.781 174.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.1 mtp85 -129.68 12.37 5.82 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.109 1.764 . . . . 0.0 113.8 -175.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -132.52 109.46 9.8 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.528 1.931 . . . . 0.0 110.899 -175.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.6 156.82 38.33 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.231 1.012 . . . . 0.0 111.547 174.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -142.5 166.47 24.59 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.136 1.375 . . . . 0.0 111.681 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -131.08 144.6 51.55 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.344 1.058 . . . . 0.0 111.424 -177.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -141.34 132.3 26.08 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.838 1.255 . . . . 0.0 111.005 -171.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 36.1 t -82.42 109.73 16.92 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.631 1.172 . . . . 0.0 111.766 173.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 6.9 mmt -72.33 -9.8 58.96 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 173.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.09 -37.15 0.46 Allowed Glycine 0 N--CA 1.474 1.211 0 C-N-CA 124.257 0.932 . . . . 0.0 114.76 178.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -141.82 -53.98 0.44 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.669 1.588 . . . . 0.0 111.248 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 36.8 t -107.7 110.3 22.11 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 125.462 1.505 . . . . 0.0 110.215 -175.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 21.4 p -74.97 146.95 41.26 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -128.58 171.86 11.73 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.524 1.93 . . . . 0.0 111.097 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.8 p -75.22 131.95 34.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.69 1.196 . . . . 0.0 111.019 172.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -145.11 163.47 34.21 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.575 1.15 . . . . 0.0 111.195 174.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -154.47 149.54 26.87 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.278 1.431 . . . . 0.0 110.229 174.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 135.16 -172.86 21.9 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 124.925 1.25 . . . . 0.0 113.359 -172.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 63.6 m -72.8 6.73 2.35 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 116.134 1.901 . . . . 0.0 116.134 -172.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -68.36 97.46 0.75 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.472 1.909 . . . . 0.0 111.789 -177.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.8 m -55.16 -41.57 71.99 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 126.319 1.848 . . . . 0.0 114.206 -174.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -84.49 58.44 4.99 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 125.16 1.362 . . . . 0.0 115.029 -171.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -100.83 173.7 24.84 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 125.118 1.342 . . . . 0.0 114.591 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -107.38 159.07 16.67 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.133 1.773 . . . . 0.0 111.186 176.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 57.3 p -79.59 -40.4 29.45 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 120.855 -1.153 . . . . 0.0 113.256 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.8 mmp_? -139.39 161.82 36.53 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.93 2.092 . . . . 0.0 111.627 -177.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 49.1 ttm -67.43 -29.19 68.61 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.398 0.679 . . . . 0.0 112.382 -177.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.53 -28.71 70.1 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.445 -0.642 . . . . 0.0 113.855 171.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -74.65 -50.85 16.16 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.796 1.298 . . . . 0.0 111.901 172.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.7 p -66.33 -19.76 65.9 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.73 -66.48 0.74 Allowed 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.465 1.506 . . . . 0.0 111.887 164.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -60.48 -28.65 68.51 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -169.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -81.05 -7.0 59.47 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.335 1.054 . . . . 0.0 113.78 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -119.72 164.98 19.01 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 125.956 1.702 . . . . 0.0 112.723 -177.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -75.94 -6.38 17.35 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.527 2.818 . . . . 0.0 115.089 -177.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.237 0 C-N-CA 126.075 1.798 . . . . 0.0 113.429 177.47 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.575 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -136.2 96.82 3.46 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.112 1.365 . . . . 0.0 110.656 -167.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -66.72 -37.14 84.09 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.809 1.243 . . . . 0.0 113.341 -176.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -111.28 173.53 6.3 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.286 1.834 . . . . 0.0 111.771 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -129.15 148.34 51.09 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.468 1.507 . . . . 0.0 111.15 177.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.9 m -71.0 135.15 47.68 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.394 0.677 . . . . 0.0 111.516 178.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.1 t -74.06 167.21 21.99 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.452 0.701 . . . . 0.0 111.842 169.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.1 t -84.63 132.86 45.36 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 124.698 1.199 . . . . 0.0 109.789 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.85 179.98 5.74 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 124.525 3.484 . . . . 0.0 112.67 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 33.9 mm -56.49 147.95 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 126.038 1.735 . . . . 0.0 112.414 -177.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.48 -60.02 1.07 Allowed Glycine 0 CA--C 1.531 1.05 0 C-N-CA 125.919 1.723 . . . . 0.0 111.918 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -81.77 -178.71 7.09 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.047 1.339 . . . . 0.0 112.654 173.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.0 t -147.41 174.88 11.27 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.082 1.753 . . . . 0.0 110.627 172.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -83.64 111.29 30.9 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 125.275 1.43 . . . . 0.0 113.266 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -74.93 158.56 42.4 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.978 2.452 . . . . 0.0 111.559 168.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.1 t -107.11 -35.12 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.835 1.254 . . . . 0.0 111.543 173.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -63.07 152.52 36.84 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.597 1.159 . . . . 0.0 112.4 175.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 81.29 -6.88 62.29 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.039 1.304 . . . . 0.0 116.21 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.8 mp -78.96 32.55 0.21 Allowed 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 119.308 1.554 . . . . 0.0 112.566 174.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 57.0 m -66.17 12.83 0.06 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 128.85 2.86 . . . . 0.0 115.428 -177.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 61.03 9.07 2.17 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 129.164 2.986 . . . . 0.0 115.607 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -70.6 169.66 13.83 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.778 1.631 . . . . 0.0 113.324 176.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.1 mtm180 -116.75 -8.68 11.37 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 -173.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -77.99 -25.83 48.26 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 177.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.3 m -62.52 147.2 49.67 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.885 1.274 . . . . 0.0 111.635 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -87.86 159.03 18.56 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.338 1.055 . . . . 0.0 111.322 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -119.66 123.86 44.88 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.258 1.023 . . . . 0.0 110.879 -172.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -119.42 130.17 55.15 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.246 1.018 . . . . 0.0 111.129 -171.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 41.8 t -73.42 97.08 2.47 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.679 0.792 . . . . 0.0 111.653 176.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 15.4 mmt -72.52 80.6 1.07 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.692 1.597 . . . . 0.0 110.668 169.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.43 -63.22 3.37 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.497 1.522 . . . . 0.0 114.456 176.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -123.63 -53.81 1.77 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.336 1.454 . . . . 0.0 112.408 -173.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 9.6 m -101.98 171.64 7.39 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.316 1.446 . . . . 0.0 111.018 177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 11.0 p -120.6 158.82 26.55 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.027 0.931 . . . . 0.0 113.372 172.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt -150.07 172.99 14.38 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 126.126 1.77 . . . . 0.0 111.239 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.3 p -76.96 125.62 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.506 1.523 . . . . 0.0 111.974 174.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -145.09 111.62 5.74 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.544 1.138 . . . . 0.0 111.206 -178.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 -75.88 98.39 4.19 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.254 -0.904 . . . . 0.0 110.901 169.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.69 167.95 38.1 Favored Glycine 0 CA--C 1.533 1.186 0 O-C-N 121.107 -0.996 . . . . 0.0 114.36 174.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 42.4 m -72.69 101.6 3.11 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.023 1.329 . . . . 0.0 111.335 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -133.42 97.41 3.95 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.75 1.22 . . . . 0.0 109.716 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 20.7 m -49.47 -49.31 46.03 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.111 1.764 . . . . 0.0 113.618 -175.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -94.48 77.4 0.95 Allowed Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.317 1.437 . . . . 0.0 112.784 178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -131.13 175.63 19.43 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.431 1.491 . . . . 0.0 114.491 -179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -130.39 134.67 47.31 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.841 1.256 . . . . 0.0 112.014 -173.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 65.4 p -79.56 -8.47 59.19 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -129.12 138.42 51.8 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.574 1.549 . . . . 0.0 112.282 -176.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 61.4 tpp -65.45 -33.5 76.09 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.574 1.15 . . . . 0.0 112.056 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.45 -37.02 85.18 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 121.71 -0.619 . . . . 0.0 112.922 175.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 82.0 mm-40 -72.01 -46.37 57.43 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.294 1.037 . . . . 0.0 112.22 176.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 13.8 p -63.54 -24.21 67.71 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.07 0.85 . . . . 0.0 113.046 -178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.62 -64.13 1.25 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.481 1.513 . . . . 0.0 112.045 170.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -62.69 -28.18 69.76 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -169.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -81.43 -6.35 58.85 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 175.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -114.4 164.14 17.22 Favored Pre-proline 0 CA--C 1.55 0.963 0 C-N-CA 126.198 1.799 . . . . 0.0 112.786 178.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -76.56 -17.18 16.44 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.66 2.24 . . . . 0.0 113.854 -173.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.381 0 C-N-CA 126.587 2.042 . . . . 0.0 115.074 -179.705 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.556 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -98.55 9.48 43.13 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.054 1.742 . . . . 0.0 114.972 -170.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.2 mtpt -58.14 161.41 4.18 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.855 1.662 . . . . 0.0 112.782 175.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -64.57 149.79 48.12 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.841 0.856 . . . . 0.0 111.892 172.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -138.57 168.26 20.16 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.974 1.71 . . . . 0.0 111.414 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.0 t -69.75 128.21 35.61 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.467 0.707 . . . . 0.0 111.287 176.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 50.6 p -136.38 169.38 17.76 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.501 1.521 . . . . 0.0 112.281 -176.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.6 t -69.24 133.93 89.37 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 123.96 0.904 . . . . 0.0 110.169 177.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.8 158.65 56.99 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 124.128 3.219 . . . . 0.0 112.516 178.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.7 mt -63.63 136.07 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.936 0.895 . . . . 0.0 109.817 177.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.42 -10.56 63.74 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.523 1.535 . . . . 0.0 115.456 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.27 172.22 11.57 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 119.535 1.667 . . . . 0.0 112.853 172.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.0 t -107.65 91.55 3.7 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.093 1.357 . . . . 0.0 110.437 177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -56.73 115.36 10.0 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 125.071 1.349 . . . . 0.0 113.32 -176.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.86 94.57 1.07 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.481 2.788 . . . . 0.0 111.739 -178.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 p -70.83 -24.42 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 124.337 1.055 . . . . 0.0 113.0 175.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -62.76 154.02 30.96 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.69 1.596 . . . . 0.0 111.78 173.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 72.62 31.87 62.36 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 123.726 0.679 . . . . 0.0 114.538 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.8 tp -74.05 59.97 0.75 Allowed 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.947 1.699 . . . . 0.0 112.583 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 31.8 p -149.7 173.74 13.36 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.457 1.903 . . . . 0.0 112.555 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.25 78.31 1.78 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 126.55 1.94 . . . . 0.0 110.984 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.74 178.55 4.11 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-O 121.787 0.804 . . . . 0.0 112.29 168.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -12.31 59.87 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.814 1.646 . . . . 0.0 113.429 171.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -126.63 105.03 8.42 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.708 2.803 . . . . 0.0 108.896 -178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.4 m -128.77 158.63 38.12 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 126.501 1.92 . . . . 0.0 110.313 -175.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.5 mpt_? -114.07 162.08 16.92 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.476 1.111 . . . . 0.0 112.834 170.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -146.98 127.83 14.41 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.999 1.32 . . . . 0.0 110.051 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -132.4 137.88 47.49 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.757 1.223 . . . . 0.0 111.701 -174.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 35.4 t -79.68 115.89 19.54 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.164 0.986 . . . . 0.0 111.792 177.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 96.3 mmm -90.25 -10.95 42.38 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.846 1.258 . . . . 0.0 114.22 -177.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 176.54 -87.94 0.08 OUTLIER Glycine 0 N--CA 1.469 0.869 0 C-N-CA 124.536 1.065 . . . . 0.0 111.807 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -86.54 -31.6 21.17 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 171.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 26.5 p -125.98 166.33 17.13 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.732 2.013 . . . . 0.0 111.74 -170.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.5 p -113.87 153.3 29.43 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.696 0.998 . . . . 0.0 113.696 167.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 15.7 ttpt -124.39 165.72 17.24 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.549 1.94 . . . . 0.0 110.513 178.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 5.2 p -69.98 135.72 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.273 1.029 . . . . 0.0 111.609 171.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -144.15 177.37 8.63 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.167 1.787 . . . . 0.0 110.515 174.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -136.38 156.79 48.13 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.982 0.913 . . . . 0.0 112.353 175.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.45 175.93 10.71 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 124.665 1.126 . . . . 0.0 113.969 -170.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 76.9 m -91.96 85.32 5.52 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.557 1.143 . . . . 0.0 110.375 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -70.08 84.82 0.53 Allowed 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.01 1.324 . . . . 0.0 111.268 -178.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 m 61.7 7.07 1.77 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 126.612 1.965 . . . . 0.0 114.018 -174.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 83.78 149.44 9.47 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 127.212 2.339 . . . . 0.0 113.295 -174.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 177.12 -91.36 0.08 OUTLIER Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.491 1.044 . . . . 0.0 112.513 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -135.31 157.41 46.97 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.346 1.058 . . . . 0.0 113.162 -174.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.9 m -123.29 5.53 9.11 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 126.153 1.781 . . . . 0.0 113.092 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 22.2 mmt85 -138.47 139.38 38.8 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 126.968 2.107 . . . . 0.0 111.0 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 30.0 tpp -59.35 -35.47 73.94 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.788 1.235 . . . . 0.0 112.14 172.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -67.09 -24.85 73.36 Favored Glycine 0 CA--C 1.533 1.188 0 O-C-N 121.196 -0.94 . . . . 0.0 114.383 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -80.32 -46.28 16.4 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.641 1.221 . . . . 0.0 111.952 175.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.6 p -64.17 -25.03 67.9 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.28 -61.62 1.76 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.59 1.556 . . . . 0.0 111.855 171.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -61.56 -27.37 68.58 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -173.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.7 m-80 -79.68 -4.82 53.48 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.442 1.097 . . . . 0.0 113.702 174.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m -125.61 166.43 21.09 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 126.431 1.892 . . . . 0.0 113.077 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -77.29 -13.76 16.76 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 122.772 2.314 . . . . 0.0 114.05 -176.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.214 0 C-N-CA 126.507 2.003 . . . . 0.0 112.95 179.611 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.521 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -132.22 80.01 1.89 Allowed 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.526 1.13 . . . . 0.0 110.928 -165.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.65 18.03 2.62 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 127.109 2.164 . . . . 0.0 114.885 -175.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -65.82 145.39 56.02 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.297 1.439 . . . . 0.0 111.403 172.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -134.58 -162.57 1.27 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.132 1.773 . . . . 0.0 110.724 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.2 m -68.28 75.77 0.25 Allowed 'General case' 0 CA--C 1.549 0.915 0 O-C-N 120.647 -1.283 . . . . 0.0 112.223 174.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.4 m -125.15 139.39 53.8 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 127.384 2.274 . . . . 0.0 109.624 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.8 t -72.89 136.25 80.09 Favored Pre-proline 0 N--CA 1.477 0.876 0 O-C-N 121.694 -0.629 . . . . 0.0 110.376 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.6 150.34 88.37 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 123.658 2.905 . . . . 0.0 112.22 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.49 HD12 ' H ' ' A' ' 28' ' ' ILE . 5.4 mp -61.66 133.43 27.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 124.357 1.063 . . . . 0.0 110.181 -178.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.58 -12.87 63.92 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 125.712 1.625 . . . . 0.0 115.415 178.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -73.51 159.87 32.53 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 119.76 1.78 . . . . 0.0 112.529 174.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.4 m -82.79 76.05 9.66 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.301 1.04 . . . . 0.0 111.749 -179.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -54.21 111.87 3.3 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 125.586 1.554 . . . . 0.0 113.457 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -78.18 113.09 3.34 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 123.241 2.627 . . . . 0.0 111.954 -176.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.7 p -76.4 -25.1 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.002 0.921 . . . . 0.0 113.171 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 pmtp? -66.74 168.16 10.02 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.101 1.36 . . . . 0.0 113.798 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -167.71 166.56 39.44 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.6 1.572 . . . . 0.0 112.566 174.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 16.0 tp -146.75 74.04 1.34 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.744 1.217 . . . . 0.0 110.987 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 76.2 m -63.68 165.56 8.13 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.474 1.11 . . . . 0.0 112.375 176.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm 60.13 -0.91 0.21 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.177 2.591 . . . . 0.0 116.505 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.18 160.4 26.96 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.023 1.329 . . . . 0.0 113.121 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 53.9 ptt85 -80.95 -0.74 40.71 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.276 1.43 . . . . 0.0 114.81 176.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -137.33 137.24 38.73 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 127.073 2.149 . . . . 0.0 109.781 -176.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 10.5 m -141.65 144.53 34.19 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 126.664 1.985 . . . . 0.0 110.098 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -123.66 157.02 34.77 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.504 1.521 . . . . 0.0 110.547 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -143.95 137.89 28.1 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.895 0.878 . . . . 0.0 111.217 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -141.0 131.33 25.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.467 1.107 . . . . 0.0 111.541 -177.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 15.2 t -77.47 126.32 30.72 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.018 0.927 . . . . 0.0 111.911 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 96.6 mmm -108.7 0.3 20.48 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.191 1.397 . . . . 0.0 113.828 -174.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.39 -78.37 0.14 Allowed Glycine 0 CA--C 1.528 0.876 0 C-N-CA 125.33 1.443 . . . . 0.0 111.79 176.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -115.11 -1.04 13.12 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.017 1.327 . . . . 0.0 113.567 177.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 38.7 t -149.07 156.4 42.17 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.252 1.821 . . . . 0.0 110.038 -176.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.2 p -119.87 103.93 9.76 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.34 1.056 . . . . 0.0 113.005 176.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 16.8 ttmt -70.52 165.97 21.55 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.245 1.018 . . . . 0.0 111.408 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.0 p -77.37 139.04 19.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.756 1.222 . . . . 0.0 111.647 168.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -138.74 172.17 13.26 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.722 2.009 . . . . 0.0 110.335 173.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.6 mp0 -134.44 123.66 24.38 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.906 1.282 . . . . 0.0 110.665 -173.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.06 173.26 49.67 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.627 1.108 . . . . 0.0 113.322 -170.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 75.9 m -82.91 85.72 7.08 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.466 1.106 . . . . 0.0 111.527 -177.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -73.95 93.91 2.27 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.116 0.966 . . . . 0.0 110.508 174.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 59.6 p 54.29 -0.65 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 128.972 2.909 . . . . 0.0 117.972 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.64 153.67 30.32 Favored Glycine 0 CA--C 1.538 1.494 0 C-N-CA 127.247 2.356 . . . . 0.0 113.359 -177.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 166.61 -86.76 0.1 OUTLIER Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.333 0.968 . . . . 0.0 113.376 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -132.65 162.76 30.52 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.319 1.448 . . . . 0.0 112.371 -175.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 74.0 m -126.59 -3.88 6.61 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -137.98 147.83 44.61 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.262 1.825 . . . . 0.0 110.306 172.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 32.7 ttm -62.52 -32.29 73.2 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 122.62 0.368 . . . . 0.0 111.934 177.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -58.72 -33.75 74.11 Favored Glycine 0 CA--C 1.533 1.163 0 O-C-N 121.446 -0.783 . . . . 0.0 114.126 175.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -72.41 -50.34 27.09 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 118.434 1.117 . . . . 0.0 111.799 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.3 p -65.5 -30.07 70.8 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.37 -58.63 3.34 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.706 1.202 . . . . 0.0 112.192 173.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -60.68 -30.05 69.69 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -171.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 -82.27 -22.57 35.69 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.194 0.998 . . . . 0.0 113.57 177.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.2 m -97.03 168.66 9.9 Favored Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 125.717 1.607 . . . . 0.0 112.208 176.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -78.71 -7.44 15.65 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.017 2.478 . . . . 0.0 114.617 -177.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.29 0 C-N-CA 126.264 1.888 . . . . 0.0 113.862 -178.401 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.429 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -151.48 165.36 34.42 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.066 1.746 . . . . 0.0 111.783 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -84.57 102.62 13.02 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.066 1.346 . . . . 0.0 111.413 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.1 -5.16 38.01 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.498 1.519 . . . . 0.0 114.178 178.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -134.22 163.64 29.16 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 126.346 1.858 . . . . 0.0 112.987 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.1 m -61.81 128.42 36.13 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.751 1.22 . . . . 0.0 111.953 170.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.6 t -145.66 164.92 30.25 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.161 1.384 . . . . 0.0 111.243 171.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.4 m -71.72 154.9 92.83 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 125.46 1.504 . . . . 0.0 112.546 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -69.94 155.64 64.85 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.906 2.404 . . . . 0.0 110.662 174.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 72.9 mt -61.28 134.98 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 123.86 0.864 . . . . 0.0 110.634 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.04 51.17 47.2 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.032 1.301 . . . . 0.0 114.006 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 37.7 p90 -76.65 -177.76 4.41 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.808 1.643 . . . . 0.0 112.528 177.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.9 m -133.54 93.09 3.08 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.473 1.909 . . . . 0.0 110.142 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -57.32 115.78 11.73 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 124.536 1.134 . . . . 0.0 113.629 -173.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.6 105.81 2.13 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.649 2.899 . . . . 0.0 111.651 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.6 t -130.64 75.76 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.126 1.37 . . . . 0.0 109.622 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -149.82 176.11 11.02 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.825 2.05 . . . . 0.0 111.656 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 60.15 65.67 3.23 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 124.58 1.086 . . . . 0.0 114.146 172.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.408 ' H ' HD23 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -62.26 -3.76 1.48 Allowed 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 116.492 2.034 . . . . 0.0 116.492 -177.651 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 67.1 m -61.17 164.26 5.42 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.952 1.701 . . . . 0.0 113.526 177.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -127.55 74.98 1.56 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 125.79 1.636 . . . . 0.0 111.638 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.94 165.9 16.8 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.87 0.868 . . . . 0.0 112.378 172.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -77.83 1.47 20.22 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 125.623 1.569 . . . . 0.0 114.12 176.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -143.2 164.67 29.55 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.746 2.818 . . . . 0.0 108.398 175.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.1 m -132.98 151.91 52.01 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 126.281 1.832 . . . . 0.0 110.479 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -85.24 150.69 24.62 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.752 1.221 . . . . 0.0 112.151 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -132.95 129.28 38.06 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.527 1.131 . . . . 0.0 110.935 -177.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -125.87 130.62 51.71 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.259 1.024 . . . . 0.0 111.707 -172.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.7 t -70.15 119.16 13.93 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 122.99 0.516 . . . . 0.0 111.116 171.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 81.8 mmm -118.05 94.37 4.48 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.293 1.837 . . . . 0.0 109.086 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.74 -65.07 4.19 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 124.728 1.156 . . . . 0.0 113.678 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -133.97 -59.76 0.83 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.376 1.47 . . . . 0.0 112.043 -172.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.5 p -96.91 168.17 10.64 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.198 1.799 . . . . 0.0 111.458 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 14.3 p -109.49 150.25 28.4 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 172.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 23.0 mtpt -133.34 162.6 31.39 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.973 1.709 . . . . 0.0 112.684 -175.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 9.4 p -78.86 126.29 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 125.884 1.673 . . . . 0.0 111.724 177.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -145.98 103.4 3.74 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.191 0.996 . . . . 0.0 111.308 -178.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -62.88 111.69 2.25 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.044 1.338 . . . . 0.0 110.826 172.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.47 -156.88 26.94 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.096 0.855 . . . . 0.0 113.863 -175.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 78.0 m -134.31 114.65 13.21 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 127.048 2.139 . . . . 0.0 109.959 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -124.94 92.14 3.58 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.661 1.985 . . . . 0.0 109.329 -178.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 1.8 m 50.07 35.94 11.01 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.589 1.955 . . . . 0.0 114.19 174.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 71.08 23.0 78.53 Favored Glycine 0 CA--C 1.539 1.567 0 O-C-N 120.865 -1.147 . . . . 0.0 115.678 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.99 174.26 5.74 Favored Glycine 0 CA--C 1.542 1.757 0 C-N-CA 125.232 1.396 . . . . 0.0 116.184 -176.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -62.87 139.32 58.72 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 -159.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.5 m -74.64 -19.04 60.45 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.904 1.681 . . . . 0.0 114.828 176.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -137.96 154.66 49.36 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.247 1.819 . . . . 0.0 112.061 -176.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 49.3 ttm -75.48 -29.79 59.69 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -176.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -65.15 -29.54 75.59 Favored Glycine 0 CA--C 1.533 1.184 0 O-C-N 121.385 -0.822 . . . . 0.0 113.047 174.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -74.52 -48.33 27.68 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.874 1.67 . . . . 0.0 111.838 173.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 14.9 p -66.27 -25.98 67.13 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 119.284 0.947 . . . . 0.0 113.426 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.09 -59.16 2.85 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.377 1.471 . . . . 0.0 111.791 173.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 -61.92 -28.3 69.43 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 -172.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 63.1 m-80 -78.57 -6.7 56.26 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.461 1.104 . . . . 0.0 113.765 175.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -129.16 168.69 15.24 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 125.845 1.658 . . . . 0.0 113.346 -175.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -74.52 -19.25 19.29 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 122.756 2.304 . . . . 0.0 113.555 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.657 1.599 . . . . 0.0 114.287 -179.391 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.548 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -73.48 157.66 36.39 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.318 1.047 . . . . 0.0 112.522 177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.5 mtpp -127.42 145.44 50.82 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.165 1.786 . . . . 0.0 111.669 178.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -91.62 87.81 6.49 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.07 1.348 . . . . 0.0 110.977 179.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -106.8 -44.61 4.4 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.372 1.069 . . . . 0.0 112.908 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 17.7 t -73.82 94.87 2.33 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.113 0.965 . . . . 0.0 110.452 167.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.5 p -80.99 175.18 10.91 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.259 1.424 . . . . 0.0 111.843 170.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.9 t -118.66 134.62 23.51 Favored Pre-proline 0 N--CA 1.478 0.94 0 C-N-CA 125.357 1.463 . . . . 0.0 109.866 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -78.05 -170.37 0.95 Allowed 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 124.685 3.59 . . . . 0.0 112.614 178.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.1 pt -55.24 165.39 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 126.341 1.856 . . . . 0.0 114.021 175.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.06 -61.23 4.76 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.803 1.668 . . . . 0.0 111.936 -178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 4.7 m-90 -78.45 -179.45 6.35 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.057 1.343 . . . . 0.0 112.85 170.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.7 t -145.45 177.06 9.13 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.211 1.804 . . . . 0.0 110.201 164.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -84.87 112.31 41.97 Favored Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 125.062 1.345 . . . . 0.0 112.15 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.05 122.6 8.57 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 123.61 2.873 . . . . 0.0 112.542 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.5 p -78.89 -25.33 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 C-N-CA 124.405 1.082 . . . . 0.0 113.414 174.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -66.9 154.99 39.63 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.458 1.503 . . . . 0.0 112.663 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.6 50.96 0.04 OUTLIER Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.933 1.254 . . . . 0.0 114.445 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.87 60.71 2.35 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.245 1.418 . . . . 0.0 111.991 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 83.3 m -117.44 155.57 29.45 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.224 1.81 . . . . 0.0 111.661 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.43 24.9 1.9 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.752 1.621 . . . . 0.0 113.944 -171.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.51 168.71 13.26 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.852 1.661 . . . . 0.0 112.279 178.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 41.0 ptt180 -73.38 0.99 10.58 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 126.526 1.93 . . . . 0.0 115.787 -178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -84.72 83.23 8.1 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.6 1.56 . . . . 0.0 111.987 -173.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.51 156.98 44.76 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.584 1.554 . . . . 0.0 111.317 -173.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 24.3 ttp180 -145.54 162.64 36.95 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.742 1.217 . . . . 0.0 111.77 -176.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -123.28 111.58 16.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.284 1.034 . . . . 0.0 111.377 -167.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -108.8 122.73 47.79 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.763 0.825 . . . . 0.0 111.729 -171.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.4 t -69.77 111.72 5.72 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.939 1.296 . . . . 0.0 111.4 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 57.7 mtp -138.26 84.35 2.03 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.943 2.097 . . . . 0.0 110.394 -175.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.4 64.01 1.41 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.245 0.926 . . . . 0.0 114.111 175.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 56.74 22.93 7.37 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 126.331 1.853 . . . . 0.0 114.485 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 9.8 t -149.48 153.0 36.57 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 128.479 2.711 . . . . 0.0 108.102 172.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 7.1 p -114.51 121.55 43.84 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.026 0.931 . . . . 0.0 111.497 165.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -100.44 160.92 13.96 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.582 1.553 . . . . 0.0 111.039 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.7 p -74.76 129.05 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 123.629 0.772 . . . . 0.0 110.834 166.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -134.94 149.33 50.22 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.693 0.797 . . . . 0.0 111.597 171.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -88.47 154.7 20.15 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.685 1.194 . . . . 0.0 110.928 173.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.26 -176.84 33.64 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-O 122.21 0.894 . . . . 0.0 114.81 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 65.3 m -94.82 23.09 5.74 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.335 1.454 . . . . 0.0 114.504 -171.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -40.18 -44.37 1.83 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 127.019 2.128 . . . . 0.0 115.419 -170.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 98.0 m -155.28 82.65 1.06 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.857 1.663 . . . . 0.0 109.224 174.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -51.72 101.99 0.07 OUTLIER Glycine 0 CA--C 1.54 1.636 0 C-N-CA 125.526 1.536 . . . . 0.0 114.862 -176.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -126.74 -90.31 0.74 Allowed Glycine 0 CA--C 1.534 1.259 0 C-N-CA 125.764 1.65 . . . . 0.0 114.008 -175.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -121.77 116.69 24.95 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.641 1.177 . . . . 0.0 113.234 -164.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.7 m -84.71 -2.34 57.44 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -127.96 139.14 52.75 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.584 1.554 . . . . 0.0 111.378 174.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 38.9 ttm -69.45 -26.41 64.58 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -178.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.61 -33.69 72.1 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 121.798 -0.564 . . . . 0.0 112.96 172.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -74.19 -48.0 31.9 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.068 0.947 . . . . 0.0 111.835 173.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 8.6 p -63.79 -24.24 67.68 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -177.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.36 -65.38 0.93 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.661 1.584 . . . . 0.0 112.226 168.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.4 ptp180 -61.46 -28.7 69.47 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -168.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -84.11 -5.99 59.33 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.142 0.977 . . . . 0.0 113.474 177.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.45 169.84 6.35 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 126.373 1.869 . . . . 0.0 112.257 177.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -77.59 -8.81 17.2 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.056 2.504 . . . . 0.0 113.765 -178.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.311 0 C-N-CA 127.57 2.51 . . . . 0.0 112.615 177.424 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.523 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -82.61 104.36 12.82 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.776 1.23 . . . . 0.0 112.522 -175.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -65.03 -30.87 71.88 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.015 1.326 . . . . 0.0 113.919 -178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.1 tp10 -82.52 113.82 20.51 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.599 1.56 . . . . 0.0 110.778 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -142.05 166.98 23.22 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.731 1.213 . . . . 0.0 112.894 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 71.8 m -65.03 134.58 54.17 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.712 0.805 . . . . 0.0 111.473 173.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 47.7 p -129.46 173.43 10.57 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.934 1.694 . . . . 0.0 111.287 177.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.6 t -58.18 134.74 84.49 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 124.39 1.076 . . . . 0.0 110.863 -179.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -65.92 155.94 66.86 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 124.488 3.459 . . . . 0.0 112.658 178.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 37.1 pt -57.37 135.42 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.738 0.815 . . . . 0.0 112.368 -178.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.47 -13.45 22.12 Favored Glycine 0 CA--C 1.539 1.578 0 C-N-CA 125.451 1.5 . . . . 0.0 116.075 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -75.55 146.06 40.77 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 119.833 1.816 . . . . 0.0 112.252 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.0 t -90.93 96.12 10.47 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.445 1.098 . . . . 0.0 111.717 -175.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -57.72 142.99 77.26 Favored Pre-proline 0 CA--C 1.554 1.109 0 C-N-CA 124.611 1.164 . . . . 0.0 113.791 -176.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -79.47 81.0 2.9 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.913 3.075 . . . . 0.0 112.677 -171.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 8.9 p -61.07 -28.4 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 125.169 1.388 . . . . 0.0 113.114 -178.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -83.08 -4.91 58.85 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.083 2.153 . . . . 0.0 114.576 176.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -88.3 -139.35 6.58 Favored Glycine 0 CA--C 1.536 1.377 0 C-N-CA 125.365 1.459 . . . . 0.0 112.789 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 26.5 mt 65.22 11.21 7.05 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 127.051 2.14 . . . . 0.0 115.419 173.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 16.7 t -73.45 150.73 41.44 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.04 1.336 . . . . 0.0 112.777 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.6 37.87 0.36 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.958 2.503 . . . . 0.0 113.593 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.16 159.7 25.71 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.107 -0.996 . . . . 0.0 113.088 179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 16.5 ptm180 -86.03 0.38 53.52 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.703 1.601 . . . . 0.0 114.88 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -144.26 122.24 12.07 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.183 2.193 . . . . 0.0 109.705 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.457 HG22 ' H ' ' A' ' 44' ' ' ARG . 1.9 m -148.31 167.57 24.83 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.969 1.308 . . . . 0.0 111.445 179.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.457 ' H ' HG22 ' A' ' 43' ' ' THR . 17.0 ttm180 -129.61 159.95 34.79 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.707 1.603 . . . . 0.0 111.513 -176.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -126.63 103.74 7.73 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.942 0.897 . . . . 0.0 111.953 -166.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -103.76 122.54 45.29 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.89 0.876 . . . . 0.0 112.346 -169.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.8 t -71.18 103.93 2.93 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.371 1.068 . . . . 0.0 110.794 171.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.1 ppp? -136.07 111.21 8.96 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.499 1.92 . . . . 0.0 110.944 -177.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.46 53.78 5.37 Favored Glycine 0 CA--C 1.536 1.391 0 C-N-CA 123.945 0.783 . . . . 0.0 112.8 -170.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 63.24 -11.0 0.1 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 129.328 3.051 . . . . 0.0 116.896 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 48.4 t -126.9 158.24 37.28 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.884 2.074 . . . . 0.0 110.213 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.9 p -108.2 150.76 26.83 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 174.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 14.3 ttpt -141.35 169.47 17.54 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.017 1.327 . . . . 0.0 111.798 172.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.26 126.16 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.006 1.322 . . . . 0.0 111.406 171.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -144.2 165.08 28.84 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.232 1.413 . . . . 0.0 111.217 174.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -126.49 104.79 8.33 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.037 1.335 . . . . 0.0 110.603 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 160.94 -178.31 36.96 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 125.466 1.508 . . . . 0.0 111.932 -176.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 77.8 m -99.36 103.35 15.15 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.625 1.17 . . . . 0.0 111.167 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -121.7 86.9 2.66 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.969 1.308 . . . . 0.0 110.402 -178.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . 0.264 1.3 t 49.43 14.67 0.11 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 129.012 2.925 . . . . 0.0 117.182 174.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 76.88 33.72 45.17 Favored Glycine 0 CA--C 1.537 1.426 0 O-C-N 120.302 -1.499 . . . . 0.0 114.241 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.37 176.24 6.58 Favored Glycine 0 CA--C 1.543 1.812 0 C-N-CA 124.923 1.249 . . . . 0.0 115.564 178.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 23.6 m-85 -70.07 147.59 49.84 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -162.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -89.38 -30.04 18.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.656 1.182 . . . . 0.0 113.158 174.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -91.17 135.51 33.73 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.84 1.256 . . . . 0.0 111.651 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 38.1 ttm -69.09 -25.32 64.37 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.432 0.693 . . . . 0.0 112.551 176.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -66.35 -46.86 75.23 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.585 0.612 . . . . 0.0 111.967 171.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -62.25 -47.05 86.07 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.149 0.98 . . . . 0.0 112.553 176.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.2 p -65.32 -23.48 67.02 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.67 -67.47 0.76 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.0 1.32 . . . . 0.0 111.643 168.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -62.08 -26.3 68.2 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 -168.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -86.05 -4.86 59.26 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.024 0.93 . . . . 0.0 113.381 175.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.37 166.5 10.85 Favored Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 126.174 1.79 . . . . 0.0 112.077 176.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -77.86 -8.76 16.87 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.217 2.612 . . . . 0.0 114.426 -175.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.231 0 C-N-CA 126.493 1.997 . . . . 0.0 114.714 179.459 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.476 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -149.33 153.45 37.48 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.417 1.487 . . . . 0.0 110.843 173.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.1 tptm 49.3 29.78 2.87 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 126.914 2.086 . . . . 0.0 114.218 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -66.28 108.84 2.45 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.674 1.99 . . . . 0.0 113.081 -173.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -80.94 -17.24 51.16 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.387 1.254 . . . . 0.0 114.387 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 4.9 t -69.39 149.94 47.83 Favored 'General case' 0 CA--C 1.546 0.823 0 CA-C-N 119.175 0.898 . . . . 0.0 112.842 -177.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 45.9 p -131.52 166.6 21.01 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.316 1.846 . . . . 0.0 112.15 -177.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.6 m -69.82 155.08 94.1 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.345 1.058 . . . . 0.0 112.341 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.7 156.14 67.22 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.934 2.423 . . . . 0.0 111.777 173.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 74.4 mt -66.92 136.15 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.034 0.934 . . . . 0.0 110.049 -178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.26 -0.84 83.17 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 125.216 1.388 . . . . 0.0 115.746 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.91 174.99 7.0 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.135 1.467 . . . . 0.0 112.693 175.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.9 t -128.31 92.23 3.4 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.926 1.29 . . . . 0.0 111.033 -179.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.59 148.48 90.73 Favored Pre-proline 0 CA--C 1.552 1.03 0 C-N-CA 124.85 1.26 . . . . 0.0 113.798 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.442 ' HG2' ' CD1' ' A' ' 55' ' ' TYR . 69.0 Cg_endo -70.98 169.33 20.73 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.762 2.975 . . . . 0.0 113.336 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.8 t -108.57 94.96 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.075 1.75 . . . . 0.0 109.366 -172.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.19 172.27 7.01 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 127.111 2.164 . . . . 0.0 112.831 -175.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 153.1 -18.85 0.73 Allowed Glycine 0 CA--C 1.536 1.364 0 N-CA-C 115.916 1.126 . . . . 0.0 115.916 173.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.8 mp -80.83 61.78 4.6 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 119.171 1.486 . . . . 0.0 110.941 178.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.7 t -71.19 3.22 3.73 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 126.564 1.946 . . . . 0.0 114.189 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -65.42 -21.88 66.71 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 126.318 1.847 . . . . 0.0 113.884 177.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.24 168.81 11.59 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.491 1.117 . . . . 0.0 112.772 171.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -115.03 17.11 16.98 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 126.214 1.805 . . . . 0.0 113.732 177.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -138.26 123.38 19.16 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.543 2.337 . . . . 0.0 109.679 -178.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.6 m -137.27 164.23 29.05 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.526 1.931 . . . . 0.0 110.149 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 20.4 ptp180 -133.5 171.7 13.73 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.675 1.19 . . . . 0.0 112.835 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -136.72 110.36 8.05 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.938 1.295 . . . . 0.0 110.394 -163.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -99.02 134.62 41.59 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.184 0.994 . . . . 0.0 111.219 -179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.9 t -69.14 128.44 36.66 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.924 -0.485 . . . . 0.0 110.947 171.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 98.7 mmm -114.68 81.55 1.58 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.581 1.952 . . . . 0.0 109.78 176.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.43 -62.42 4.08 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.304 1.43 . . . . 0.0 114.087 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -133.32 -53.83 0.9 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.296 1.439 . . . . 0.0 112.647 -179.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 14.6 p -76.02 176.3 8.07 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.535 1.134 . . . . 0.0 111.335 171.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.23 163.27 16.23 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.261 -0.899 . . . . 0.0 111.617 161.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -134.22 154.81 51.04 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.441 1.496 . . . . 0.0 112.042 175.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 p -82.26 130.17 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.54 1.136 . . . . 0.0 112.52 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.442 ' CD1' ' HG2' ' A' ' 33' ' ' PRO . 68.1 m-85 -145.06 170.34 16.37 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.349 1.46 . . . . 0.0 111.579 173.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -124.57 161.03 27.05 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.102 1.361 . . . . 0.0 112.082 -169.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 70.74 177.64 24.39 Favored Glycine 0 CA--C 1.538 1.524 0 C-N-CA 124.843 1.211 . . . . 0.0 114.324 -177.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 27.3 t -81.83 80.81 8.04 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 121.521 -0.988 . . . . 0.0 111.184 175.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -84.01 76.46 10.05 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 122.167 0.984 . . . . 0.0 110.511 171.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 4.6 m 60.82 32.07 20.09 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.926 1.29 . . . . 0.0 112.861 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.47 -85.34 0.84 Allowed Glycine 0 CA--C 1.531 1.078 0 C-N-CA 125.799 1.666 . . . . 0.0 113.319 178.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 59.24 -131.63 51.73 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.811 1.672 . . . . 0.0 113.744 -176.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -100.52 163.92 12.14 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.775 1.23 . . . . 0.0 112.133 -176.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.0 m -129.12 -0.7 5.19 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.771 1.228 . . . . 0.0 114.112 -178.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -143.4 162.16 36.5 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.697 1.599 . . . . 0.0 112.833 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.7 -42.5 95.26 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.205 1.802 . . . . 0.0 111.286 177.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.14 -25.67 75.25 Favored Glycine 0 CA--C 1.534 1.263 0 O-C-N 121.493 -0.755 . . . . 0.0 114.155 175.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -74.26 -46.71 39.68 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 119.006 1.403 . . . . 0.0 112.037 175.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.7 p -61.14 -31.45 71.16 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.69 -0.631 . . . . 0.0 112.339 176.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.07 -53.47 6.38 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.999 1.72 . . . . 0.0 113.05 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -58.77 -28.17 65.67 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 120.203 1.365 . . . . 0.0 114.385 -174.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -84.08 -6.28 59.38 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.086 1.354 . . . . 0.0 113.858 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 2.0 m -129.85 162.97 50.31 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 125.197 1.399 . . . . 0.0 114.311 -172.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.98 -9.82 14.14 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.468 2.779 . . . . 0.0 114.943 -175.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.41 0 C-N-CA 125.816 1.674 . . . . 0.0 114.593 -177.685 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.528 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -131.0 0.76 4.24 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -161.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -71.37 159.51 34.42 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.218 1.407 . . . . 0.0 112.054 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -72.84 161.76 30.32 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.431 1.093 . . . . 0.0 112.081 170.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -140.28 139.2 35.47 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.519 1.528 . . . . 0.0 111.13 177.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 75.3 m -80.69 170.55 16.17 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 123.754 0.821 . . . . 0.0 112.174 170.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.9 p -135.36 159.6 41.06 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.462 1.505 . . . . 0.0 111.541 168.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.0 p -79.9 130.67 66.09 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 124.701 1.2 . . . . 0.0 110.997 176.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.46 141.43 42.37 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 122.457 2.105 . . . . 0.0 110.993 171.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 34.1 pt -56.68 134.67 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.551 0.74 . . . . 0.0 112.336 -178.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 100.7 -8.01 57.95 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 125.388 1.47 . . . . 0.0 115.53 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 24.6 t-105 -77.75 152.85 33.4 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 119.728 1.764 . . . . 0.0 110.12 168.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.5 t -78.24 72.58 4.78 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-O 122.564 1.173 . . . . 0.0 112.178 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -66.79 154.52 91.69 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 125.67 1.588 . . . . 0.0 114.022 -178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -76.26 150.8 33.33 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 123.09 2.527 . . . . 0.0 111.627 175.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.5 t -136.84 76.86 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.099 1.36 . . . . 0.0 109.813 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.71 -28.57 0.43 Allowed 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 116.143 1.905 . . . . 0.0 116.143 -177.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 141.3 -169.61 24.99 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.16 0.886 . . . . 0.0 113.169 -165.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 98.0 mt -134.75 113.46 11.67 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.311 2.244 . . . . 0.0 108.404 177.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 63.1 m 61.4 29.3 18.43 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.437 1.895 . . . . 0.0 114.628 177.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -53.49 -53.57 49.56 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 126.123 1.769 . . . . 0.0 112.57 175.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.26 169.31 10.48 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.091 1.356 . . . . 0.0 112.19 174.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -108.49 5.07 24.87 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 126.348 1.859 . . . . 0.0 114.592 -178.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -143.48 102.81 4.01 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.751 2.02 . . . . 0.0 110.85 -176.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.467 HG21 HG22 ' A' ' 54' ' ' VAL . 23.3 m -150.36 155.38 39.51 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 120.806 -1.184 . . . . 0.0 111.51 -177.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -77.71 160.99 28.08 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.771 1.228 . . . . 0.0 112.673 173.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -131.58 107.67 9.01 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.911 1.285 . . . . 0.0 110.759 -174.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -114.6 122.26 45.96 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.959 1.304 . . . . 0.0 112.462 -168.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 35.3 t -67.64 122.7 18.62 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.279 1.032 . . . . 0.0 112.008 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.34 -10.6 1.24 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 -171.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 169.23 70.97 0.03 OUTLIER Glycine 0 N--CA 1.47 0.921 0 O-C-N 121.498 -0.751 . . . . 0.0 111.84 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.7 m120 60.83 1.86 0.48 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 127.953 2.501 . . . . 0.0 116.253 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 79.8 m -132.14 160.44 36.03 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.121 1.768 . . . . 0.0 110.158 163.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.7 p -101.26 91.22 4.41 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.93 1.292 . . . . 0.0 111.13 167.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -67.64 154.25 41.89 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.727 1.611 . . . . 0.0 112.319 -176.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.467 HG22 HG21 ' A' ' 43' ' ' THR . 8.9 p -66.64 121.49 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 125.425 1.49 . . . . 0.0 112.351 172.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -140.05 122.48 16.09 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 125.451 1.5 . . . . 0.0 111.796 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -74.33 150.68 40.02 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.491 0.716 . . . . 0.0 112.02 171.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.8 174.65 13.41 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.138 1.352 . . . . 0.0 115.417 176.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 17.6 p -80.33 39.08 0.44 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 126.513 1.925 . . . . 0.0 114.14 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -51.51 -34.91 38.11 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.196 1.398 . . . . 0.0 113.522 178.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.1 t -144.05 -23.86 0.56 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 169.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 75.63 15.0 81.54 Favored Glycine 0 CA--C 1.539 1.537 0 O-C-N 120.908 -1.12 . . . . 0.0 115.675 171.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -54.26 -68.63 1.56 Allowed Glycine 0 CA--C 1.535 1.33 0 C-N-CA 126.054 1.787 . . . . 0.0 115.073 -174.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 46.3 m-85 -140.31 151.14 44.82 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.889 1.276 . . . . 0.0 112.525 -172.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.8 m -117.89 0.84 12.01 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.341 1.456 . . . . 0.0 114.499 -177.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -135.96 144.77 45.59 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.193 1.797 . . . . 0.0 110.771 174.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -62.91 -35.58 80.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.873 0.869 . . . . 0.0 111.755 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -72.75 -11.34 77.72 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.356 0.979 . . . . 0.0 114.925 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -96.16 -37.7 10.46 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.986 1.393 . . . . 0.0 112.099 176.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 29.7 p -70.79 -45.91 63.82 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.194 -0.941 . . . . 0.0 112.005 171.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.21 -12.48 61.19 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -177.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -85.33 -25.53 27.09 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 119.821 1.192 . . . . 0.0 113.626 168.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -91.47 -29.0 17.26 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.844 1.258 . . . . 0.0 112.995 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.3 m -106.53 165.41 13.0 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 126.009 1.724 . . . . 0.0 112.68 175.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -79.12 -4.92 14.18 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.049 2.5 . . . . 0.0 114.775 -171.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.333 0 C-N-CA 126.823 2.154 . . . . 0.0 115.236 -178.737 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.525 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -140.78 171.0 14.71 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.921 1.688 . . . . 0.0 111.248 -174.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm 48.15 47.06 19.56 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.317 1.847 . . . . 0.0 113.188 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -60.9 -34.07 74.09 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.801 1.641 . . . . 0.0 113.328 -177.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -106.13 157.71 17.35 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.624 1.57 . . . . 0.0 110.851 169.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 35.8 t -140.27 143.45 35.93 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.936 1.294 . . . . 0.0 111.149 177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.4 m -132.79 146.03 51.49 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.445 1.498 . . . . 0.0 110.937 -168.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.1 m -100.49 155.94 35.79 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 125.037 1.335 . . . . 0.0 112.822 -173.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.3 157.06 62.68 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 123.436 2.757 . . . . 0.0 112.435 172.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.461 HD12 ' H ' ' A' ' 28' ' ' ILE . 5.4 mp -66.06 137.22 25.31 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.832 1.253 . . . . 0.0 110.385 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.31 -4.56 67.04 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 125.549 1.547 . . . . 0.0 115.781 176.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -74.03 172.66 11.26 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 118.826 1.313 . . . . 0.0 113.048 177.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -115.77 80.75 1.49 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.127 1.371 . . . . 0.0 111.53 -175.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -67.96 155.04 92.74 Favored Pre-proline 0 CA--C 1.554 1.098 0 C-N-CA 125.275 1.43 . . . . 0.0 114.176 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.24 168.27 25.02 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 124.025 3.15 . . . . 0.0 112.594 174.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.3 t -130.54 10.85 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 125.216 1.406 . . . . 0.0 112.706 -174.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -131.12 170.16 14.91 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.575 1.95 . . . . 0.0 112.252 -179.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -165.69 31.55 0.22 Allowed Glycine 0 CA--C 1.538 1.492 0 C-N-CA 124.988 1.28 . . . . 0.0 115.053 -177.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.6 mp -90.14 85.18 6.21 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.442 1.497 . . . . 0.0 110.735 -175.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 77.0 m -68.3 77.39 0.26 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.711 1.604 . . . . 0.0 112.9 176.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? -129.86 73.26 1.52 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.571 2.348 . . . . 0.0 110.88 -176.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . 46.33 42.47 10.48 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.407 1.883 . . . . 0.0 114.659 -179.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -74.05 -30.31 62.34 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.146 1.378 . . . . 0.0 113.088 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 50.81 26.57 2.65 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.897 2.079 . . . . 0.0 114.589 -175.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 68.1 m -60.03 152.67 23.38 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 127.749 2.42 . . . . 0.0 113.026 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.6 152.21 45.68 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.378 1.471 . . . . 0.0 112.028 176.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -129.6 144.89 51.48 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.84 1.256 . . . . 0.0 111.366 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -143.78 139.91 29.63 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.304 1.442 . . . . 0.0 110.722 178.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 38.0 t -89.95 123.18 33.65 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.878 0.871 . . . . 0.0 111.981 173.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 29.5 mtt -79.25 -12.84 59.96 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 175.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 154.46 -39.72 0.65 Allowed Glycine 0 N--CA 1.475 1.288 0 CA-C-N 119.293 0.951 . . . . 0.0 114.974 171.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -126.61 -12.06 6.11 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 174.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 25.8 p -151.91 163.43 39.26 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.878 2.071 . . . . 0.0 110.284 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 2.4 p -119.57 151.34 38.8 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.37 1.068 . . . . 0.0 112.68 176.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -122.53 178.89 4.79 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.795 1.638 . . . . 0.0 111.668 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.1 p -115.09 122.56 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.636 1.974 . . . . 0.0 110.806 -174.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -129.33 116.69 19.46 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.133 1.373 . . . . 0.0 111.068 -169.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -57.62 117.97 4.75 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.34 1.456 . . . . 0.0 112.972 -176.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.42 173.52 49.86 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 125.387 1.47 . . . . 0.0 114.478 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 76.4 m -78.38 84.4 4.55 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.443 -1.033 . . . . 0.0 111.159 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -50.25 -50.66 49.37 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.453 1.501 . . . . 0.0 112.703 -178.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 90.6 m -136.89 -44.68 0.58 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 126.08 1.752 . . . . 0.0 111.723 169.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 132.5 56.82 0.08 OUTLIER Glycine 0 CA--C 1.536 1.367 0 C-N-CA 126.409 1.957 . . . . 0.0 112.636 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -81.09 -92.62 0.5 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.826 1.203 . . . . 0.0 113.745 -173.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -110.93 158.18 19.05 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.578 1.151 . . . . 0.0 112.6 -174.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.8 t -102.7 -30.29 10.99 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.594 1.958 . . . . 0.0 111.87 174.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 37.4 mmt180 -132.3 151.09 52.0 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.319 1.848 . . . . 0.0 111.589 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 48.8 ttm -66.93 -19.01 65.65 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.54 0.736 . . . . 0.0 112.926 177.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -62.61 -16.35 55.38 Favored Glycine 0 CA--C 1.539 1.548 0 O-C-N 121.149 -0.969 . . . . 0.0 114.561 168.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -87.78 -25.5 23.35 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 118.894 1.347 . . . . 0.0 112.761 173.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -61.05 -59.3 5.57 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.392 -0.817 . . . . 0.0 109.752 165.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.84 -12.45 59.17 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -170.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -92.37 -25.19 18.63 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 170.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -90.79 -13.7 33.38 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.946 1.298 . . . . 0.0 113.186 175.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.5 m -129.63 159.17 70.94 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.852 1.661 . . . . 0.0 113.187 -175.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -76.59 -10.39 18.68 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 123.85 3.033 . . . . 0.0 114.63 -176.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 C-N-CA 127.017 2.246 . . . . 0.0 112.276 176.922 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.4 t0 49.9 42.15 23.8 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.514 1.926 . . . . 0.0 114.685 177.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.98 159.95 8.58 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.537 1.535 . . . . 0.0 113.972 177.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -61.26 119.87 9.29 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.54 1.936 . . . . 0.0 113.275 -176.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -85.68 174.6 9.27 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.089 1.356 . . . . 0.0 113.154 173.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 19.6 p -110.47 16.22 21.69 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.952 1.701 . . . . 0.0 114.49 -171.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 3.2 m -16.2 -72.93 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 130.085 3.354 . . . . 0.0 116.378 -163.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.3 m -143.28 151.29 54.64 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 127.195 2.198 . . . . 0.0 111.399 -178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.9 -27.3 7.18 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.575 2.85 . . . . 0.0 113.621 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.2 pt -136.06 -177.62 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.466 2.306 . . . . 0.0 111.014 -178.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.39 41.64 0.3 Allowed Glycine 0 CA--C 1.538 1.507 0 C-N-CA 125.691 1.615 . . . . 0.0 114.248 172.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -59.31 143.52 49.13 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.931 2.092 . . . . 0.0 111.211 175.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.5 t -76.41 85.3 3.16 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.475 1.11 . . . . 0.0 112.116 178.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -63.98 155.74 76.82 Favored Pre-proline 0 CA--C 1.552 1.056 0 C-N-CA 125.155 1.382 . . . . 0.0 113.236 175.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.05 138.75 31.54 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.173 2.582 . . . . 0.0 111.076 174.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.6 t -73.39 -40.11 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.733 0.813 . . . . 0.0 111.141 175.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -69.52 161.32 29.77 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.137 1.375 . . . . 0.0 112.124 174.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 169.0 -126.12 1.34 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.41 1.481 . . . . 0.0 111.274 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 60.9 mt 49.27 45.48 23.43 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.771 1.628 . . . . 0.0 112.479 -177.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 65.9 m -63.22 149.66 44.94 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.964 1.706 . . . . 0.0 112.364 -177.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.97 -5.15 3.12 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.502 1.521 . . . . 0.0 114.804 -177.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.17 168.89 16.26 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.063 0.945 . . . . 0.0 112.144 169.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 15.8 ptm180 -105.62 5.64 31.41 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.563 1.945 . . . . 0.0 113.939 177.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 29.9 p90 -147.3 116.28 6.86 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.119 2.167 . . . . 0.0 110.335 -176.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.0 m -142.16 159.16 42.77 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.994 1.317 . . . . 0.0 110.775 179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -76.92 147.06 37.19 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.538 1.135 . . . . 0.0 111.319 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -132.94 120.55 21.59 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.122 0.969 . . . . 0.0 111.908 -174.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -113.63 122.88 48.54 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.709 1.204 . . . . 0.0 111.567 -175.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 48.7 t -70.95 115.9 10.62 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.937 0.895 . . . . 0.0 110.852 171.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 3.4 mmt -82.23 -16.79 48.34 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 165.99 -45.21 0.27 Allowed Glycine 0 N--CA 1.468 0.792 0 C-N-CA 124.675 1.131 . . . . 0.0 113.22 -173.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -136.55 -62.68 0.65 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.292 1.837 . . . . 0.0 110.471 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -81.13 168.43 18.59 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.3 1.04 . . . . 0.0 111.198 173.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 p -121.88 143.89 49.17 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.182 0.993 . . . . 0.0 112.993 170.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -110.48 148.88 31.19 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.778 1.631 . . . . 0.0 111.578 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 p -69.44 127.51 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 126.465 1.906 . . . . 0.0 112.254 169.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 25.7 m-85 -136.02 129.86 32.66 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.085 1.354 . . . . 0.0 111.013 175.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -65.85 100.55 0.57 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.999 1.32 . . . . 0.0 112.114 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.73 179.63 50.21 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.076 1.322 . . . . 0.0 114.937 176.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 79.4 m -75.19 75.69 2.33 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.044 1.338 . . . . 0.0 112.002 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 46.0 t80 -50.18 -49.78 51.35 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.02 1.728 . . . . 0.0 113.116 177.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 6.4 t -146.93 1.27 0.76 Allowed 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 174.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 111.04 33.54 2.35 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.773 1.178 . . . . 0.0 115.704 173.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.32 -173.67 42.35 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.776 1.655 . . . . 0.0 114.469 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -64.81 148.66 50.84 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.858 1.263 . . . . 0.0 114.108 -173.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.1 t -100.79 -5.43 26.32 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.617 1.567 . . . . 0.0 113.549 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 89.2 mmt-85 -134.84 139.54 45.14 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.314 1.446 . . . . 0.0 111.351 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 47.4 ttm -69.15 -26.32 64.81 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -58.88 -42.81 96.86 Favored Glycine 0 CA--C 1.531 1.042 0 O-C-N 121.946 -0.471 . . . . 0.0 112.589 169.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -70.06 -45.84 66.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.794 0.838 . . . . 0.0 112.968 177.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 12.9 p -66.68 -20.41 65.97 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 119.584 1.084 . . . . 0.0 113.355 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.14 -66.19 0.91 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.58 1.552 . . . . 0.0 111.919 168.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -60.22 -27.75 67.45 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 115.356 1.614 . . . . 0.0 115.356 -168.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -85.48 -3.16 58.77 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.576 1.15 . . . . 0.0 113.253 176.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -122.14 166.29 17.57 Favored Pre-proline 0 CA--C 1.551 1.012 0 C-N-CA 126.858 2.063 . . . . 0.0 112.671 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.71 -8.11 13.48 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.253 2.636 . . . . 0.0 114.838 -176.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.429 0 C-N-CA 125.88 1.705 . . . . 0.0 114.298 -179.53 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.538 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -143.01 166.71 23.9 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.699 1.599 . . . . 0.0 112.797 -176.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -135.3 87.61 2.34 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.383 1.873 . . . . 0.0 110.957 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -85.77 2.18 46.61 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.694 1.198 . . . . 0.0 113.853 175.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -62.18 161.4 11.2 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.635 1.574 . . . . 0.0 113.48 177.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 24.8 t -62.91 120.02 10.53 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.267 1.427 . . . . 0.0 112.697 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 4.9 m -68.39 154.44 41.8 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.548 1.539 . . . . 0.0 111.4 174.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.7 t -111.05 135.78 20.85 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 125.594 1.557 . . . . 0.0 110.803 -173.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.62 165.69 26.67 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.685 3.59 . . . . 0.0 113.546 -177.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 63.2 mt -58.96 140.33 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 125.199 1.399 . . . . 0.0 110.629 177.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.85 25.05 47.13 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 124.143 0.878 . . . . 0.0 114.622 179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -63.02 175.26 0.91 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.293 1.837 . . . . 0.0 115.505 -178.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.7 m -139.74 65.99 1.41 Allowed 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 127.374 2.269 . . . . 0.0 110.45 178.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.8 155.61 69.9 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 124.583 1.153 . . . . 0.0 113.564 177.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -74.78 96.97 1.02 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.724 2.949 . . . . 0.0 113.253 -174.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.5 t -59.97 -43.87 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.316 1.046 . . . . 0.0 111.274 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -76.43 3.66 10.69 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.288 1.835 . . . . 0.0 114.927 173.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.76 -11.44 30.03 Favored Glycine 0 CA--C 1.541 1.698 0 C-N-CA 124.534 1.064 . . . . 0.0 115.531 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.3 mt -66.43 -27.31 67.72 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.525 1.53 . . . . 0.0 113.228 167.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 9.2 t -76.81 165.54 24.57 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.341 1.456 . . . . 0.0 112.077 178.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -118.05 70.87 0.81 Allowed 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 126.228 1.811 . . . . 0.0 110.805 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.36 158.71 19.79 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.428 1.091 . . . . 0.0 112.846 176.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -95.26 9.35 40.11 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.09 1.756 . . . . 0.0 114.577 -177.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -136.17 118.21 15.37 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.467 2.307 . . . . 0.0 110.057 -175.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.64 139.66 47.48 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 121.467 -0.771 . . . . 0.0 110.41 169.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.37 154.24 44.47 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.694 1.197 . . . . 0.0 112.201 -177.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -140.35 130.8 25.36 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.829 1.252 . . . . 0.0 111.069 -164.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -141.12 126.39 18.56 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.323 1.049 . . . . 0.0 111.956 -168.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 18.1 t -75.39 120.1 20.39 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 118.514 0.597 . . . . 0.0 112.303 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 37.5 mtm -135.73 87.11 2.29 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.353 1.461 . . . . 0.0 110.528 171.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.0 68.05 1.26 Allowed Glycine 0 N--CA 1.47 0.945 0 C-N-CA 124.777 1.18 . . . . 0.0 113.479 177.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 66.31 -2.67 0.95 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 127.759 2.424 . . . . 0.0 115.682 175.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.7 p -137.23 151.07 48.31 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.807 2.043 . . . . 0.0 110.4 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.5 p -118.88 93.94 4.27 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.848 0.859 . . . . 0.0 112.72 173.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -67.72 167.02 14.06 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.642 1.177 . . . . 0.0 112.784 170.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 7.2 p -90.21 129.0 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.736 1.614 . . . . 0.0 111.69 175.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -135.17 113.9 11.82 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.091 1.757 . . . . 0.0 110.426 -174.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -71.58 169.23 15.95 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.096 0.959 . . . . 0.0 112.667 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.42 167.39 42.6 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 125.064 1.316 . . . . 0.0 113.557 -176.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 8.8 t -83.47 71.74 10.29 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.489 -1.006 . . . . 0.0 112.157 -177.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -81.94 83.05 7.35 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 121.251 -0.906 . . . . 0.0 110.711 169.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 25.0 m -48.7 -35.08 13.19 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 125.434 1.494 . . . . 0.0 114.828 178.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -81.34 73.11 2.64 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 125.319 1.438 . . . . 0.0 114.948 -171.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 178.85 -115.8 0.5 Allowed Glycine 0 CA--C 1.53 1.0 0 CA-C-N 118.079 0.94 . . . . 0.0 114.257 171.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -129.8 175.61 8.7 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.156 1.382 . . . . 0.0 112.432 -170.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 80.8 p -123.82 -2.94 8.23 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.219 1.407 . . . . 0.0 114.76 178.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -140.06 144.95 37.12 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 126.21 1.804 . . . . 0.0 111.97 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 38.6 tpp -60.67 -31.12 70.37 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.657 1.183 . . . . 0.0 112.202 173.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.94 -14.34 70.5 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.568 1.08 . . . . 0.0 115.296 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -89.97 -43.73 10.36 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 119.051 1.425 . . . . 0.0 111.823 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 18.1 p -67.62 -23.03 65.32 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.42 -61.99 1.57 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.128 1.371 . . . . 0.0 111.845 170.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -62.29 -26.97 68.71 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 -174.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -77.18 -6.61 53.64 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' CYS . . . . . . . . . . . . . 1.1 m -123.43 164.91 25.32 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 126.347 1.859 . . . . 0.0 112.607 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -76.44 -17.59 16.37 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.009 2.473 . . . . 0.0 113.934 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.256 0 C-N-CA 126.081 1.801 . . . . 0.0 114.503 -177.593 . . . . . . . . 0 0 . 1 stop_ save_